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Abstract 
Exploiting the concept that pathogenic and commensal Escherichia coli strains can be 
distinguished on the basis of housekeeping enzymes by MLEE, a panel of 58 virulence 
genes was used to analyse the phylogenetic relationship between commensal E. coli and 
pathogenic E. coli from clinical cases of porcine neonatal and post-weaning diarrhoea 
(PWD).  Of the 58 virulence genes examined, 17 (STb, iha, hlyA, STa, aidA, F18, east1, 
LT, fimH, iroNE.coli, aah, F4, traT, F41, F5, saa and stx2) were able to differentiate between 
the groups of isolates based on Chi-squared analysis. Application of two other statistical 
methods; an agglomerative hierarchical algorithm and principle coordinate analysis (PCO) 
to the isolates resulted in a relational depiction consisting of a branching tree dendrogram 
and point-clustering respectively. In both situations, member clones designated as 
commensals and pathogens were separated from each other. However, commensal and 
neonatal diarrhoea (ND) isolates tended to be more similar to each other and together, more 
different from post-weaning diarrhoea clones. 
 
The observation that individual post-weaning and commensal clones could be segregated 
suggested that a similar approach based on an analysis of many clones from healthy and 
scouring weaners may be able to distinguish pigs on their health status. This was 
successfully tested by analysis of virulence gene profiles of representative subset 
populations of E. coli recovered from individual animal samples using a replicating 
machine to entrap bacteria on hydrophobic grid membrane filters (HGMF). This method 
referred to as population based microbial analysis (PoMA) provided a reliable tool to 
distinguish between clinical, subclinical and healthy pigs.  PoMA was used to determine 
the population virulence gene profile, generating a host profile for each individual pig.  
Using the 58 virulence genes analysed, 13 (LT, aah, aidA, cvaC, STb, STa, bmaE, papC, 
iroNE.coli, papG allele I’, ehxA, cdt & F18) could be used to distinguish between the two 
groups of piglets (based on Chi-squared analysis).  Further statistical analysis to generate a 
cluster dendrogram, and principle coordinate (PCO) analysis revealed segregation of 
XVII 
isolates based on health status (healthy and scouring separated into different groupings).  
When extended to a group of subclinical animals, the method also successfully clustered 
these in between the healthy and scouring weaners by principle coordinate analysis PoMA 
has the hallmarks of a statistically reliable diagnostic tool for the analysis of clinical 
samples from individual animals, pools of animals and even, pools of samples from 
different farms for comparative analysis. 
 
When applied to newborn piglets with neonatal diarrhoea, PoMA replication on 
CHROMAgar Orientation medium successfully identified the presence of an unreported 
population of enterococci that dominated on culture media intended to recover primarily E. 
coli.  Selection of single clones followed by enumeration revealed elevated numbers of 
enterococci in scouring neonates compared to healthy piglets with E. faecium present at a 
similar ratio to E. faecalis whilst none of the latter was present in the enterococci isolated 
from healthy piglets.  Since antibiotic resistance of enterococci has recently gained 
eminence as a threat to human health and because microbial contamination from pig meat 
can also enter the human food chain, an analysis of porcine enterococci isolates was carried 
out to compare their virulence genes and antibiotic resistance gene (ARG) profiles to 
clinical human enterococci isolates. The porcine strains had similar virulence genes to 
human isolates but fortuitously, none of the isolates examined so far in this thesis contained 
the vanA or vanB genes for vancomycin resistance. A role for enterococci in neonatal 
diarrhoea remains to be elucidated. 
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Chapter 1 
 
Literature Review 
 
The focus of this review is to provide background information on the intestinal tract and the 
bacteria within.  The main focus being that of Escherichia coli, the diversity of the 
organism and its role in neonatal and weaner porcine colibacillosis.  
 
1.1 Its all about balance 
Life is all about balance, even within our bodies, and nowhere more important than within 
the gastrointestinal tract.  A constant competition exists between the ‘good’ (commensal) 
and ‘bad’ (pathogenic) bacteria.  Commensal bacteria co-exist within the intestinal tract 
with each other and the host organism that they live in.  There are several environmental 
constraints that can directly stress or traumatise a host, which affects this balance (Barnett 
& Hemsworth, 1986; Chin 1989).  When this balance is disturbed opportunity is created for 
pathogenic bacteria to cause disease in the host organism.  If the commensal bacteria and 
the host are in perfect symbiotic harmony within the gastrointestinal ecosystem, pathogenic 
bacteria cannot establish and cause disease (McCracken & Lorenz, 2001). 
 
The gastrointestinal ecosystem is a complex system that requires the cooperation of all 
members.  An alliance has been formed between the intestinal epithelium, immune cells 
and resident commensal bacteria (McCracken & Lorenz, 2001).  This alliance is 
functionally beneficial to all parties, both in terms of health status and protective status, 
with commensal bacteria constantly competing with pathogenic bacteria for binding sites 
(Barrow et al., 1998; Hentges, 1983; McCracken & Lorenz, 2001). 
 
1. 1 
1.2 The gastrointestinal ecosystem 
 
1.2.1 The gastrointestinal tract  
The ecosystem that exists within the gastrointestinal tract (GIT) is governed by the 
physiology of this highly sophisticated system.  Beginning at the mouth and extending to 
the anus, the GIT consists of the mouth, pharynx, esophageus, stomach, small intestine and 
large intestine (Figure 1.1) (Tortora, 1995).  In this review, the focus is on the intestinal 
tract, consisting of the small and large intestine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        (Madigan et al., 1997) 
 
Figure 1.1: The gastrointestinal and respiratory tract  
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The small intestine: Consisting of three sections; duodenum, jejunum, and ileum, the small 
intestine extends from the pyloric valve of the stomach to the beginning of the large 
intestine at the caecum (Figure 1.2) (Moog, 1981).  At a pH of 4-5, the small intestine has 
the dual functions of digestion and absorption of molecules including; monosaccharides, 
amino acids, fatty acids and water (Fenoglio-Preiser et al., 1988).  The majority of 
digestion occurs in the duodenum which descends directly from the stomach.  The 
mesentery, a membranous tissue, securely connects the duodenal region of the intestine to 
the posterior abdominal wall allowing for a greater range in motion, resulting from 
muscular contractions during the digestion process (Moog, 1981; Olsson & Holmgren, 
2001; Tortora, 1995).  In order for food to be digested and broken down into simple 
molecules for absorption, pancreatic enzymes enter the duodenum via the duodenal 
ampulla.  Enterokinase (duodenal hormone) converts these enzymes into active enzymes 
that digest carbohydrates, proteins, nucleic acids and lipids (Imwold, 2000).  The 
gallbladder assists by secreting bile into the duodenum when fat enters from the stomach, 
fat is then emulsified by the bile.  Absorption begins in the jejunum, capillaries of the villi 
allow for transport of small molecules, while larger molecules enter small lymphatic 
channels (lacteals) flowing along the mesenteric lymph vessels into general circulation 
(Imwold, 2000).  In the ileum bile acids are absorbed and returned to the liver and vitamin 
B12 is absorbed (Imwold, 2000).  The ileum joins the large intestine at the ileocecal valve.   
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(Madigan et al., 1997) 
 
 
Figure 1.2: The human gastrointestinal tract showing functions and the distribution of 
microorganisms. 
 
 
The structure of the small intestine is based on three layers; serosa, submucosa and 
muscularis mucosae (Imwold, 2000; Olsson & Holmgren, 2001).  The submucosa consists 
of connective tissues, glands, small vessels along with a second ganglionated nerve plexus, 
the submucous or Meissner’s plexus.  The submucosa also contains a duodenal gland 
(Brunner’s gland) which is responsible for secreting alkaline mucus, to neutralize gastric 
acid in digesting food, also known as chyme (Tortora, 1995).  Muscularis mucosae is a thin 
muscle layer that separates the submucosa and mucosa.  The mucosa contains sensory 
nerve fibres from nerve cells in the plexuses and endocrine and paracrine cells involved in 
gut functions, including motility (Olsson & Holmgren, 2001).  These structures surround 
the inner layer of the intestine, the mucosa.  The mucosal surface contains three structures; 
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circular folds called plicae circulares, villi and microvilli (Imwold, 2000, Moog, 1981).  
Approximately 10 mm in height, the plicae extend from the duodenum till the middle of the 
ileum, they are positioned around the inner circumference of the intestine.  The plicae cause 
chyme to spiral, allowing for more contact with the surface area during absorption (Tortora, 
1995).  Villi project into the lumen from the folds in the surrounding mucosal surface.  The 
plicae and villi increase the surface area of the intestine for the absorption of nutrients.  The 
approximate surface area of a human intestine is 400 m2 (Chin et al., 2000).     
 
The entire intestinal track is lined with a single layer of epithelial cells, providing a 
protective barrier against lumen contents.  Intestinal epithelial cells also serve 
immunoregulatory functions by presenting antigens to immune cells, secrete cytokines, 
express cell adhesion molecules, release eicosanoids and produce nitric oxide (Bocker et 
al., 1998; Olsson & Holmgren, 2001). There are a number of different types of epithelial 
cells in the GIT with distinctive ultrastructural features; Paneth’s cells, undifferentiated 
crypt cells, enteroendocrine cells, cup cells, tuft cells, goblet cells, absorptive cells and M 
cells (Fenoglio-Preiser et al., 1988; Moog, 1981).    
 
Epithelial cells: The villi cells originate as immature proliferative cells at the base of the 
villi, in depressions called crypts where cells are mitotically active (Fenoglio-Preiser et al., 
1988; Moog, 1981; Tortora, 1995).  Cells differentiate as they migrate up the villi towards 
the lumen, in humans this is approximately a 5-6 day process, but only 3 days in ileum villi 
due to height differences (Blikslager & Roberts, 1997; Fenoglio-Preiser et al., 1988).  The 
most abundant cells on the villi are absorptive cells whose function is to absorb nutrients 
including: lipids, sugars and amino acids (Fenoglio-Preiser et al., 1988).  These cells 
possess enzymes necessary for terminal digestion for carbohydrates and proteins, they also 
have a basophilic cytoplasm and brush border.  The brush border is composed of 
microscopic finger like projections called microvilli (Fenoglio-Preiser et al., 1988; Imwold, 
2000).    
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Goblet cells are both mucus secreting, ion and water secretors (Fenoglio-Preiser et al., 
1988).  The mucus is a mix of glycoprotein that serves to reduce shear forces in the luminal 
stream and to aggregate adherent bacteria (Neish, 2002).  The most abundant cell in the 
crypt, yet they are only in small numbers on the villi (Fenoglio-Preiser et al., 1988; Tortora, 
1995).    
 
M cells are specialized epithelial cells which transport antigens to underlying aggregation 
of lymphoid cells (Peyer’s patches) where antigen presentation and affinity maturation 
occurs (McCracken & Lorenz, 2001; McGhee et al., 1999; Owen, 1999; Siebers & Finlay, 
1996).  M cells contain folds and crevices that aid in entrapment of bacteria, they also 
contain receptors that are recognised by Salmonella, Shigella and Yersina (Chin et al., 
2000; Siebers & Finlay, 1996).  
 
Paneth’s cells are at the base of the crypt (Fenoglio-Preiser et al., 1988).  Their function is 
to maintain the mucosal defence barrier, achieved by production of antimicrobial peptides 
(e.g. cryptdins and lysozymes).  These cells are also responsible for producing growth 
factors and other molecules that regulate the proliferation and differentiation of epithelial 
cells; goblet cells, enteroendocrine cells, absorptive cells and Paneth’s cells (Fenoglio-
Preiser et al., 1988).   
 
Lamina propria is an areolar connective tissue which supports the epithelium and binds it to 
the muscularis mucosae.  Containing blood and lymphatic vessels, and lymphatic nodules it 
provides blood and lymph supply for the muscularis mucosae (Tortora, 1995).  Located in 
the lamina propria are the cells of the mucosa associated lymphoid tissue (MALT), which 
contain the cells of the immune system (lymphocytes and macrophages) that protect against 
disease (Tortora, 1995). 
 
Large Intestine: The large intestine is comprised of three sections; caecum, colon 
(transverse and ascending) and the rectum (Figure 1.2).  With a pH of 7 the main function 
of the large intestine is absorption of water and bile acids (Imwold, 2000).  Following 
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digestion, the intestinal contents become faeces as they move through the large intestine.  
Bacteria in the colon synthesize vitamins from the food by-products remaining (Guamer & 
Malagelada, 2003; Imwold, 2000).      
 
The physiology of the large intestine is different from the small intestine.  There are no villi 
or circular folds, rather the mucosa contains simple columnar epithelium consisting of 
goblet and absorptive cells (Tortora, 1995).  The primary function of the goblet cells is to 
secret mucus for lubrication as the faecal material passes, while the absorptive cell 
primarily absorbs water (Tortora, 1995).  The submucosa is similar to the small intestine 
mucosa while the muscularis consists of an external layer of longitudinal muscles and an 
internal layer of circular muscles (Tortora, 1995). 
 
1.2.2 Bacteria and the GIT  
The intestinal tract contains a diverse array of bacteria including aerobes, anaerobes and 
obligate anaerobes.  Colonization begins immediately after birth when the intestine and 
immune system are still immature (Chin & Mullbacher, 2003; Chin et al., 2000).  New-
borns are colonised with bacteria that are of maternal origin and from the environment 
(Chin & Mullbacher, 2003).  Typically the first bacteria to begin colonising the GIT are E. 
coli, followed by Clostridium spp., Streptococcus spp., Enterococcus spp., Lactobacillus 
spp., Bacteroides spp. and Bifidobacterium spp. (Rotimi & Duerden, 1981).  Studies have 
shown that in human infants that are breast fed bifidobacterium increases considerably 
(Benno et al., 1984; Holzapfel et al., 1998).  The bacterial population continues to change 
while the intestinal and immune systems mature from birth to weaning and continues into 
adulthood (Chin et al., 2000).  Once this diverse bacterial population has established in 
adulthood it becomes more stable (McCartney et al., 1996).  Certain species of lactobacilli 
have been shown to dominate in an individual (Tannock, 2001), while other studies have 
examined bifidobacteria and lactobacilli species within human subjects over a 12 month 
period and have shown variation and complexity and stability of these populations 
(McCartney et al., 1996).  However, it is known that microbial populations in different 
humans are substantially different.  This is believed to be due to continuous selective 
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pressures exerted by the gut immune system matched by selective adaptation of specific 
bacterial strains (McCartney et al., 1996). 
 
Generally the intestinal microflora of humans is at a concentration of approximately 1 x 
1010 colony forming units (CFU) per gram of faeces, or per gram/ml of intestinal contents 
(Tannock, 2001).  There are at least 400 species of bacteria within the human intestinal 
tract (Chin et al., 2000; Falk, 1998) including the following bacteria: Acidaminococcus, 
bacteroides,bifidobacterium, Escherichia, eubacterium, fusobacterium, klebsiella, 
Lactobacillus, megamonas, megasphaera, Peptostreptococcus, Proteus, Ruminococcus and 
veillonella (Tannock, 2001).  Due to the diverse physiology of the GIT, different bacteria 
are suited to different regions.  The stomach (pH 2) and duodenum (pH 4-5) are a more 
acidic environment which favours bacteria such as lactobacilli and streptococci (Holzapfel 
et al., 1998).  The bacterial load in this region of the GIT is considerably lower than other 
regions with approximately 101-103 CFU/ml of intestinal contents (Drasar et al., 1989; 
Holzapfel et al., 1998).  The conditions in the jejunum and ileum (pH of 4-5) typically 
favours bacteria such as lactobacilli, Enterobacteriaceae, streptococci, bacteroides, 
bifidobacteria and fusobacteria in concentrations of 104-108 CFU/ml (Holzapfel et al., 
1998).  The colon is a milder environment with a neutral pH of 7 allowing a greater number 
of bacteria to inhabit this region with concentrations of approximately 1010-1012 CFU/g of 
contents.  With a neutral pH a greater diversity of bacteria are able to inhabit the colon; 
bacterioids, bifidobacteria, streptococci, enterococci, fusobacteria, enterobacteriaceae, 
clostridia, veillonella, lactobacilli, proteus, staphylococci, pseudomonas, yeasts and 
protozoa (Holzapfel et al., 1998). 
 
Traditionally the bacteria identified in the intestinal tract are biased towards bacteria that 
are culturable on bacteriological media.  Molecular techniques such as polymerase chain 
reaction (PCR) involving the use of 16S ribosomal RNA genes allows identification of non-
culturable species of bacteria (Tannock, 2001).  The 16S sequences are not able to 
differentiate between bacteria belonging to the same species.  Techniques such as 
multilocus enzyme electrophoresis (MLEE), pulsed-field gel electrophoresis (PFGE), 
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ribotyping and random-amplification of polymorphic DNA can be used to differentiate 
bacteria isolated from the GIT (Tannock, 2001).  For this reason there are contrasting 
reports on the stability of the commensal bacteria in the GIT, with more recent reports 
demonstrating that bifidobacteria and Lactobacillus populations analysed in human subjects 
over a 12 month period showed variation in both the complexity and stability of these 
bacteria (McCartney et al., 1996).  The results demonstrate that each subject harboured a 
characteristic lactobacilli strain that predominated over the 12 month period (McCartney et 
al., 1996).   
 
A mutually beneficial relationship is formed between commensal bacteria and the GIT 
(McCracken & Lorenz, 2001).  Bacteria have a number of roles in the processing of chyme; 
they degrade food components and produce valuable by products for both themselves and 
its host including B vitamins and short chain fatty acids.  Bacteria also metabolise 
potentially carcinogenic substances, stimulate the immune system and produce digestive 
and protective enzymes (Guamer & Malagelada, 2003; Holzapfel et al., 1998; McCracken 
& Lorenz, 2001; Neish, 2002).  Bacteria also have a direct impact on the morphology of the 
gut.  Bacteria such as Peptostreptococcus micros, Ruminocuccus and bifidobacteria 
produce glycoside hydrolase which degrades the mucus glycoproteins produced by goblet 
cells (Carlstedt-Duke et al., 1986; Hoskins, 1985).  Commensal bacteria participate in 
biochemical, physiologic and immunological characteristics of their host.  Table 1.1, as 
presented by Tannock (2001) provides details of the impact microbial populations have on 
the intestine and its functions, as demonstrated in experiments using germfree and 
conventional animals.      
 
The GIT not only provides a habitat for bacterial populations, but it also regulates the 
number and type of bacteria it accommodates.  Host intestinal physiology and defence 
mechanisms prevent the overgrowth of microbial populations.  Host mediated factors 
include the pH of the intestine, secreted substances such as immunoglobulins, bile acids 
and enzymes (Holzapfel et al., 1998).  While the motility of the intestine regulates the 
speed chyme travels, while peristalsis flow prevents the majority of bacteria colonising the 
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1. 10 
duodenum, with only those capable of adherence to the cell wall being able to colonise 
(Holzapfel et al., 1998; Olsson & Holmgren, 2001).  The physiology of the intestine, for 
example the compartmentalisation provides different ecological niches, encouraging 
different types of bacteria, and therefore preventing over dominating of a species.  The 
intestine is also constantly renewing the epithelial layer, with redundant cells ending in the 
intestinal lumen where they are excreted out of the body, containing any adherent bacteria 
with them (Neish, 2002). 
 
(Tannock, 2001) 
Biochemical, physiologic, and immunologic 
host characteristics Conventional Germfree 
Bile acid metabolism Deconjugation, dehydrogenation, and dehydroxylation 
Absence of deconjugation, dehydrogenation, 
and dehydroxylation 
Bilirubin metabolism Deconjugation and reduction Little deconjugation; absence of reduction 
Cholesterol Reduction to coprostanol Absence of coprostanol 
β-Aspartylglycine Absent Present 
Intestinal gases Hydrogen, methane, and carbon dioxide 
Absence of hydrogen and methane; less 
carbon dioxide 
Short-chain fatty acids Large amounts of several acids Small amounts of a few acids 
Tryptic activity Little activity High Activity 
Urease Present Absent 
β-Glucuronisdase (pH 6.5) Present Absent 
Organ weights (heart, lung, and liver) High Low 
Cardiac output and oxygen utilization High Low 
Mucin content of intestinal mucus High Low 
Extent of degradation of mucins More Less 
Cecal size (rodents) Small Large 
Enzyme activites associated with duodenal 
enterocytes Low High 
Intestinal wall Thick Thin 
Intestinal mucosal surface area Great Small 
Rate of enterocyte replacement Fast Slow 
Peristaltic movement of contents through small 
bowel Fast Slow 
Body temperature High Low 
Serum cholesterol concentration Low High 
Lymph nodes Large Small 
γ-Globulin fraction in blood More Less 
Table 1.1: Comparison of selected properties of germfree (absence of microflora) and conventional (presence of microflora) 
animals. 
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Not only does the GIT have systems in place to prevent bacterial over population, but 
individual bacteria also contain mechanisms preventing them from surviving in certain 
ecological niches.  Bacteria contain mechanisms which give them a competitive advantage 
against other bacteria, allowing them to out-compete the competition.  Factors such as 
adhesins, motility, nutritional flexibility, spores, capsules, enzymes, antimicrobial 
components and generation time all dictate the environment in which individual bacteria 
can survive and compete (Holzapfel et al., 1998).  An important competitive advantage that 
bacteria frequently exploit, is their ability to produce antimicrobial components which 
specifically target either other species of bacteria or bacteria of the same species.  Such 
antimicrobial components include: colicins produced by Escherichia coli, bacterocine 
produced by lactobacilli and enterocine produced enterococci (Reviewed by; Dae & 
Falkiner, 1996; Jan van der Wal et al., 1995; Riley & Wertz, 2002).         
 
One of the main influences on the commensal bacteria in the GIT are external pressures; 
environmental, physiological, social and nutritional stressors.  Stressors act on the 
sympathetic nervous system and hypothalamic pituitary adrenal axis which alter hormonal 
levels that affect the production of cytokines by immune cells (Del Aguila et al., 1999) in 
turn stimulating immunity, while chronic stress down-regulates immune responses (Olff, 
1999).  The chain of events that an external pressure initiates (Figure 1.3) affects the 
indigenous or autochthonous commensal bacteria (Chin et al., 2000).  This directly results 
in the dismantling of the protective barrier which commensal bacteria provide.  An opening 
then arises for pathogenic or opportunistic bacteria (discussed later) to initiate disease 
(Holzapfel et al., 1998).  An additional influence that affects commensal bacteria is 
administration of antibiotics that kill susceptible bacteria and again leave an opening for 
pathogenic or opportunistic bacteria which are resistant to colonise the GIT.  In one study, 
E. coli isolated from human subjects were tested for antibiotic resistance and found to be 
susceptible to ampicillin, doxycycline, nalidixic acid and trimethoprim.  Amoxicillin was 
administered and the E. coli subsequently isolated were multi-drug resistant to ampicillin, 
doxycycline and trimethoprim, and remained in the faecal flora for approximately 13 
weeks.  Six months following antibiotic therapy, faecal bacteria contained antibiotic 
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susceptible Enterobacteriaceae, with a single strain of E. coli predominating.  Multi-drug 
resistant E. coli were no longer detectable, they were replaced with a complex community 
containing ampicillin resistant klebsiella and antibiotic susceptible enterobacter and serratia 
strains (McCartney et al., 1996). 
 
 
Stress, change in diet, 
administration of antibiotics 
Affects bacteria 
in the gut 
Affects gut 
health 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: A single change can affect all levels of the circle, each circle is a level of 
complexity where the outer circle is general stress applied to an individual.  The next level 
represents the bacteria living within the gut and the inner circle is the impact in relation to 
gut health.  
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1.3 When the balance is disturbed – beware of opportunistic 
pathogens 
Bacteria in the intestinal tract share a symbiotic relationship with their host, where both are 
mutually benefited.  Typically commensal bacteria lack the specialised virulence traits 
which intestinal and extraintestinal pathogens possess.  Commensals do not ordinarily 
cause disease, though some do contain a repertoire of virulence genes or antibiotic 
resistance traits that under the right conditions (e.g. when host is stressed or receiving 
antibiotic therapy) allow these bacteria to become pathogenic.  When an imbalance within 
the intestinal environment occurs these so called commensals can multiply and inflict 
disease.  There are many bacterial species which can be classified as opportunistic 
pathogens including many members of the Enterobacteriaceae family; Escherichia, 
Salmonella, Shigella, Klebsiella, Serratia, Proteus, Yesinia and Enterobacter (Tortora, 
1995).  This review will focus on two bacteria, Escherichia coli (E. coli; which is important 
in both animals and humans) and the enterococci, including E. faecium and E. faecalis 
which are becoming of increasing importance in human health.   
 
1.3.1 Escherichia coli 
Escherichia coli belongs to the order Eubacteriales, and is a member of the 
Enterobacteriaceae family belonging to the genera/genus Escherichia (Buxton & Fraser, 
1977).  Enteric is the common name used to describe Enterobacteriaceae members because 
they primarily inhabit the intestinal tract of humans and animals (Tortora, 1995).  Members 
of the Enterobacteriaceae family are facultatively aerobic, gram-negative rods (1.1-1.5 μm 
x 2.0-6.0 μm), which are oxidase negative and are either motile with peritrichous flagella, 
or non-motile (lack flagella).  Enterobacteriaceae have simple nutritional requirements and 
are capable of fermenting sugars to a variety of end products (Bergey et al., 1984; 
Koneman et al., 1997; Sojka, 1965).  Enteric bacteria can be differentiated on the basis of 
their fermentation of glucose and the end products they produce (Koneman et al., 1997; 
Madigan et al., 1997).  Table A1.1 in Appendix 1 lists the differential media used for 
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classifying enteric bacteria and the diagnostic reactions (Table A1.2, Appendix 1) used to 
separate the genera of enteric bacteria.   
 
Escherichia coli, or as it is commonly known E. coli, was first identified in 1885 by 
Theobald Escherich when he isolated it from the faeces of a new-born baby.  At this stage 
‘bacterium coli commune’ as it was named was considered harmless (Sojka, 1965).  The 
first suggestion that E. coli was pathogenic was made by Laruelle in 1889, who isolated it 
in cases of appendicitis with peritonitis (Sojka, 1965).  Since then it has been determined 
that E. coli is the dominant aerobe in the intestinal tract of humans and mammals (Gordon 
& Cowling, 2003; Hartl & Dykhuizen, 1984; Selander et al., 1987).  The majority of these 
commensals do not carry virulence genes, and therefore are not capable of being pathogens 
(Dixit et al., 2004; Hartl & Dykhuizen, 1984).  E. coli is however, considered an 
opportunistic pathogen (Brenner, 1981; Tannock 2001) with strains that carry virulence 
genes capable of colonising and inducing disease.  Depending on the repertoire of virulence 
genes, E. coli can be implicated in intestinal or extraintestinal disease (Ørskov & Ørskov, 
1992).  
 
1.3.1.1 Serological classification of E. coli 
The heterogeneous nature of E. coli requires a method to identify isolates; serotyping is the 
accepted epidemiological classification system.  In 1947 Kauffman first developed the 
antigenic scheme to identify E. coli based on the three fundamental antigenic components 
on the bacterial surface; coli; O-antigens (O), capsular K-antigens (K) and H-antigens (H).  
A fourth system used for strains that carry external appendages are fimbrial antigens (F) 
(Edwards & Ewing, 1972; Lior, 1994; Ørskov & Ørskov, 1984; Ørskov et al., 1977; Sojka, 
1965).  Currently there are 167 O antigens designated O1 to O173, seven serotypes were 
removed including O31, O47, O67, O72, O93, O94 and O122.  There are 74 K antigens 
numbered K1 to K103, of which also some have been removed and some re-designated to 
F-antigens.  H-antigens are numbered from H1-H56 (53 H-antigens in total), with H13, 
H22, and H50 being removed (Ewing, 1986; Lior, 1994; Ørskov & Ørskov, 1984; Ørskov 
1. 15 
& Ørskov, 1992).  Serology of an E. coli designates O:K:H and when F is identified 
O:K:H:F (Ørskov & Ørskov, 1984), with the O and H antigens being most commonly used. 
 
Somatic lipopolysaccharide O-antigens: The outer membrane of E. coli is unique to 
gram-negative bacteria (Figure 1.4).  Its structural component is lipopolysaccharide (LPS), 
a complex glycolipid which consist of a lipid portion (Lipid A), a polysaccharide core and 
an O-specific side chain.  These O-specific side chains consist of repeating oligosaccharide 
units (up to 40) comprised of three to five monosaccharides. The unique serological identity 
of the O-antigen is a direct result of the variable biochemical structure of the side chains.  
These side chains often contain unusual or uncommon carbohydrate residues including 
aminohexuronic acid, 6-deoxyhexoses and 2,6-dideoxyhexoses (Koneman et al., 1997).  
The lipid A appears to be the principal component responsible for endotoxin activity, while 
the lipid rich outer membrane allows for the identification of gram negative bacteria using a 
gram stain.  During gram staining (Section 2.2.3) the acetone disrupts the lipid outer layer, 
allowing the crystal violet/iodine complex to leach from the cells, leaving them colourless, 
requiring a counter stain of safranin or neutral red which gives the characteristic pink 
colour for the identification of gram negative bacteria (Koneman et al., 1997).    
 
 
 
 
 
 
 
 
 
 
 
 
    
 
        (Koneman et al., 1997) 
 
Figure 1.4: Cell wall structure of gram negative bacteria, the lipopolysaccharide (LPS) 
consists of the O-antigen structure, keto-deoxyoctulonate (KDO) and the Lipid A layer. 
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The O-antigens occur in smooth (S) and rough (R) forms, which occur due to mutations in 
either the genes for the synthesis of O-specific polysaccharide chains, or in the basal core 
(Sojka, 1965).  The R forms are O- (negative), meaning they have lost their antigenic 
structure and cannot be typed.  O-antigens are serotyped using agglutination tests carried 
out on a slide or in a microtitre tray system (Bettleheim & Thompson, 1987).  Antisera is 
produced in rabbits inoculated with heated thermostable (100oC for 2½ hours or 121oC for 
2 hours) O-antigen suspension.  These antisera are mixed with E. coli, if clumping of 
bacteria is observed the result is considered positive (Ørskov & Ørskov, 1984). 
 
Serotyping of the O-antigen is not full-proof as cross-reactions amongst E. coli have been 
reported (Ewing, 1986) as well as cross-reaction with other members of the 
Enterobacteriaceae family (Ørskov & Ørskov, 1984) and non-members including 
Citrobacter and Vibrio cholerae (Winkle et al., 1972).  
 
Capsular K-antigens: Some E. coli possess a capsule external to the outer layer of the cell 
wall.  This polysaccharide material consists of polymers of single monosaccharides 
(glucans, dextrans or levans), or heteropolysaccharides (hexose and pentose sugars) plus 
ribitol, glycerol or other sugar alcohols.  This capsule provides a protective layer from 
desiccation, and from toxic materials. The polyanionic nature of the capsule promotes the 
concentration of nutrients at the bacterial cell surface, and also offers resistance to a host’s 
immune system defense mechanisms (Koneman et al., 1997).  K antigens are determined 
using slide or tube agglutination of live or formalin-treated cultures in whole cell antisera.  
Cross-reactions of K-antigens with other members of the Enterobacteriaceae family have 
also been reported (Sojka, 1965). 
 
Flagella H-antigens: Flagella are long filamentous appendages that extend from the 
cytoplasmic membrane through the cell wall and are responsible for motility.  Flagella 
consist of three parts, filament, hook and basal body.  The antigen type of flagella is 
controlled by a gene coding for flagellin proteins (Koneman et al., 1997; Lior, 1994).  The 
motility of E. coli is established when the organism passes through fluid or semisolid agar 
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media, the H-antigen can be determined by slide or tube agglutination tests (Sojka, 1965).  
Unlike O and K antigens, H are specific for E. coli and show little or no significant cross-
reactivity (Ewing, 1986).   
 
Fimbrial F-antigens: An additional surface antigen used to further classify E. coli is 
fimbriae or pili.  Fimbriae, as they are historically known are composed of fimbrillin, a 
protein.  Located on the bacterial cell surface; these appendages are 3-10 nm in diameter 
and 15-20 μm long.  They are actively involved in the exchange of genetic material by pair 
formation during conjugation, and serve as attachment sites for bacteriophages.  They are 
involved in bacterial attachment to cells and mucosal surfaces; this type of fimbriae are 
referred to as adhesins.  Adhesins display lectin-like binding to terminal carbohydrate 
residues like mannose moieties (de Graaf, 1990; Gasstra & de Graaf, 1982; Hacker, 1992; 
Koneman et al., 1997). 
 
Originally fimbrial antigens were identified as K-antigens, subsequently they have be 
redesignated as F-antigens; type 1 fimbriae = F1, colonization factor antigen (CFA)/I = F2, 
CFA/II = F3, K88 = F4, K99 = F5 and 987P = F6 (Ørskov & Ørskov, 1984).  Fimbrial 
antigens were originally classified using agglutination tests with antisera (Ørskov & 
Ørskov, 1983).  Some strains of E. coli can possess several different antigenic types (Lior, 
1994), so the preferred methods of identification include ELISA, DNA hybridization and 
PCR (Ojeniyi et al., 1994; Woodward & Wray, 1990). 
 
1.3.1.2 From commensal to pathogen 
Commensal E. coli have diverged over time with the acquisition and deletion of genes, 
turning them from harmless commensals into pathogenic bacteria.  The pathogenicity of an 
organism is its ability to cause disease within a host.  The two essential elements of 
pathogenesis are: ability to initiate a disease (infectivity) and the severity of the disease 
condition it produces.  For an organism to infect it must be able to attach/adhere to either 
the host mucous membrane or epithelial cells and once attached it must have an arsenal of 
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genes which allows it to survive the host’s defence system and in turn infect host cells 
(Hartl, 1994). 
 
Natural Selection: The theory of natural selection was first proposed by Charles Darwin 
who stated that “the driving force of adaptive evolution is natural selection, which is the 
consequence of hereditary difference among individuals in their ability to survive and 
reproduce in the prevailing environment” (Hartl, 1994).  Since this first concept of 
evolution, the idea has been expanded to incorporate three principles: 
1. In all organisms, more offspring are produced than survive and reproduce. 
2. Organisms differ in their ability to survive and reproduce and some of these 
differences are due to genotype. 
3. In every generation, genotypes that promote survival in the prevailing 
environment (favoured genotypes) are present in excess among individuals of 
reproductive age and hence they contribute disproportionately to the offspring of the 
next generation.  In this way, the alleles that enhance survival and reproduction 
increase in frequency from generation to generation, and the population becomes 
progressively better able to survive and reproduce in the environment.  The 
progressive genetic improvement in populations constitutes the process of 
evolutionary adaptation (Hartl, 1994). 
 
There are two stages of evolution for bacteria; (i) macroevolution and (ii) microevolution.  
Macroevolution occurs over a long period of time where changes lead to the formation of 
new species or pathotypes within a species (Morschhauser et al., 2000).  Microevolution in 
bacterial terms are changes that occur within days or weeks, which contributes to new 
variants in a given species or pathotype (Hacker & Kaper, 2000).  The genetic evolution of 
E. coli from a commensal to a pathogen has been demonstrated to be attributed to a 
combination of horizontal gene transfer, point mutations and genetic rearrangements 
(Hacker & Kaper, 2000).  Point mutations can lead to modification, inactivation or 
differential regulation of existing genes (Ochman et al., 2000).  In order for an organism to 
compete and survive successfully in their ecological niche, both commensals and pathogens 
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have to overcome environmental restrictions.  This may occur through point mutation 
where a mutation is caused by a substitution, deletion or addition of a single nucleotide 
pair. Mutation rates are low and most newly arising mutations are harmful to an organism 
(Hartl, 1994).  Occasionally a mutation may be beneficial and that organism will continue 
to evolve.  The more effective means of genetic evolution is through the acquisition of new 
genetic material by lateral gene transfer.  There are three ways by which E. coli shares 
genetic material; transformation, transduction and conjugation, also known as lateral gene 
transfer (Reviewed in Hartl, 1994 and Ochman et al., 2000).  Lateral gene transfer can 
occur not only between the E. coli genus but between non-Escherichia species such as 
Shigella and Yersinina.  As a result the E. coli genus is genetically diverse with both 
commensal and pathogenic isolates acquiring traits such as antibiotic resistance, virulence 
attributes and metabolic properties which provide a venue for bacterial diversification 
(Reviewed in Ochman et al., 2000).   
 
1.3.1.3 Genetic relatedness of E. coli 
Phylogenetic studies look at the genetic relatedness of bacterial isolates within species, 
families and orders.  Multilocus enzyme electrophoresis (MLEE) is historically the 
technique of choice for diversity studies.  First applied to E. coli by Roger Milkman in 
1973 (Feil & Spratt, 2001; Milkman, 1973; Milkman, 1975), the technique is used to index 
allelic variation by detecting differences in the amino acid sequence of metabolic enzymes 
(these differences alter their electrophoretic mobility of the enzymes on starch gels).  
Typically the technique is used to detect variation within 20 or more loci in each isolate.  
Each genotype is defined as a series of intergers that correspond to the alleles present at 
each of the loci (allelic profile) (Cohan, 2002; Feil & Spratt, 2001; Selander et al., 1986).  
In 1984, Ochman and colleagues assembled 72 reference strains of E. coli isolates from a 
variety of hosts and geographical locations.  These isolates were analysed by MLEE using 
11 enzymes; malate dehydrogenase, 6-phosphogluconate dehydrogenase, adenylate kinase, 
peptidase-2, glutamic oxaloacetic transaminase, isocitrate dehydrogenase, phosphoglucose 
isomerase, aconitase, mannose phosphate isomerase, glucose-6-phosphate degydrogenase 
and alcohol dehydrogenase.  These isolates (now known as the E. coli Reference Collection 
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(ECOR)) established a basic population genetic framework for analysing isolates (Ochman 
& Selander, 1984). 
 
Four major groupings/clusters of E. coli have been identified using MLEE; A, B1, B2 and 
D (Herzer et al., 1990; Selander et al., 1987).  MLEE analysis has shown that group B2 is 
primarily dominated by extraintestinal pathogenic E. coli (ExPEC); some ExPEC isolates 
are classed as D (Johnson et al., 2000; Johnson et al., 2001; Picard et al., 1999).  The 
majority of commensals isolated from the faeces of humans and domestic animals belong to 
groups A or B1 (Goullet & Picard, 1986; Picard et al., 1999).  Pathogenic intestinal E. coli 
have been associated with all four groups (Pupo et al., 1997; Reid et al., 2000).  This result 
led researchers to suggest that clones causing intestinal disease have evolved several times 
in different lineages, explaining their presence in all four clusters (Gordon, 2001; Reid et 
al., 2000). 
 
Genetic relatedness can be determined using MLEE.  In 1999, Gordon looked at 246 
isolates from five species of Enterobacteriaceae, from a variety of Australian mammals. 
The results demonstrated that bacteria were not randomly distributed; instead there were 
two population levels (i) The taxonomic family of the host from which the isolate was 
collected, and (ii) The geographical locality where the host was collected.  A 5% genetic 
variation was observed in E. coli based on locality, while host family exhibited a 6% 
variation (Gordon & FitzGibbon, 1999).  In 2001, Gordon concluded there was a 
population structure, and that species may exhibit adaptations specific to particular types of 
environments; (i) primary (host environment), and (ii) secondary (external environment) as 
defined by Savageau (Savageau, 1983).  This analysis was advanced in 2004 when Dixit 
and colleagues used MLEE analysis to look at the genetic variation in E. coli isolated from 
faeces and different regions of the pig intestine; duodenum, ileum, colon.  A total of 151 
isolates were analysed from eight, 13 week old male pigs, the results demonstrated that 
different geographical locations and species are not need to observe genetic diversity within 
the species of E. coli.   A mean differentiation of 27% was observed, which exceeds the 2-
6% observed among populations isolated from different geographical locations and 
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different species (Gordon, 1997; Gordon & Lee, 1999; Gordon et al., 2002; Whittam et al., 
1983a).  The analysis showed clustering of commensal isolates.  E. coli from the small 
intestine clustered predominantly in group A, and E. coli from the large intestine clustered 
in group B2.  The results showed greater genetic relatedness between duodenum and ileum 
isolates, and between colon and faeces isolates (Dixit et al., 2004).  This result suggests that 
different environmental niches in the intestinal tract, have bacteria which have evolved 
specialized traits to help them survive (Dixit et al., 2004).  If the small intestinal isolates are 
predominantly classed in group A, while large intestine isolates are in group B2, then these 
isolates may have diverged at some stage and evolved separately due to the selection 
pressures associated with their specific environmental niche.  An environmental condition 
such as greater motion of the small intestine, compared to the colon suggests that E. coli is 
unlikely to establish in the small intestine unless it is capable of cell wall growth which 
requires specialized adhesin genes (Chivers & Langer, 1994).   
 
MLEE studies have revealed the extensive genetic diversity in bacteria, but have also 
highlighted the clonal (multiple isolates with identical allelic profiles, (Reid et al., 2000) 
nature of different bacteria.  S. enterica are a highly clonal species where high levels of 
linkage disequilibrium has been observed in all samples of the population examined 
(Maynard Smith et al., 1993; Selander et al., 1986).  There are non-clonal populations 
where alleles are at, or close to, linkage equilibrium and where clones are rare or even 
absent in species such as Neisseria gonorrheoae (O’Rourke & Stevens, 1993; O’Rourke & 
Spratt, 1994) or Helicobacter pylori (Go et al., 1996; Suerbaum et al., 1998).  Even though 
E. coli is genetically diverse, it is also considered ‘clonal’ (Awadalla, 2003; Levine, 1981; 
Maynard Smith, 1991; Whittam et al., 1993).  Recent studies using multilocus sequence 
typing (MLST) have provided evidence of DNA recombination (Bisercic et al., 1991; 
Dubose et al., 1988; Dykhuizen & Green, 1986; Guttman & Dykuizen, 1994; Milkman & 
Bridges, 1993; Nelson & Selander, 1994).   
 
MLST can detect all nucleotide polymorphisms within a gene, rather than just those non-
synonymous changes that alter the electrophoretic mobility of the protein product as with 
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MLEE.  Genotypes of isolates analysed by MLST are defined by their allelic profile, and 
these profiles can be compared with others in a single database available 
(http://www.mlst.net/) (Feil & Spratt, 2001).  In a study using MLST 14 enteropathogenic 
E. coli (EPEC), enterohaemorrhagic E. coli (EHEC) and six additional shiga-toxin 
producing strains, along with a laboratory K-12, analysed focussing on the sequences of 
seven housekeeping genes.  The results showed more than 70% of the informative sites 
agreed with there being a single phylogeny.  In 21 of the E. coli between 1-8% variation 
was observed per locus at the nucleotide and amino-acid level (Reid et al., 2000).  Based on 
this study, Reid estimated the rate of evolution of these strains and the rate of synonymous 
substitution of E. coli and Salmonella enterica was estimated as 4.7x10-9 per site per year, 
with the radiation of clones beginning around 9 million years ago and O157:H7 separating 
from K-12 as long as 4.5 million years ago.  Reid concluded that the old lineage of E. coli 
revealed the same virulence factors being acquired in parallel including pathogenicity 
islands involved in adhesion, plasmid born haemolysin and phage-encoded shiga-toxins, 
indicating natural selection has favoured ordered acquisition of genes with a progressive 
build up of molecular mechanisms that increase virulence.  MLST has also been used to 
detect the divergence observed within genes, the intimin gene has >15%  variation amongst 
α, β and γ variants, suggesting the locus of enterocyte effacement (LEE) has diversified in 
situ by mutation and recombination (McGraw et al., 1999). 
 
The MLEE and MLST techniques have demonstrated that E. coli is not always clonal but 
rather is part of a clonal complex, in which groups of isolates have similar allelic profiles 
(Reid et al., 2000).  The clonal frame work of individual isolates represents their ancestral 
DNA heritages which is constantly evolving and diversifying by mechanical mechanisms 
such as point mutations and recombination of DNA through transformation, transduction 
and conjugation (Feil & Spratt, 2001).  MLEE and MLST provided powerful tools to study 
bacteria and genetic diversity.  Though the time consuming complexity of MLEE has 
limited the number of researchers in this area, and the diversity of isolates that can be 
studied at any given time.  With this in mind, researchers have searched for alternative 
avenues to phylogenetically classifying E. coli.   
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In 2000 an alternative method was developed for assigning phylogenetic classification 
using polymerase chain reaction (PCR) protocols to allocate phylogenetic status on the 
basis of three genes (Clermont et al., 2000): (i) chuA; a gene involved in haeme uptake 
system found in EHEC isolates, particularly O157, (ii) yjaA; a segment identified in E. coli 
K12, of which the function is currently unknown, and (iii) TSPE4.C2 which is an 
anonymous DNA fragment.  PCR amplification of these gene products are used to 
determine the phylogenetic groupings as depicted in the dichotomous tree in Figure 1.5.  
This protocol was assessed on 230 E. coli isolates (including 72 from ECOR collection) 
and 228 (99%) of these were identified to be the same designation as identified by MLEE.  
This methodology allows many more researchers to classify E. coli into phylogenetic 
groupings.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
-+
-
chuA 
B1 or A 
TspE4.C2 yjaA 
B2 or D 
+
B2  D 
-+
B1 A
(Clermont et al., 2000)  
 
Figure 1.5: Dichotomous decision tree to determine the phylogenetic group of an E. coli 
strain by using the results of PCR amplification of the chuA and yjaA genes and DNA 
fragment TSPE4.C2. 
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A group of researchers that have taken advantage of the Clermont technique is Zhang and 
colleagues (2002) who looked at E. coli isolated from urinary tract infections (UTI) and 
commensals isolated from rectal swabs.  The results showed that the UTI strains were 
predominantly located in B2, with nearly half of the intestinal commensals (Zhang et al., 
2002).  This group also used the Enterobacterial repetitive intergenic consensus (ERIC) 
typing to compare genetic diversity of these strains which showed that the group B2 and D 
UTI strains were less diverse than the commensal strains (Zhange et al., 2002).  A more 
recent study (Escobar-Paramo et al., 2004) used virulence genes and six chromosomal 
genes (which have been shown to exhibit low levels of horizontal gene transfer in E. coli 
(Denamur et al., 2000; Lecointre et al., 1998)) to determine phylogenetic classification.  
This study found pathotypes to be associated with phylogenetic groups.  Commensal strains 
were located throughout the phylogenetic groupings, while those found in group B2 
harboured more extraintestinal E. coli (ExPEC) genes.  Enterohaemorrhagic E. coli (EHEC) 
were located in groups A and B1 with O157:H7 isolates in group E, enterotoxigenic E. coli 
(ETEC) in groups A, B1 and C and enteroinvasive E. coli (EIEC) in groups B2 and D, none 
of these three pathotypes were located in groups B2 or D.  Enteropathogenic E. coli (EPEC) 
primarily located in groups B1 and B2 were also scatted throughout the phylogenetic 
groupings like enteroaggretative E. coli (EaggEC) and diffusely adhering E. coli (DAEC) 
(Escobar-Paramo et al., 2004). 
 
The transfer of genetic material between strains, species and genera has occurred over 
millions of years of evolution (Hall, 2004) resulting in the diversity of E. coli.  This 
diversity through macroevolution is a result of ecological conditions and different selection 
pressures.  The opportunity for E. coli to gain genetic information through lateral gene 
transfer has opened many pathways of opportunity.  This genetic information allows E. coli 
to incorporate genetic material from within the species or outside of the species.  For 
example, the exchange of genetic material such as the genes for shiga toxins from Shigella, 
which have been incorporated by E. coli and allowed it to evolve into a pathogen which has 
a distinct disease profile.  These traits have brought fourth the classification of E. coli into 
pathotypes.  Pathotypes are defined on the basis of clinical presentation of the disease with 
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isolates carry a repertoire of virulence genes that are capable of causing the same clinical 
disease.  
 
1.3.1.4 E. coli Classification – Pathotypes 
E. coli are divided into three major groups; commensals, intestinal pathogens and 
extraintestinal pathogens (Russo & Johnson, 2000).  Commensal E. coli are a semi-stable 
population within the intestinal tract which interact peacefully with their host (McCartney 
et al., 1996).  Intestinal and extraintestinal pathogens are transient populations which do not 
reside in the body, but rather they enter the body to inflict infection and leave (Tortora, 
1995).  Both intestinal and extraintestinal pathogens are classified into different pathotypes, 
also called pathovars.  Some pathotypes are clearly defined, yet as we learn more about E. 
coli and in particular the virulence genes it possess and how it functions both in vivo and in 
vitro new pathotypes are being characterised.  There are currently nine classes of 
pathotypes.  Infections involving E. coli which are associated with the intestine are called 
enteric pathogens.  These enteric pathogens are currently divided into five defined 
pathotypes associated with human diarrhoea: 
 
Enterotoxigenic Escherichia coli (ETEC) 
Enteropathogenic Escherichia coli (EPEC) 
Enteroinvasive Escherichia coli (EIEC) 
Enterohaemorrhagic Escherichia coli (EHEC) 
Enteroaggregative Escherichia coli (EaggEC or EAEC) 
 
These pathotypes are defined on the basis of the clinical symptomology and their 
pathogenic phenotype in terms of the virulence genes they possess (Table 1.2) and their 
mode of infection (Figure 1.6).  In addition to the above, additional pathotypes which are 
involved in diarrhoea, other than human include: 
 
Shiga-toxin producing Escherichia coli (STEC) 
Diffusely Adhering Escherichia coli (DAEC) 
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Figure 1.6: Pathogenic schemes of diarrhoeagenic E. coli.  The six recognized categories 
of diarrhoeagenic E. coli each have unique features in their interaction with eukaryotic 
cells.  Here, the interaction of each category with a typical target cell is schematically 
represented.  It should be noted that these descriptions are largely the result of in vitro 
studies and may not completely reflect the phenomena occurring in infected humans 
(Nataro & Kaper, 1998). 
        (Nataro & Kaper, 1998) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
While bacteria that are only involved in extraintestinal infections are: 
 
Pathogenic E. coli which are involved in intestinal and extraintestinal infections include  
Extraintestinal Escherichia coli (ExPEC) 
Necrotoxigenic Escherichia coli (NTEC) 
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Table 1.2: The five pathotypes associated with human diarrhoea are classified on the basis of clinical symptomology and their 
pathogenic phenotype on the basis of the virulence gene they possess. 
 
Pathotype Pathogenic Phenotype Signs and Symptoms 
Enterotoxigenic E.coli (ETEC) 
Elaboration of secretory toxins (LT, ST) 
that do not damage the mucosal 
epithelium 
Travelers diarrhoea – profuse watery diarrhoea is 
predominat symptom often accompanied by mild abdominal 
cramps. Dehydration and vomiting occur in some cases 
Enteropathogenic E.coli (EPEC) 
Adhere to epithelia cells in localized 
microcoloines and cause attaching and 
effacing lesions 
Usually occurs in infants.  Characterized by low-grade fever, 
malaise, vomiting, and diarrhoea, with a prominent amount 
of mucus, but with no gross blood 
Enteroinvasive E.coli (EIEC) Invade Epithelial Cells 
Dysenter; hallmarks are fever and colitis.  Symptoms are 
urgency and tenesmus; blood, mucus, and many leukocyts 
in stool 
Enterohemorrhagic E.coil (EHEC) Elaboration of cytotoxins (Stx) Bloody diarrhoea without WBCs.  Often no fever. Abdominal pains is common, may progress to HUS 
Enteroaggregative E.coli (EaggEc or EAEC) Adhere to epithelial cells in a pattern resembling a pile of stacked bricks 
Watery diarrhoea, vomiting, dehydration and less 
commonly, abdominal pain. 
(Koneman et al., 1997) 
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Traditionally pathotypes are assigned on the basis of clinical symptomology and the 
possession of certain virulence genes.  More recently, virulence genes are being identified 
in numerous different pathotypes e.g. EAST1 which is an EaggEC gene (Table 1.3), but it 
has also been identified in ETEC isolates (Choi et al., 2001). 
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Table 1.3: Serotypes and virulence genes associated with the nine different classes of pathotypes. 
 
Pathotype Serotype Typical Virulence Gene/Gene Products Additional Virulence Genes/Gen Products Identified 
ETEC 
O6, O8, O11, O15, O11, O15, O20, O25, O27, O63, 
O78, O86, O127, O128, O146, O148, O149, O153, 
O159, O167, O169, O173 
STa (STI), STb (STII),  LT, F4, F5, F6, F18, 
F41 
uidA, IngA, sth, stp, leoA, 
rfbO101, F17A, F17G, cfaI, cs1, 
cs3, rfc04, paa, aidA, cdt, east1 
EPEC O6, O18, O26, O55, O63, O86, O111, O114, O119, O125, O126, O127, O128, O142, O153, O166 eaeA, LEE, bfpA, tir, esp, EAF cdt 
EIEC O28, O29, O112, O124, O136, O143, O144,O152, O159, O164, O167 ipaC, ipaH inVX 
EHEC O26, O55, O91, O103, O104, O111, O113, O117, O133, O145, O157 ehxA, eaeA, stx1, stx2 
etpD, KatP, 19075, rfbEO157, 
rfbO111, rfbEO157H7, rtx, esp, 
tir, east1 
EaggEC 
or EAEC 
O3, O6, O8, O15, O18, O25, O27, O128, O44, O86, 
O77, O111, O119, O126, O127, O146, O153, O158, 
O159, O166, O168, O169 
aggA, aggC, east1, Pet aspU, AAF/I, virK, shf, she, iuCA, fepC, fyuA, chuA, pic, aafA 
STEC O5, O8, O18,O22, O26, O91, O103, O111, O113, O118, O128, O145, O153, O157, exhA, eaeA, stx1, stx2 saa 
DAEC O44, O86, O126, O127, O158 Afa/Dr, LEE, hlyA, P pilli, aidA irp2, iuC, iroNE.coli, F1845, shu, modD, dra, daa 
NTEC O2, O4, O8, O15, O18, O23, O45,O54, O55, O63, O78, O86, O88, O103, O117, O132, O140 cnf1, cnf2, cdt, cdt-III 
Afa, hlyA, P pilli, F17, pap/prs, 
sfa/foc, afa-8 
ExPEC O1, O1/O2, O4, O6, O15, O18, O75 
papA, papG, sfa/foc, sfa/S, iha, fimH, hlyA, 
cnf1, cdtB, iutA, iroNE.coli, fyuA, ireA, iss, 
ompT, malX, F1C, chu, aer, afaI, cdt, uspA, 
traT, sfaDE, clpG, nfaE, ompA, PAI, cvaC, 
KpsmTII, KpsmTIII, hlyC, focG, bmaE, cs31A, 
drb122, kfiB, afa, papEF, papC, papAH 
F165 
(Bekal, 2003; Benz, 1989; Benz, 1992; Bettleheim, 2003; Bilge et al., 1989; Blanc-Potard et al., 2002; Blank et al., 2000; Choi et al., 2001; Czeculin et 
al., 1999; De Rycke et al., 1999; Dezfulan et al., 2003; Garabal et al., 1996; Guignot et al., 2000; Guyer et al., 1998; Hudault et al., 2004; Johnson et al., 
1997; Johnson, 2002; LeBouguenec et al., 1992; Mainil et al., 2003; Mangia et al., 1999; Morin et al., 2002; Nataro & Kaper, 1998; Oelsctlaeger et al., 
2002; Okeke et al., 2004; Osek, 1998; Paciorek, 2002; Paton & Paton, 2002; Peres et al., 1997; Pickett & Whitehouse, 1999; Ratchtrachenchai, et al., 
2004; Scaletsky et al., 1999; Schmidt et al., 1999; Troth, 2003; Van Bost et al., 2001). 
Enterotoxigenic Escherichia coli (ETEC): ETEC are defined as containing at least one or 
a combination of the enterotoxins; heat-stable enterotoxin (ST) and heat-labile enterotoxin 
(LT) (Levine, 1987).  ETEC are an important cause of diarrhoea and death in humans and 
animals (Dubreuil, 1997; Nataro & Kaper, 1998).  In humans, ETEC diarrhoea resulting in 
death has been attributed to 380,000 deaths annually in children from developing countries 
(WHO, 1998), while it is also attributed to the main cause of travelers diarrhoea (Black, 
1990).  In animals ETEC are primarily associated with young animals such as cattle (Jay et 
al., 2004) and pigs (Nataro & Kaper, 1998; Wilson & Francis, 1986).  ETEC infection in 
neonatal and weaner pigs is a major problem for the pig farmers, this will be discussed 
later.    
  
ETEC infect the small bowel mucosa (Nataro & Kaper, 1998).  Isolates that carry the F4 
(K88) fimbriae are capable of colonizing the entire small intestine, while isolates carry F5 
(K99), F6 (987P) and F41 are only capable of colonizing the ileum (Bertschinger & 
Fairbrother, 1999; Hohmann & Wilson, 1975; Sojka, 1965).  Fimbriae expression allows 
ETEC to attach to intestinal epithelium, where it can colonise, multiply and express 
endotoxins which induce water and electrolyte loss from the intestine in the form of 
diarrhoea (Jay et al., 2004; Nataro & Kaper, 1998; Smith & Linggood, 1971; Sojka, 1965). 
 
LT are oligomeric toxins which are structurally and functionally related to the chlorea 
enterotoxin (CT).  Commonalities include; a holotoxin structure, protein sequence, primary 
receptor identity, enzymatic activity and activity in animal and cell culture systems 
(Dickinson & Clements, 1995; Nataro & Kaper, 1998).  There are two types of LT; LT-I 
and LTII.  LT-I has been identified in isolates from humans and animals, while LT-II is 
primarily found in animal ETEC (Nataro & Kaper, 1998).  Their function is similar but 
they bind to different receptors; LT-I to GM1 while LT-II binds to GD1 (Fukuta et al., 
1988; Nataro & Kaper, 1998). 
 
LT is encoded by the gene elt (or etx), which is located on a plasmid, that may contain the 
genes encoding ST and/or the colonization factor antigens (CFAs) (Nataro & Kaper, 1998).  
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LT-I consists of an A subunit (28 kDa) and five identical B subunits (11.5 kDa) (Hofstra & 
Witholy, 1985; Robertson, 1988; Sixma et al., 1991; Streatfield et al., 1992).  Enzymatic 
activity of the toxin is the responsibility of the A subunit, while the B subunit binds the 
ganglioside GM1 which acts as receptors on cell membranes (Gyles et al., 1994; Nagy & 
Fekete, 1999; Nataro & Kaper, 1998; Teneberg et al., 1994).  The cellular target of LT is 
adenylate cyclase located on the basolateral membrane of polarized intestinal epithelial 
cells.  LT reaches its target by being endocytosed and translocated through the cell via 
trans-golgi vesicular transport (Lencer et al., 1995).  Once bound adenylate cyclase activity 
is stimulated by actions of the A subunit transferring ADP-ribosyl moiety from NAD to the 
alpha subunit of GTP-binding protein (Gs).  Adenylate cyclase becomes permanently 
activated, resulting in increased levels of intracellular cyclic AMP (cAMP).  The persistent 
elevation of cAMP results in the stimulation of Cl- secretion from secretory crypt cells and 
inhibition of NaCl absorption by the villus tip cells.  The increased ion content results in 
osmotic or watery diarrhoea (Gyles, 1994; Nataro & Kaper, 1998; Uzzau & Fasano, 2000). 
 
The genes that encode the heat stable toxins (estA) are predominantly located on plasmids, 
they have also been identified on transposons.  ST are small monomeric toxins that are heat 
stable due to the disulfide bonds between the multiple cystein residues (Nataro & Kaper, 
1998).  ST enterotoxins are divided into two classes; STa and STb.  These toxins are 
different in both structure and mechanism of action (Gyles, 1994; Nataro & Kaper, 1998; 
Rose et al., 1987).  STa is a small nonimmunogenic protein with a  molecular weight of 2 
kDa.  There are two variants of the STa; STp (STporcine or STIa) and STh (SThuman or 
STIb).  STa binds to guanylate cyclase C (GC-C), located in the apical membrane of 
intestinal epithelial cells, once bound it stimulates intracellular enzymatic activity (Nataro 
& Kaper, 1998).  The result is increased intracellular cGMP levels (Crane et al., 1992; 
Mezoff et al., 1992; Sears & Kaper, 1996) and reduced absorption of water and 
electrolytes, the net result is intestinal fluid secretion (Nataro & Kaper, 1998). 
 
The STb toxin is encoded by the estB gene, which is responsible for synthesis of the mature 
protein, a 48 amino acid protein with a molecular weight of 5.1 kDa (Arriaga et al., 1995; 
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Dreyfus et al., 1992) and is primarily associated with ETEC of porcine origin (Nataro & 
Kaper, 1998).  STb stimulates secretion of bicarbonate from intestinal cells (Sears & Kaper, 
1996), and stimulates the release of PGE2 and serotonin (Fujii et al., 1995; Hitotsubashi, 
1993), while also increasing intracellular calcium levels from extracellular sources 
(Dreyfus et al., 1993).  Unlike STa and LT, STb induces histological damage to the 
intestinal epithelium which consists of loss of villus epithelial cells, and partical villus 
atrophy (Fujii et al., 1995; Rose et al., 1987), this damage may be responsible for the 
impaired absorption of fluids (Whipp et al., 1987). 
 
ETEC were initially though to carry the fimbrial adhesins (F4, F5, F6, F18 & F41) and the 
toxin genes ST and LT, and the colonization factors (CFA), however more virulence genes 
are being associated with ETEC including: east1, aidA, paa and cdt (Choi et al., 2001; da 
Silva & da Silva Leite, 2002; Niewerth et al., 2002).  There are a variety of serotypes of 
ETEC identified, yet in the case of ETEC isolated from clinical cases of porcine diarrhoea 
the serotypes are isolated to a common subset: O8, O9, O101, O141, O149 (Gyles, 1994).   
 
Enteropathogenic Escherichia coli (EPEC): EPEC usually cause disease in infants 
younger than 2 years of age (Bokete et al., 1997; Cravioto et al., 1988; Gomes et al., 1989; 
Levine & Edelman, 1984; Robins-Browne et al., 1982; Robins-Browne, 1987).  Infections 
involve acute, profuse watery diarrhoea, with vomiting and low grade fever, and 
occasionally there is a presence of faecal leukocytes (Miller et al., 1994; Nataro & Kaper, 
1998).  EPEC are capable of colonizing any region of the small intestine.  The defining 
characteristic of EPEC is the presence of the locus of enterocyte effacement (LEE) (Nataro 
& Kaper, 1998).   
 
LEE has three separate domains; (i) the eaeA gene which encodes for the adhesion, intimin 
and the gene coding for the translocated intimin receptor (Tir), (ii) the Type III secretion 
system that directs the secretion of bacterial proteins, and (iii) the EPEC-secreted proteins 
(Esp), which are involved the induction of the signal transduction pathways within the 
epithelial cells.  Esp also induce elevation of intracellular leaves of Ca2+ and inositol 
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phosphate and phosphorylation of cellular proteins (Donnenberg & Kaper, 1992; Nataro & 
Kaper, 1998). 
 
EPEC infection involves a process of events which include: (i) localized adherence (LA), 
(ii) signal transduction, and (iii) intimate attachment (Donnenberg & Kaper, 1992).  Initial 
attachment is mediated by pili which loosely attach bacteria to the epithelium.  Bacteria 
secrete Tir a 90 kDa tyrosine phosphorylated protein into epithelial cells, which is then 
incorporated into the apical membrane by the type III secretion system.  Tir serves as a 
receptor for intimin adhesion (Rosenshine et al., 1996).  Intimin is a 94-97 kDa outer 
membrane protein responsible for the intimate adherence of EPEC to epithelial cells.  
Bacterial and epithelial cell interactions result in the development of ultrastructural 
alterations and the formation of A/E lesions which mediate bacterial attachment.  Below the 
bacteria is an accumulation of polymerized actin, which results in a pedestal like structure 
which the bacteria sit on (Moon et al., 1983).  Actin rearrangement is involved in 
internalization of a subpopulation of EPEC by epithelial cells.  The A/E lesions result in 
effacement of brush border microvilli (Frankel et al., 2001).  A detailed explanation of 
EPEC infections was reviewed by Nataro & Kaper, 1998. 
 
Enteroinvasive Escherichia coli (EIEC): The knowledge of the pathogenesis of EIEC is 
still limited, what is known is that EIEC are biochemically, genetically, and 
pathogenetically similar to Shigella species (Nataro & Kaper, 1998).  EIEC cause Shigella-
like dysentic enteritis in humans (Formal & Hornick, 1978; Simi et al., 2002).  Infection 
characteristically includes a period of watery diarrhoea which can result in the onset of 
scanty dysenteric stools containing blood and mucus (Nataro & Kapter, 1998). 
 
The infection site is the colonic mucosa, where EIEC invade epithelial cells, including M 
cells and also macrophages (Sansonetti, 2001).  Once invasion occurs, bacteria multiply 
within the cell and then spread to adjacent cells, resulting in severe inflammation of the 
colon and severe desquamation and ulceration and destruction of the mucosa (Hale et al., 
1985; Nataro & Kaper, 1998; Sansonetti, 2001). 
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Enterohaemorrhagic Escherichia coli (EHEC): EHEC isolates are defined on the 
possession of one or both of the shiga toxin genes; stx1 and stx2.  Symptomology of 
diarrhoea attributed to EHEC isolates is bloody diarrhoea with abdominal pain, rarely 
associated with fever.  Sometimes EHEC infections can progress to haemolytic uremic 
syndrome (HUS) or haemorrhagic colitis (HC) (Beutin et al., 2004; Blanco et al., 2003; 
Blanco et al., 2004; Karmali, 1989; Koneman et al., 1997; Paton & Paton, 1998).  Transfer 
of EHEC isolates is generally through food and water, although person to person transfer 
may occur.  Most reported incidences of EHEC infection are a result of contaminated food 
of bovine origin (Blanco et al., 2003; Blanco et al., 1997; Meichtri et al., 2004, Parma et 
al., 2000).   
 
Within the EHEC pathotype there is a subclass of E. coli called shiga toxin producing E. 
coli (STEC).  STEC are also regarded as verotoxin producing E. coli (VTEC).  STEC is the 
general name given to E. coli of animal origin which carry one or both of the shiga toxin 
genes.  STEC isolates are not necessarily pathogenic isolates, especially in ruminants, 
whereas EHEC isolates are always pathogenic.  STEC have been described as a pathogen 
of emerging importance in the cause of morbidity and mortality in humans (Bettelheim, 
2003; Blanco et al., 2004).    Most reported outbreaks of STEC infections are attributed to 
the serotype O157:H7 (Center for Disease Control, 1993; Riley et al., 1983; Watanabe et 
al., 1996).  A number of non-O157 STEC have also been implicated in human disease with 
reported outbreaks of O4:H-, O45:H2, O111:H- and O145:H- in the United States of 
America (Tzipori et al., 1988), O4:H5 and O111:H2 in Australia (Gunzburg et al., 1988) 
and O26:H11, O104:H2, O153:H25, O163:H19, O5:H-, O5:H7 and O103:H2 in the United 
Kingdom (Dorn et al., 1989; Scotland et al., 1988; Bettelheim, 2003).  Studies have 
confirmed that ruminant derived STEC are potential human pathogens (Bettelheim, 2003; 
Djordjevic et al., 2001; Pradel et al., 2001; Ramachandran et al., 2001). 
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Enteroaggregative Escherichia coli (EaggEC or EAEC): Enteroaggregative E. coli are 
typically associated with watery, mucus secreting diarrhoea in young children.  These 
bacteria were initially named based on their pattern of aggregative adherence (AA) which 
forms a characteristic stacked-brick configuration when adhering to HEp-2 cells in culture 
(Nataro & Kaper, 1998).  More recently, EaggEC have been described as a pathogen of 
emerging importance based on its increasing isolation rate in diarrhoea in young children 
(Table 1.4) (Presterl et al., 2003).  EaggEC is associated with diarrhoea in children, 
particularly in cases of persistent chronic diarrhoea (lasting in excess of 14 days) originally 
thought to be only found in developing countries.  It is more frequently being reported in 
industrialized countries (Nataro et al., 1998).  Recently EaggEC has been isolated from 
cases of travellers’s diarrhoea.  50 of 517 patients who had diarrhoea and had been 
traveling in different tropical countries, contracted diarrhoea which was associated with 
EaggEC (Vila et al., 2001). 
 
Table 1.4: Incidence of E. coli pathotypes; EAEC, EPEC, ETEC, EIEC and EHEC/STEC 
isolated from children with clinical cases of diarrhoea 
 
Country EAEC EPEC ETEC EIEC EHEC/STEC 
Thailand  10.2% 3.2% 3% 0.5% 0.04% 
Taiwan  8.7% 4% 3.3% 2.7% 0% 
Switzerland  10.2% 10% 4.3% 1.1% 1.6% 
   (Pabst et al., 2003; Ratchtrachenchai et al., 2004; Teng et al., 2004) 
 
Diarrhoea associated with EaggEC is predominantly secretory based on the mode of 
pathogenesis.  Mucosal adherence is mediated by aggregative adherence fimbriae (AAF).  
Once attached, EaggEC enhance mucus secretion which trap bacteria in a bacterium-mucus 
biofilm.  The elaboration of toxins results in damage to the mucosa and intestinal secretion, 
leading to exfoliation of epithelial cells and mucus into the lumen, and watery diarrhoea 
with excess mucus (Nataro et al., 1998).  Infection of rabbit and rat ileal loop models with 
EaggEC have resulted in shortening of villi, haemorrhagic necrosis of villous tips and a 
mild inflammatory response with oedema and mononuclear infiltration of the submucosa 
(Vial et al., 1988).  In vitro experiments using the human intestinal carcinoma cell line T84 
infected with EaggEC strain O42 resulted in cytotoxic effects with vesiculation of 
1. 36 
microvillar membrane occurring, accompanied by increased vacuole formation and 
separation of the nucleus from the surrounding cytoplasm.  The result was cell death and 
exfoliation of cells from the monolayer (Nataro et al., 1996).   
 
Diffusely Adhering Escherichia coli (DAEC): DAEC was initially used to describe the 
pattern of adherence that some E. coli expressed when attaching to HEp-2 and HeLa cells 
(Nataro & Kaper, 1998).  E. coli strains that cause non-bloody diarrhoea in infants adhere 
to HEp-2 and HeLa cells in culture in three different patterns: (i) localized adherence (LA, 
Figure 1.7A), where bacteria only bind to one or two regions on the cells; (ii) diffuse 
adherence (DA, Figure 1.7B) (Scaletsky et al., 1984), bacteria attach uniformly across the 
whole cell, and (iii) enteroadherent aggregative adherence (AA, Figure 1.7C), bacteria 
display a stacked-brick like arrangement on the surface of cells (Nataro et al., 1987). 
 
 
 A 
 
 
 
 
 
 
          
 
 
 
(Nataro & Kaper, 1998) 
 
Figure 1.7: Patterns of adherence of diarrhoeagenic E. coli adhering to HEp-2 cells; 
localized adherent pattern (A), diffusely adherent pattern (B) and aggregative adherence 
pattern (C). 
B 
C 
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For many years there was controversy in the validity of the DAEC pathotype, as studies had 
demonstrated similar numbers of DAEC strains being recovered from children with 
diarrhoea (20.7%) and healthy children (17.3%) (Scaletsky et al., 2002).  This is consistent 
with the findings of other researchers (Giron et al., 1991; Jallat et al., 1993).    
 
DAEC is typically associated with infantile diarrhoea in humans (Bilge et al., 1989; Benz 
& Schmidt, 1989; Giron et al., 1991; Jallat et al., 1993; Scaletsky et al., 1999, 2002). It has 
also been implicated in uropathogenic infections (Blanc-Potard et al., 2002).  Two distinct 
subclass have been identified; (i) DA-EPEC, and (ii) Afa/Dr DAEC.  The subclass DA-
EPEC contains a homologue of the locus of enterocyte effacement (LEE), like found in 
EPEC strains (Beinke et al., 1998).  The DAEC subclass express the Afa/Dr  family (Afa-I, 
Afa-III, Dr, Dr-II, and F1845) which recognize the decay-accelerating factor (DAF or 
CD55) (Nowicki et al., 2001).  The EC7372 strain which is an Afa/Dr DAEC subclass has 
been identified containing a PAI (pathogencity island) similar to the uropathogenic strain 
CFT073 (PAICFT073) (Guignot et al., 2000) which encodes the UTI virulence determinants 
hlyA and P pili (Guyer et al., 1998 
 
Necrotoxigenic Escherichia coli (NTEC): Necrotoxigenic E. coli produce the toxin 
cytotoxic necrotising factor (CNF).  NTEC are considered as emerging human and animal 
pathogens which have been implicated in extraintestinal and intestinal infections (De Rycke 
et al., 1999), as well as being identified in healthy cattle (Orden et al., 2002; Osek, 2001).  
Molecular analysis has revealed distinct classes of NTEC; NTEC1 and NTEC2.  This 
classification is based on the type of CNF carried; CNF1 or CNF2 (DeRycke et al., 1999). 
 
CNF1 and CNF2 are highly homologous holoproteins which contain 1014 amino acids that 
exert lethal and necrotic activities in vivo and are capable of inducing multi-nucleation and 
actin stress fibres in cell cultures (DeRycke et al., 1999).  CNF1 is located on a 
pathogenicity island along with hlyA and P fimbria (Oswald & De Rycke, 1990), while 
CNF2 is encoded by the Vir plasmid along with F17 (Oswald et al., 1991; El Mazourai et 
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al., 1994; Peres et al., 1997), and AFA (Mainil et al., 1997).  CNF1 and CNF2 are 
specifically associated with NTEC1 and NTEC2, respectively.   
 
NTEC1 strains have been isolated from cases of enteritis in ruminants, pigs, dogs, rabbits 
and horses and extraintestinal infections in pigs, dogs, cats and humans (DeRycke et al., 
1999).  NTEC2 has been identified in ruminants with intestinal infections or septicemia 
(Blanco et al., 1996; Cid et al., 1996; Pohl et al., 1997).  More recently a study of E. coli 
collected from diseased calves between 1958 and 1970 identified 7-8% of invasive and 
faecal E. coli was NTEC.  Of these isolates 26 or 30 were NTEC2, with 5 or 35 faecal 
NTEC being NTEC1 (Van Bost et al., 2001).  NTEC strains have also been implicated in 
diarrhoea in dogs with 19 of the 24 strains being classified as NTEC1 carrying CNF1 
(Starcic et al., 2002). 
 
Extraintestinal Escherichia coli (ExPEC):  Extraintestinal E. coli infections are common 
in all age groups and can involve almost any organ or anatomical site, including; urinary 
tract infection (UTI), meningitis (mostly in neonates and after neurosurgery), divers 
intraabdominal infection, osteomyelitis, and soft-tissue infection which usually occurs 
when the tissue is compromised.  E. coli is primarily considered to be a community 
acquired pathogen where it is the most frequently isolated gram negative bacillus found in 
long term care facilities and hospitals (Roberts et al., 1991).  If an infection occurs, severe 
illness and death can occur in otherwise healthy hosts, but adverse outcomes are 
considerably more likely with immunoimpaired host defences (Russo & Johnson, 2000).  
ExPEC appear to be incapable of causing enteric disease but they can stably colonize the 
host intestinal tracts and may constitute the predominant strain in ~20% of healthy human 
hosts (Johnson, 1991). 
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1.3.2 Enterococci 
Enterococci are gram positive organisms that are cocci shaped and occur either singly, in 
pairs or short chains (Koneman, 1997; Tendolkar et al., 2003).  Gram positive members of 
the order Eubacteria can be classified into genera using biochemical methods (Table A1.3, 
Appendix 1).  Within the genus Enterococcus there are 23 identified species (Klare et al., 
2001; Tendolkar et al., 2003), these are facultative aerobes which can be classified using 
differential media and diagnostic reactions to separate the species (Table A1.4 & A1.5 
Appendix 1)(Koneman, 1997, Madigan et al., 1997). 
 
Enterococci are one of the predominant inhabitants of the intestinal tract of humans and 
most animals, and like E. coli they are one of the first organisms to colonise the intestinal 
tract (Klare et al., 2001).  In their natural environment, enterococci are harmless 
commensals.  When the natural bacterial balance is displaced, these commensals can turn 
rogue and act upon their host inflicting disease (Tendolkar et al., 2003).  The incidence of 
enterococcal associated infections has increased in the past 20 years (Klare et al., 2001; 
Koneman et al., 1997; Madigan et al., 1997; Simjee et al., 2002; Woodford et al., 1998), 
and is believed to be the direct result of the overuse of antibiotics in today’s society (Bager 
et al., 1997; JETACAR report, 1999; Torres et al., 2003).  The increase in enterococci 
infection is believed to be a direct result of the increased use of third generation 
cephalosporins, against which enterococci have natural resistance, and the use of broad-
spectrum antibiotics (e.g. quinolones) which have only intermediate activity against 
enterococci (JETACAR report, 1999; Klare et al., 2001).  Antibiotics are being used to 
either neutralize a primary infection or prevent infection in an open wound.  This 
neutralises the infectious agent along with the commensal bacteria.  Antibiotic resistant 
enterococci isolates can colonise and dominate because they have a competitive advantage 
over other isolates.  If the opportunity arises for a commensal isolate carrying virulence 
genes to cause disease, they are equipped to do so.  For this reason E. faecalis is isolated in 
90% of nosocomial (latin word for hospital) infections as it carries a number of virulence 
genes (to be discussed later), unlike its counterpart E. faecium (responsible for 10% of 
nosocomial infections), which only possess a few genes, however to compensate for this E. 
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faecium has a more impressive antimicrobial resistance profile (Bertuccini, 2002; Huycke 
et al., 1998; Klare et al., 2001).  
 
Enterococci are now the second highest cause of nosocomial infections in today’s society 
after E. coli (Gin & Zhanel, 1996; Maki & Agger, 1988; Murray, 1990).  Their selective 
advantage against other bacteria is based on their resistance to antibiotics, in the form of 
both natural (intrinsic) and acquired resistance (Klare et al., 1997; Koneman, 1997; 
Madigan et al., 1997; Tendolkar et al., 2003).  The majority of enterococcal infections are 
hospital acquired infections, where the infective agent is either part of the patient’s normal 
flora or originates from the hospital environment (Klare et al., 1997, Koneman, 1997, 
Madigan et al., 1997).  The major sites of infections due to enterococci include: urinary 
tract infection (UTI), surgical wounds, respiratory tract infections and septicemia (Table 
1.5) (Madigan et al., 1997).  
 
Table 1.5:  Major sites and pathogen distribution for nosocomial infections.                                             
  Pathogen Urinary tract infection (%) 
Surgical 
wound (%) 
Respiratory 
tract (%) 
Septicemia 
(%) 
Escherichia coli 26 10 6 6 
Enterococcus 16 3 2 8 
Pseudomonas aeruginosa 12 8 17 4 
Staphylococcus aureus 2 17 16 16 
Staphylococcus spp. 
(coagulase-negative) 4 12 2 27 
Candida spp. 9 2 5 8 
Streptococcus spp. 0 3 1 4 
Other gram negative 
organisms 20 18 26 12 
All other organisms 11 27 25 15 
         (Madigan et al., 1997) 
 
 
Another major concern for the overuse of antibiotics is the practice of the animal industry.  
In the past 30 years, animal feed has been supplemented with antimicrobial agents (growth 
promontants).  This practice is occurring worldwide because of its direct result on the 
growth performance of the animal (JETACAR report, 1999).  The direct effect of growth 
promotants is not fully understood, it has been suggested that bacterial populations that are 
1. 41 
diverting nutrients away from the animal are being suppressed by growth promotants.  This 
in turn results in increased growth and improved meat quality in terms of higher protein 
content and less fat (JETACAR report, 1999).  The beneficial effects of growth promotants 
generates higher profits for the producer.  The use of growth promotants is a selective 
pressure which is being directly applied to bacterial populations.  The bacteria that are 
sensitive to the antimicrobials are being suppressed or destroyed, nevertheless this opens 
the door for bacteria like enterococci which are naturally resistant, allowing them to have a 
more dominant role (Klare et al., 2001).  There are two main reasons for this occurrence; (i) 
resistant pathogens are being transferred from the animal populations to human populations 
and/or (ii) resistant genes are being transferred amongst bacterial populations in both 
humans and animals (Figure 1.8) (JETACAR report 1999).   
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         (JETACAR report, 1999)  
Antibiotic use in 
animals amplifies 
resistant bacteria 
Antibiotic use in 
humans amplifies 
resistant bacteria 
Step 1: Emergence of antibiotic resistant 
bacteria in animals 
Step 2: Spread of resistant bacteria from 
animals to humans 
Step 3: Clinical disease in humans 
Emergence of antibiotic-resistant 
bacteria in humans 
Transfer of antibiotic-resistance 
genes between animal bacteria 
Additional Step 2: Transfer of 
antibiotic resistance genes from 
animals to human bacteria 
Transfer of antibiotic-resistance 
genes from human to other human 
bacteria 
 
 
Figure 1.8: Spread of antibiotic resistant bacteria and/or transfer of antibiotic resistance 
genes from animals to humans (and humans to humans). 
 
 
1.3.2.1 Antibiotics  
Antibiotics are a microorganism’s ways of defending itself.  These chemical substances are 
produced for the purpose of inhibiting (bacteriostatic effect) or killing (bactericidal effect) 
other microorgansims.  Commercialisation of antimicrobials has led to the discovery of a 
wide range of antimicrobials and the development of synthetic antibiotics.  Table 1.6 lists 
the antibiotics used in humans in Australia according to the JETACAR report in 1999, and 
also includes the mode of action and the effect on the microorganism.  Of the numerous 
antibiotics available, the microorganisms they affect and the degree of the effect varies.  
There are five different modes of actions (Figure 1.9) by which antimicrobials work; (i) 
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Figure 1.9: Mode of action of major antibacterial antibiotics and growth factor analogs; 
THF=tetrahydrofolate; DHF=dihydrofolate; mRNA=messenger RNA; tRNA=transfer RNA 
(Madigan et al., 1997). 
         (Madigan et al., 1997) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
inhibition of cell wall synthesis, (ii) inhibition of protein synthesis, (iii) injury to plasma 
membrane, (iv) inhibition of nucleic acid replication and transcription and (v) inhibition of 
synthesis to essential metabolites (Reviewed in Madigan et al., 1997 & Tortora, 1995).   
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Table 1.6: Summary and description of antibiotic usage in humans in Australia, including the effect on the microorganism and 
the mode of action. 
Antibiotic Effect on Microorgansim Mode of action Clinical use/Toxicity 
Narrow-spectrum penicillins 
Benzylpenicillin (penG) 
phenoxymethylpenicillin (pen V) 
Procaine 
Benzathine pencillins 
Bactericidal Inhibition of cell wall synthesis Active against gram-positive bacteria (e.g. streptococci, enterococci) and some anaerobes 
Moderate-spectrum penicillins 
Aminopenicillins (amoxicillin, 
ampicillin) Bactericidal 
Inhibition of cell 
wall synthesis 
Active against GNR (e.g. E. coli, Klebsiella) plus Haemophilus influenzae, destroyed by staphylococcal β-
lactamase enzymes 
Broad-spectrum penicillins 
Antipseudomonal penicillins 
(piperacillin, ticarcillin)  
β-lactamase inhibitors (clavulanate, 
tazobactam) 
Bactericidal Inhibition of cell wall synthesis 
Similar to amoxil but have antipseudomonal activity and some additional gram negative activity e.g. Klebsiella 
Used for combination treatment (e.g. with amoxil, ticarcillin, piperacillin) to prevent β-lactamase destruction of 
partner compound (e.g. amoxil against S. aureus) 
Other penicillins 
Antistaph penicillins (Dicloxacillin, 
flucloxacillin, cloxacillin, methicillin) Bactericidal 
Inhibition of cell 
wall synthesis Essential treatment against S. aureus.  Not destroyed by straphlococcal β-lactamase 
Cephalosporins 
1st generation (cephalexin, cefaclor, 
cephalothin, cephazolin) 
2nd generation (cephamandole, 
cefotetan, cefoxitin) 
3rd generation (cefotaxime, 
ceftriaxone) 
4th generation (ceftazidime, 
ccefpirome, cefepime) 
Bactericidal Inhibition of cell wall synthesis 
Widely used broad-spectrum, no activity against enterococci or MRSA. Same activity as amoxil, but also against 
staphylococci and better against GNR  
Slightly increased activity against GNR. Some activity against anaerobes 
Slightly increased activity against GNR, less against staphylococci, main major advance in meningitis treatment. 
Also antipseudomonal 
Carbapenems 
Imipenem, meropenem Bactericidal Inhibition of cell wall synthesis 
β-lactams with broadest cover, no activity against MRSA or VRE, poor activity against xanthomonas, others are 
sensitive but some (e.g. pseudomonas) can develop resistance 
Monobactams 
Aztreonam   Little use in Australia, only active against GNR 
Aminoglycosides/aminocyclitols 
Paromomycin, neomycin, gentamicin, 
tobramycin, netilmicin, amikacin 
Spectinomycin 
Bactericidal Inhibition of protein synthesis 
Most predictably active against aerobic GNR (but more toxic than some other antibiotics). No activity against 
streptococci, enterococci or anaerobes 
Tetracyclines 
Demeclocycline, doxycycline, 
minocycline, tetracycline Bacteriostatic 
Inhibition of 
protein synthesis Mainly 2
nd line agents, useful for atypical infections e.g. mycoplasma, Chlamydia 
Sulfonomides-trimethoprim 
Sulfadiazine, trimethoprim, 
sulfamethoxazole (co-trimoxazole) Bacteriostatic 
Competitive 
inhibition 
Mainly 2nd line agents but with serious side effects, many are still sensitive.  Trimethoprim used alone to reduce 
side effects, very high resistance in organism such as pneumococci but still recommended drug for respiratory 
infection in developing countries.  Drug of choice for some condition e.g. pneumocystis in AIDS, nocardia  
Macrolides    
Azithromycin, clarithromycin, 
erythromycin, roxithromycin Bacterostatic 
Inhibition of 
protein synthesis 
Mainly for gram-positive infection (Staph and strep) but resistance is increasing. First choice for some conditions 
e.g. mycoplasma, chlaymdia.  
Lincosamides    
Clindamycin, lincomycin Bacterostatic Inhibition of protein synthesis Similar to macrolides 
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Table 1.6 continued. 
 
Antibiotic Effect on Microorgansim Mode of action Clinical use/Toxicity 
Glycopeptides 
Teicoplanin, vancomycin Bactericidal Inhibition of cell wall synthesis Last resort for many gram-positives including MRSA and for enterococci in allergic patients 
Nitroimidazoles 
Metronidazole, tinidazole   Very active against  anaerobes, also active against protozoans (e.g. giardia) which have few other options for therapy 
Quinolones    
Nalidixic acid Bacteriocidial Inhibit DNA synthesis  Active against most GNR 
Fluoroquinolones    
Ciprofloxacin, enoxacin, norfloxacin, 
ofloxacin   
Last major new class of human antibiotic, very active against GNR including some with no other oral 
treatments. May be only active agent against multiresistant Klebsiella or E. coli, poor activity against strep, 
not against anaerobes 
Stretogramins    
Quinupristin with dalfopristin Bactericidial Inhibition of protein synthesis New class, hopes it will be useful for resistant gram positive infection. 
Antimycobacterials    
Pyrazinamide, streptomycin, rifampicin, 
rifabutin, isoniazid, ethambutol Bacteriocidial 
Inhibition of 
protein synthesis 
Effective against tuberculosis but resistance is a problem and 2nd line drugs now have to be reused in some 
cases 
Antileprotics 
Clofazimine, rifampicin, dapsone   Very effective against leprosy but resistance is a problem especially if drugs not taken correctly 
Polypeptides 
Bacitracin, capreomycin, colistin, 
gramicidin, polymyzin B, thiostrepton   Colistin useful for pseudomonas, may need to be resurrected if multiple resistance occurs 
Miscellaneous 
Chloramphenicol 
Hexamine hippurate, nitrofurantoin 
Sodium fusidate 
  
Broad spectrum activity for respiratory tract infections and useful for oral therapy of meningitis but little use in 
developed countries. 
Fusidic acid very good in combination as antistaph, one of few orals for MRSA  
GNR=gram negative rod, MRSA=multiresistant Staphylococcus aureus, VRE=vancomycin resistant enterococci 
           (JETACAR report, 1999; Madigan et al., 1997) 
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1.3.2.2 Antibiotic resistance 
There are two forms of antibiotic resistance; (i) natural (intrinsic) and (ii) acquired.  
Intrinsic resistance is usually attributed to either bacterial physiology or the pharmacology 
of the antimicrobial drug, which may be designed to target certain types of bacteria, e.g. 
gram positive or gram negative.  Acquired resistance occurs because of mutations in DNA 
sequences which results in resistance to certain antibiotics, or the acquisition of new DNA 
either chromosomal or plasmid bone through lateral gene transfer (Reviewed in Klare et al., 
2001 & Koneman et al., 1997). 
 
The genes that regulate the mechanisms for resistance are either located on a chromosome 
or plasmid.  These genes are most commonly transferred by conjugation by transposons; 
transpososable genetic elements.  Transposons can carry either portions of plasmids or 
pieces of chromosomes, which are transferred between bacteria by conjugal transfer 
(conjugative transposon or ‘jumping genes’).  Transposons allow for the transfer of 
antimicrobial resistance genes between isolates of the same species as well as with bacteria 
of different species including the transfer of genes between gram negative and gram 
positive bacteria   (Courvalin, 1994).  The transfer of antimicrobial resistance genes allows 
bacteria that are ordinarily susceptible to certain antibiotics due to their physiology, to 
become resistant.  These genes are either switched on continuously (constitutive 
expression), or require inducement to be switched on (Koneman et al., 1997).  There are 
four common mechanisms by which bacteria overcome the effects of antibiotics: (i) 
enzymatic inactivation of antimicrobial agents, (ii) change in receptors for antibiotic 
attachment to critical structures, (iii) membrane permeability resistance to several classes of 
antibiotics, and (iv) bypass of metabolic block imposed by antibiotics (Reviewed in 
Koneman et al., 1997). 
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Table 1.7: Enterococci have both natural (intrinsic) and acquired resistance to antibiotics which include the antibiotics listed. 
(Klare et al., 2001; Koneman et al., 1997) 
Antibiotic Mechnisms/Examples 
Natural (intrinsic) resistance 
Isoxazolylpenicillins  
Cephalosporins Low-affinity penicillin-binding proteins 
Monobactams  
Aminoglycosides (low-level) Low-level: poor transport across membrane High-level: aminoglycoside-modifying enzyme 
Lincosamides (mostly) Ineffective against enterococci 
Polymyxins  
Glycopeptides (VanC types in E. 
gallinarium group) E. gallinarum, E. casseliflavus, E. flavescens have natural low level resistance (MIC 2-32 µg/ml) 
Streptogramins (in E. faecalis)  
Acquired resistance 
Tetracyclines Resistance is encoded by genes such as tetM and tetN, resulting from production of a protein that interacts with the ribosome so protein sysnthesis is unaffected by the antibiotic. 
Macrolides, Lincosamides and  
Streptomgramins 
High-level resistance to macrolides (e.g. erythromycin) and lincosamides (e.g. clindamycin) is often 
encode on conjugative plasmids with vanA gene cluster.  Resistance is encoded by ermB gene 
cluster conferring resistance via a methylation of an adenosine residue in the bacterial 23S rRNA. 
Aminoglycosides (high-level) 
Resistance is due to acquisition of genes encoding aminoglycoside modifying enzymes 
(aminoglycoside nucleotidyl transferases, ANT; aminoglycoside acetyltransferases, ACC; 
aminoglycoside phosphotransferases, APH). Streptomycin resistance based on ribosomal resistance 
or enzymatic modification of antibiotic by ANT, while kanamycin (and amikacin) due to 3’ APH.  A 
bifunctional enzyme exists (AAC(6’)/APH(2”) for high-level resistance to gentamicin, kanamycin and 
tobramycin and to all aminoglycosides except streptomycin. 
Chloramphenicol Mediated by a plasmid-encoded chloromphenicol acetyltransferase gene cat  
Trimethoprim/sulfamethoxazole  
Quinolones Mutations in the genes for A subunit of the gyrase (gyrA) and for ParC subunit of topoisomerase IV (parC) responsible for supercoiling status and decatenation of DNA. 
Glycopeptides (VanA, VanB, VanD, 
Van E) 
Van gene clusters consist of structural genes that encode different enzymes for regulation and 
expression of resistance. The mechanism of resistance results in modified target, the pentapeptide of 
the murein precursor to which glycopeptides cannot bind. 
Penicillins (High-level) Based on modifications in expression of binding affinities of essential penicillin binding proteins. Resistance is frequent in E. faecium (>50% strains), but rare in E. faecalis (≤1%) 
1.3.2.3 Enterococci and virulence genes 
The number of virulence genes currently associated with enterococci are limited with the 
majority of genes associated with E. faecalis and only a few associated with both E. 
faecalis and E. faecium.  Pathogenicity islands (PAI) have also been identified in 
enterococci.  The first PAI (150 kb, encoded 129 ORF’s, and has a significantly variant G + 
C content of 32.2% compared with the chromosomal average of 37.5%) was identified in a 
multiple antibiotic resistant strain of E. faecalis (MMH594).  The PAI contained genes that 
encoded transposases, transcriptional regulators and proteins with known or potential roles 
in virulence or adaptation and survival in different environments (Shankar et al., 2002).   
 
It is currently known there are a number of virulence genes identified in enterococci 
isolated from human clinical infections and generally these genes are not associated with 
human commensal enterococci, however some genes are found in both clinical and 
commensal isolates (Tendolkar et al., 2003).  The most commonly identified virulence 
genes are Esp (Enterococcal surface protein) and AS (aggregation substance), other factors 
include; secreted toxin cytolysin, secreted proteases, gelatinase and serine protease, 
enterococcal capsule, cell wall polysaccharide and extracellular superoxides (Dupre et al., 
2003; Semedo et al., 2003; Tendolkar et al., 2003; Vergis et al., 2002).   
 
Esp: One of the few genes identified in both E. faecalis and E. faecium clinical isolates.  
The structure of Esp consists of multiple repeat structure which allows for the expression of 
alternate forms that differ in the number of repeats.  The structure is comprised of a core 
region of which is 50% protein.  The first repeating unit is located downstream of the N-
terminal, three 84 residue repeats specified by nearly identical 252-nucleotide tandem 
repeating units (C-repeats), which encode reiterations of an 82-amino acid sequence which 
are flanked by B repeats.  These B repeats share 74% sequence identity at the amino acid 
level (Shankar et al., 1999; Tendolkar et al., 2003). 
 
AS: A pheromone inducible surface protein identified in E. faecalis.  AS contains two 
RGD motifs that have been found in fibronectin, and are commonly associated with 
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integrin-binding proteins (Kreft et al., 1992).  Different functions have been attributed to 
AS including mediation of adhesion in vitro to cultured renal tubular cells, promoting cell-
cell contact and adhesion to host cells, adhesion to extracellular matrix (ECM) proteins and 
increased cell surface hydrophobicity. Enterococci expressing AS have been found to be 
resistant to phagocytosis (Kreft et al., 1992; Sartingen et al., 2000; Tendolkar et al., 2003; 
Wells et al., 2000). 
 
Ace: Collagen-binding adhesin (Ace) has been identified in both pathogenic and 
commensal isolates of E. faecalis (Duh et al., 2001).  A homologue of Ace designated acm 
has been identified in E. faecium and demonstrated to be the primary adhesin responsible 
for E. faecium binding to collagen (Nallapareddy et al., 2003; Tendolkar et al., 2003).  Ace 
has been shown to mediate binding to an extracellular matrix component type 1 collagen 
(Rich et al., 1999).  Additional experiments have demonstrated binding to type IV collagen 
at 46oC, but not at 37oC (Nallapareddy et al., 2003). 
 
Cytolysin: Has been demonstrated to contribute to enterococcal virulence.  It is responsible 
for lysing a broad range of eukaryotic and prokaryotic cells (Ike et al., 1992).  Regulated by 
a two component regulatory system (cylR1 and CylR2) encoding a transmembrane protein, 
which is regulated by a quorum sensing mechanism (Semedo et al., 2003; Tendolkar et al., 
2003).  
 
Gelatinase, serine protease and the Fsr regulator: The Fsr locus regulates the expression 
of both gelatinase (encoded by gelE) and serine proteases (encoded by sprE).  Fsr, gelE and 
sprE have been identified in pathogenic E. faecalis isolates (Mylonakis et al., 2002; Pillai et 
al., 2002; Qin et al., 2000, 2001; Tendolkar et al., 2003; Vergis et al., 2002) 
 
Cell wall carbohydrate and capsular polysaccharide: Capsular polysaccharide operon 
encoded by cps which has been found to be specific for the enterococcal type carbohydrate.  
Both the cell wall carbohydrate and the capsular polysaccharide provide resistance to 
phagocytosis (Tendolkar et al., 2003). 
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Extracellular superoxide: E. faecalis from the bloodstream have been shown to produce 
substantial amount of superoxide (Huycke et al., 2001).  This indicates that E. faecalis 
could be a potent source of oxidative stress on the intestinal epithelium.  There may be a 
role for superoxide production in bacterial translocation across the epithelium or 
contribution to chromosomal instability associated with intestinal polyps and colorectal 
cancer (Tendolkar et al., 2003). 
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1.4 A Model for investigating intestinal health 
E. coli is the most commonly recovered bacterial species in clinical laboratories, and has 
been associated with disease involving virtually every human tissue and organ and in 
particular intestinal disease (Koneman , 1997).  E. coli has been extensively researched 
over the years with a vast array of information available in the literature about it.  For this 
reason it is a good candidate for investigating intestinal health.  This is even more so in 
pigs, as colibacillosis, E. coli associated diarrhoea is a major problem in the pig industry 
and the pig, which is so closely related to humans provides as excellent model to evaluate 
intestinal health. 
 
1.4.1 Intestinal diseases of pigs 
There are a number of disease that cause diarrhoea in both unweaned and weaned pigs.  
The most common cause of diarrhoea in unweaned pigs includes: colibacillosis, 
hypoglycemia, transmissible gastroenteritis (TGE), clostridial enteritis (CE), coccidosis, 
and rotaviral enteritis (RE) (Alexander, 1994; Straw et al., 1999).  Table 1.8 is taken from 
Straw et al., 1999 and details these diseases and additional diseases that are less prevalent.  
In recently weaned pigs diarrhoea can be attributed to a number of disease including: TGE, 
RE, lawsonia, and colibacillosis (Table 1.9). 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Disease Age when signs 
occur 
Morbidity Mortality Other signs in 
piglets 
Appearance of diarrhoea Onset and course 
Colibacillosis Anytime, but peck at 
1-4 days and 3 wks 
Variable, usually 
moderate.  
Typically all of one 
litter is affected 
Variable moderate Dehydration, pasty 
peritoneum, tail may 
necrose 
Yellowish white, watery with 
gas, fetid odour, pH 7-8 
Gradual onset and slow 
spread through the room.  
Severity worsens toward 
the end of farrowing group 
Epizootic transmissible 
gastroenteritis 
Any age over 1 day Near 100% Near 100% in pigs 
under 1 wk. Near 
)% in pigs over 4 
wks 
Vomiting, 
dehydrating 
Yellow-white (possibly 
greenish), watery, 
characteristic odor, pH 6-7 
Explosive, all litters affected 
at once 
Enzootic transmissible 
gastroenteritis 
6 days and older Moderate, 10-50% Low, 0-20% Vomiting, 
dehydration 
Yellow-white (possibly 
greenish), watery, 
characteristic odour, pH 6-7 
Litters affected sporadically, 
chronic low level 
Coccidiosis Not in pigs under 5 
days, Usually in 6-15 
(especially at 7) days 
of age 
Variable, up to 75% Usually low Gaunt, rough hair 
coat, lower weight at 
weaning 
Pasty to profuse, watery, 
yellow-grey, fetid, pH 7-8. 
Slow spread and gradual 
build-up 
Rotaviral enteritis 1-5 wks old Variable up to 75% Low, 5-20% Occasionally will 
vomit, gaunt, rough 
hair coat 
Watery, pasty with yellow curd 
like material, pH 6-7 
 
Epizootic: abrupt onset and 
rapid spread. Enzootic: like 
TGE 
99)               (Straw et al., 19
1. 53 
Table 1.8: Diseases that cause diarrhoea in unweaned pigs. 
Clostridium perfringes 
type C or A: PA: 
Peracute 
A: Acute 
SA: Subacute 
C: Chronic 
Typically 1-7 days old 
PA: 1 day 
A: 3 days 
SA: 5-7 days 
C: 10-14 days 
1-4 pigs per litter, 
often biggest, 
healthiest piglets 
are affected 
Nearly 100% of 
acutely affected 
pigs.  Higher 
survival if chronic 
PA: Paddling, 
prostration, 
occasional vomiting. 
SA: emaciation, 
rough hair coat 
PA: watery, yellow to bloody; 
A: reddish brown liquid faeces 
SA: non-haemorrhagic, watery, 
yellow-grey 
C: yellow-grey, mucoid 
Slow spread throughout the 
farrowing room.  All four 
forms may be seen at the 
same time in different litters 
Strongyloides 4-10 days  Up to 50% Dyspnea, CNS signs   
Swine dysentery 7 days and older.  
Especially 2 wks 
Sporadic by litters Low No dehydration Watery with blood and mucus, 
yellow-grey 
 
Salmonellosis 3 wks   Septicaemia Mucohaemorrhagic  
Erysipelas Usually over 1 wk Entire litter, 
sporadic 
Moderate to high  Watery  
Epizootic pseudorabies Any age, severe in 
younger piglets 
High, up to 100% High, 50-100% Dull, salivate, vomit, 
dyspnea, ataxia, 
CNS signs 
 Explosive outbreak in 
previously uninfected herd 
Hypoglycaemia 
(agalactia) 
Postpartum agalactia, 
1-3 days, inadequate 
underline 2-3 wks 
Variable, 5-15% of 
litters 
High in affected 
litters 
Weak, inactive, 
hypothermia, CNS 
signs 
Watery  
Toxoplasmosis Any age Variable Variable Dyspnea, CNS signs Watery  
Porcine epidemic 
diarrhoea 
Any age Variable, but often 
high 
Moderate to high Vomiting, 
dehydration 
Watery Explosive onset and rapid 
course 
 
 
 
Table 1.9: Diseases of recently weaned and older swine with diarrhoea. 
 
Blood Site of Lesions Possible Causes 
Diarrhoea, not bloody Small Intestine Transmissible gastroenteritis, 
rotaviral diarrhoea, Lawsonia-
related enteropathies (porcine 
intestinal adenomatosis [PIA]) 
Porcine epidemic diarrhoea 
 Large Intestine Salmonella enterocolitis, 
Oesophagostomum spp. 
 Both large and small intestine Tricothecene toxin 
 No gross lesions Colibacillosis. Lincomycin or 
tylosin. Early sign of oedema 
disease prior to neurologic 
signs. Acute leptospirosis 
Blood diarrhoea, melena Stomach Gastric ulceration 
 Large intestine, colon Swin dysentery. Trichuris suis, 
Salmonella enterocolitis 
 Both large and small intestine Proliferative haemorrhagic 
enteropathy. Tricothecene 
toxin. Intestinal anthrax 
          (Straw et al., 1999) 
 
 
1.4.1.1 Neonatal colibacillosis 
Neonatal colibacillosis is primarily associated with ETEC, which are the most frequent 
cause of diarrhoea worldwide (Alexander, 1994; DebRoy & Maddox, 2001; Nagy & 
Fekete, 1999).  Neonatal diarrhoea (ND) attributed to E. coli can occur in neonatal piglets 
as early as a few hours after birth up until 14 days of age when it is considered pre-weaning 
diarrhoea.  Most commonly ND occurs within 72 hours of life (Spicer et al., 1986), with 
the incidence of mortality decreasing in older piglets (Alexander, 1994; Fairbrother, 1999; 
Fahy et al., 1987a).  The initial signs of infection include raised hair and a slight shiver, 
which progresses to watery diarrhoea, varying from brown and watery or brightly coloured 
creamy-white, grey or fawn.  The onset of diarrhoea causes a piglet to deteriorate rapidly 
becoming thin, hairy, dehydrated and weak.  As the disease progresses eyes become dull 
and sunken, emaciation progresses and ribs, spinal and pelvic bones become increasingly 
prominent (Figure 1.10).  If treatment is not administered, piglets become recumbent, cold, 
and comatose, and then die (Alexander, 1994; Craven, 1970).  Generally the younger the 
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piglet infected the higher the rate of mortality, while older pigs usually survive, but 
experience reduced rate of growth (Alexander, 1994; Fairbrother, 1999; Fahy et al., 1987a).   
 
 
 
 
 
 
 
 
 
 
Figure 1.10: Neonatal piglet with ND, as the emaciation progresses, ribs, spinal and pelvic 
bones become increasingly prominent.  Photo provided by Dr Darren Trott, School of 
Veterinary Science, The University of Queensland. 
 
 
E. coli associated with ND are non-mucoid, β-haemolytic and of serotypes O8, O45, O138, 
O141, O147, O149 and O157 (Alexander, 1994; Fairbrother, 1999; Guinee & Jansen, 1979; 
Morris & Sojka, 1985; Sojka, 1971; Wilson & Francis, 1986; Harel et al., 1991) and 
express F4, LT alone or in combination with ST enterotoxins (Alexander, 1994; Moon & 
Whipp, 1970; Smith & Gyles, 1970; Whipp et al., 1981).  These strains were designated as 
typical ETEC strains and allocated a ‘class 1’ status.  More recently serotypes that include; 
O9, O64, and O101 that produce fimbrial antigens F5 (K99), F41 or F6 (987P) and ST 
enterotoxins (Fairbrother, 1992; Guinee & Jansen, 1979; Harnett & Gyles, 1985; Moon & 
Whipp, 1970; Moon et al., 1980).  The later serotypes are the same serotypes that have 
been identified in Australia, with O9, O8, O20, O101 and O157 predominantly isolated 
(Fahy, 1987a; Woodward et al., 1993).  These strains of E. coli were designated as atypical 
and assigned as ‘class 2’ ETEC.  Class 2 ETEC are usually mucoid colonies, rarely 
haemolytic, and usually possess fimbrial adhesins belonging to F4, F5, F6 and F41, 
carrying ST (Alexander, 1994; Fahy et al., 1987a; Woodward et al., 1993).  More 
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frequently the isolates recovered in Australia lack fimbrial adhesins, this has been 
hypothesized to be related to the wide-scale vaccination programs in Australia, which will 
be discussed later (Alexander, 1994).   
 
The infectious dose for ETEC is between 103 and 108 bacteria (Saunders et al., 1963).  
Once ingested ETEC has an incubation period of 12-24 hours, in which the bacteria 
replicate to sufficient numbers in the small intestine to induce disease (Hall, 1989).  Once 
bacteria proliferate, they elaborate enterotoxins (ST and/or LT) and initiate diarrhoea 
(Section 1.3.1.4).  When diarrhoea occurs bacteria are excreted between 107 and 109 per 
gram of faeces (Fahy, 1987a; Saunders et al., 1963). 
 
When ND occurs in a piggery it is sporadic, initially beginning with one or two piglets, 
then gradually progresses to the whole litter (Alexander, 1994).  In a large farrowing house 
ND can be isolated to a few litters, or outbreaks can occurs where a majority of the 
farrowing house is affected (Alexander, 1994; Tzipori et al., 1980).  In acute, cases, ND 
can strike within 2-4 hours of birth, when this happens morbidity rates are high (Alexander, 
1994).  The small intestine of piglets that have died as a result of ND contain undigested 
milk.  Histopathological examination of the small intestine show an accumulation of ETEC 
adhering to the brush borders of enterocytes lining villi (Fairbrother, 1999; Moon et al., 
1970).  The intestinal tract yields a profuse pure culture of the particular serogroup it is 
infected with (Smith, 1963; Stevens, 1963).  The intestine becomes thin-walled and flaccid 
due to fluid accumulation, blood vessels in the lamina propria become congested 
(Fairbrother, 1999; Wilson & Francis, 1986).  Macrophages and neutrophil numbers 
increase and migrate to the lumen (Fairbrother, 1999; Wells et al., 1984). 
 
ETEC are not the only contributing factor in ND, it is also thought of as a husbandry 
disease (Alexander, 1994).  Primarily management of intensive piggeries has a big impact 
on the health of its pig.  Ideally the farrowing crate should be equipped with a non-slip 
surface, be a warm, dry environment, with a high standard of hygiene.  The gilt or sow 
should be quiet and calm to allow uninterrupted farrowing and suckling (Alexander, 1994).  
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Suckling for the piglet is important in the protection of the piglet against disease.  The sow 
produces colostrums during the first 24 hours after farrowing.  Colostrum is rich in IgA, 
when ingested by the piglet it lines the mucosal surface of the gut preventing bacteria for 
which the sow has immunity against, from adhering to the intestinal wall (Isaacson, 1994; 
Porter et al., 1970).  This protection is essential until the piglets own immune system 
develops.  There are a number of predisposing factors relating to the protection of piglets 
from disease: 
• Insufficient exposure of dam to ETEC so that protective antibodies in milk and 
colostrum (gut-mammary gland link) are not sufficient to prevent attachment and 
proliferation of ETEC. 
• Sufficient antibodies are present, but piglets are not able to gain adequate access to 
milk, e.g. (i) sow factors – agalactia, restless sow and insufficient or injured teats, 
(ii) piglet factor – splay leg, too small to compete, peripaturient anoxia, infections 
(such as arthritis) and hypothermia (Fahy, 1987a). 
 
Treatment and prevention of ND: Current treatment of ND involves antibiotic and 
electrolyte therapy in the form of oral dosing or in severe cases they are administered 
intravenously.  In Australia the antibiotics used include neomycin, antibiotics from the class 
sulfonamide-trimethoprim, apralan and excenel (Ireland & Sharrock, personal 
communication).  Preventative measures in the form of vaccines are widely used, and 
nowhere more profusely than in Australia.  These vaccines are bacterins which involve the 
use of fimbrial antigens and other bacterial cell surface antigens such as porins that are not 
serogroup specific.  These antibodies also prevent the colonization of the GIT by non-
pathogenic strains of E. coli or commensals that can otherwise fulfill an important role in 
developing GALT (Cox et al., 2002).  These vaccines are administered to gilts in either a 
two or three stage regime.  The two stage regime involves vaccination of the gilt at 7 weeks 
pre-farrowing and then again at 3 weeks pre-farrowing.  This is followed up with booster 
vaccines 3-4 weeks pre-farrowing of every litter (Ireland, personal communication).  The 
three stage regime involves the first vaccination before a gilt is mated, then followed by 
vaccination at 7 weeks pre-farrowing and again at 3-4 weeks pre-farrowing.  Again a 
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booster is administered 3-4 weeks pre-farrowing before each subsequent litter (Sharrock, 
personal communication).  These vaccines include Neovac by Pfizer and Ecovac by 
Ausvac.  It is the use of these types of vaccines that has reduced the incidence of ND in 
Australia (Sharrock, personal communication).  It is also hypothesized that the use of these 
vaccines is directly related to the emergence of class 2 ETEC infections in ND, which do 
not possess fimbrial adhesions (Alexander, 1994). 
 
1.4.1.2 Post-weaning colibacillosis 
Post-weaning colibacillosis attributed to E. coli is commonly referred to as post-weaning 
diarrhea (PWD).  First described in Canada, when β-haemolytic E. coli were isolated from 
the proximal small intestines of affected pigs (Richards & Fraser, 1961), since then PWD 
has been associated with considerable economic loss worldwide (Tzipori et al., 1980).  
PWD is the most important cause of mortality in weaner pigs (Fahy et al., 1987b).  E. coli 
is not the sole reason for clinical diarrhoea, PWD is also a result of husbandry practices 
(Moon & Bunn, 1993).   
 
At weaning the protection the mother was providing in terms of maternal antibodies are 
removed (Tzipori et al., 1980), allowing β-haemolytic E. coli to proliferate.  Bacteria 
adhering to the villi in the small intestine cause damage, resulting in the shrinkage of villi 
(Muirhead & Alexander, 1997).  This atrophy reduces the absorptive capacity of the 
intestine, resulting in malabsorption of food, resulting in poor digestion.  Regeneration of 
villi takes between 5 and 7 days if the animal is not stressed (Muirhead & Alexander, 
1997).   
 
The age of weaning also relates to the incidence of PWD.  When piglets are weaned at a 
younger age, not only is the immune system immature and unable to provide adequate 
protection, but the digestive system is immature (Muirhead & Alexander 1997).  This 
means a piglet requires a specialized diet as it is less efficiently able to digest solid food, 
resulting in poor appetite and a lower daily weight gain.  The balance of the intestinal 
microflora also participates in the health of the weaned piglet.  If this balance is disrupted, 
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the pathogens have a competitive advantage (Barrow et al., 1980; Hentges, 1983).  In a 
weaner pig this balance is affected by three main stressors: (i) Change in diet; there can be 
a period of starvation, followed by irregular attempts to eat solid food, resulting in poor 
digestion (Murihead & Alexander, 1997). (ii) Environmental temperatures; chilling reduces 
intestinal motility, decreasing peristaltive action, preventing pathogens from being flushed 
from the intestine (Moon, 1974; Moon et al., 1979).  (iii) Transport/changing of pens; at 
weaning, pigs are taken from their mother and either moved to another shed or transported 
to another location, which can be stressful for young pigs.  This stress is then increased 
when they are mixed with new pigs, which can result in fighting (Fahy et al., 1987b; 
Muirhead & Alexander, 1997). 
 
The final stage of PWD is the proliferation of β-haemolytic E. coli in the small intestine, 
which occurs in both healthy (2-7% of strains isolated, Hinton et al, 1985) and scouring 
animals.  Experimental models of PWD have shown an infectious dose between 108 and 
1012 CFU (Casey, 1992; Cox et al., 1991; Madec et al., 2000; Sarmiento et al., 1988; 
Tzipori et al., 1984) is required, although this does not always translate to infection, with 
the timing of infection (Tzipori et al., 1980) and environmental stresses of intensive 
farming acting as contributing factors (Madec et al., 2000).  High levels of ETEC, even in 
the intestinal tract, does not necessarily result in the development of diarrhoea (Hinton et 
al., 1985; Kenworthy & Crabb, 1963). 
 
E. coli isolated from PWD are primarily β-haemolytic ETEC, with the occasional non-
haemolytic isolate implicated (Hoblet et al., 1986).  Diarrhoea associated with PWD is 
classed as diarrhoea occurring within a few days of weaning (between 14-28 
days)(Murhead & Alexander, 1997), typically occurring within the first 3-10 days after 
weaning and persisting to between 10 and 15 days post-weaning (Richards & Fraser, 1961; 
Nabuurs et al., 1993; Madec et al., 1999).  Class 1 ETEC isolates are primarily isolated 
from clinical cases of PWD, the predominant serotypes being O8, O45, O138, O141, O147, 
O149 and O157 (Alexander, 1994; Fairbrother, 1999; Guinee & Jansen, 1979; Morris & 
Sojka, 1985; Sojka, 1971; Wilson & Francis, 1986; Harel et al., 1990) that express F4, LT 
1. 59 
alone or in combination with ST enterotoxins (Alexander, 1994; Moon & Whipp, 1970; 
Smith & Gyles, 1970; Whipp et al., 1981).  Worldwide, the most prevalent serotypes are 
O8, O141 and O149 (Fahy et al., 1987b; Hamspon, 1994).  The fimbria associated with 
these serogroups has been associated with the timing of PWD infection.  F4 (K88) strains 
cause scouring 4 days post-weaning, while non-fimbriated isolates (e.g. O141) cause 
diarrhoea 7-10 days post-weaning (Fahy et al., 1987b).  This is linked to the absence of 
appropriate receptors to the F4 on the brush border of the small intestine a week post-
weaning (Sarmiento et al., 1988).  The 4 day PWD syndrome is typically associated with 
100% morbidity and 10% mortality if adequate treatment is administered (For a review on 
the F4 antigen and receptors see Van den Broeck et al., 2000).  The 10 day PWD syndrome 
can have an observed morbidity of 80%, however a dramatic reduction in growth rates is 
observed in survivors and mortality occurs if adequate treatment is not administered 
immediately.  Death occurs when the loss of body fluid exceeds 10% (Fahy et al., 1987b). 
 
Typically PWD is attributed to proliferation of a single ETEC serogroup, though two 
serotypes can be implicated (Hampson, 1994).  A field investigation into PWD in pig herds 
revealed multiple infections (47%) involving more than one serotype across the 84 herds 
sampled (Awad-Masalmed et al., 1988).  Symptomology of PWD infection includes 
sunken eyes, slight bluing of extremities, reduced appetite, development of rough hair coat, 
become pot-bellied and sometimes shivering (Muirhead & Alexander, 1997; Richards & 
Fraser, 1961).  Clinical presentation of diarrhoea can vary from pig to pig in consistency 
and colour, however the pH of the faeces will always remain alkaline (Muirhead & 
Alexander, 1997).  Dehydration is a result of watery diarrhoea that may last a week or 
more.  In extreme cases where infection is severe, there may be no clinical signs or 
symptoms and the first evidence is a dead pig (Richards & Fraser, 1961). 
 
Autopsies of deceased pigs reveal hyperemic, dilated, thin walled intestines containing 
varying amounts of fluid contents with an accumulation of gas.  The stomach is often full 
and the contents of the large intestine may be semi-fluid.  A heavy growth of β-haemolytic 
E. coli are observed throughout the small intestine (Figure 1.11) (Svendsen, 1974; 
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Svendsen et al., 1977), which is usually between 103 to 105 CFU higher than in healthy 
weaners (Svendsen et al., 1977). 
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Figure 1.11: Cross section of small intestine taken from a scouring weaner pig.  ETEC 
have adhered to the epithelial cell lining of the lumen.  Image provided by Dr Darren Trott, 
School of Veterinary Science, The University of Queensland. 
 
 
Occasionally oedema disease is implicated in PWD, this however rarely occurs in Australia 
(Drisen, personal communication; Fahy et al., 1987b).  Serogroups including O138, O139 
and O141 carrying the Stx2e gene have been implicated in oedema disease (Awad-
Masalmeh et al., 1982; Sojka, 1965; Sweeney, 1976).  The toxin produced is odema disease 
principle.  This exotoxin is absorbed from the gut and causes disease by injuring small 
arteries and arterioles.  The damage to blood vessels results in hypertension and leakage of 
fluid from blood vessels into extracellular compartments of the body (Fahy et al., 1987b). 
   
Treatment and prevention of PWD: In Australia, pigs with PWD are treated with 
electrolytes and antibiotics in water.  The antibiotics used include neomycin, apralan and 
excenel (Ireland & Sharrock, personal communication).  If an outbreak of PWD occurs in a 
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weaner shed vaccination is used.  There are two types of vaccinations which are commonly 
used (i) a commercially available vaccine from Ausvac Pty. Ltd. called WEANAVac.  This 
is an adjuvant vaccine prepared from formalin-killed cultures of E. coli serotypes 
associated with PWD (Ireland, personal communication).  This vaccine is administered 7 
days pre-weaning and again at weaning if there is a severe case of  PWD (Ireland, personal 
communication).    (ii) the second approach taken is the administration of an autogenous 
vaccine.  These vaccines are prepared by the E. coli Reference Laboratory, Bendigo from 
pathogenic E. coli isolated from the infected farm.  The serogroup identified is cultured 
overnight (~ 107 CFU/ml), pelleted and resuspended in a milk based product (Driesen, 
personal communication).  This vaccine is sent to farmers where it is orally administered to 
suckling pigs 1-2 weeks pre-farrowing.  These preventative treatments reduce the incidence 
of diarrhoea; however they do not eradicate the problem (Ireland & Sharrock, personal 
communication).  The low dose of live vaccines given orally is designed to prime the 
immune system.  Stimulation of mucosal immunity produces secretory antibodies that are 
efficiently transported into the intestinal lumen.  This priming of the immune system 
educates, so when the piglets come into contact with ETEC at weaning, they have already 
developed an immune response and can protect themselves against the pathogens (Moon & 
Bunn, 1993; Van den Broeck et al., 2002; Van der Stede et al., 2001).       
 
Vaccination regimes are currently used as preventative measures against both neonatal and 
weaner colibacillosis.  Currently there is no definitive data on the efficacy of commercial 
vaccines in field use (Moon & Bunn, 1993).  There is nevertheless a prevailing perception 
among animal health professionals that vaccines are effective (Moon & Bunn, 1993, 
Driesen, Ireland & Sharrock personal communication).  Methods for assessment of 
vaccines include: serum testing for pilus specific antibodies by agglutination in microtitre 
plates; double diffusion test in agar gel for detection of pilus-specific antibody in 
colostrum; enumeration of bacteria and identification of fimbrial adhesins of a few isolates; 
and morbidity and mortality rates in challenged pigs (Moon, 1981; Nagy et al., 1985; Osek 
et al., 1995).  There is currently no method to determine if vaccination or any preventative 
treatment sees the eradication of potential pathogens from the intestines of susceptible pigs.  
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There are also no surveillance techniques in place to examine the health status of a herd of 
pigs based on the presence of pathogenic E. coli (Moon & Bunn, 1993). 
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Chapter 2 
 
Materials and Methods 
 
2.1 Bacterial Culture Media 
 
2.1.1 Non-Selective media 
 
Blood agar (Appendix 2.1 {A2.1}): A non-selective nutrient medium consisting of 
10% sheep blood allowing for the visualization of haemolytic and non-haemolytic 
bacteria (Figure 2.1).  Blood agar plates were incubated at 37oC for 18-24 h before 
enumerating colonies and determining their haemolytic properties. 
 
 
 
A B  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Two E. coli isolates streaked onto blood agar and incubated at 37oC 
overnight to identify (A) a β-haemolytic isolate and (B) a non-haemolytic isolate.  
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CHROMagar Orientation media (A2.2): Nutrient agar for the non-selective isolation 
of microorganisms.  This medium was used for the primary isolation and identification 
of bacteria in faecal samples.  CHROMagar consists of substrates that different bacteria 
utilize, resulting in the visualization of different colours representative of different 
bacteria (Merlino et al., 1996); i.e. E. coli are mauve (Figure 2.2A), salmonella white 
and enterococci (Figure 2.2B) are blue.  Streaked CHROMagar plates were incubated in 
the dark at 37oC for 18-24 h. 
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Figure 2.2: Escherichia coli streaked on CHROMagar orientation (A) displays a 
characteristic mauve colour, while Enterococcus faecium (B) is characteristically a blue 
colour.  
 
 
2.1.2 Selective Media 
 
MacConkey agar (A2.3): Contains bile salts and crystal violet which inhibit the growth 
of gram positive bacteria, making this media selective for gram negative organisms 
including Escherichia coli, Enterobacteriaceae and salmonella (Amyl Media Sheets).  
The majority of E. coli and Enterobacteriaceae degrade lactose in the medium and 
absorb the pH indicator neutral red allowing the colony to be identified as pink (Figure 
2.3) after incubation at 37oC for 18-24 h.  
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Figure 2.3: Classic representation of a lactose fermenting Escherichia coli on 
MacConkey agar. 
 
 
Kanamycin Esculin Azide (KEA) agar (A2.4): Faecal streptococci and enterococci 
are capable of hydrolyzing the glycoside esculin to produce dextrose and esculin.  
Esculin reacts with ferric ions to form iron phenolic derivatives resulting in a black halo 
surrounding colonies or formation of black colonies (Figure 2.4) after incubation at 
37oC for 18-24 h (Mossel et al., 1978). 
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Figure 2.4: Identification of esculin-utilizing enterococci on KEA (A) and a non-
esculin-utilitizing staphylococci (B) on KEA.  
 
 
 2. 3 
MRS (de Man, Rogosa, Sharpe) agar (A2.5): Lactobacilli were isolated on the 
selective medium MRS.  Sodium acetate and ammonium citrate inhibit the growth of 
gram-negative bacteria.  The pH of 6.2 +/- 0.2 allows for the growth of Lactobacillus 
(Figure 2.5) while inhibiting streptococci, and considerably reducing the growth of 
enterococci (Amyl Media Sheets).  A majority of lactobacilli require incubation at 37oC 
with 5% CO2 for 36-40 h. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5: Growth of lacotobacilli on MRS agar after 36 h at 37oC and 5% CO2. 
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2.2 Bacterial Isolation  
  
2.2.1 Recovery of bacteria from rectal swabs 
AMIES Transport Medium tubes (Sarstedt, 80.9921.452) were used to swab the rectums 
of pigs.  Samples were transported on ice and stored at 4oC for no longer than 3 days.  
Bacteria were released from the swab by vortexing for 30 seconds (Figure 2.6) in 2 ml 
of Brain Heart Infusion Broth (BHIB, A2.6) containing 20% (v/v) glycerol (Amyl, 
RM283).  Any remaining liquid was removed by firmly pressing the swab against the 
tube.  Samples were stored (2 x 800 µl) in cryovials (Sarstedt, 72.692.005) at -80oC.   
  
2ml BHIB/Glycerol 
Vortexed for 30 seconds 
Rectal Swab 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: Bacteria were recovered from rectal swabs transported in AMIES media 
into BHIB/glycerol by vortexing.  
 
2.2.2 Enumeration of bacterial suspensions 
Bacterial suspensions were enumerated on Blood agar to determine the total number of 
cultivable bacteria in a sample.  MacConkey agar was used to determine the number of 
Escherichia coli, KEA was used to determine the number of streptococci and 
enterococci and MRS to enumerate lactobacilli.  Bacterial suspensions (100 μl) were 
serially diluted at 1:4 in Phosphate Buffered Saline (PBS, A2.8, 40 μl of Bacterial 
suspension in 120 μl of PBS) in a 96 well sterile plate (Figure 2.7) using a multichannel 
pipette.  Samples were plated in 10 μl drops (Drop Colony Counts, DCC) in duplicate 
using a multichannel pipette onto Blood, MacConkey, KEA and MRS agars in square 
10 x 10 cm petri dishes (Sarstedt 82.9923.422) and incubated (MRS supplemented with 
5% CO2) at 37oC overnight (Figure 2.8) and then enumerated. 
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Figure 2.7: Rectal swab suspensions (100 µl) were transferred to row A (brown) of a 96 
well sterile plate and serially diluted (40 µl) into PBS (120 µl).  10 µl drops were then 
plated onto blood, MacConkey, KEA and MRS media and incubated overnight. 
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Figure 2.8: Overnight incubation is sufficient for growth of colonies on blood (A), 
MacConkey (B), KEA (C) and MRS (D) agar to be enumerated.  Drop Colony Counts 
(DCC) were enumerated using a stereomicrocope. 
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2.2.3 Identification of bacteria using the gram stain technique 
A gram staining kit was purchased from Amyl Media.  The bacteria were inoculated 
from a single colony on an agar plate and mixed with a drop of water on a glass slide to 
give a thin film of bacteria.  The slide was allowed to dry, then fixed with heat by gently 
running through a Bunsen flame.  The slide was stained with crystal violet for 90 
seconds then washed with water.  This was followed by staining with concentrated 
iodine for 90 seconds, which was then washed with water.  The slide was decolourised 
with acetone until the crystal violet ceased to run, and counter-stained with neutral red 
for 2 minutes.  The slide was then rinsed until the water ran clear, and allowed to dry.  
Visualization was observed using immersion oil under 100 x magnification.  Gram-
negative bacteria such a E. coli stain pink (Figure 2.9) while gram positive bacteria such 
at Lactobacillus stain purple. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9: Gram-negative bacteria such as E. coli are not capable of retaining the 
crystal violet dye after decolourization and are counterstained by neutral red giving 
them a pink appearance. 
 
 
2.2.4 Identification of Escherichia coli 
Single colonies from MacConkey agar were aseptically transferred and streaked onto 
fresh MacConkey agar.  A single colony was inoculated in 2 ml of Luria-Bertani broth 
(LB, A2.7), incubated at 37oC with shaking (150 rpm) for 2-5 h.  Identification of E. 
coli was determined by streaking enriched culture onto Simmons Citrate Agar (A2.9, 
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Figure 2.10A) and Minimal Medium (A2.10, Figure 2.10B), with overnight incubation 
at 37oC.  Indole reaction was confirmed by adding 50 μl of Kovacs reagent to 50 μl of 
bacterial suspension in a well of a microtitre plate; indole positive reaction generated a 
pink colour (Figure 2.10C).  Identification was confirmed with negative growth on 
citrate agar and positive growth on minimal agar. 
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Figure 2.10: Identification of E. coli is confirmed when there is no growth on Simmons 
Citrate Agar (A), positive growth on minimal medium (B) and pink colouration (C) 
following reaction with Kovac’s Reagent.  
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2.2.5 Storage of bacterial cultures 
Single colonies from pure cultures were aseptically transferred to 2 ml of LB and then 
incubated overnight at 37oC with shaking (100 rpm).  Bacterial suspensions (500 μl) 
were transferred to a cryovial containing 500 μl of cryoprotective media (LB with 20% 
v/v glycerol e, A2.7), vortexed and transferred to -80oC. 
 
2.2.6 Recovery from -80oC storage 
Stored isolates were transferred from -80oC directly to ice.  A sterile disposable loop 
(86.1562.010) was used to remove a chip of the frozen culture and transferred directly 
to an agar plate.  This was streaked with a sterile loop then incubated at 37oC overnight, 
this was subculture 1 (sub 1). 
 
2.2.7 Maintenance of bacterial cultures 
After overnight incubation at 37oC, bacterial cultures were stored at 4oC until use.  After 
one week of storage, isolates were subcultured from a single colony onto fresh agar and 
incubated.  To ensure reproducibility of isolates and results, bacteria were not 
subcultured more than twice. 
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2.3 Extraction of DNA for PCR  
Bacterial DNA was processed by the boiling method (Section 2.3.1) if PCR analysis 
was to be completed within one week.  If the DNA was required at a later date, it was 
processed using a DNA extraction kit (Section 2.3.3).   
 
2.3.1 Extraction of E. coli DNA using the boiling method 
A single colony of bacteria was inoculated into 2 ml of LB broth and incubated 
overnight at 37oC with shaking at 150 rpm.  The bacterial culture was vortexed and 1 ml 
transferred to a sterile 1.5 ml centrifuge tube, before centrifugation at 10,000 rpm 
(Eppendorf Centrifuge, 5415C) for 3 minutes.  The pellet was washed with 1 ml of 
sterile MilliQ water (MQH2O) and then re-pelleted. The pellet was resuspended in 200 
µl of sterile MQH2O and heated at 100oC for 15 minutes, transferred to ice, and 
centrifuged at 10,000 rpm for 5 minutes.  The supernatant (150 μl) was transferred to a 
sterile tube and stored at 4oC for up to one week before transference to -20oC for 
storage.  To avoid DNA shearing, the frozen DNA was never thawed more than twice.  
 
2.3.2. Extraction of enterococci DNA using the boiling method 
The protocol for extraction of enterococci DNA was the same as for E. coli (Section 
2.3.1), with the exception that the bacteria were inoculated into 2 ml of BHIB instead of 
LB. 
 
2.3.3 Extraction of DNA using a DNA extraction kit  
DNA was extracted using the Promega DNA Purification Kit – Wizard Genomic 
(Catalogue No. A1120), the protocol was modified for optiminal DNA extraction under 
our conditions.  A single colony of bacteria was inoculated into 2 ml of LB broth and 
incubated overnight at 37oC with shaking at 150 rpm.  The bacterial culture was then 
vortexed and 1 ml transferred to a sterile 1.5 ml centrifuge tube.  The bacteria were 
pelleted by centrifugation at 10,000 rpm for 3 minutes, resuspended in 1 ml of MQH2O 
and re-centrifuged at 14,000 rpm for 2 minutes.  The supernatant was removed and the 
bacterial pellet was resuspended gently in 600 µl of Nuclei lysis solution and incubated 
at 80oC for 5 minutes to lyse the cells.  The sample was transferred to the bench and 
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allowed to cool to room temperature, 3 μl of RNase solution was added, the tube was 
inverted 5 times and incubated in a 37oC water bath for 30 minutes.  Once cooled 
protein precipitation solution (200 μl) was added, vortexed for 20 seconds, then 
incubated on ice for 5 minutes then spun at 14,000 rpm for 5 minutes.  DNA was 
precipitated by transferring the supernatant to 600 μl of isopropanol and inverting until 
it was visible as thread-like strands.  DNA was pelleted by centrifugation at 14,000 rpm 
for 2 minutes, the isopropanol was poured off and drained on absorbent paper, followed 
by air drying for 10-15 minutes.  The DNA was rehydrated with 100 μl of rehydration 
solution.  DNA concentration and purity was measured using a Gene Quant II.  DNA 
was diluted to a concentration of 100 μg/ml in TE Buffer (100 mM Tris-HCl pH 8, 100 
mM EDTA pH 7.6, MQH2O), pH 7.8, and stored at 4oC.  The remaining stock solution 
was stored at -20oC.   
 
2.3.4 Preparation of primers 
All primers were purchased from Sigma Aldrich.  Centrifuge primers at 10,000 rpm for 
1 minute then resuspended in 200 µl of TE buffer using a flicking motion.  Pulse 
centrifuge for 5 seconds, and stored at -20oC.  A working stock was prepared by diluting 
primers in MQH2O to a final concentration of 50 pmol, primers requiring lower 
concentrations were further diluted from this working stock solution.  All primer stocks 
were stored at -20oC.   
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2.4 Pulsed-Field Gel Electrophoresis (PFGE)  
This methodology was adapted from a paper published by Osek in 2000. 
 
2.4.1 PFGE of Escherichia coli isolates 
 
Bacterial Preparation: Bacteria were sub-cultured onto Luria-Bertani agar and 
incubated at 37oC overnight immediately before use.  
 
Cell lysis: Low melting point agarose (Bio-Rad 162-0017) was prepared to 2% (w/v) in 
SE buffer (75 mM, 25 mM EDTA, MQH2O), autoclaved at 102oC for 5 minutes and 
transferred to a 45oC heating block.  Ten bacterial colonies were transferred to a 1.5 ml 
sterile tube containing 150 μl of SE buffer then vortexed and transferred to ice.  The 
suspensions were heated for 30 seconds in a 50oC heating block, 150 μl of the 2% 
agarose in SE was added and vortexed briefly and returned to the heating block for a 
further 2 minutes.  The sample was allowed to solidify at 4oC for 30 minutes in two 
wells of the plug mold.  Both were transferred to 760 μl of lysis buffer (6 mM Tris-HCl 
pH 7.6, 1 M NaCl, 100 mM EDTA pH 7.6, 0.5% Brij58, 0.5% SLS, 0.2% SDC, 
MQH2O, 0.5 mg/ml lysozyme, 20 μg/ml RNaseA) in a 2 ml tube and incubated 
overnight at 37oC with gentle shaking (40 rpm). 
 
Deproteinase: Lysis buffer was removed via vacuum suction and the plugs were 
washed by inversion with 560 μl of ESP buffer (0.5 M EDTA pH 8.5, 1% Sodium 
buroylsarcosine {SLS}, MQH2O).  ESP buffer was then removed and the plugs were 
digested overnight in a 50oC water bath with 560 μl of ESP buffer containing 0.5 mg/ml 
of proteinase K.   
 
Washing of plugs: Plugs were washed for 1 hour at room temperature (RT) with 1.5 ml 
TE buffer followed with washing for 1 hour at 37oC with 1.5 ml TE containing 1 mM 
PMSF.  This two step washing was repeated, then fresh TE was added and the plugs 
were stored at 4oC or used in the restriction enzyme digest. 
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Restriction enzyme digestion: A 2 x 3 mm section of one plug was transferred to 200 
μl of Reaction Buffer (Buffer 3, 10x conc., B7003S New England BioLabs, BSA, 100x 
conc., B9001S New England BioLabs, MQH2O) and incubated at 37oC for 1 hour.  This 
buffer was replaced with an additional 200 μl of Reaction Buffer containing 10 U/μl of 
Not 1 (10 U/ml RO189L New England BioLabs) and incubated at 4oC for 1 hour, then 
transferred to 37oC overnight. 
 
Preparation of agarose gel: Pulse field plugs were transferred to ice for 1 hour while 
the buffer and gel were prepared.  3 litres of TBE Buffer, 0.5x (45 mM Tris-Base, 
45mM Boric acid, 10 mM EDTA) was prepared, 120 ml was combined with 1.5 g of 
Pulsed Field Certified Agarose (Bio-Rad 162-0137) and microwaved until completely 
melted, then allowed to cool for 10 minutes in a 60oC water bath.  The gel was poured, 
with 5 ml remaining in the bottle to seal the wells and the gel was left for 40 minutes to 
set.  The remainder of the TBE was transferred to the gel tank and allowed to cool to 
12oC.   
 
The digested DNA agarose blocks were transferred using a small spatula to a sterile 
petri dish where a thin slice was cut, and washed with 200 μl of TBE 3x at 15 minute 
intervals.  Two slices of a low range PFG marker (25 μl/ml of lambda DNA-Hind III 
fragments and lambda concatemers embedded in 1% LMP agarose size 0.1-200 kb - 
NO35OS New England BioLabs) were processed with the agarose blocks.  The DNA 
ladder was loaded into wells 2 and 18 of the gel.  The plugs were then loaded into wells 
3 to 17 of the gel using a spatula rinsed with 0.5x TBE by pressing the plug against the 
front of the well.  The wells were filled with the remaining 5 ml of molten agarose.  
Once set, the gel was loaded into the pulsed field gel tank (Pharmacia Biotech), and 
electrophoresis performed at 12oC with 200 Volts, 400 milli Amps, 90 Watts for 25 h 
(pulse details outlined in Table 2.1).   
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Table 2.1: Pulse profile for molecular separation of E. coli DNA samples  
 
Phase Number North/South(Seconds) 
East/West
(Seconds) 
Phase Time 
(Hours) 
1 4 4 5 
2 10 10 5 
3 20 20 5 
4 25 25 4 
5 30 30 4 
6 35 35 2 
 
 
Staining and viewing of agarose gel: The agarose gel was removed from the tank 
using a scalpel to separate it from the platform.  The gel was then stained for 30 minutes 
in 500 ml of 0.5x TBE containing 0.5 μg ml-1 ethidium bromide with gentle agitation.  
The gel was then de-stained using 500 ml of 0.5x TBE for an additional 30 minutes with 
gentle agitation.  The TBE was then removed and the gel (Figure 2.11) was visualized 
under UV light using a Gel Doc system (Bio-Rad) and analysed using the gel imaging 
software Diversity One (Bio-Rad). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11: Visualisation under UV light of an ethidium bromide stained pulsed-field 
gel electrophoresis gel showing the molecular finger prints of E. coli isolates from 
weaner pigs. 
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2.4.2 PFGE of enterococci isolates 
The enterococci isolates were prepared for PFGE using a method adapted from Murray 
(1990) and Osek (2000).  Bacteria were streaked onto BHIB agar and incubated at 37oC 
for 18-24 h.  Bacteria were inoculated into 150 µl of PIV buffer (10 mM Tris-HCl pH 
7.6, 1 M NaCl, MQH2O), vortexed and heated at 45oC for 30 seconds.  Then a further 
150 µl of molten PIV containing 1.6% low melting point agarose (BioRad) was added, 
the tubes were vortexed and then heated for 2 minutes.  The contents of the tubes were 
then allowed to solidify in plug wells.  Plugs were incubated in 760 µl of lysis buffer (6 
mM Tris-HCl pH 7.6, 1 M NaCl, 100 mM EDTA pH 7.6, 3.5% Brij58, 1% SLS, 2% 
SDC, lysozyme 50 mg/ml, RNaseA 1 mg/ml, MQH2O) at 37oC with shaking overnight.  
Plugs were subsequently washed with ESP buffer (0.5 M EDTA pH 8.5, 1% SLS, 
MQH2O), then digested overnight in a 50oC water bath with ESP buffer containing 0.5 
mg/ml proteinase K.  TE buffer at pH 8 (10 mM Tris-HCl {pH 7.6}, 0.1 M EDTA {pH 
7.6}, MQH2O) was used to wash the plug 3x.  A 2 x 3 mm section of a plug was 
transferred to reaction buffer (25 µl Buffer 4, New England Biolabs, 200 µl MQH2O, 2 
µl of restriction enzyme SmaI) and incubated at 25oC overnight.  Agarose blocks were 
washed in 1 ml of 0.5x TBE buffer (Tris-base, boric acid, EDTA, MQH2O) at 37oC for 
1 hour, which was then removed and the plugs then incubated in a heating block (50oC) 
for 20 minutes.  The molten agarose samples were loaded into the wells of a 1.2% 
agarose gel, with a slice of low range PFG marker (25 µl/ml of lambda DNA-Hind III 
fragments and lambda concatemers embedded in 1% LMP agarose size 0.1-200kb, New 
England Biolabs) placed in wells 2 and 18.  The gel was electrophoresed (Pharmacia 
Biotech) at 12oC with an interpolation cycle set at 5-35 second pulses for 25 h.  Gels 
were stained and visualized with a Gel Doc System (BioRad) as previously described in 
2.4.1.  
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Chapter 3 
 
Establishing Genetic Relationships between Commensal 
Escherichia coli and Pathogenic Isolates from Pigs with 
Neonatal and Post-Weaning Diarrhoea using Virulence 
Gene Profiles 
 
 
3.1 Introduction 
The acquisition of virulence genes is believed to provide an evolutionary pathway to 
pathogenicity.  As a genetically diverse group, most strains of E. coli are harmless 
commensals of mammals (Hartl & Dykhuizen, 1984; Selander et al., 1987), but others are 
capable of causing either intestinal or extra-intestinal disease (Ørskov & Ørskov, 1992).  In 
E. coli manifestation of clinical symptomology and pathology appears to be closely 
associated with the possession of certain virulence gene combinations (Grauke et al., 2002; 
Law, 2000).  For instance, diarrhoeagenic E. coli are classified on the basis of their 
virulence properties as: enterotoxigenic E. coli (ETEC), enteropathogenic E. coli (EPEC), 
enterohaemorrhagic E. coli (EHEC), enteroinvasive E. coli (EIEC) or enteroaggregative E. 
coli (EAEC) (Nataro & Kaper, 1998).  In general, these pathotypes have in common 
various virulence gene combinations for attachment and elaboration of haemolysins and 
enterotoxins. However, there is considerable polymorphism and sequence variation in the 
molecular identity of genes that code for these virulence factors (Bertin et al., 2001; Nagy 
& Fekete, 1999).  
 
Indeed, PCR analysis has revealed that even commensal E. coli isolates possess some 
virulence genes (Beutin, et al., 2003; Dixit et al., 2004).  However, mere possession of a 
single or a few virulence genes does not endow pathogenic status to a strain unless that 
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strain has acquired the appropriate virulence gene combination to cause disease in a 
specific host species (Gilmore & Ferretti, 2003).  At present, it is debatable whether isolates 
that have one or a few virulence genes represent pathogenic clones that have lost virulence 
genes or are commensals in the process of acquiring them.  Using a more phylogenetic 
approach, in 2000, Clermont described a 3-gene combination to differentiate between 
strains in the E. coli reference collection (ECOR) that are pathogens (phylogenetic groups 
B2 and D) and those members that are mainly commensals (phylogenetic groups A and 
B1).  These three genes alone were capable of providing a phylogenetic classification that 
closely mirrored similar groupings based on a more complex analysis of multilocus enzyme 
electrophoresis.  Furthermore, these relationships were established with a population of 
assembled clones, primarily of commensal origin, and in the absence of a panel of 
functionally accredited virulence genes.  
 
Diarrhoea in pigs can be caused by a number of pathogens, with transmissible 
gastroenteritis virus (TGEV), rotavirus (RV), enterotoxigenic E. coli (ETEC), Clostridium 
perfringens and Isospora suis being the most common.  Of these, ETEC are recognised as 
the most likely cause of neonatal diarrhoea (ND) in 0 to 4 day-old piglets with 
accompanying high morbidity and mortality rates.  Strains of E. coli isolated from piglets 
with ND are mucoid (A-type capsule), often non-haemolytic and usually confined to 
serogroups O8, O9, O20, O64 and O101.  These strains have been classified as atypical 
“class 2” ETEC as they possess fimbrial adhesins belonging to F4, F5, F6 and F41 and are 
generally LT- (heat labile enterotoxin) and ST+ (heat stable enterotoxin).  Older pre-
weaning pig and pigs with post-weaning diarrhoea (PWD, up to 12 weeks of age) are 
affected by haemolytic ETEC.  These are frequently represented by the classic serogroups 
including O8, O138, O139, O145, O141, O149 and O157 and predominate in isolations 
from clinical animals.  These strains are considered to be typical “class 1” diarrhoeagenic 
ETEC associated with expression of F4 fimbrial adhesins as well as LT alone, or in 
combination with STa and/or STb (Moon & Whipp, 1970; Smith & Gyles, 1970; Whipp et 
al., 1981).  More recently, Benz and Schmidt (1989, 1992, and 2001) have reported the 
detection of a class of diffusely adhering E. coli (DAEC) possessing the adhesin virulence 
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factor AIDA from piglets with diarrhoea.  Specific combinations of virulence genes 
encoding virulence factors such as adhesins and enterotoxins are the characteristic signature 
of pathogenic ETEC isolates.   
    
Unlike commensals, extraintestinal pathogenic strains of E. coli (ExPEC) do not establish 
long-term symbiotic relationships with their host.  Like strains that cause intestinal 
infections in humans, ExPEC possess virulence genes that have a range of functions 
including attachment/invasion, toxin production, iron scavenging and immune evasion.  
Extraintestinal E. coli are divided into three major pathotypes (Bekal et al., 2003): (i) 
uropathogenic (UPEC) strains that cause urinary infections; (ii) strains that cause neonatal 
meningitis (MENEC); and (iii) strains that cause septicaemia.  ExPEC possess virulence 
gene combinations that are distinctive from those found in their intestinal counterparts that 
cause intestinal disease.  For instance, uropathogenic strains are more likely to possess P 
pili, S pili, afimbrial adhesins and toxins such as haemolysin and cytotoxic necrotizing 
factor 1 (Johnson & Stell, 2000; Marrs et al., 2002).   
 
The main objective in this study was to assemble a panel of virulence genes known to occur 
in intestinal and extraintestinal E. coli pathotypes associated with both human and animal 
disease, and develop uni/multiplex combinatorial PCR assays for their detection in porcine 
isolates.  The assays were then used to determine the presence of these genes in pathogenic 
strains of E. coli isolated from clinical cases of ND and PWD to explore the possibility that 
pathogenic isolates can be identified by their virulence gene combinations.  E. coli isolates 
from healthy pigs or commensals (C) were also included in the analysis to assess whether 
there exists, a genetic evolutionary and phylogenetic relationship between pathogens and 
commensals modelled principally on their virulence gene repertoire.  A mathematical 
model involving principal coordinate analysis was used to demonstrate these relationships.  
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3.2 Materials and Methods 
 
3.2.1 Bacterial strains 
Table 3.1 lists 75 E. coli strains used in this study.  These were obtained from pigs with 
diarrhoea, also known as scouring neonates (Nos. 1-20), scouring weaner (Nos. 21-52) pigs 
and healthy pigs (Nos. 53-75).  The ND and PWD strains were obtained from diarrhoea 
samples cultured on blood agar plates, following overnight incubation at 37oC, a dominant 
colony that was suspected of being E. coli was subcultured onto MacConkey agar to 
confirm its identity (Do et al., 2005; Fahy, et al., 1987b).  ND and PWD isolates were 
obtained from a number of different sources as indicated in Table 3.1.  The commensal 
isolates represent a subset of E. coli previously isolated from different intestinal 
compartments of healthy pigs (Dixit et al., 2004).  Briefly, these isolates were recovered 
from plate spreads on MacConkey agar of diluted (50 mg/ml) intestinal and faecal contents.  
Isolates were confirmed to be E. coli by subculturing onto minimal and citrate agars and 
using the indole test as described in section 2.2.4.  
 
Additional strains used as a reference source of virulence genes for PCR analysis were 
provided as indicated in the Table 3.2.  The identity of all isolates as E. coli was confirmed 
with a positive indole test, displayed no growth on Simmons citrate agar and indicate 
growth on minimal lactose agar plates (Section 2.2.4).  
 
3.2.2 Bacterial serotyping  
Both O and H serotyping of E. coli was performed using previously reported methods 
(Bettleheim & Thompson, 1987; Chandler & Bettlehiem, 1974). 
 
3.2.3 Haemolysis  
Haemolysis was determined by streaking E. coli isolates onto blood agar containing 10% 
sheep blood and incubating at 37oC for 24 h.  A clear zone around colonies where the blood 
cells had been utilized was characteristic of β-haemolytic E. coli (Section 2.1.1).  
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Table 3.1: List of 75 E. coli strains used in this study.  The list includes isolates from clinical cases of ND (No. 1-12), PWD (No. 21-
52), and commensal isolates (No. 53-75) from healthy pigs.  
 
Type of 
Isolate 
Reference 
Code Serogroup 
Origin of 
Isolate 
Type of 
Isolate 
Reference 
Code Serogroup 
Origin of 
Isolate 
Type of 
Isolate 
Reference 
Code Serotype 
Origin of 
Isolate 
Neonatal 1 O8:F- Faecala Weaner 21 O8G7 Faecalb Commensal 53 O8:H- Ileume
Neonatal 2 O8:F41 Faecalb Weaner 22 O8G7 Faecalb Commensal 54 O18a,b:H- Ileume
Neonatal 3 O8:K99 Faecalb Weaner 23 O8G7 Faecalb Commensal 55 O40:H25 Faecale
Neonatal 4 O8:K88 Faecalb Weaner 24 O8G7:K88 Faecala Commensal 56 O40:H25 Faecale
Neonatal 5 O8:K88 Faecalb Weaner 25 O45 Faecalc Commensal 57 O75:H- Faecalc
Neonatal 6 O8:K88 Faecalb Weaner 26 O138 Faecald Commensal 58 O75:H- Faecalc
Neonatal 7 O8:K99 Faecalb Weaner 27 O138:K81:Hnt Faecalc Commensal 59 O77:H- Duodenume
Neonatal 8 O9:F41 Faecalb Weaner 28 O139 Faecalb Commensal 60 O82:H8 Colone
Neonatal 9 O9:F41 Faecalb Weaner 29 O141:K85ab Faecald Commensal 61 O106:H- Duodenume
Neonatal 10 O9:F41 Faecalb Weaner 30 0141:K85ab Faecalb Commensal 62 O121:H21 Faecalc
Neonatal 11 O9:987P Faecalb Weaner 31 O141ac Faecald Commensal 63 O126:H- Faecalc
Neonatal 12 O20:K99 Faecalb Weaner 32 0141:K85ac Faecalb Commensal 64 O130:H- Faecalc
Neonatal 13 O20:K99 Faecalb Weaner 33 O141:K85ab:H4 Faecalc Commensal 65 O130:H11 Feacalc
Neonatal 14 O64:K99 Faecala Weaner 34 O141:K85ac:H- Faecalc Commensal 66 OR:H- Faecale
Neonatal 15 O99:ksnt:H38 Faecalc Weaner 35 O141:K85ac Faecalc Commensal 67 OR:H38 Faecale
Neonatal 16 O101:F41 Faecalb Weaner 36 O141:K85ac Faecalc Commensal 68 Ont/R:H- Ileume
Neonatal 17 O101:K88 Faecala Weaner 37 O141K85ac Faecalb Commensal 69 Ont:Hnt Ileume
Neonatal 18 O101:Ksnt:H11 Faecalc Weaner 38 O141K85ac Faecalb Commensal 70 Ont:H- Duodenume
Neonatal 19 O109:Knst:H11 Faecalc Weaner 39 O141K85ac Faecalb Commensal 71 Ont:H- Duodenume
Neonatal 20 O157:K88 Faecalb Weaner 40 O141K85ac Faecalb Commensal 72 Ont:H- Faecale
Weaner 41 O141K85ac Faecalb Commensal 73 Ont:H11 Faecalc
Weaner 42 O141K85ac Faecalb Commensal 74 Ont:H27 Ileume
Weaner 43 O149:K88 Faecald Commensal 75 Ont:H45 Duodenume
Weaner 44 O149K88 Faecalb
Weaner 45 O149K88 Faecalb
Weaner 46 O149K88 Faecalb
Weaner 47 O149K88 Faecalb
Weaner 48 O149K88 Faecalb
Weaner 49 O149K88 Faecalb
Weaner 50 O149K88 Faecalb
Weaner 51 O149:K88 Faecalb
Weaner 52 O149:K91:Hnt Faecalc
a School of Veterinary Science, The University of Queensland, b Department of Primary Industries, Victoria, c Regional Veterinary Laboratory, EMAI, d Chris 
Richards and Associates, Bendigo, Victoria, e Dixit et al., 2004 
Table 3.2: Additional strains used as a reference source for the detection of virulence genes 
by PCR amplification.  
 
Identification 
Code Virulence Genes Reference 
DH5a fimH, ompT, yjaA Wu et al., 2003 
BL-21 fimH Wu et al., 2003 
XL-10 traT, ompT, yjaA Wu et al., 2003 
DG1-10 
PAI, papA, fimH, papEF, fyuA, sfa/focDE, papG allelle III, hlyA, kpsMTII, 
papC, papG allele II & III, cnf1, sfaS, K5, unicnf, iroNE.coli, chuA, yjaA, 
TspE4.C2 
Wu et al., 2003 
JA1-18 PAI, papA, fimH, papEF, fuyA, iutA, hlyA, papC, traT, papG allele II, papG allele II & III, cnf1, kspMT K5, unicnf, iha, ompT, ireA, chu, yjaA, TSPE4.C2 Wu et al., 2003 
FF1-78 PAI, fimH, ibeA, fyuA, kpsMT K1, kpsMTII, traT, iss, ireA, chuA, yjaA, TspE4.C2 Wu et al., 2003 
TA165 PAI, fimH, ibeA, fyuA, sfa/focDE, focG, iroNE.coli, chuA, yjaA, TSPE4.C2 Wu et al., 2003 
STJ1-K4 PAI, fimH, ibeA, fuyA, ompT, chuA, yjaA, TspE4.C2 Wu et al., 2003 
STJ1-1 fimH, kpsMTII, fyuA, iutA, cvaC, traT, iroNE.coli, iss, chuA Wu et al., 2003 
Shigella flexneri 
serotype 1 ipaH 
Wu personal 
communication 
Shigella flexneri 
TW6395 bfpA 
Wu personal 
communication 
O4:H5 8985 PAI, papA, fimH, fyuA, sfa/focDE, papG allele III, rfc, KpsMTII, papC, papG allele II, K5, iroNE.coli, chuA, yjaA 
Wu personal 
communication 
O75:H- fimH, fyuA, sfa/focDE, iutA, KpsMTII, traT, afa/draBC, K5, iha, ompT, chuA, yjaA, TSPE4.C2 
Wu personal 
communication 
1500 F6 Do et al., 2005 
1547 F5 Do et al., 2005 
1520 F41 Do et al., 2005 
214/081 F18 Do et al., 2005 
FV847a LT, STa, STb, F4 Do et al., 2005 
O157:H7 eaeA, ehxA, stx1, stx2 Fagan et al., 1999 
O139 fimH, traT,K5, iha, chuA, KpsMTII, F4, F5, F18, saa. aah (orfA), aidA (orfB),  This study 
O8G7 fimH, hlyA, traT, chuA, east1, cdt, LT, STb, F18, aah (orfA), aidA (orfB), orfBc This study 
O45 fimH, fyuA, traT. iha, ompT, eaeA, TSPE4.C2, STb, paa This study 
O101 papA, fimH, bmaE, papC, traT, yjaA, STb  This study 
O157:K88 fimH, fyuA, hlyA, traT, papG allele I, LT, east1, F4, saa, aah This study 
O8:K99 fimH, hlyA, cdtB, traT, iha, ompT, eaeA, chuA, yjaA, east1, cdt, LT, STa, F18, aah, aidA (orfB) This study 
 
 
3.2.4 Maintenance of bacteria  
E. coli strains were stored at -80oC in Luria-Bertani broth (LB) containing 20% glycerol 
(Section 2.2.5).  Bacteria were recovered from frozen stocks and plated on LB agar 
(Section 2.2.6) and never subcultured more than twice before DNA extraction (Section 2.3). 
 
3.2.5 Virulence genes  
A list of 58 virulence genes, reported in the literature to be associated with different E. coli 
pathotypes, were selected as the panel to be used in this analysis (Table 3.3). 
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Table 3.3: A list of 58 virulence genes reported in the literature to be associated with 
different E. coli pathotypes associated with human and animal disease. 
Virulence 
Gene Description/Function 
Adhesins 
8afa / draBC Central region of Dr antigenspecific fimbrial and afimbrial adhesin operons (e.g. AFA, Dr, and F1845) 
6aidA Adhesin involved in diffuse adherence, consists of AIDA-I (orfB) and AIDAc (orfBc) 
6aah Autotransporter adhesin heptosyltransferase encoding the AAH protein which modifies the AIDA-I adhesin 
2bfpA Type IV bundle-forming pili 
8bmaE M-agglutinin subunit 
2,3eaeA Intimin 
1faeG F4 Fimbrial Adhesin 
1fanC F5 Fimbrial Adhesin 
1fasA F6 Fimbrial Adhesin 
1fedA F18 Fimbrial Adhesin 
1F41 Fimbrial Adhesin 
8fimH D-mannosespecific adhesin, type 1 fimbriae 
8focG Pilus tip molecule, F1C fimbriae (sialic acid specific) 
3iha Novel nonhemagglutinin adhesin (from O157:H7 and CFT073) 
8nfaE Nonfimbrial adhesin I assembly and transport 
2paa Porcine A/E associated gene 
8papA Major structural subunit of pilus associated with pyelonephritis (P fimbriae); defines F antigen 
8papC Pilus assembly; central region of pap operon 
8papEF Minor tip pilins; connect PapG to shaft (PapA) 
8papG  Gal(1-4)Gal-specific pilus tip adhesin molecule 
8papG allele I (Rare) J96-associated papG variant 
8papG allele II Pyelonephritis-associated papG variant 
8papG allele III Cystitis-associated (prs or pap-2) papG variant 
8papG allele l’ papG variant identified in canine urine 
3saa STEC autoagglutinating adhesin 
8sfa / focDE Central region of sfa (S fimbriae) and foc (F1C fimbriae) operons 
8sfaS Pilus tip adhesin, S fimbriae (sialic acid specific) 
Toxins 
2,8cdt Cytolethal distending toxin 
8cdtB Cytolethal distending toxin 
8cnf1 Cytotoxic necrotizing factor 1 
8univcnf Universal primer for cytotoxic necrotizing factor 1 
8cvaC Colicin V; conjugative plasmids (traT, iss, and antimicrobial resistance) 
4east1 EaggEC heat-stable enterotoxin 
2,3exhA Enterohaemolysin 
8hlyA α-Hemolysin 
1LT Heat-labile toxin 
1STa Heat-stable enterotoxin a 
1STb Heat-stable enterotoxin b 
3stx1 Shiga toxin I 
3stx2 Shiga toxin II 
Capsule Synthesis 
8kpsMT II Group II capsular polysaccharide synthesis (e.g., K1, K5, and K12) 
8kpsMT III Group III capsular polysaccharide synthesis (e.g., K3, K10, and K54) 
8kpsMT K1 Specific for K1 (group II) kpsMT 
8kpsMT "K5" Specific for non-K1 and non-K2 group II kpsMT 
8rfc O4 lipopolysaccharide synthesis 
Siderophores 
8fyuA Yersinia siderophore receptor (ferric yersiniabactin uptake) 
8ireA Iron-regulated element, a siderophore receptor 
8iroNE.coli Novel catecholate siderophore 
8iutA Ferric aerobactin receptor (iron uptake: transport) 
Invasins 
8ibeA Invasion of brain endothelium 
5ipaH Invasion plasmid antigen 
Additional Virulence Genes 
3chuA Gene required for heme transport in EHEC O157:H7 
8iss Serum survival gene 
8ompT Outer membrane protein A and T (protease) 
8PAI Pathogenicity associated island, provide mechanism for coordinate horizontal transfer of VF genes between lineages 
TSPE4C2 Anonymous DNA fragment 
8traT Surface exclusion, serum survival 
yjaA Identificed in E.coli K12, function currently unknown 
1ETEC, 2EPEC, 3EHEC, 4EaggEC, 5EIEC, 6DAEC, 7NTEC, 8ExPEC
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3.2.6 DNA extraction  
All isolates were prepared as described in section 2.3.3 using a Promega DNA Purification 
Kit. 
 
3.2.7 PCR analysis  
A series of 12 multiplex PCR sets (Table 3.4, sets I to XII) was adapted from published 
protocols and optimised for the amplification of 52 virulence genes. The remaining 6 genes 
were individual PCR amplifications represented by sets XIII to XVIII (Table 3.4). Cocktails 
for PCR sets I to VI were prepared to deliver in a final volume of 25 μl: 2 μl of extracted 
DNA, 2.5 μl 10x PCR buffer (Qiagen), 1.5 mM MgCl2, 400 μM of each deoxynucleoside 
triphosphate (dNTP – Astral Scientific) with 1.25 U HotStar Taq Polymerase (Qiagen), and 
primer concentrations as shown in Table 3.4.  Set VII (50 μl) contained 2 μl of PCR template, 
5 μl 10x PCR buffer (Qiagen), 2 mM MgCl2, 200 μM of each dNTP, 1 U Taq polymerase 
(Qiagen) and 20 pmol of each primer.  PCR sets VIII-X (25 μl) contained 2 μl DNA, 2.5 μl 
10x PCR Buffer (Invitrogen), 2 mM MgCl2, 200 μM of each dNTP, 1.25 U Taq polymerase 
(Invitrogen) and 3.2 pmol of each primer.  Set XI (25 μl) contained 5 μl DNA, 2.5 μl 10x PCR 
Buffer (Invitrogen), 9 mM MgCl2, 200 μM of each dNTP, 1 U Taq Polymerase (Invitrogen) 
and 10 pmol of each primer. Set XII (20 μl) contained 2 μl DNA, 2 μl 10x PCR Buffer 
(Invitrogen), 50 μM of each dNTP, 1.5 mM MgCl2, 1 U Taq polymerase (Invitrogen) and 20 
pmol of each primer. Primer sets XIII and XVII (50 μl) contained 2 μl DNA, 5 μl 10x PCR 
buffer (Invitrogen), 200 μM of each dNTP, 1 U Taq Polymersase (Invitrogen) and 50 pmol of 
each primer. Primer set XVI (50 μl), 2 μl DNA, 2.5 μl 10x PCR Buffer (Invitrogen), 100 μM 
of each dNTP, 1 mM MgCl2, 1 U Taq Polymersase (Invitrogen) and 50 pmol of each primer. 
Primer set XVI (48 μl) consisting of 2 μl DNA, 5 μl of 10x PCR buffer (Qiagen), 200 μM of 
each dNTP, 1 mM MgCl2, 0.2 U Taq Polymersase (Qiagen) and 50 pmol of each primer. 
Primer set XV (50 μl), 2 μl DNA, 5 μl 10x PCR Buffer (Invitrogen), 200 μM of each dNTP, 8 
mM MgCl2, 1 U Taq Polymerase (Invitrogen) and 50 pmol of each primer. Primer set XVIII 
(50 μl) contained 2 μl DNA, 5 μl 10x PCR Buffer (Invitrogen), 100 μM of each dNTP, 1 U 
Taq Polymerase (Invitrogen) and 50 pmol of each primer.  PCR amplifications were 
conducted using a PC960 Air Cooled Thermal Cycler (Corbett research) with program cycles 
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listed in Table 3.5.  Amplicons were visualized by electrophoresis (80 V, 500 mA for 2.5 h for 
sets I-VI, and 1.5 h for sets VII-XVIII) in 2% agarose gels prepared in 0.5X TBE buffer (45 
mM TrisBase, 45 mM Boric Acid, 10 mM EDTA, pH 8) containing 4 μl of 5 μg/ml ethidium 
bromide. Amplicons were sized with corresponding 100 bp DNA markers (New England 
Biolabs) and processed in a Gel Doc system (BioRad).   
 
* Note: Multiplex PCR sets I-VI were optimised using bacterial isolates 21-23, 28, 30, 37-51 
by Kent Wu (Wu et al., 2003). 
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Table 3.4: Summary of 12 multiplex (Set I-XII) and 6 uniplex (XIII-XVIII) primer sets 
for the amplification of the 58 virulence genes.  Forward and reverse primer sequence for 
each virulence gene, together with the size of the expected amplicon products are also 
shown. 
 
Primer 
Set Virulence Gene 
Primer 
Name DNA Sequence 5’  3’ 
Amplified 
Product (bp) Primer Conc. 
PAI RPAi-F RPAi-R 
GGACATCCTGTTACAGCGCGCA 
TCGCCACCAATCACAGCCGAAC 930 0.6 μM 
papAH PapA-F PapA-R 
ATGGCAGTGGTGTCTTTTGGTG 
CGTCCCACCATACGTGCTCTTC 720 0.6 μM 
fimH FimH-F FimH-R 
TGCAGAACGGATAAGCCGTGG 
GCAGTCACCTGCCCTCCGGTA 508 0.6 μM 
kps MTIII kpsII-F kpsII-R 
GCGCATTTGCTGATACTGTTG 
CATCCAGACGATAAGCATGAGCA 392 0.6 μM 
papEF PapEF-F PapEF-R 
GCAACAGCAACGCTGGTTGCATCAT 
AGAGAGAGCCACTCTTATACGGACA 336 0.6 μM 
Ia
ibeA ibe10-F ibe10-R 
AGGCAGGTGTGCGCCGCGTAC 
TGGTGCTCCGGCAAACCATGC 170 0.6 μM 
fyuA FyuA-F FyuA-R 
TGATTAACCCCGCGACGGGAA 
CGCAGTAGGCACGATGTTGTA 880 0.6 μM 
bmaE bmaE-F bmaE-R 
ATGGCGCTAACTTGCCATGCTG 
AGGGGGACATATAGCCCCCTTC 507 0.6 μM 
sfa/focDE sfa 1-F sfa 2-R 
CTCCGGAGAACTGGGTGCATCTTAC 
CGGAGGAGTAATTACAAACCTGGCA 410 0.6 μM 
iutA AerJ-F AerJ-R 
GGCTGGACATCATGGGAACTGG 
CGTCGGGAACGGGTAGAATCG 300 0.6 μM 
papG allele III Allele III-F Allele III-R 
GGCCTGCAATGGATTTACCTGG 
CCACCAAATGACCATGCCAGAC 258 0.6 μM 
IIa
kpsMT K1 K1-fc-F KpsII-R 
TAGCAAACGTTCTATATTGGTGC 
CATCCAGACGATAAGCATGAGCA 153 0.6 μM 
hlyA hly-F hly-R 
AACAAGGATAAGCACTGTTCTGGCT 
ACCATATAAGCGGTCATTCCCGTCA 1177 0.6 μM 
rfc rfc-F rfc-R 
ATCCATCAGGAGGGGACTGGA 
AACCATACCAACCAATGCGAG 788 0.6 μM 
nfaE nfaE-F nfaE-R 
GCTTACTGATTCTGGGATGGA 
CGGTGGCCGAGTCATATGCCA 559 0.3 μM 
papG allele I Allelel-F Allelel-R 
TCGTCTCAGGTCCGGAATTT 
TGGCATCCCCCAACATTATCG 461 0.3 μM 
kpsMT II kpsII-F kpsII-R 
GCGCATTTGCTGATACTGTTG 
CATCCAGACGATAAGCATGAGC 272 0.3 μM 
IIIa
papC PapC-F PapC-R 
GTGGCAGTATGAGTAATGACCGTTA 
ATATCCTTTCTGCAGGGATGCAATA 200 0.3 μM 
cvaC ColV-C-F ColV-C-R 
CACACACAAACGGGAGCTGTT 
CTTCCCGCAGCATAGTTCCAT 680 0.6 μM 
cdtB 
cdt-a1-F 
cdt-a2-R 
cdt-s1-F 
cdt-s2-R 
AAATCACCAAGAATCATCCAGTTA 
AAATCTCCTGCAATCATCCAGTTTA 
GAAAGTAAATGGAATATAAATGTCCG 
GAAAATAAATGGAACACACATGTCCG 
430 0.6 μM 
focG FocG-F FocG-R 
CAGCACGGCAGTGGATACGA 
GAATGTCGCCTGCCCATTGCT 360 0.6 μM 
traT TraT-F TraT-R 
GGTGTGGTGCGATGAGCACAG 
CACGGTTCAGCCATCCCTGAG 290 0.6 μM 
IVa
papG allele II AlleleII-F Allele II-R 
GGGATGAGCGGGCCTTTGAT 
CGGGCCCCCAAGTAACTCG 190 0.6 μM 
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Table 3.4 continued. 
 
Primer 
Set 
Virulence 
Gene Primer Code DNA Sequence 5’  3’ 
Amplified 
Product (bp) 
Primer 
Conc.  
papG allele I pG-F pG1”-R 
CTGTAATTACGGAAGTGATTTCTG 
TCCAGAAATAGCTCATGTAACCCG 1190 0.6 μM  
papG allele II 
and III 
pG-F 
pG-R 
CTGTAATTACGGAAGTGATTTCTG 
ACTATCCGGCTCCGGATAAACCAT 1070 0.6 μM 
afa/draBC Afa-F Afa-R 
GGCAGAGGGCCGGCAACAGGC 
CCCGTAACGCGCCAGCATCTC 559 0.3 μM 
cnf1 cnf1-F cnf2-R 
AAGATGGAGTTTCCTATGCAGGAG 
CATTCAGAGTCCTGCCCTCATTATT 498 0.3 μM 
sfaS SfaS-F SfaS-R 
GTGGATACGACGATTACTGTG 
CCGCCAGCATTCCCTGTATTC 240 0.3 μM 
Va
kpsMT K5 K5-F kpsII-R 
CAGTATCAGCAATCGTTCTGTA 
CATCCAGACGATAAGCATGAGCA 159 0.6 μM 
univcnf CONCNF-F CONCNF-R 
ATCTTATACTGGATGGGATCATCTTGG 
GCAGAACGACGTTCTTCATAAGTATC 1105 0.6μM 
iha IHA-F IHA-R 
CTGGCGGAGGCTCTGAGATCA 
TCCTTAAGCTCCCGCGGCTGA 827 0.6 μM 
iroNE.coli  
IRONEC-F 
IRONEC-R 
AAGTCAAAGCAGGGGTTGCCCG 
GACGCCGACATTAAGACGCAG 665 0.6 μM 
ompT OMPT-F OMPT-R 
ATCTAGCCGAAGAAGGAGGC 
CCCGGGTCATAGTGTTCATC 559 0.6 μM 
allele I’ ALLELE I’-F ALLELE I’-R 
CTACTATGTTCATGCTCAGGTC 
CCTGCATCCTCCACCATTATCGA 479 0.6 μM 
iss ISS-F ISS-R 
CAGCAACCCGAACCACTTGATG 
AGCATTGCCAGAGCGGCAGAA 323 0.6 μM 
VIa,b
ireA IRE-F IRE-R 
GATGACTCAGCCACGGGTAA 
CCAGGACTCACCTCACGAAT 254 0.6 μM 
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Table 3.4 continued. 
 
Primer 
Set Virulence Gene 
Primer 
Code DNA Sequence 5’  3’ 
Amplified Product 
(bp) 
ehxA ehxA-F ehxA-R 
GCATCATCAAGCGTACGTTCC 
AATGAGCCAAGCTGGTTAAGCT 534 
eaeA eaeA-F eaeA-R 
GACCCGGCACAAGCATAAGC 
CCACCTGCAGCAACAAGAGG 384 
stx2
stx2-F 
stx2-R 
GGCACTGTCTGAAACTGCTCC 
TCGCCAGTTATCTGACATTCTG 255 
VIIc
stx1
stx1-F 
stx1-R 
ATAAATCGCCTATCGTTGACTAC 
AGAACGCCCACTGAGATCATC 180 
eltA LTA-1 LTA-2 
GGCGACAGATTATACCGTGC 
CCGAATTCTGTTATATATGTC 696 
fasA F6 - Fw F6 - Rv 
TCTGCTCTTAAAGCTACTGG 
AACTCCACCGTTTGTATCAG 333 VIII
d
estII STb-1 STb-2 
ATCGCATTTCTTCTTGCATC 
GGGCGCCAAAGCATGCTCC 172 
faeG F4 - Fw F4 - Rv 
GGTGATTTCAATGGTTCG 
ATTGCTACGTTCAGCGGAGCG 764 
fanC F5 - Fw F5 - Rv 
TGGGACTACCAATGCTTCTG 
TATCCACCATTAGACGGAGC 450 IX
d
estI STa1 STa2 
TCTTTCCCCTCTTTTAGTCAG 
ACAGGCAGGATTACAACAAAG 166 
fedA FedA-1 FedA-2 
GTGAAAAGACTAGTTTATTTC 
CTTGTAAGTAACCGCGTAAGC 510 Xd
F41 F41 - Fw F41 - Rv 
GAGGGACTTTCATCTTTTAG 
AGTCCATTCCATTTATAGGC 431 
aah (orfAa) 
UN19 
UN20 
CTGGGTGACATTATTGCTTGG 
TTTGCTTGTGCGGTAGACTG 
370 
aidA AIDA-I (orfB) 
UN21 
UN22 
TGCAAACATTAAGGGCTCG 
CCGGAAACATTGACCATACC 
450 XIe
aidA AIDAc 
(orfBC) 
UN23 
UN24 
CAGTTTATCAATCAGCTCGGG 
CCACCGTTCCGTTATCCTC 
543 
chuA ChuA.1 ChuA.2 
GACGAACCAACGGTCAGGAT 
TGCCGCCAGTACCAAAGACA 279 
yjaA YjaA.1 YjaA.2 
TGAAGTGTCAGGAGACGCTG 
ATGGAGAATGCGTTCCTCAAC 211 XII
f
TSPE4.C2 TspE4C2.1 TspE4C2.1 
GAGTAATGTCGGGGCATTCA 
CGCGCCAACAAAGTATTACG 152 
XIIIg east1 east 11a east 11b 
CCATCAACACAGTATATCCGA 
GGTCGCGAGTGACGGCTTTGT 111 
XIVh cdt CDT3A CDT3B 
GAGTTATTCCTTCCCCAGGC 
CAAAGGCATCAACAGCAGAA 108 
XVi paa M155-F1 M155-R1 
ATGAGGAAACATAATGGCAGG 
TCTGGTCAGGTCGTCAATAC 350 
XVIj saa SAADF SAADR 
CGTGATGAACAGGCTATTGC 
ATGGACATGCCTGTGGCAAC 119 
XVIIk ipah ipaHIII ipaHIV 
GTTCCTTGACCGCCTTTCCGATACCGTC 
GCCGGTCAGCCACCCTCTGAGATAC 600 
XVIIIl bfpA EP1 EP2 
AATGGTGCTTGCGCTTCGTGC 
GCCGCTTTATCCAACCTGGTA 326 
 
aJohnson and Stell, 2000, b Wu et al., 2003, c Paton and Paton 1998, d Do et al., 2005, e Niewerth et al., 
2001, f Clermont et al., 2000, g Yamamoto and Echeverria 1996, h da Silva and da Silva Leite, 2002, I 
Batisson et al., 2003, j Paton and Paton 2002, k Rich, et al., 2001, l Gunzburg et al. 1995. 
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Table 3.5: Details of PCR amplification cycles for the 12 multiplex and 6 uniplex PCR sets. 
 
Primer 
Set 
Denaturation 
Temp. (oC) 
Time 
(mins) 
Denaturation 
Temp (oC) Time 
Annealing 
Temp. (oC) Time 
Extension 
Temp. (oC) Time 
Number 
of Cycles 
Final 
Extension 
Temp (oC) 
Time 
(mins) 
Quantity 
Loaded on 
Agarose Gel 
I-VI 95 15 94 30 secs 63 30 s 68 3 min 25 72 10 2 μl 
VII 95 3 
95 
95 
95 
95 
95 
95 
95 
1 min 
1 min 
1 min 
1 min 
1 min 
1 min 
1 min 
65 
64 
63 
62 
61 
60 
60 
2 min 
2 min 
2 min 
2 min 
2 min 
2 min 
2 min 
72 
72 
72 
72 
72 
72 
72 
1 min 
1.5 min 
1.5 min 
1.5 min 
1.5 min 
1.5 min 
2.5 min 
10 
1 
1 
1 
1 
10 
10 
- - 8 μl 
VIII & X 94 5 94 1 min 58 1 min 72 1 min 30 72 7 8 μl 
IX 94 5 94 1 min 53 1 min 72 1 min 30 72 7 8 μl 
XI 94 2 94 1 min 63 1 min 72 30 s 30 72 10 8 μl 
XII 94 3 94 5 s 59 10 s - - 30 72 5 5 μl 
XIII 94 3 94 30 s 45 30 s 72 30 s 30 72 10 8 μl 
XIV 94 3 94 30 s 53 30 s 72 30 s 35 72 10 8 μl 
XV 94 2 94 30 s 62  45 s 72 30 s 30 72 7 8 μl 
95 1 min 65 2 min 72 1.5 min 10 
95 1 min 60 2 min 72 1.5 min 15 XVI 94 3 
95 1 min 60 2 min 72 2.5 min 10 
72 7 8 μl 
XVII 94 3 94 30 s 50 30 s 68 2 min 25 72 5 8 μl 
XVIII 94 3 94 30 s 50 30 s 68 2min 25 72 5 8 μl 
 
 
 
 
 
 
 
3.2.8 ECOR assignment   
E. coli isolates were assigned to one of the four main groups identified in the ECOR collection 
(Herzer et al., 1990; Ochman & Selander, 1984) by the method of Clermont (2000).  Any 
strain that failed to yield amplicons for the three Clermont genes - chuA, yjaA and TSPE4.C2 
by PCR were further identified using the BBL Crystal Enteric/Nonfermenter Identification 
System (Becton Dickinson) according to the manufacturer’s protocol.  When confirmed to be 
E. coli, these isolates were then classified as ECOR group A strains (Gordon & Cowling, 
2003).  
 
3.2.9 Generalized linear model  
A generalized linear model (GLM) was used to assess the significance of differences between 
groups of isolates (ND, PWD and commensals) for each gene.  The ranked relative importance 
of these genes was based on the deviance value contributed to by group differences. Consider 
a model that can relate a dependent variable xjr (value 0=absent or 1=present) to the group 
parameters (β) according to a logistic function –  
 θi = prob(xjr=1) = exp(Gβ)/(1+ exp(Gβ)) and 
1-θi = prob(xjr=0) = 1/(1+ exp(Gβ)) 
where G is a N x t design matrix (values = 0 or 1), N is the number of observation and t is the 
number of E. coli groups. A Logic transformation was used to linearise the above relationship 
to the following form: 
 yi = log(θi /(1- θi)) = Gβ   
The group parameters (β) were then estimated using the maximum likelihood estimation and 
the deviance value (Chi-squared) was determined using a likelihood ratio test.  Details of this 
method have been described by Cox in 1970.  The comparisons between group means were 
determined by forming factors of group contrasts and Chi-squared value associated with these 
contrasts were calculated. 
 
3.2.10 Cluster analysis  
An agglomerative hierarchical algorithm was used to establish cluster relationships between E. 
coli strains essentially as described by Kaufman and Rousseeuw (1990).  Let X be an n x v 
data matrix with elements xir having values 0=absent or 1=present where n is the number of 
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isolates and v is the number of genes.  A simple matching coefficient was calculated as 
follows: m12 = 1-d2ij/v  and the sum of  squared distances between all pairs of isolates to form a 
dissimilarity matrix Q with element given by qij = -½ d2ij, where d2ij =  Σ(xir – xjr)2 .      
The between cluster dissimilarity (d(K1, K2)) was then determined by the complete linkage 
method (the furthest neighbour method), that is  
d(K1,K2) =  max (qij )   ; i Є K1, j Є K2    
Once the longest distance was established for the first cluster, the same calculations were 
performed to compute the second longest cluster and this was repeated until all cluster 
combinations were set within the framework defined by the first cluster.   
 
3.2.11 Principal Coordinate (PCO) analysis  
The technique of principal coordinate analysis (also known as principle component analysis, 
PCA) was used to convert the data matrix of 58 virulence genes (or dimensions) into 2 or 3 
major coordinates (reduced number of dimensions).  The conversion of 58 dimensional data 
(v1 … v58) to the principal coordinates (Pco1 … Pcok) is represented by multiple linear 
equations as follows: 
Pco1 = a1,1 v1 + a1,2 v2 + …..a1,j vj ….. +a 1,58 v58
Pco2 = a2,1 v1 + a2,2 v2 + …..a2,j vj ….. +a 2,58 v58
Pcok = ak,1 v1 + ak,2 v2 + …..ak,j vj ….. +a k,58 v58
The coefficients (ak,j) are latent vectors and are derived from an association matrix of “simple 
matching” coefficients and calculated via the principal component analysis technique.  Gower 
(1966) introduced the principal coordinate analysis by implementing the conventional 
principal component analysis on the squared distance matrix Q which has latent root λ = [λ1 λ2  
λ3 … λn ]T and latent vector a; such that 
 Qa = λa.  
The methodology described by Morrison (1976) was used to derive the latent root λ and the 
latent vector a.  All computations were carried out using GenStat Release 7.1 (International, 
2003).  
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* Note: All raw data was statistically analysed by the statistician at Elizabeth MacArthur 
Agricultural Institute, Idris Barchia using the three previously mentioned protocols. 
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3.3 RESULTS 
 
3.3.1 Bacteria serogroups and phenotypes  
The 75 porcine isolates were characterised for serogroup, haemolytic phenotype and 
phylogenetic status as shown in Table 3.6.  Three main serogroups represented by O8, O9 and 
O101 predominated in ND isolates while PWD isolates were represented primarily by O8G7, 
O141 and O149.  
 
All the commensal isolates belonged to serogroups that did not match either ND or PWD 
strains.  Almost half of these were not typeable by currently available protocols.  All ND and 
commensal isolates, with one exception each, were non-haemolytic on blood agar. In contrast, 
PWD isolates were all β-haemolytic.  
 
3.3.2 Phylogenetic status based on Clermont virulence gene combinations  
The phylogenetic groupings of porcine ETEC were established using Clermont’s three genes 
PCR for chuA, yjaA and TSPE4.C2 (Table 3.6).  On this basis, 90% and 81% of ND and PWD 
isolates respectively can be classified as being non-pathogenic [Phylogenetic groups A (chuA-, 
yjaA-, TSPE4C2-or chuA-, yjaA+, TSPE4C2-) and B1 (chuA-, yjaA-, TSPE4C2+)] along with all 
commensal strains.  The phylogenetic group B2 was represented by only 1 isolate each in the 
ND and PWD collection.  There was only one group D representative in ND (Isolate 4) and C 
(Isolate 56) isolates compared to 5 in the PWD (Nos. 22, 23, 26-28) assemblage.     
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Table 3.6: A list of the 75 E. coli isolates used in this study.  Isolates are grouped as neonatal strains from ND, weaner strains from 
PWD and commensal strains from healthy pigs.  The serogroup, haemolytic phenotype and phylogenetic status as designated using the 
Clermont (2000) classification of each strain have been identified. 
  
Neonatal Strains Weaner Strains Commensal Strains 
Reference 
Code Serogroup 
Haemolytic 
Phenotype 
Phylogenetic 
Status*
Reference 
Code Serogroup 
Haemolytic 
Phenotype 
Phylogenetic 
Status*
Reference 
Code Serotype 
Haemolytic 
Phenotype 
Phylogenetic 
Status*
1 O8:F- nh A 21 O8G7 β-h A 53 O8:H- β-h A 
2 O8:F41 nh A 22 O8G7 β-h D 54 O18a,b:H- nh B1 
3 O8:K99 nh A 23 O8G7 β-h D 55 O40:H25 nh A 
4 O8:K88 nh D 24 O8G7:K88 β-h A 56 O40:H25 nh D 
5 O8:K88 nh A 25 O45 β-h B1 57 O75:H- nh A 
6 O8:K88 nh B2 26 O138 β-h D 58 O75:H- nh A 
7 O8:K99 nh B1 27 O138:K81:Hnt β-h D 59 O77:H- nh B1 
8 O9:F41 nh A 28 O139 β-h D 60 O82:H8 nh A 
9 O9:F41 nh A 29 O141:K85ab β-h A 61 O106:H- nh B1 
10 O9:F41 nh A 30 0141:K85ab β-h A 62 O121:H21 nh A 
11 O9:987P nh A 31 O141ac β-h A 63 O126:H- nh A 
12 O20:K99 nh A 32 0141:K85ac β-h A 64 O130:H- nh B1 
13 O20:K99 nh A 33 O141:K85ab:H4 β-h A 65 O130:H11 nh B1 
14 O64:K99 nh B1 34 O141:K85ac:H- β-h A 66 OR:H- nh A 
15 O99:ksnt:H38 nh B1 35 O141:K85ac β-h B1 67 OR:H38 nh A 
16 O101:F41 nh A 36 O141:K85ac β-h B1 68 Ont/R:H- nh A 
17 O101:K88 nh B1 37 O141K85ac β-h A 69 Ont:Hnt nh B1 
18 O101:Ksnt:H11 nh A 38 O141K85ac β-h A 70 Ont:H- nh A 
19 O109:Knst:H11 nh B1 39 O141K85ac β-h A 71 Ont:H- nh A 
20 O157:K88 β-h A 40 O141K85ac β-h A 72 Ont:H- nh A 
 41 O141K85ac β-h B2 73 Ont:H11 nh B1 
 42 O141K85ac β-h A 74 Ont:H27 nh A 
 43 O149:K88 β-h A 75 Ont:H45 nh B1 
 44 O149K88 β-h A 
 45 O149K88 β-h A 
 46 O149K88 β-h A 
 47 O149K88 β-h A 
 48 O149K88 β-h A 
 49 O149K88 β-h A 
 50 O149K88 β-h A 
 51 O149:K88 β-h A 
 52 O149:K91:Hnt β-h A 
Note: nh is non-haemolytic phenotype and β-h is β-haemolytic phenotype.   
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3.3.3 Distribution of virulence genes  
The identification of 58 virulence genes by PCR in 18 multiplex sets is depicted in Figure 3.1.  
Additional gels showing some selected results are attached in Appendix 3 (Figures A3.1-
A3.4).  A gene matrix was assembled identifying the genes carried by each isolate (Appendix 
3, Figure A3.5 – A3.7)   Prior to this study, only 8 (F4, F5, F6, F18, F41, STa, STb and LT) 
out of the 58 virulence genes examined have been used routinely assayed to characterise 
porcine isolates from ND and PWD (Figure 3.2a).  Other genes including AIDA (aah, aidA, 
AIDAc), eaeA, stx2, east1 and east1 are found in both porcine and human isolates.  As a 
consequence of this investigation, Figure 3.2b shows that 25 additional virulence genes can 
now be added to the porcine E. coli repertoire.  Of the 25 virulence genes detected, 19 are 
primarily associated with ExPEC isolated from humans (Johnson & Stell, 2000), with four 
associated with EHEC (iha, chuA, saa & ehxA) and 1 with EPEC (saa).  
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Figure 3.1: Image of an ethidium bromide stained 2% agarose gel showing amplified bands corresponding to the 58 virulence 
genes associated with the representative pathotypes of E. coli known to cause intestinal and extraintestinal disease in humans and 
animals. Note: Multiplex V contains an internal control and is identified as papG II/III
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Figure 3.2A: Venn diagram identifying the 58 virulence genes selected for analysis in this study.  These virulence genes are currently 
reported in the literature to be associated with E. coli of human and porcine origin, with designated pathotypes accompanying each 
gene.  
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Figure 3.2B: Venn diagram illustrating the contributions this study has made to the literature with 25 additional virulence genes being 
identified in porcine E. coli isolates.  The superscript number relates to the ranking of the genes as assigned by Chi-squared analysis.
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3.3.4 Prevalence of significant virulence genes in commensal, ND and PWD 
isolates  
The generalized linear model was used to establish the role and level of significance each gene 
played in determining similarities and differences between groups of isolates originating from 
commensals and scouring neonates and weaners.  As illustrated in Table 3.7, the frequency of 
occurrence of each gene in the three groups of animals can be ranked on the deviance value 
contributed to by group differences.  In this analysis, 17 out of 58 genes were found to be 
significantly different (P<0.05) for isolates from the three different sources of origin.  The 
Chi-squared ranking varied from 48.3 for STb to 7.5 for Stx2. Nine of these 17 genes 
represented by iha, hlyA, aidA (orfB), east1, aah (AIDA orfA), fimH, iroNE.coli, traT and saa 
have not been previously identified as key virulence genes in the identification of porcine 
diarrhoeagenic isolates.  Not surprisingly though, the prevalence of virulence genes encoding 
STb, STa, F18, LT, stx2, F4, F5 and F41 were considered to be significant in differentiating 
between pathogenic and commensal isolates.    
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Table 3.7: Prevalence of the 58 virulence genes was determined as a percentage.  Chi-squared 
analysis was used to differentiate between the three groups; ND, PWD and commensal.  Of 
the 58 genes, 17 were able to statistically (P<0.05) distinguish between the E. coli in the three 
groups based on the number of isolates that carried the gene. 
 
Neonatal E.coli 
(% positive) 
Weaner E.coli 
(% positive) 
Commensal E.coli 
(% positive) Virulence Gene Chi-squared Value 
STb 25 81.3 0 48.33 
15 81.3 4.3 44.93 iha 
10 71.9 4.3 37.55 hlyA 
STa 35 68.8 0 34.43 
aidA (orfB) 10 56.3 0 30.12 
F18 10 46.9 0 23.04 
10 40.6 17.4 18.82 east1 
LT 15 37.5 0 15.81 
100 62.5 69.6 14.28 fimH 
25 0 0 14.25 iroNE.coli
aah (orfA) 20 56.3 13 13.79 
F4 5 37.5 4.3 11.25 
95 65.6 56.5 10.15 traT 
F41 0 0 17.4 9.98 
F5 25 6.3 0 9.07 
40 9.4 13 7.56 saa 
5 34.4 13 7.47 stx2
TSPE4.C2 25 9.4 34.6 5.63 
10 0 0 5.44 cvaC 
10 0 0 5.44 iss 
AIDAc 0 9.4 0 5.28 
0 0 8.6 3.1 sfa/focDE 
10 0 4.3 3.96 iutA 
10 3.1 0 3.29 eaeA 
10 6.3 0 3.27 ireA 
5 0 0 2.68 bmaE 
5 0 0 2.68 K1 
5 0 0 2.68 papC 
5 0 0 2.68 cdtB 
5 0 0 2.68 papG allele I 
5 0 0 2.61 papA 
PAI 0 0 4.3 2.39 
10 18.8 4.3 2.29 chuA 
5 6.3 0 2.29 paa 
30 25 13 2.05 ompT 
F6 0 3.1 0 1.72 
10 6.3 17.4 1.7 cdt 
5 3.1 0 1.6 kpsMTII 
5 3.1 0 1.6 ehxA 
0 3.1 4.3 1.6 K5 
20 12.5 13.1 0.59 fyuA 
35 34.4 39.1 0.17 yjaA 
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3.3.5 Cluster analysis – an association between virulence gene signatures 
and serogroups 
Cluster analysis (Figure 3.3) was used to establish the relationship between individual E. coli 
strains based on the possession or non-possession of the 17 significant virulence genes in the 
data matrix.  An agglomerative hierarchical algorithm was employed to form a gradual nesting 
of individual isolates into larger clusters.  On this basis, all 75 isolates were distributed in one 
of two main branches (Figure 3.3) A and B which effectively partitioned ND/commensal 
isolates from PWD strains, respectively.  However, 3 ND isolates (Nos. 6, 20, 15) and 3 
commensal isolates (53, 56, 66) were located in the B branch whilst 2 PWD isolates (Nos. 24, 
25) were in the A branch. Within the B branch, PWD isolates in B1, B2-B4 and B5 were for 
the most part highly associated with their respective serogroup clusters; O8:G7, O141:K85 
and O149:K88.   
 
Ownership of the 17 significant genes by each strain is shown in Table 3.8.  Two genes - fimH 
and traT, are present in most of the isolates in both branches designated A and B.  The traT 
gene was missing in almost all B3 members while fimH was not detected in B5 strains.  Unlike 
branch B strains, branch A strains in general, displayed tracts of missing genes corresponding 
to STb, iha, STa, aidA, F18, east1 and LT that were signature genes for PWD strains.  
Virulence genes such as saa and iroNE.coli were detected in some of the ND strains but were 
absent from PWD isolates (all members of branch B).  A number of other ExPEC genes were 
also detected occasionally in ND isolates including; bmaE, cdtB, cvaC, iutA, papA, papG 
allele I, papC and K1 which were never identified in PWD or commensal isolates.    
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Figure 3.3: A cluster analysis dendrogram generated using an agglomerative hierarchical 
algorithm.  The cluster analysis is used to establish a relationship between individual E. coli 
isolated from clinical cases of ND (Red) and PWD (Black) and commensal isolates (green) 
from healthy pigs based on the possession or non-possession of the 17 significant virulence 
genes as determined by Chi-squared analysis.   
 
fimH, traT, STa, STb 
fimH, traT, iroNE.coli, saa 
fimH, traT 
No fimH 
No traT 
fimH, traT, saa, stx2
fimH, traT, iha &/or STb 
fimH, traT, aah 
fimH, traT, stx2, aah, aidA
fimH, stx2, aah, aidA,  
no traT 
east1, LT, STa, STb,  
F4, no fimH 
traT, aah, aidA, no stx2 
C
on
ta
in
s 
vi
ru
le
nc
e 
ge
ne
 c
om
bi
na
tio
ns
 o
f i
ha
, h
ly
A
, L
T,
 S
Ta
, 
S
Tb
, F
4 
&
 F
18
 
M
aj
or
ity
 o
f i
so
la
te
s 
co
nt
ai
n 
fe
w
 if
 a
ny
 o
f v
iru
le
nc
e 
ge
ne
s 
ih
a,
 
hl
yA
, L
T,
 S
Ta
, S
Tb
, F
4 
an
d 
F1
8 
01 O8:F-
03 O8:K99
02 O8:F-
75 Ont:H45
74 Ont:H27
73 Ont:H11
72 Ont:H-
71 Ont:H-
70 Ont:H-
69 Ont:Hnt
68 Ont/R:H-
67 OR:H38
66 OR:H-
65 O130:H11
64 O130:H-
63 O126:H-
62 O121:H21
61 O106:H-
60 O82:H8
59 O77:H-
58 O75:H-
57 O75:H-
56 O40:H25
55 O40:H25
54 O18ab:H-
53 O8:H-
52 O149:K88
51 O149:K88
50 O149:K88
49 O149:K88
48 O149:K88
47 O149:K88
46 O149:K88
45 O149:K88
44 O149:K88
43 O149:K88
42 O141:K85ac
41 O141:K85ac
40 O141:K85ac
39 O141:K85ac
38 O141:K85ac
37 O141:K85ac
36 O141:K85ac
35 O141:K85ac:H-
34 O141:K85ac:H-
33 O141:K85ab:H4
32 O141:K85ac
31 O141:K85ac
30 O141:K85ab
29 O141:K85ab
28 O139
27 O138:K81:Hnt
26 O138
25 O45
24 O8G7
23 O8G7
22 O8G7
21 O8G7
20 O157:K88
19 O109:Ksnt:H11
18 O101:K88
17 O101:K88
16 O101:F41
15 O99:Ksnt:H38
14 O64:K99
13 O20:K99
12 O20:K99
11 O9:987P
10 O9:F41
09 O9:F41
08 O9:F41
07 O8:K99
06 O8:K88
05 O8:K88
04 O8:K88
A 
B 
A1 
A2 
A3 
A4 
A5 
A6
1
A7 
B1 
B2 
B3 
B4 
B5 
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Table 3.8a: Data matrix of the possession of the 17 significant virulence genes (P<0.05, Chi-
squared) of the 75 E. coli isolates based on the dendrogram organisation of cluster group A.  
Where ● indicates the isolate is carrying that specific gene.  
 
 
 
 
 
  STb iha hlyA STa aidA F18 east1 LT fimH iroNE.coli aah F4 traT F41 F5 saa stx2
1 ●       ● ●         
17 ●        ●    ●     
18 ●        ●    ●     
24 ●   ●     ●    ●     
3         ●  ●  ●  ● ●  
13         ●    ●  ● ●  
12         ●    ●  ●   
 
 
 
A1 
14         ●    ●  ●   
2         ● ●   ●   ●  
4         ● ●   ●   ●  
5         ● ●   ●   ●  
16         ● ●   ●   ●  
 
 
A2 
11         ● ●   ●     
8         ●    ●     
9         ●    ●     
68         ●   ● ●     
70       ●  ●    ●     
74         ●    ●     
57         ●    ● ●    
 
 
 
A3 
63         ●    ● ●    
58         ●     ●    
62              ●    
59         ●         
61       ●  ●         
 
 
A4 
67       ●  ●         
31    ●        ● ●     
55                  
71       ●           
60         ●    ●     
72             ●     
69             ●     
 
 
 
A5 
75                  
7 ●        ●    ●  ●   
19  ●       ●    ●     
54         ●    ●     
 
A6 
25 ● ●       ●    ●     
10         ●    ●   ●  
64         ●    ●   ● ● 
65         ●    ●   ● ● 
 
A7 
73       ●  ●    ●   ● ● 
3. 28  
Table 3.8b: Data matrix of the possession of the 17 significant virulence genes (P<0.05, Chi-
squared) of the 75 E. coli isolates based on the dendrogram organisation of cluster group B.  
Where ● indicates the isolate is carrying that specific gene.  
  
 
 
 
 
  STb iha hlyA STa aidA F18 east1 LT fimH iroNE.coli aah F4 traT F41 F5 saa stx2
6  ● ●  ● ● ● ● ●  ●  ●     
22 ●  ●  ● ● ● ● ●  ●  ●     
23 ●    ● ● ● ● ●  ●  ●     
20   ●    ● ● ●  ● ● ●   ●  
21 ● ● ●    ● ● ●   ● ●   ●  
28  ●   ● ●   ●  ● ● ●  ● ●  
53  ● ●      ●  ●       
56         ●  ●       
 
 
 
 
B1 
66         ●  ●  ●     
15  ●   ● ●   ●  ●  ●    ● 
35 ● ●  ● ● ●   ●  ●  ●    ● 
33 ● ● ●  ● ●   ●  ●  ●    ● 
34 ● ● ●  ● ●   ●  ●  ●    ● 
 
B2 
36  ● ●  ● ●   ●  ●      ● 
26 ●  ● ● ● ●   ●  ●  ●  ●   
30 ● ● ● ● ● ●   ●  ●     ● ● 
32 ● ● ● ● ● ●     ●      ● 
37  ● ●  ● ●   ●  ●      ● 
38 ● ● ● ● ● ●   ●  ●      ● 
39 ● ● ● ● ● ●   ●  ●      ● 
40 ● ● ● ● ●    ●  ●      ● 
 
 
 
B3 
41 ●   ● ● ● ●  ●  ●      ● 
27  ●  ● ●    ●  ●  ●     
42  ● ● ● ● ●   ●  ●  ●     
 
B4 
29 ● ● ● ● ●      ●       
43 ● ● ●    ● ●    ●      
52  ● ●    ●     ●      
44 ● ● ● ●   ● ●    ● ●     
45 ● ● ● ●   ● ●    ● ●     
46 ● ● ● ●   ● ●    ● ●     
47 ● ● ● ●   ● ●    ● ●     
48 ● ● ● ●   ● ●    ● ●     
49 ● ● ● ●   ● ●    ● ●     
50 ● ● ● ●   ● ●    ● ●     
 
 
 
 
B5 
51 ● ●  ●    ●    ● ●     
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3.3.6 Genetic relationships between commensal and pathogenic E. coli 
clones from scouring neonatal and weaner pigs 
Principal coordinate (PCO) analysis was applied to model the genetic relationships between 
individual clones representing the three main groupings (ND, PWD and commensal) from 
which they originated.  The data in Figure 3.4 displays the genetic relationship between clones 
based on the combination of 17 genes found previously to be significantly different between 
the 3 groups of animals (Table 3.7).  The distribution for clones 1-20 (ND isolates) is 
displayed in Figure 3.4a; clones 21-52 (PWD isolates) in Figure 3.4b; clones 53-75 
(commensals isolates) in Figure 3.4c and the composite for all 3 groups in Figure 3.4d.  An 
identical representation is also depicted in Figure 3.5 except that this was based on all 58 
genes reduced to 2 principal coordinate (PCO) dimensions.  In both cases, 16 out of the 20 ND 
isolates were clustered in quadrant 2. Similarly, 22 out of 23 commensal isolates were also 
located in quadrant 2. 18 of the 32 PWD isolates were located in Q3 and 11 located in Q4.  
Analysing the ND, PWD and commensal isolates with PCO using the 17 significant virulence 
genes resulted in a tighter cluster between ND and commensal isolates which resulted in 
isolate 1 moving from borderline Q2-Q3 in 58 gene analysis to Q1 in the 17 gene analysis.  
The analysis of the 17 virulence genes of the PWD isolates resulted in isolate 31 moving from 
Q1 to Q2. PWD isolates clustered in Q3 and Q4 (Figure 3.4b) were also grouped co-ordinately 
with their serogroup.  
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Figure 3.4: Principal coordinate analysis using the 17 virulence genes (Chi-squared P<0.05) to establish a relationship between the 75 
E. coli clones and their clinical origin.  The coordinate value of each isolates is derived by 2 dimensions; axis X is PCO1 (dimension 
1), axis Y is PCO2 (dimension 2).  Values of the ND isolates    are graph in A, where each isolate is identified by its individual 
reference code, 1-20 (Table 3.1).  PWD     isolates are graphed in B (21-52) and commensal isolates      are in C (53-75).  The 
composite of the three graphs is represented in D.   
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Figure 3.5: Principal coordinate analysis using the full panel of 58 virulence genes to establish a relationship between the 75 E. coli 
clones and their clinical origin.  The coordinate value of each isolates is derived by 2 dimensions; axis X is PCO1 (dimension 1), axis 
Y is PCO2 (dimension 2).  Values of the ND isolates     are graph in A, where each isolate is identified by its individual reference code, 
1-20 (Table 3.1).  PWD    isolates are graphed in B (21-52) and commensal isolates       are in C (53-75).  The composite of the three 
graphs is represented in D.   
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3.4 Discussion 
A pathogenic E. coli is defined by its serogroup, the repertoire of virulence genes it carries and 
the clinical symptomology that it induces.  This information allows E. coli isolates to be 
classified into a specific pathotype.  Porcine colibacillosis, both neonatal and post-weaning is 
typically caused by enterotoxigenic E. coli (ETEC) which specifically carry one or more of a 
select group of genes; F4, F5, F6, F18, F41, STa, STb and LT.  This study has illustrated that 
porcine ETEC are carrying more virulence genes than previously reported in the literature.  
Not only are these virulence genes unreported, but they are associated with several different 
pathotypes of intestinal and extraintestinal origin.  This work illustrates that virulence genes 
cannot fully define a pathotype, instead virulence genes contribute to the functionality of E. 
coli.   
 
Intestinal or extraintestinal strains of pathogenic and commensal E. coli isolated from different 
animal species, with or without clinical disease, have been found to be extremely diverse in 
their genetic makeup.  Such diversity has been demonstrated by different analytical methods 
including multilocus enzyme electrophoresis, multilocus sequencing typing (Lemee et al., 
2004; Tarr et al., 2002; Whittam et al., 1993; Woodward et al., 1993) and PCR analysis of 
virulence genes.  Over time, genetic diversity has been exploited by selection and adaptation 
so that pathogenic strains have tended to become host-specific, with strains identified in 
scouring pigs being phenotypically and serotypically different from those that cause diarrhoea 
in humans (Hart et al., 1993).  Within each host species, genetic differences can still be found 
in different pathogenic isolates.  For example, E. coli strains associated with intestinal disease 
are genotypically different from those that cause extra-intestinal disease.  In pigs, a similar 
difference can be found between isolates responsible for ND and PWD.  An unanswered 
question is the way virulence genes continue to be acquired or lost in each “adapted” 
individual’s evolutionary pathway. Commensal E. coli on the other hand have attracted very 
little attention because they are not overtly involved in causing disease.  Commensal bacteria, 
while non-pathogenic, could potentially also harbour virulence genes, but are incapable of 
causing disease because they lack the appropriate virulence gene combinations.  
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To obtain a better understanding about the role of virulence genes in the pathogenicity of 
porcine isolates, a total of 58 genes were assembled and their presence or absence in 
commensal, ND and PWD isolates analysed.  As shown in Figure 3.6, 15 genes out of 58 were 
shared between pathogenic and commensal isolates; 11 genes were common between ND and 
PWD isolates.  9 ND, 2 PWD and 3 commensal isolates also carried specific genes that were 
not shared.  Exclusion or inclusion of virulence genes as depicted in the Venn diagram (Figure 
3.6) may be biased in favour of the minority genes because a single gene that has occurred 
only once in a single isolate can be partitioned and included in the diagram.  Notwithstanding 
this limitation, it is clear that a number of commensal isolates have acquired one or more 
virulence genes.  For example, isolates Nos. 64 and 65, which belong to serogroup O130, may 
not possess pathogenic functionality because they have a non-pathogenic serogroup or lack the 
appropriate combination of virulence genes.  However, it is conceivable that over time, further 
gene acquisitions, particularly entire pathogenicity islands, could re-equip such a commensal 
with the potential to develop into a pathogen. 
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Figure 3.6: Venn diagram identifying the virulence genes detected in E. coli isolates from the 
three groups; Neonatal diarrhoea (ND), Post-weaning diarrhoea (PWD) and commensal (C).  
The distribution of virulence genes identified 15 genes in all three groups, while 11 genes 
were only identified in the pathogenic ND and PWD isolates. 
 
 
According to the GLM, 9 virulence genes represented by iha, hlyA, aah (orfA), aidA (orfB), 
east1, fimH, iroNE.coli, traT and saa, in addition to the 8 genes normally associated with 
pathogenic ETEC (STb, STa, F18, LT, stx2, F4, F5 and F41), were found to be significant in 
distinguishing between commensal, ND and PWD clones.   
 
• iha has been described as a nonhaemagglutinin adhesin found in O157:H7 and CFT073 
(Tarr et al., 2000) 
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• AIDA is an adhesin involved in diffuse adherence, the autotransporter 
adhesinheptosyltransferase (aah, formally orfA) encodes the 44.8 kDa protein AAH 
which modifies AIDA-I (orfB) by 19 heptose residues, AIDA-I remains covalently 
associated with the bacterial surfaces and is responsible for diffuse adherence (DA) 
patterns when E. coli attach to HeLa and HEp-2 cell culture lines (Benz & Schmidt, 
1989; Benz & Schmidt, 1992; Benz & Schmidt, 2001)  
• saa – STEC autoagglutinating adhesin (Paton & Paton, 2002)  
• fimH - D-mannose specific adhesin or type 1 fimbriae (Sokurenko et al., 1994; 
Sokurenko et al., 1998)   
• hlyA - α-hemolysin is a member of the RTX family of cytotoxins which is 
phenotypically observed on sheep blood agar (washed and unwashed) (Beutin et al., 
1989)  
• east1 - EaggEC heat-stable enterotoxin (Savarino et al., 1993)  
• iroNE.coli, a novel catecholate siderophore (Johnson et al., 2000b)  
• traT is one of the F factor genes involved in encoding the outer membrane protein, the 
TraT lipoprotein is responsible for surface exclusion activity (Achtman & Kennedy, 
1977; Aguero et al., 1984; Chang et al., 1999).  
   
One of the main limitations inherent with Venn diagrams in this application is the inability to 
evaluate relationships between strains based on virulence gene combinations.  An 
agglomerative hierarchical algorithm was used to establish cluster relationships between 
isolates based on mutual possession or non-possession of all possible gene combinations of the 
17 significant virulence genes examined in this study.  As shown in Figure 3.3, isolates 
clustered on the basis of genes were grouped according to their serogroups and this in turn, 
enabled PWD isolates to be distinguished from ND and commensal strains.  A similar cluster 
analysis utilising all 58 genes yielded a clustering pattern that was similar to that obtained with 
the panel of 17 virulence genes.  The pattern of ownership of these 17 genes provided an 
opportunity to identify subclusters that were closely associated with the serogroup of member 
strains (Table 3.8).  Thus, the B1, B2-B4 and B5 strains subclustered in accordance with 
serogroups O8, O141 and O149 respectively.  It is interesting to note in terms of gene 
acquisitions, that ND and commensal isolates carried primarily ExPEC virulence genes while 
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PWD genes were sourced from a range of pathotypes including ETEC, ExPEC, EHEC/EPEC, 
EaggEC and DAEC.  
 
Principal coordinate analysis provided another method of examining relationships between 
individual isolates by reducing 58 genes or dimensions to 3 principal coordinates or 3 
dimensions that can be plotted along the X, Y and Z axis.  While the 3-dimensional plots can 
provide a better perspective, the 2-axis plots shown in Figures 3.4 and 3.5 provide valuable 
insight into the relationship between individual clones.  The genetic relationship supports the 
previous analytical methods that ND, PWD and commensal isolates can be segregated on the 
basis of their virulence gene signatures.  Unlike the dendrogram analysis, PCO plots have 
positioned the commensal isolates within the ND quadrant showing that there is greater 
similarity between these because they have fewer virulence genes in common compared to 
PWD isolates.  Two dimensional PCO plots depict quadrant (Q) 2 primarily containing ND 
and commensal isolates while Q3 and Q4 are dominated by PWD isolates.  This clustering of 
ND and commensal isolates together and the distinct separation of the PWD isolates was 
apparent in the PCO analysis using only 17 virulence genes.  A similar computation using the 
full panel of 58 virulence genes did not significantly alter the clustering pattern.  
 
Until this study, only 8 virulence genes (F4, F5, F6, F18, F41, STa, STb and LT) were used 
routinely to characterise porcine ETEC (Do et al., 2005; Melin et al., 2000; Osek, 1999; Osek, 
2000b).  More recently, additional genes have been identified in porcine ETEC including aidA 
& aah (Niewerth et al., 2001), CDT (da Silva & da Silva Leite, 2002) and EAST1 (Choi et al., 
2001).  This study has revealed a further 25 genes from other pathotypes that have not 
previously been identified in porcine isolates.  Of these, 19 are closely associated with 
ExPECs with four members of this group represented by fimH, hlyA, iroNE.coli and traT which 
play a significant role in distinguishing between porcine commensal, ND and PWD isolates 
(Table 3.7).  The deployment of GLM and PCO methods of analysis was mandated by an 
accumulation of relatively large numbers of genes acquired in the course of this study. In the 
past, when only 8 genes were used to characterise porcine ETEC, differences or similarities 
were recorded as percentages of occurrence of each gene in an assembly of isolates (DebRoy 
& Maddox, 2001; Frydendahl, 2002; Ojeniyi et al., 1994; Osek, 1999; Wittig & Fabriciu, 
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1992).  Such data unsuccessfully demonstrated the relationship between isolates and also did 
not associate virulence genes with serogroups and pathotypes.  
 
A conclusion that can be drawn from this study is that virulence genes cannot fully define each 
pathotype.  Instead, the genes associated with each pathotype contribute to the functionality of 
that E. coli.  For example ND strains probably have a survival advantage over PWD strains 
because they do not require fimbriae to colonise the intestinal wall of the neonate with its 
immature and under-developed immune system and gut maturity.  Under a different set of 
selection pressures, clones that possess disadvantageous genes could be eliminated and be 
replaced with other clones. Such changes could be associated with the increasingly prevalent 
practice of immunizing sows with E. coli vaccines which generate protective antibodies in the 
colostrum (Woodward et al., 1993).  This affects the bacteria that can survive the immune 
system, changing the intestinal environment and profoundly alter the capacity of both 
commensals and pathogens to colonise this environment.  The presence of virulence genes 
from human isolates in porcine E. coli strains should not be interpreted as a process of active 
gene acquisition.  Only 8 virulence genes are routinely identified in porcine ETEC, additional 
genes have not been reported because they have not been looked for.  This data suggests that 
both porcine commensal and pathogenic strains have over the years, acquired and maintained 
these genes as part of a survival mechanism to engender greater diversity and hence increase 
their survival capability in the host animal.  This study has not only shown the significant 
difference between ND and PWD isolates based on their profiles of virulence genes, but 
identified prevalent non-ETEC virulence genes in ND, PWD and commensal isolates.   
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Chapter 4 
 
Analysis of Escherichia coli Populations from Healthy 
and Scouring Weaner Pigs  
 
 
4.1 Introduction 
Post-weaning diarrhoea (PWD) occurs in pigs 3-10 days after weaning.  The E. coli 
implicated in PWD are β-haemolytic belonging to the serogroups O8, O138, O139, 
O141, O147, O149 and O157, with O8, O141 and O149 the most frequently reported 
worldwide (Hampson, 1994).  Symptomology of PWD infection includes sunken eyes, 
slight bluing of extremities, reduced appetite, development of rough hair coat, become 
pot-bellied and possibly shivering (Muirhead & Alexander, 1997; Richards & Fraser, 
1961).  Clinical presentation of diarrhoea can vary from pig to pig in consistency and 
colour, however the pH of the faeces will always be alkaline (Muirhead & Alexander, 
1997).  Dehydration is a result of watery diarrhoea that may last a week or more.  In 
extreme cases where infection is severe there may be no clinical signs or symptoms and 
the first evidence is a dead pig (Richards & Fraser, 1961). 
 
Routine diagnosis of PWD involves culturing E. coli from a faecal swab onto blood and 
MacConkey agar.  When a sample yields growth of a pure or dominant β-haemolytic 
mucoid colony, one or two isolates are subcultured and subjected to serogroup and 
fimbrial identification by slide agglutination tests for O and F antigens, respectively 
(Bettleheim & Thompson, 1987; Chandler & Bettelheim, 1974; Fahy et al., 1987b).  By 
analysing a number of PWD isolates retrieved in this manner, virulence gene profiles 
were established (Chapter 3) for the common serogroups identified in PWD in 
Australia; O8, O141 and O149.  Using statistical approaches the 58 virulence genes 
were ranked with respect to their ability to differentiate between neonatal diarrhoea 
(ND), PWD and commensal isolates.  It was not until a relationship profile was 
established on the basis of combinations of virulence genes that a distinct segregation 
was observed between PWD and commensal isolates.  The virulence gene profiles of 
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PWD isolates were not only clustered together, separating them from the ND and 
commensal isolates, but within PWD isolates there were two distinct subgroups where 
O141 and O149 could be identified.  This segregation was based on virulence gene 
profiles that were unique to serogroups O141 and O149.   
 
E. coli is a genetically diverse species with some individual members sharing similar 
genes (genetically related) or possessing different combination of unique genes that 
have been acquired by pathogenic strains for colonization and infection.  Even many of 
the shared genes that encode housekeeping metabolic enzymes for example, can vary in 
their amino acid sequence.  These variations can arise by mutation or by recombination 
through a number of sexual and asexual genetic exchanges, which represent a critical 
process for generating the variation needed by E. coli to adapt to selection pressures.  
Individual clones that have survived selection pressure form lineages that are both 
similar and different from other lineages.  Lineages with similar allelic profiles 
(Selander & Musser, 1990) are assembled as complexes that resemble branches of a tree 
and are spatially separated from other lineages that have fewer genes in common.  
 
There are several methods used to define the diversity of genetic relationships between 
clonal lineages.  These are: multilocus enzyme electrophoresis (MLEE) and pulsed-field 
gel electrophoresis (PFGE) (Previously outlined in Chapter 1).  While MLEE is used to 
analyse diversity based on differences in house keeping genes, PFGE is based on DNA 
segments cut by restriction enzymes.  PFGE is more likely to identify genetic 
differences in isolates and on this basis determine the clonal relationship between 
isolates (Osek, 2000a).  Many studies have looked at the diversity of E. coli isolates 
from different scouring pig samples.  The degree of clonality and diversity detected 
depends on the objective of the individual studies.  In a recent introduction of Oedema 
disease in Denmark, the infective serotype was tracked by its unique clonal PFGE 
fingerprint; 1-3 band difference between isolates had occurred over a 22 month period 
(Aarestrup et al., 1997).  MLEE has also been used to look at the diversity of isolates 
from clinical cases of ND in Australia.  Thirty-nine E. coli of serogroup O9 were 
analysed and 18 different clones were identified.  This diversity was also noted in 16 
different clones arising from 22 isolates of O20 and 12 clones in 26 isolates 
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serogrouped O101 (Woodward et al., 1993).  In 1997, Whittam and colleagues, used 
MLEE to study E. coli in related serogroups, from which it was concluded that (i) there 
was considerable diversity, even within a single country, and that (ii) E. coli are 
heterogeneous and classification of pathogenic strains based on O:H serotyping is not 
always indicative of genetic relatedness.  Our laboratory has taken this analysis one step 
further and compared the genetic diversity of E. coli isolates from different 
compartments of the intestinal tract, including faecal samples (Dixit et al., 2004).  
MLEE was used to analyse the genetic variation of 151 E. coli isolates from eight 13 
week old male pigs.  The results demonstrated a mean differentiation of 27% which far 
exceeds the 2-6% observed among E. coli isolated from different geographical localities 
and species (Gordon, 1997; Gordon & Lee, 1999; Gordon et al., 2002; Whittam et al., 
1983a, 1983b).  It was concluded that the different environmental niches of the intestine 
exhibit varying selection pressures, requiring the E. coli within these niches to adapt, 
explaining the diversity of isolates identified.   
 
If E. coli belonging to the same clonal complexes occur in different scouring animals 
(Osek, 2000a; Wu et al., 2003), then does this diversity exist in a sample isolated from a 
single animal?  Studies involving the use of molecular markers have revealed that non-
identical E. coli clones have arisen in laboratory experiments where isolates have been 
maintained in serial batch cultures (Imhof & Scholtterer, 2001).  If clonal complexes 
can evolve in a culture flask from identical clones, then it is not unreasonable to 
question the clonality of the E. coli in faecal samples of scouring animals.  The E. coli 
which are associated with infection replicate within the intestine where there are 
selection pressures, however E. coli also undergo spontaneous natural mutations as part 
of the replication process.    
 
The objective was to investigate a larger more representative population of E. coli from 
scouring animals and compare these isolates with those from healthy pigs.  The 
previously mentioned method of isolating E. coli from faecal swabs and selecting single 
clones by subculturing is a very laborious task.  An alternative approach was required, 
which would allow for (i) the identification of isolate phenotype on the basis of 
haemolysis and E. coli identification, and (ii) simultaneous examination of multiple 
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isolates.  Such a technique was developed in the 1970’s by Sharpe and colleagues.  This 
technique was based on a traditional process involving membrane filtration, which was 
used because of its ability to concentrate organisms, therefore limiting dilutions (Sharpe 
& Michaud, 1975).  The membrane filtration technique was the platform from which a 
new technique was developed, incorporating a hydrophobic grid membrane filter 
(HGMF).  The 0.2 μM filter contains a hydrophobic border which encloses 1600 
squares, each outlined with the same hydrophobic border.  This border limits the size 
variation in the colonies, and prevents colonies growing too close or on top of each 
other which makes enumeration impossible (Sharpe & Michaud, 1975).  The advantage 
of this type of filter is that it allows as much as 10 ml of fluid to be placed on the 
surface of the HGMF.  The hydrophobic nature of the HGMF prevents overflow of the 
10 ml solution thereby avoiding contamination of the filtration device, which therefore 
does not require sterilizing between each sample (Sharpe et al., 1986).  This technique 
was developed for enumeration of bacteria in food and milk products by using a 
solution of 0.1% peptone and 1.0% Tween80 as a dilution buffer in the stomacher and 
the filtration apparatus.  The types of applications that have been used include 
enumeration of bacteria in: soup, meat, milk, green beans and ice-cream (Peterkin & 
Sharpe, 1980; Sharpe et al., 1986).  
 
In 1982 Entis used the HGMF to develop a Salmonella spp. detection method which 
was comparable to the Health Protection Branch cultural method.  The traditional 
method recovered 618 spiked samples compared to 622 in the conventional method 
with 94.6% recovery for HGMF and 96.7% for the conventional method, this difference 
was not significant and it reduced the time of the assay from 3-4 days (conventional 
method) to 2-3 days (HGMF method).  The technique was further developed when 
Dunlop (1998a, 1998b, 1998c) used the hydrophobic grid membrane filter technology to 
measure resistance among E. coli found in pig faecal samples to ampicillin, 
sulfisoxazole and tetracycline.  This method accurately measured resistance, with 
sensitivities ranging from 96.5-99.5% and specificities ranging from 87-98.3%, it 
identified E. coli with 96% confidence.  The HGMF was taken to the next level when it 
was used as a platform for colony hybridization for shiga toxins (Stx) using a PCR Dig 
Probe synthesis kit (Cobbold & Desmarchelier, 2000).  E. coli that were Stx positive 
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were enriched and plated on a HGMF.  Colonies were hybridized with Stx1 and Stx2 
probes and positive colonies were subcultured from a replica grid for serotyping.   
 
The HGMF method can be used for a diverse range of applications; however it still has 
the potential for more.  A population based microbial analysis (PoMA) technique was 
developed.  The objective of developing the PoMA technique was to look at a more 
representative population of E. coli within a scouring pig and compare this to the E. coli 
from healthy pigs.  With this technique we could look at the phenotypic characteristic of 
E. coli including enumeration of haemolytic samples and select these isolates for 
virulence gene profiling.   
 
Cobbold and Desmarchelier had used the HGMF colonies directly in colony 
hybridization assays, however only two probes had been utilized, while in this study 58 
virulence genes were being assessed.  Rather than looking at the virulence gene profiles 
of individual isolates, it was decided to look at the virulence gene profile of the entire 
bacterial population on a HGMF.  This would yield a host virulence gene profile or host 
profile.  The rationale behind this approach was based on the finding in Chapter 3; that 
pathogenic E. coli of a certain serotype possessed a distinct virulence gene profile that 
was statistically different to that of commensals.  If in a scouring pig the E. coli 
population was dominated by pathogenic E. coli, a distinct virulence gene profile should 
be observed.  In healthy pigs, pathogenic E. coli would not be present or present in very 
low numbers so that only the virulence genes carried by commensal isolates would be 
detected.  In both cases a larger population of E. coli would be examined and the true 
diversity or lack of it should be observed in the host virulence gene profiles (host 
profiles).  In the case where more than a single serogroup is involved in PWD (Awad-
Masalmeh et al., 1988; Hampson, 1994) these clones should be detectable based solely 
on the distinct virulence gene profiles.  The generation of host profiles would avoid any 
bias that is created when only suspected pathogens are analysed, as these isolates 
represent only a minor component (designated atypical) of the E. coli in pigs (Feil & 
Spratt, 2001). 
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Data presented in Chapter 3 clearly demonstrates a statistical difference in the virulence 
gene profiles of PWD and commensal isolates.  Based on this information, the objective 
was to evaluate the host profiles of healthy and scouring weaner pigs and to apply the 
same statistical methodologies to evaluate host profiles.  If it is possible to detect as 
little as a few colonies it opens up the possibility of using this assay as a diagnostic tool 
for evaluating the health status of a herd.  This could be tested by looking at samples 
from subclinical pigs, which are pigs that are either carrying pathogenic organisms that 
are not symptomatic, or are in the early stages of the disease and have been in contact 
with the pathogenic organism but have not yet developed clinical symptomology. 
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4.2 Materials and Methods 
 
4.2.1 Sample collection in the form of rectal swab samples from healthy 
and scouring weaner pigs 
 
Sample collection: Rectal swab samples were collected from two groups of weaner 
pigs at QAF Meat Industries, Cowora (Table 4.1).  Healthy pigs (5-6 weeks old) with no 
clinical signs of disease were sampled from different sexes (6 male and 6 female) and 
pens.  The second group consisted of weaner pigs with clinical signs and symptoms of 
E. coli associated colibacillosis as diagnosed by the on farm veterinarian.  These pigs 
were aged 5-8 weeks and from different pens, the group was predominantly male (11) 
with a single female pig. Once rectums were sampled, the swab was transferred in 
AMIES transport medium (Sarstedt 80.9921.452) and shipped on ice packs directly to 
EMAI. 
 
Table 4.1: List of rectal swab samples collected from healthy weaners (HW, n=12) and 
scouring weaners (SW, n=12) pigs post weaning. 
 
 Piglet Number Health Status Age of Piglet (Weeks) Sex (M/F) 
1 Healthy (HW) 5 M 
2 Healthy (HW) 5 M 
3 Healthy (HW) 5 M 
4 Healthy (HW) 6 M 
5 Healthy (HW) 6 M 
6 Healthy (HW) 6 M 
7 Healthy (HW) 6 F 
8 Healthy (HW) 6 F 
9 Healthy (HW) 6 F 
10 Healthy (HW) 5 F 
11 Healthy (HW) 5 F 
12 Healthy (HW) 5 F 
13 Scouring (SW) 5  M 
14 Scouring (SW) 5 M 
15 Scouring (SW) 5 M 
16 Scouring (SW) 5 M 
17 Scouring (SW) 5 M 
18 Scouring (SW) 5 M 
19 Scouring (SW) 7 M 
20 Scouring (SW) 7 M 
21 Scouring (SW) 7 M 
22 Scouring (SW) 8 M 
23 Scouring (SW) 5 F 
24 Scouring (SW) 5 M 
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Bacterial isolation: Bacteria were recovered from rectal swabs and stored in 
BHIB/glycerol media as previously described in Section 2.2.1. 
 
4.2.2 Enumeration of bacteria in rectal swab samples collected from 
healthy and scouring weaner pigs 
 
Drop Colony Count (DCC) enumeration: Bacterial suspensions were serially diluted 
(1 in 4) in PBS and enumerated on blood, MacConkey, KEA and MRS agars as 
previously described in Section 2.2.2. 
 
4.2.3 Population based Microbial Analysis (PoMA) 
 
Development of a population based microbial analysis assay (PoMA): PoMA was 
developed based on previously published protocols (Dunlop et al., 1998; Entis et al., 
1982, Peterkin & Sharpe, 1980; Sharpe & Michaud, 1975; Sharpe et al., 1986; Sharpe et 
al., 1989).  Bacterial suspensions were diluted in 0.1% Tween80 to a concentration of 
100-200 colony forming units (CFU) in a final volume of 2 ml.  A Hydrophobic Grid 
Membrane Filter (HGMF, ISO-GRID, Neogen, 6802) was used to isolate bacterial 
colonies. Bacteria were dispersed on the HGMF using a sterile glass spreader (Figure 
4.1), dilutant was removed with vacuum suction immobilizing the colonies on the 
HGMF.  To determine the total culturable population, the grid was transferred to blood 
agar (Figure 4.2) and for the selective growth of E. coli the grid was placed on 
MacConkey agar.  Samples were incubated at 37oC for 18-26 h.  
4. 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Dispersal of bacterial colonies across the HGMF using a glass spreader, 
dilutant was removed under vacuum suction.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: HGMF were incubated on blood agar plates for enumeration of the 
culturable population. 
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Following incubation (Figure 4.3) the HGMF population was enumerated by capturing 
the image as a tiff file using a HP flatbed scanner.  The HGMFRES Analysis software 
written by Dr David Jordan (Agricultural Institute, Wollongbar) converted the image 
data and counted the number of colonies.  Once enumerated, the entire HGMF 
population was replicated onto an additional HGMF on blood agar.  Colonies were 
transferred from the first grid (Master Grid) onto a second grid (Replica 1) using a 
sterile 1600 point metal inoculator (Filtaflex, Canada, Figure 4.4A).  The replicating 
device (Filtaflex, Canada, Figure 4.4B) allowed for the alignment of the inoculator and 
each consecutive grid.  Gentle pressure was applied using the replicating device to 
ensure that only single colonies were applied to each replica grid.  If too much pressure 
is applied, water is released from the agar, flooding the grid and producing a higher and 
inaccurate distribution of bacteria onto the HGMF (Appendix 4, Figure A4.1).  Once 
colonies were transferred, the HGMF was inverted on the blood agar plate (Figure 4.5) 
and incubated at 37oC for 18-26 h.  Subsequently, the haemolytic properties of each 
colony were determined and the numbers of haemolytic and non-haemolytic colonies 
were enumerated.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Colonies are restricted to the 
square because of the 
hydrophobic border 
 
Figure 4.3: Overnight growth of the culturable bacterial population from a rectal swab 
sample on blood agar.   
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Figure 4.4: Apparatus used for replicating colonies from a Master Grid to each 
subsequent replica; A) 1600 point metal inoculator, B) Replicating device. 
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Figure 4.5: Replication of HGMF from blood/MacConkey agar onto blood agar to enumerate and determine the percentage of haemolytic 
isolates present in the population. 
  E.coli isolates on MacConkey agar  
Haemolytic colony on Blood agar 
β-Haemolytic zone 
  Colonies on HGMF incubated      
 on Blood agar 
MacConkey agar 
Replica 1 
Blood agar 
Blood agar plate – 
inverted filter 
Blood agar plate with haemolysis 
imprint when filter removed
Replica 1 
Storage of HGMF populations: MacConkey Master Grid populations were prepared 
for storage at -80oC by replicating onto a HGMF (Replica 2) placed on brain heart 
infusion agar plate (BHIA, A1.6).  The BHIA plate was incubated at 37oC for 5 h.  The 
HGMF was transferred to a BHIA plate containing 20% glycerol (A1.6), parafilm was 
used to seal the petri dish.  The colonies were prepared for storage by reducing the 
temperature gradually by incubating at -20oC overnight and then transferring to -80oC 
for storage (Figure 4.6). 
 
 
Replica 2 
BHIA 
incubated for 
5 hrs
HGMF transferred to 20% 
glycerol/BHIA plate parafilm petri dish 
Transferred to -20oC for 2-5 h, 
then stored at -80oC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: Flow diagram of freeze down procedure for the storage of HGMF grid 
populations at -80oC.  
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4.2.4 Validation of the PoMA technique 
 
4.2.4.1 Comparison between DCC and PoMA enumeration 
 
Selection of samples: Rectal swab samples were selected randomly from 5 healthy (1-
5) and 5 scouring (6-10) weaner pigs.  Bacteria were recovered as previously described 
in Section 2.2.1.   
 
Comparison between drop colony count (DCC) and HGMF enumeration: The 
bacterial suspensions were serially diluted (1 in 4) and enumerated using both the DCC 
technique (Section 4.2.2) and the HGMF technique (Section 4.2.3) for both blood and 
MacConkey agars. 
 
4.2.4.2 Recovery of HGMF populations from -80oC storage  
Eight of the BHIB/glycerol plates were used to determine the percentage recovery of E. 
coli isolates from HGMF freeze down.  Plates were removed from -80oC after 3 months 
storage, parafilm removed and incubated at 37oC for 1 hour.  The HGMF was then 
transferred to a MacConkey plate and incubated at 37oC for 18-26 h.  Plates were 
enumerated to determine the rate of recovery after -80oC storage. 
 
4.2.4.3 Enumeration of haemolytic colonies – a comparison between spread 
plate and HGMF techniques   
The E. coli selected for the haemolytic comparison consisted of a non-haemolytic 
bovine Ont:H8 and the β-haemolytic O149:K88 (Reference code 43).  Luria-Bertani 
(LB) broth (10 ml) cultures were grown for 1-2 h until mid-log phase (optical density of 
0.5-0.6 at 650 nm) was reached.  An aliquot of the cultures was serially diluted as 
previously described (Section 2.2.2) and plated on LB agar and incubated overnight at 
27oC, by incubating at a lower temperature, colonies were small and a greater number of 
colonies could be enumerated.  The broth cultures were stored on ice overnight at 4oC.  
LB plates were counted and bacterial concentrations enumerated.   
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Equal numbers of the haemolytic (h) and non-haemolytic (nh) E. coli were mixed at 
ratios of 4:0, 3:1, 2:2, 1:3 and 0:4.  Mixed populations were plated in triplicate onto 
HGMF and spread plated on blood agar using a sterile glass spreader, and incubated for 
18-26 h at 37oC. HGMF populations were replicated and inverted on blood agar and 
incubated for a further 18-26 h.  Both spread plates and inverted HGMF plates were 
enumerated for haemolytic and non-haemolytic colonies. 
 
4.2.5 Enumeration of bacteria in rectal swab samples collected from 
healthy and scouring weaner pigs using PoMA 
The previously described PoMA technique (Section 4.2.3) was used to analyse the 
bacterial populations recovered from the rectal swabs collected from both healthy 
(n=12) and scouring (n=12) weaner pigs.  The frequency of haemolytic and non-
haemolytic colonies on blood and MacConkey agar were analysed. 
 
4.2.6 Clone identity based on DNA finger prints of randomly selected 
isolates from a single scouring animal 
 
Analysis of Pulsed-Field Gel Electrophoresis (PFGE) profiles: Three pigs (16, 17 
and 20) with post-weaning diarrhoea were selected randomly for clonal analysis of 
isolates.  The samples were plated in 10 fold serial dilutions on 10% sheep blood agar 
plates and spread using a sterile glass spreader, allowed to dry, inverted and incubated 
overnight at 37oC.  Plates that contained between 50 and 100 colonies from each pig 
were selected for use.  10 haemolytic colonies which were phenotypically identical were 
randomly selected from the blood agar plates and subcultured onto MacConkey agar.  
The colonies were subcultured from the MacConkey plates again onto blood agar for 
confirmation of the β-haemolytic phenotype.  The isolates were then confirmed to be E. 
coli by plating on citrate and minimal agar plates and the indole test was completed as 
outlined in Section 2.2.4.   
 
The 10 β-haemolytic E. coli isolates from all three pigs were prepared for frozen storage 
at -80oC using the protocol in Section 2.2.5.  The 30 E. coli were prepared for pulsed-
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field gel electrophoresis using the protocol provided in Section 2.4.1.  The 
electrophoresed gels were photographed and the bands in each gel analysed by 
numbering common bands across the profiles of all 30 isolates (Figure 4.7).  The raw 
data was assembled in an Excel spreadsheet (Appendix 4, Table A4.1).  An 
agglomerative hierarchical algorithm was used as previously described in Chapter 3 
(Section 3.2.10) to establish a relationship between the bands present in each PFGE 
profile.  This data was then translated into a relationship based cluster analysis. 
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Figure 4.7: Images of ethidium bromide stained agarose gels of the PFGE finger prints of 10 randomly selected β-haemolytic E. coli 
from 3 pigs (16, 17 and 20) with post-weaning diarrhoea.  Lanes 1-10 represent individual E. coli clones.  
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4.2.7 Development of a population PCR assay 
 
A representative E. coli population: The E. coli cultured on HGMF incubated on 
MacConkey agar (Master Grid) were used as the representative E. coli population for 
each healthy and scouring weaner pig.  The HGMF was removed using sterile forceps 
and transferred to a 50 ml sterile tube that contained 5 ml of sterile MQH2O.  The tube 
was capped and vortexed for 30 seconds to remove all colonies from the grid (Figure 
4.8).  Bacteria were pelleted in a 5 ml centrifuge tube at 14,000 rpm for 10 minutes.  
The colonies were washed once with 1 ml of sterile MQH2O and finally resuspended in 
200 µl of MQH2O.  The DNA was extracted using a DNA extraction kit (Section 2.3.3).   
The extracted DNA was diluted to a concentration of 100 µg/ml and analysed using the 
PCR analysis protocol previously described in Chapter 3 for the presence of the 58 
virulence genes. 
 
 
 
 
Vortexed for 30 seconds 
HGMF grown on MacConkey Agar 
5ml Sterile MQH2O
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: Recovery of E. coli from a HGMF for subsequent DNA extraction. 
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Determining the sensitivity of the population PCR assay: A β-haemolytic O149:K88 
(Reference Code 43) and a non-haemolytic O157:H7 were used for the determination of 
the sensitivity of the population PCR assay.  Cultures were grown individually in 2 ml 
of LB broth until mid-log phase and enumerated by DCC on blood agar; cultures were 
stored on ice overnight.  O148:K88 and O157:H7 bacteria were mixed at concentrations 
of 100:0 (O149:K88):(O157:H7), 99:1, 90:10, 10:90, 1:99 and 0:100 in 2 ml of 0.1% 
Tween80, transferred to individual HGMF and incubated overnight at 37oC on blood 
agar.  Each HGMF was replicated onto 2 additional filters and incubated on 
MacConkey and blood (inverted) agars and incubated overnight at 37oC.  The ratio of 
haemolytic and non-haemolytic colonies was determined.  The MacConkey Master Grid 
was used for the population PCR assay as previously described.  Extracted DNA was 
diluted to concentrations of 100 μg/ml, 10 μg/ml, 1 μg/ml, 0.1 μg/ml, and 0.01 μg/ml.  
All diluted DNA samples were used in two separate PCRs for multiplex VII and IX, 
amplified products were electrophoresed on 2% agarose gel at 80V for 2 h. 
 
4.2.8 Analysis of pig swab samples using the PoMA and population 
PCR techniques  
 
Population PCR analysis: The MacConkey Master Grids of the 12 healthy and 12 
scouring weaner pigs were used for population PCR analysis of the 58 virulence genes. 
 
4.2.7 Host profile analysis of subclinical weaner pigs 
 
Sample collection: Rectal swab samples (15) were collected from 5 week old male 
weaner pigs (Table 4.2).  These pigs came from a low health status farm where there are 
regular outbreaks of several different pig diseases including colibacillosis.  However, 
these pigs were clinically healthy at the time of sampling.   
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Table 4.2: List of rectal swab samples collected from subclinical/low health status 
weaner pigs (LHSP, n=15). 
 
 
Piglet Number Age of Piglet (Weeks) Sex (M/F) 
25 5 M 
26 5 M 
27 5 M 
28 5 M 
29 5 M 
30 5 M 
31 5 M 
32 5 M 
33 5 M 
34 5 M 
35 5 M 
36 5 M 
37 5 M 
38 5 M 
39 5 M 
 
 
Bacterial isolation: Bacteria were isolated from rectal swabs as described in Section 
2.2.1.  A 100 µl aliquot of the bacterial suspension was retained for serial dilution 
(Section 2.2.2).  100 µl aliquots of the 1/64 (Row D) dilution of each sample were 
individually inoculated into 2 ml of MacConkey enrichment broth and incubated at 
37oC overnight with shaking at 100 rpm.  2 x 500 μl aliquots of culture were transferred 
to 2 cryovials containing 500 µl of cryoprotective media (A1.7) for storage at -80oC 
(Section 2.2.5).  The remaining 1 ml was used in the DNA extraction procedure 
(Section 2.3.3). 
 
Virulence gene profiling of E. coli populations: The 15 samples of extracted DNA 
were assessed for the presence of the 58 virulence genes as previously described in 
Section 3.2.7. 
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4.3 Results   
 
4.3.1 Enumeration of bacteria in rectal swabs taken from healthy and 
scouring weaner pigs  
Unlike enumeration protocols based on estimating bacterial numbers in a known 
amount of faeces, rectal swabs do not provide a standardised sample quantity from 
which a bacterial concentration can be derived.  To determine if bacterial concentrations 
collected in a swab can be enumerated, samples were collected from healthy and 
scouring pigs and enumerated on blood, MacConkey, KEA and MRS agars to compare 
the variation between samples collected.   
 
Blood agar: The total culturable population was enumerated by drop colony count 
(DCC) on blood agar.  The enumeration of the healthy population revealed a 
consistency between samples (Figure 4.9A) with a mean of 1.9x105 ± 6.6x104 
CFU/swab.  Enumeration of the scouring pigs (Figure 4.9B) was not as reproducible 
with a mean of 1.8x107 ± 1.4x107 CFU/swab.  These results were statistically analysed 
using analysis of variance (ANOVA), revealing the number of bacteria recovered from 
scouring pigs was significantly (P<0.05) higher than those recovered from healthy pigs.   
 
MacConkey agar: The number of bacteria enumerated by DCC on MacConkey agar 
(Figure 4.10) revealed a similar trend as seen on the blood agar.  Enumeration values of 
healthy pigs were consistent with a mean recovery of 7.6x104 ± 1.2x104 CFU/swab 
compared to 2.4x107 ± 1.4x107 CFU/swab in the scouring pigs; the latter was 
significantly higher (P<0.01, ANOVA). 
 
KEA agar: Bacterial numbers recovered on KEA (Figure 4.11) were similar across the 
healthy pigs with the exception of pigs 4, 6 and 11 where no bacteria were recovered.  
The number of bacteria recovered in the scouring pigs was also similar across pigs with 
the exception of pig 13, the mean enumerated value was 3.1x106 ± 1.5x106 CFU/swab 
which was significantly higher than the healthy pigs (8.5x103 ± 2.5x103 CFU/swab) 
using ANOVA (P<0.01). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9: Histograms showing enumeration of rectal swab samples collected from healthy (n=12, A    ) and scouring weaner (n=12, B    ) 
pigs grown on Blood agar.  Enumeration of healthy samples revealed similar quantities of bacteria with a mean of 1.9x105 ± SE of 1.4x107 
CFU/swab (C).   
Pig Number 
1E+00
1E+01
1E+02
1E+03
1E+04
1E+05
1E+06
1E+07
1E+08
1E+09
Healthy Scouring
M
ea
n 
C
FU
/S
w
ab
1E+00
1E 01
1E 02
1E 03
1E 04
1E 05
1E 06
1E 07
1E 08
1E 09
 C
FU
/S
w
ab
+
+
+
+
+
+
+
+
+
   1         2        3          4          5          6          7          8          9         10       11        12   
A B 
1E+00
1E+01
1E+02
1E+03
1E+04
1E+05
1E+06
1E+07
1E+08
1E+09
CF
U/
Sw
ab
13        14       15       16        17       18       19        20       21       22        23       24    
Pig Number C 
4. 22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1E+00
1E+01
1E+02
1E+03
1E+04
1E+05
1E+06
1E+07
1E+08
1E+09
Healthy Scouring
M
ea
n 
C
FU
/S
w
ab
1E+00
1E+01
1E+02
1E+03
1E+04
1E+05
1E+06
1E+07
1E+08
1E+09
C
FU
/S
w
ab
13        14       15        16        17       18       19        20       21       22        23       24    
1E+0
Figure 4.10: Histograms showing enumeration of rectal swab samples collected from healthy (n=12, A     ) and scouring weaner (n=12,B              
    ) pigs grown on MacConkey agar.  Enumeration of healthy samples revealed similar quantities of bacteria with a mean of 7.6x104 ± SE 
of 1.2x104 CFU/swab (C).   
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Figure 4.11: Histograms showing enumeration of rectal swab samples collected from healthy (n=12, A    ) and scouring weaner (n=12, B    
     ) pigs grown on KEA agar.  Enumeration of healthy samples revealed similar quantities of bacteria (with the exception of 4,6 and 11 
where no bacteria were present), with a mean of 3.1x106 ± SE of 1.5x106 CFU/swab (C).    
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MRS agar: The number of bacteria growing on MRS agar (Figure 4.12) showed a 
slight variation amongst the healthy pigs but more variation was evident in the scouring 
populations.  The mean enumeration of the bacteria in the samples collected from 
healthy pigs was 1.0x106 ± 5.4x105 CFU/swab versus 2.2x107 ± 1.2x107 CFU/swab for 
the scouring.  These values were analysed using ANOVA to show that even though a 
higher number of bacteria grown on MRS were recovered from the scouring pigs, this 
was not significant. 
 
Enumeration of bacteria in rectal swab samples from healthy pigs showed consistency 
between values recovered from the 12 different pigs, suggesting that a rectal swab can 
be used with confidence in enumeration of these samples.  Analysis of bacteria from 
scouring pigs was not as consistent; however the variability seen in these samples is 
also seen in faecal samples with a quantifiable volume (Fahy et al., 1987b; Melin et al., 
2000; Svendsen et al., 1977; Tzipori et al., 1980)  
 
The statistical analysis using ANOVA demonstrated that the number of bacteria 
recovered from rectal swabs on blood, MacConkey and KEA agar was significantly 
higher (P<0.5) in scouring pigs compared to healthy pigs.  This result is consistent with 
faecal sample data obtained from scouring pigs (Alexander, 1994; Fahy et al., 1987b; 
Hampson, 1994).  An interesting result was that scouring weaner samples yield a higher 
number of bacteria on MRS than the healthy weaners, this result however was not 
statistically significant.  Recovery of a higher concentration of bacteria from scouring 
pig samples could be attributed to the better absorption of bacteria in a diarrhoea 
affected rectum rather than a healthy drier rectum.   
 
While the DCC enumeration allowed for the bacterial populations recovered from rectal 
swab samples to be compared, it did not allow for the identification and enumeration of 
haemolytic populations which are characteristic of PWD E. coli.  In order for 10 µl 
drops to be counted, colonies must be pin head size which requires a stereomicroscope 
for enumeration.  Bacteria the size of pin heads cannot be distinguished by phenotype as 
colonies are too small and too crowded as each drop contains 40-60 colonies.  As 
bacteria are too closely situated together, enumeration of haemolytic colonies are 
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impossible as haemolytic zones are too close to distinguish which isolate is truly 
haemolytic.  DCC enumeration is a rapid method for accurately determining bacterial 
concentrations, however its limitations are such that, for the purposes of this study, 
further development of the HGMF technique into a population based microbial analysis 
(PoMA) was required. 
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Figure 4.12: Histograms showing enumeration of rectal swab samples collected from healthy (n=12, A    ) and scouring weaner (n=12, B    
    ) pigs grown on MRS agar.  Enumeration of healthy samples revealed slight variation amongst the healthy pigs with a mean enumeration 
of 1.0x106 ± SE of 5.4x105 CFU/swab (C).      
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4.3.2 Development of a Population based Microbial Analysis (PoMA) 
technique 
A technique was required that could simultaneously enumerate both the total number of 
bacteria and the numbers of haemolytic bacteria.  This technique was adapted for the 
analysis of bacterial populations in rectal swab samples collected from healthy and 
scouring weaner pigs.  The E. coli recovered from clinical cases of post-weaning 
diarrhoea are predominantly β-haemolytic.  The requirement of the PoMA technique 
was to recover and accurately enumerate the haemolytic and non-haemolytic bacteria 
present.   
  
4.3.3 Validation of the PoMA technique 
To assess the PoMA technique it was compared to the DCC assay for enumeration of 
total number of bacteria and the traditional spread plate method for enumeration of 
haemolytic colonies.  
 
Comparison between DCC and PoMA enumeration: To determine if the the PoMA 
technique could be used for the enumeration of bacteria isolated from rectal swab 
samples it was to be compared to the DCC technique.  Rectal swab samples were 
randomly selected to include 5 from healthy (1-5) and 5 from scouring (6-10) weaner 
pigs.  The swabs were enumerated using both DCC and PoMA techniques on blood 
(Figure 4.13A) and MacConkey agar (Figure 4.13B).  The variation between the two 
techniques was compared using the T-test.  The results showed no significant difference 
(P<0.05) in the enumeration values obtained using either technique.  
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Figure 4.13: Bacteria were enumerated on Blood (A) and MacConkey (B) agar using drop colony count (DCC,     ) and hydrophobic grid 
membrane filters (HGMF,    ).  The enumeration values of bacterial numbers recovered from 5 healthy (1-5) and 5 scouring (6-10) weaner 
pigs were plotted.   
Enumeration of haemolysis – a comparison between spread plate and PoMA: A β-
haemolytic O149:K88 and a non-haemolytic Ont:H8 were grown in broth cultures, 
enumerated and mixed at ratios of 4:0, 3:1, 2:2, 1:3 and 0:4.  Bacteria were enumerated 
on the basis of haemolysis, samples were plated in triplicate and the mean value 
recorded in Table 4.3.  Figure 4.14 shows 3:1 ratio plates comparing haemolysis 
between the two samples.  The PoMA technique can be used confidently to measure 
haemolysis as there was no significant difference (P<0.05) between PoMA and spread 
plates enumeration when compared using the T-test. 
 
Recovery of HGMF populations from -80oC storage: The viability of storing the 
HGMF at -80oC was assessed.  If colonies could be stored and recovered successfully it 
would allow for additional testing of samples at a later date.  Of the MacConkey Master 
Grids which were stored at -80oC, eight were randomly selected and recovered.  These 
plates were enumerated following incubation and compared to the previous enumeration 
values.  There was slight flooding on some plates (Figure 4.15), this was compensated 
for in the software which allows selection of colonies which do not require counting, 
and therefore these bacteria were excluded from the enumeration value.  The percentage 
recovery was calculated (Table 4.4), this ranged from 88.3-96.7% with a mean of 91.5 ± 
1.4 % recovery after 3 months storage at -80oC. 
 
 
Table 4.3: Enumeration based on haemolysis was assessed using two techniques; plate 
spread and population based microbial analysis (PoMA).  The haemolytic O149:K88 is 
denoted as h and non-haemolytic Ont:H8 is denoted as nh. Enumeration values are as 
colony forming units (CFU).    
   
Spread Plate Inverted Grid Ratio 
O149:K88/Ont:H8 
Expected CFU 
O149:K88/Ont:H8 h O149:K88 nh Ont:H8 h O149:K88 nh Ont:H8 
4:0 40:0 39.0 ± 1.2 0 37.7 ± 1.9 0 
3:1 30:10 32.7 ± 1.2 12.3 ± 1.2 35.7 ± 1.2 14.3 ± 1.5 
2:2 20:20 26.1 ± 1 19.33 ± 1.8 24 ± 0.6 22.3 ± 2.03
1:3 10:30 10.33 ± 0.9 32 ± 1.2 12.7 ± 1.2 32 ± 1.2 
0:4 0:40 0 42.35 ± 1.5 0 44 ± 1.15 
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Table 4.4: Recover of colonies on HGMF after -80oC storage for 3 months.  HGMF 
were recovered on MacConkey agar and enumerated to determine the percentage 
recovery after frozen storage. 
 
 
Sample 
Number 
CFU/Grid on the Master 
Grid 
CFU/Grid on the Replica after  
-80oC Storage 
Percent 
Recovery 
1 111 98 88.3% 
2 108  97 89.8% 
3 106 93 87.7% 
4 160 140 87.5% 
5 211 204 96.7% 
6 360 341 94.7% 
7 287 260 90.6% 
8 87 84 96.6% 
 
 
 
 
 
 
 
 
             
 
 
 
 
 
 
 
 
 
                                      
  
A 
B C 
 
 
 
 
 
 
 
Figure 4.14: The hydrophobic grid membrane filter (HGMF, A) was plated with 
differing ratios of haemolytic (30 CFU) and non-haemolytic (10 CFU) E. coli and 
replicated and inverted on blood agar.  After incubation, the HGMF was removed (B) 
and enumerated.  The same ratio of bacteria was plated on a blood agar plate using a 
sterile glass spreader, known as the spread plate technique (C). 
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Figure 4.15: (A) E. coli isolates (pink colonies) were enumerated on a HGMF 
incubated on MacConkey agar. (B) HGMF replica recovered from -80oC storage and 
incubated on MacConkey agar.  When too much pressure is applied to the replicating 
device water breaches the hydrophobic border causing colonies to flood to adjacent 
squares. 
 
 
4.3.4 Enumeration of bacteria in rectal swabs samples collected from 
healthy and scouring weaner pigs using PoMA 
Once the PoMA technique had been validated, the twelve healthy and twelve scouring 
weaner rectal swab samples were plated on HGMF and incubated on blood and 
MacConkey agar.  Following incubation, HGMF were replicated onto additional grids 
and inverted on blood agar for the detection of haemolytic bacteria.  Blood and 
MacConkey agar plates were enumerated and the percentages of haemolytic colonies 
present were determined (Figure 4.16 and 4.17).   
 
The mean of the healthy and scouring populations was determined.  The number of 
bacteria detected in the scouring weaner samples on both blood and MacConkey agar 
was significantly higher (P<0.05, T-test) than in the healthy pig samples.  This result 
corroborates the result in the DCC enumeration.  The mean number of haemolytic 
isolates was greater in scouring pigs; however this value was not significantly higher 
due to the variability in the number of haemolytic colonies in each pig sample.  
Analysis of the MacConkey master grid population replicated onto blood agar revealed 
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four of the twelve healthy pigs had haemolytic isolates; 1 (38%), 3 (31%), 11 (2%), 12 
(12%), while 11 of the scouring pigs had haemolytic isolates.  Further analysis of the 
scouring pigs revealed that of the bacterial colonies, 10% or more were haemolytic in 
only ten of the 12 pigs.  Four (17, 18, 20 & 23) of the pigs had bacterial populations 
where 50% or more of the colonies were haemolytic.  Comparing the mean percentage 
of haemolytic bacteria equates to 6.9 ± 3.9 % in healthy pigs and only 38 ± 8.7 % in 
scouring pigs, which was significantly higher (P<0.01).  The number of haemolytic 
colonies recovered from the scouring pig samples do not concur with the literature 
which states that generally E. coli recovered in a diarrhoea sample are a pure culture 
(100% haemolytic, Hampson, 1994, or the dominant colony (70-90%, Hampson, 1994; 
Melin et al., 2000).  The discrepancy may have arisen because the rectums were 
samples at the first sign of diarrhoea, and therefore less shedding of pathogenic bacteria 
at the initiation of infection (Svendsen et al, 1977; Tzipori et al., 1980) 
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Figure 4.16: Histogram plots showing single PoMA enumeration of each pig sample on blood agar. (A) Healthy pig samples (n=12), and 
(B) scouring pig samples (n=12) showing the number of bacteria enumerated per swab (    ) and the number of haemolytic bacteria (    ) 
determined.  The mean values of CFU/swab and percentage of haemolytic colonies were determined with standard errors and plotted in C.     
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Figure 4.17: Histogram plots showing single PoMA enumeration of each pig sample on MacConkey agar.  (A) Healthy pig samples 
(n=12), and (B) scouring pig samples (n=12) showing the number of bacteria enumerated per swab (    ) and the number of haemolytic 
bacteria (    ) determined.  The mean values of CFU/swab and percentage of haemolytic colonies were determined with standard errors and 
plotted in C.     
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4.3.5 Clonal identity based on DNA finger prints of randomly selected 
isolates from a single scouring animal 
Three pigs with clinical symptoms of PWD were selected at random to assess the 
clonality of the E. coli within the population.  From the HGMF incubated on 
MacConkey agar, 10 E. coli colonies were selected from each pig; the 10 colonies were 
phenotypically identical.  All colonies selected were smooth and mucoid in appearance 
and all isolates were β-haemolytic on sheep blood agar, which is classical for PWD 
isolates.  The isolates were subcultured onto MacConkey agar and confirmed to be E. 
coli (Section 2.2.4).  The restriction enzyme Not1 was selected for cutting E. coli DNA 
based on a previous study by Osek in 2000a, who found better resolution with Not1 
compared to XbaI and that the two enzymes generated similar dendrogram profiles 
when analysed.  The PFGE finger prints of the 10 E. coli from pigs A, B and C (Figure 
4.7) were analysed using an agglomerative hierarchical algorithm based on the 
similarity of the bands in each profile (Figure 4.18).  The dendrogram revealed five 
divisions designated A, B, C, D and E.   
 
The E. coli from pig 16 segregated into two divisions with approximately 65% 
similarity between the two groups.  Within A1, five isolates shared 80% or higher 
similarity, while the other two isolates (18-8 and 16-9) were 85% similar to each other 
but only shared 75% similarity with the remainder of isolates in A1.  The 3 remaining 
isolates 16-5, 16-7 and 16-6 shared greater than 75% similarity with each other, yet only 
65% similarity with isolates in A1.  
 
Of the E. coli isolates from pig 17, nine were located in section B while one was located 
in C and only had 40% similarity with group B.  Isolates in group B contained two 
major divisions (i) B1; seven isolates with a minimum of 75% similarity and (ii) B2 
contained the two remaining isolates (17-8 and 17-9) which share 95% similarity with 
each other and only 65% with B1.  E. coli isolated from pig 20 are located in group D 
with the exception of isolate 20-3 which shares only 40% similarity with all other 
isolates and is located in group E.  Group D is also segregated into two groups, where 
D1 contains two isolates with 80% similarity and group D2 contains seven isolates of 
which 20-4, 20-5, 20-6 and 20-7 share 85% similarity with the second branch of D2 
4. 36 
(20-8, 20-9, 20-10) and share greater than 95% similarity with each other.  The analysis 
using PFGE to generate molecular profiles identified that while E. coli isolated from 
scouring weaners are clonal, they are not identical (which is often assumed).  The E. 
coli isolated from each scouring pig could be referred to as a clonal complex rather than 
clonal. 
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Figure 4.18: Dendrogram showing the similarity relationships of E. coli isolates 
analysed from scouring weaner diarrhoea samples using PFGE analysis (Section 4.2.6).  
PFGE finger prints were analysed using an agglomerative hierarchical algorithm to 
establish a similarity relationship in the form of a dendrogram which showed isolates to 
be clonal not identical.   
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4.3.6 Development of a population PCR assay 
 
Determining the sensitivity of the population PCR assay: To develop a population 
based PCR analysis technique it was necessary to determine the sensitivity of the 
technique.  This was assessed to determine the minimum bacterial load in a population 
that could be detected.  Two E. coli isolates were selected based on their haemolytic 
phenotype for determination of bacterial numbers and their different virulence gene 
profiles.  O149:K88 was selected as it is β-haemolytic and O157:H7 was non-
haemolytic.  The multiplex sets IX and VII were selected as the virulence genes were 
exclusive for each isolate.  Bacteria were grown in broth culture and enumerated and 
diluted to ratios of 100:1, 99:1, 90:10, 10:90, 99:1, 0:100, where 100:1 is 100 CFU of 
O149:K88 mixed with 1 CFU of O157:H7.  Bacterial numbers were determined on the 
basis of haemolysis, where haemolytic colonies were counted as O149:K88 and non-
haemolytic colonies counted as O157:H7 (Table 4.5).  The concentration of the 
extracted DNA used was 100 µg/ml so 10 fold dilutions were included to determine the 
sensitivity of the PCR assays (Figures 4.19-4.24).   
 
 
Table 4.5: Two E. coli isolates O148:K88 and O157:H7 were selected on the basis of 
virulence gene profiles and haemolytic and non-haemolytic phenotype.  The expected 
CFU and the enumerated ratios were used as a reference for the PCR sensitivity assay. 
 
Expected CFU 
O149:K88/O157:H7 
Enumerated Ratio 
O149:K88/O157:H7 
100:1 114:0 
99:1 85:1 
90:10 92:11 
10:90 10:95 
99:1 1:89 
0:100 0:110 
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Amplification of the different DNA concentrations of the enumerated ratios (Table 4.5) 
of E. coli showed that Multiplex set IX was not as sensitive as set VII because when 
114 CFU of O149:K88 was present the genes F4 and STa were not detectable at a DNA 
concentration lower than 10 µg/ml.  The results demonstrated that a single isolate 
carrying the F4 and STa gene was not detectable within a population.  However, 
analysis of primer set VII showed that it was possible to detect a single colony when the 
DNA concentration was as low as 1 µg/ml. 
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Figure 4.19: Images of ethidium bromide stained 2% agarose gels showing the sensitivity of PCR multiplex IX (A) and VII (B) with DNA 
extracted from a HGMF containing an E. coli ratio of 114 CFU of O149:K88 and 0 CFU of O157:H7 (Ratio 100:0).  Multiplex PCR IX (A) 
demonstrates that both F4 and STa can be detected at a 1µg/ml concentration of DNA and VII (B) shows no detectable bands, therefore no 
false positives.  
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Figure 4.20: Images of ethidium bromide stained 2% agarose gels showing the sensitivity of PCR multiplex IX (A) and VII (B) with DNA 
extracted from a HGMF containing an E. coli ratio of 85 CFU of O149:K88 and 1 CFU of O157:H7 (Ratio 99:1).  Multiplex PCR IX (A) 
demonstrates that both F4 and STa require at least 10 µg/ml concentration of DNA, while multiplex VII (B) bands are detectable for all 4 
genes at a DNA concentration of 1 µg/ml. 
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Figure 4.21: Images of ethidium bromide stained 2% agarose gels showing the sensitivity of PCR multiplex IX (A) and VII (B) with DNA 
extracted from a HGMF containing an E. coli ratio of 92 CFU of O149:K88 and 11 CFU of O157:H7 (Ratio 90:10).  Multiplex PCR IX (A) 
demonstrates that both F4 and STa are clearly detectable with a DNA concentration of 10 µg/ml containing, while VII (B) is able to detect 
all 4 virulence genes at a DNA concentration of 0.1 µg/ml.  
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Figure 4.22: Images of ethidium bromide stained 2% agarose gels showing the sensitivity of PCR multiplex IX (A) and VII (B) with DNA 
extracted from a HGMF containing an E. coli ratio of 10 CFU of O149:K88 and 95 CFU of O157:H7 (Ratio 10:90).  Multiplex PCR IX (A) 
was unable to amplify any bands when the DNA concentration was less that 100 µg/ml, while VII (B) is clearly able to detect bands for all 
4 virulence genes at a DNA concentration of 0.01 µg/ml. 
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Figure 4.23: Images of ethidium bromide stained 2% agarose gels showing the sensitivity of PCR multiplex IX (A) and VII (B) with DNA 
extracted from an HGMF containing an E. coli ratio of 1 CFU of O149:K88 and 89 CFU of O157:H7 (Ratio 1:99).  Multiplex PCR IX (A) 
cannot detect any bands and the 5 DNA concentrations, while multiplex VII (B) is able to detect bands for all 4 virulence genes at DNA 
concentration of 0.01 µg/ml. 
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Figure 4.24: Images of ethidium bromide stained 2% agarose gels showing the sensitivity of PCR multiplex IX (A) and VII (B) with DNA 
extracted from a HGMF containing an E. coli ratio of 0 CFU of O149:K88 and 110 CFU of O157:H7 (Ratio 0:100).  Multiplex PCR IX (A) 
shows no visible bands, therefore no false positives, while VII (B) is able to detect bands for all 4 virulence genes at a DNA concentration 
of 0.01 µg/ml. 
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4.3.7 Virulence gene profiling of E. coli populations from healthy and 
scouring weaner pig rectal swab samples  
The population virulence gene profiles of the healthy and scouring weaner pigs were 
determined using the multiplex and uniplex PCR primer sets 1-XVIII.  The host profile 
results are represented in a gene matrix in Figures A4.2 and A4.3 in Appendix 4.  The 
raw data generated, was given to the EMAI statistician, Idris Barchia for analysis.   
 
Of the 58 virulence genes, 40 were identified within the host profiles sampled.  As 
identified in the Venn diagram in Figure 4.25, 21 of the genes were identified in at least 
one of the pigs from each of the healthy and scouring groups.  In the healthy pigs, 12 
genes were identified which were not present in the scouring weaners, while 7 genes 
were only found in scouring weaners. 
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Figure 4.25: Venn diagram of the distribution of virulence genes between E. coli 
isolates from healthy and scouring weaner piglets.  40 of the 58 genes were found in 
both groups of piglets with 21 genes shared between the groups.  The superscript 
numbers represent the Chi-squared ranking for the significant genes. 
 
 
The virulence gene profiles were analysed using Chi-squared to determine if any of the 
58 genes were able to differentiate between healthy and scouring weaner pigs.  Table 
4.6 shows the percentage of animals that carried each of the 40 virulence genes.  On the 
basis of Chi-squared analysis of the genes analysed, 13 could be used to significantly 
(P<0.05) distinguish between the two populations.  6 of these genes were only identified 
in scouring weaners; LT, aah (orfA), aidA (orfB), papG allele l’, cdt, F18, while 4 of 
the significant virulence genes were only found in healthy pigs; cvaC, bmaE, papC, 
ehxA.  The STa and STb genes were found in 67% of scouring weaners and 8% of 
healthy weaners, while iroNE.coli was found in 50% of healthy weaners and 8% of 
scouring weaners. 
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The 13 virulence genes as determined by Chi-squared analysis were used in an 
agglomerative hierarchical algorithm (Section 3.2.10) to establish a relationship (Figure 
4.26).  The cluster analysis tree contained four major divisions designated A, B, C and 
D.  Group A consisted of 6 scouring pigs and 1 healthy pig; these pigs carried the genes 
LT, STa, STb, F18, aah and aidA which are characteristic of weaner diarrhoea E. coli 
serotypes O8G7, O138, O141:K85.  Group B, the largest of the groups, contains 10 pigs 
which can be further divided into 4 additional groups.  3 pigs (3, 7, 15) located in B1 
contain none of the significant genes, B2 contains 3 healthy pigs that contain either STb 
or ehxA, B3 is comprised of 1 healthy and 1 scouring pig that only have the iroNE.coli 
gene, while B4 consists of 2 scouring pigs that have the papG allele l’ gene only.  Group 
C contains 2 pigs, 19 and 21, which contain the genes LT, STa, STb and F18 which is 
characteristic of the serotype O149:K88.  Group D is the most unrelated of all the 
groups; it consists of only healthy pigs which carry all or a combination of the genes 
cvaC, bmaE, papC, iroNE.coli and exhA of which only exhA was found in the E. coli 
reference clones. 
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Table 4.6: Prevalence of the 58 virulence genes was determined as a percentage. Chi-
squared analysis revealed that 13 of the genes could be used to statistically (P<0.05 in 
bold) differentiate between groups of healthy and scouring weaner pigs. 
 
Virulence Gene Healthy Weaners (% positive) 
Scouring Weaners 
(% positive) Chi-squared Value 
LT 0 50 10.60 
aah (orfA) 0 50 10.60 
aidA(orfB) 0 50 10.60 
cvaC 50 0 10.36 
STb 8 67 9.59 
STa 8 67 9.59 
bmaE 33 0 6.35 
papC 33 0 6.35 
iroNE.coli 50 8 5.45 
papG allele l’ 0 25 4.59 
ehxA 25 0 4.59 
cdt 0 25 4.59 
F18 0 25 4.59 
papA 17 0 2.95 
sfa/focDE 17 0 2.95 
focG 17 0 2.95 
Univcnf 17 0 2.95 
east1 58 25 2.80 
papEF 8 0 1.43 
kpsMTII 8 0 1.43 
traT 92 100 1.43 
papG allele I 8 0 1.43 
K5 8 0 1.43 
stx2 0 8 1.43 
ireA 25 8 1.25 
hlyA 17 33 0.90 
yjaA 75 58 0.76 
Iss 50 33 0.69 
cnf1 17 8 0.39 
chuA 8 17 0.39 
paa 8 17 0.39 
ompT 25 17 0.28 
iutA 50 42 0.17 
eaeA 50 42 0.17 
fimH 100 100 0.00 
fyuA 92 92 0.00 
papG allele III 8 8 0.00 
papG allele II 8 8 0.00 
sfaS 8 8 0.00 
iha 67 67 0.00 
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Figure 4.26: A dendrogram showing the similarity relationship between pigs based on 
the virulence genes possessed by the E. coli population from the rectal swab samples, 
using an agglomerative hierarchical algorithm.  The analysis was based on the 13 genes 
designated by Chi-squared analysis that are capable of distinguishing between healthy 
(HN) and scouring (SW) weaner pigs; LT, aah, aidA cvaC, STb, STa, bmaE, papC, 
iroNE.coli, papG allele l’, exhA, CDT, & F18.   
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Like the reference isolates described in Chapter 3 (Section 3.2.11), the population PCR 
profiles were subjected to principle coordinate (PCO) analysis where only the 13 
significant genes (designated by Chi-squared analysis) were included (Figure 4.27).  A 
second PCO analysis using the full panel of 58 genes (Figure 4.28) was also prepared.  
When the pig virulence gene profiles were analysed using only the 13 genes there were 
tighter clustering of groups with healthy pigs predominating in Q3 and Q4 and scouring 
pigs primarily isolated to Q2 (with the exception of 2 pigs in Q4 and 1 in Q3).  This 
analysis supports the Chi-squared results as the 13 gene analysis resulted in a tighter 
clustering of samples.  Using the full panel of 58 virulence genes in the PCO analysis 
caused a shift in the sample locations, with the healthy pigs predominating in Q2 and 
Q3 and a single pig (12) located in Q4.  The scouring pigs were not in as tight a cluster 
as observed when using the 13 virulence gene analysis, with samples being primarily 
located in Q1 and Q2 and 2 pigs (13 & 16) located in Q3 and pig 19 in Q4. 
 
Both the PCO analyse using the full panel of 58 virulence genes and the subset of 13 
genes were able to segregate between healthy and scouring weaner pigs based on their 
virulence gene profiles or host profiles.  The next step in the analysis was to determine 
if host profiles of pigs could be used to assess the health status of a pig.  The remaining 
aspect to be tested was pigs that have been exposed to pathogenic E. coli but are not 
showing clinical symptoms at the time of sampling, denoted as subclinical pigs.    
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Figure 4.27: Principal coordinate analysis using the 13 virulence genes (Chi-squared, P<0.05) to establish a relationship between the 12 
healthy (A), and 12 scouring weaner pig samples.  The coordinate value of each host profile is defined by 2 dimensions, axis X is PCO1 
(dimension 1), while Y axis is PCO2 (dimension 2).  Values of the healthy pigs     are graphed in A, while the values of the scouring pigs     
are graphed in B.  The pig number is used to identify the pig.  The composite of the two plots is represented in C. 
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Figure 4.28: Principal coordinate analysis using the full panel of 58 virulence genes to establish a relationship between the 12 healthy and 
12 scouring weaner pig samples.  The coordinate value of each host profile is defined by 2 dimensions, axis X is PCO1 (dimension 1), 
while Y axis is PCO2 (dimension 2).  Values of the healthy pigs     are graphed in A, where the values of the scouring pigs     are graphed 
in B.  The pig number is used to identify the pig.  The composite of the two plots is represented in C. 
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4.3.8 Host profile analysis of subclinical weaner pigs 
Subclinical weaner pigs were selected from a low health status farm and rectal swab 
samples were collected and analysed.  A group of 15 pigs were selected randomly; these 
pigs were showing no clinical symptoms of PWD at the time of sampling.  The rectal 
swabs were analysed using multiplex and uniplex PCR analysis to generate host profiles 
(A4.4 in Appendix 4).  These profiles were subjected to Chi-squared analysis (Table 
4.7), where 18 virulence genes could differentiate (P<0.05) between the three groups.  
The 13 virulence genes as defined by chi-squared analysis still remained with 6 
additional genes fyuA, fimH, iha, iss, yjaA and hlyA.  These 6 genes differentiated 
between the healthy and scouring weaners and the subclinical pigs.  Of these genes only 
yjaA was found in higher prevalence in the subclinical pigs with 100% versus 75% and 
58% in healthy and scouring weaners respectively. 
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Table 4.7: Prevalence of the 58 virulence genes was determined as a percentage. Chi-
squared analysis revealed that 18 of the genes could be used to statistically (P<0.05 in 
bold) differentiate between the three groups of weaner pigs.  
 
Virulence Gene Healthy Weaners (% postivie) 
Scouring Weaners 
(% positive) 
Low Health Status 
Pigs - LHSP  
(%  positive) 
Chi-squared 
Value 
fyuA 92 92 0 39.65 
fimH 100 100 33 25.31 
iha 67 67 0 22.25 
cvaC 50 0 0 16.85 
LT 0 50 0 16.85 
STb 8 67 73 14.48 
iroNE.coli 50 8 0 13.19 
iss 50 33 0 12.49 
papC 33 0 0 10.52 
bmaE 33 0 0 10.52 
aidA (orfB) 0 50 27 10.37 
aah (orfA) 0 50 27 10.37 
yjaA 75 58 100 9.78 
STa 0 42 13 8.63 
ehxA 25 0 0 7.66 
F18 0 25 0 7.66 
papG Allele ’ 0 25 0 7.66 
hlyA 17 33 0 7.4 
ompT 25 17 0 5.56 
eaeA 50 42 13 4.93 
cdt 0 25 13 4.59 
chuA 8 17 0 3.45 
iutA 50 42 20 2.97 
traT 92 100 87 2.49 
kpsMTII 8 0 0 2.42 
K5 8 0 0 2.42 
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The relationship between virulence genes was established in a cluster analysis 
dendrogram using the 13 virulence genes which could statistically (P<0.05) differentiate 
between the healthy and scouring weaner pigs (Figure 4.29).  The previous 4 major 
divisions (Figure 4.26) remained with no change to group D, however the other 3 
groups had changed.  Group A became the largest division with 5 subdivisions; where 
A1, A2 and A3 containing 3, 3 and 5 subclinical/low health status pigs, respectively, 
while A1 also contained a single healthy pig (1).  The other subdivisions of A consisted 
of A4 and A5 where A4 contained 2 scouring weaners and A5 containing 3 scouring 
and 4 LHSP.  The pigs in group A were segregated on the basis that they possessed the 
genes: fimH, traT, yjaA, STb, LT, aah and aidA.  Group B was comprised of a single 
division which contained 6 healthy weaners and 2 scouring weaners; these pigs 
contained the genes fimH, fyuA, iha, eaeA & yjaA.  Group C consisted of 5 scouring 
weaners which contained the genes fimH, fyuA, hlyA, iha, LT, STa and STb. 
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Figure 4.29: A dendrogram showing the similarity relationship between pigs based on 
the virulence genes possessed by the E. coli population from rectal swab samples 
collected from healthy (HW), scouring (SW) and subclinical/low health status (LHSP) 
weaner pigs using an agglomerative hierarchical algoritm.  The analysis was based on 
the 13 virulence genes as determined by Chi-squared analysis that are capable of 
distinguishing between healthy and scouring weaner pigs; LT, aah, AIDA-I cvaC, STb, 
STa, bmaE, papC, iroNE.coli, papG allele l’, exhA, CDT, & F18.   
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The virulence gene profiles of bacteria from the subclinical pigs were included in the 
PCO analysis of the healthy and scouring weaners using the 13 virulence genes (Figure 
4.30) and full panel of 58 virulence genes (Figure 4.31).  Using the 13 virulence genes 
generated a cluster of the subclinical pigs in Q2 with 3 pigs (27, 29 & 31) in Q3, this 
demonstrated that the pigs could be classified as subclinical as they fell in between the 
healthy and scouring weaners, demonstrating these pigs could potentially develop post 
weaning diarrhoea as they are carrying E. coli which have a repertoire of genes capable 
of initiating disease.  When the full panel of 58 genes is used to generate the PCO, a 
similar picture is seen.  The subclinical pigs are located in Q1; with some pigs (26, 28, 
30, 33-35, 37-39) more closely located to the scouring weaners and the remaining were 
more closely located to the healthy weaners. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.30: Principal coordinate analysis using 13 virulence genes (Chi-squared, P<0.05) to establish a relationship between the 12 
healthy, 12 scouring and 15 subclinical/low health status weaner pig rectal swab samples.  The coordinate value of each host profile is 
defined by 2 dimensions, axis X is PCO1 (dimension 1), while Y axis is PCO2 (dimension 2).  Values of the healthy pigs     are graphed in 
A, while the values of the scouring pigs     are graphed in B, and the subclinical pigs    in C.  The pig number is used to identify the pig.  
The composite of the two plots is represented in D. 
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Figure 4.31: Principal coordinate analysis using the full panel of 58 virulence genes (Chi-squared, P<0.05) to establish a relationship 
between the 12 healthy, 12 scouring and 15 subclinical/low health status weaner pig rectal swab samples.  The coordinate value of each 
host profile is defined by 2 dimensions, axis X is PCO1 (dimension 1), while Y axis is PCO2 (dimension 2).  Values of the healthy pigs     
are graphed in A, while the values of the scouring pigs     are graphed in B, and the low health status pigs     in C.  The pig number is used 
to identify the pig.  The composite of the two plots is represented in D. 
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A Venn diagram was used to display the virulence genes identified in the three groups 
of pigs.  No additional virulence genes were found in the subclinical group that had not 
been previously identified.  Of the 4 virulence genes identified as being present in 
bacteria in both the scouring and the subclinical weaners, 3 (aah, aidA and STa) could 
differentiate between healthy and scouring pigs.  The genes that were only identified in 
healthy pigs, none were found in the subclinical pigs, reinforcing the idea that these pigs 
are subclinical. 
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Figure 4.32: Venn diagram of the distribution of virulence genes between E. coli 
isolates from healthy (HW), scouring (SW) and subclinical weaner pigs.   
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4.4 Discussion 
In order to expand our knowledge of porcine pathogenic E. coli, we need to investigate 
the commensal E. coli population.  This was conducted by enumeration and phenotypic 
identification based on haemolysis.  Enumeration by drop colony count (DCC) provided 
a rapid method to enumerate bacteria in rectal swab samples rather than faecal samples.  
Rectal swabs were taken as they were more convenient to collect for farm staff, and 
there was less chance of contamination than collecting a faecal sample from the floor of 
the pig pen.  Enumeration of bacteria from rectal swabs collected from healthy pigs 
showed consistency in the sampling technique and the absorption of bacteria on all 
media types.  The bacteria enumerated from samples taken from scouring pigs did not 
show the same level of consistency; however this could be attributed to the ‘watery’ 
nature of the diarrhoea with some samples having more faecal material on the swab 
itself.  The results showed a significantly higher level of bacteria in the samples from 
the scouring versus healthy pigs which is consistent with faecal sample studies (Fahy et 
al., 1987b).  The fact that the level of bacteria recovered on MRS media was higher, yet 
not significantly higher, validates the enumeration of a faecal swab, because even 
though there are more bacteria collected from a diarrhoea swab due to the fluid nature 
of the sample, this did not result is a significantly higher number of all bacteria.  
 
While DCC is a rapid technique for enumeration of rectal swab samples it does have 
inherent disadvantages, one such disadvantage involves the phenotypic identification of 
colonies, including haemolysis which was necessary for this study.  As the drops were 
only 10 µl, the colonies needed to be the size of pin heads at the time of enumeration, 
this made colony morphology and haemolytic phenotype hard to distinguish.  This 
prompted the search for a more versatile technique which could incorporate 
enumeration and phenotype identification.  The HGMF technique was such a technique, 
it had many advantages including: (i) enumeration could be done with a computer 
(Sharpe & Michaud, 1975), (ii) the replication device allowed for many copies of the 
culture to be tested (Sharpe et al., 1989), and (iii) hydrophobic borders on the HGMF 
prevented overspill of samples, therefore the filtration device did not get contaminated 
and did not require sterilizing between samples (Sharpe et al., 1986).  This technique 
has been previously tested on food and milk products for bacterial contamination and 
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for antibiotic profiling of E. coli faecal samples (Dunlop et al., 1998; Entis et al., 1982; 
Peterkin & Sharpe, 1980).  This microbiological tool is valuable for evaluating bacterial 
populations as it provides easy replication of numerous bacteria from one media source 
to another.  Development of this population based microbial analysis (PoMA) technique 
allowed for the enumeration of haemolytic colonies in both healthy and scouring pig 
rectal swab populations.  The results obtained using PoMA were comparable to the 
DCC enumeration technique and the spread plate technique for enumeration of 
haemolytic colonies as confirmed by statistical analysis.   
 
In a healthy pig there can be between 103-106 CFU/g of faeces haemolytic E. coli (Fahy 
et al., 1987b).  The findings of this study (Figure 4.17) agree with this with the mean 
percentage of haemolytic isolates being less than 10% (1x105 CFU/swab).  The mean of 
the scouring pigs was 38 ± 8.7% (6.8x105 CFU/swab) which is much lower than the 109 
CFU/g stated in the literature (Fahy et al., 1987b).  A plausible explanation could relate 
to the swab samples being collected at the onset of diarrhoea when the proliferation of 
pathogenic bacteria has just started and therefore lower numbers of haemolytic E. coli 
are recovered (Tzipori et al., 1980; Svendsen et al., 1977).  
 
As the rectal swab samples are diluted before being plated on the HGMF, the dominant 
colonies within the population should be present.  The colonies grown can then be used 
as a representative E. coli population within the sample.  Representative E. coli 
populations obtained from healthy and scouring pigs were used to phenotypically 
identify pathogenic E. coli on the basis of their mucoid appearance and β-haemolytic 
phenotype.  To investigate if the E. coli isolated from a scouring weaner pig were clonal 
(identical) or part of a clonal complex (not identical), PFGE was used.  From three 
separate pigs with diarrhoea, 10 phenotypically identical β-haemolytic isolates were 
selected and subjected to PFGE analysis.  The hypothesis was that if the E. coli isolates 
were identical they would have exactly the same PFGE finger print.  The analysis 
revealed that the majority of isolates were not identical.  In the analysis there were only 
two identical (clonal) isolates in each pig; 16-1 &16-3, 20-4 & 20-5 and 20-8 & 20-9.  
Within each pig there were two distinct clonal complexes exhibiting between 65 and 
75% similarity with the other.  Within the two clonal complexes the isolates shared 
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between 75 and 100% similarity.  The only exceptions in this analysis were isolates 17-
7 and 20-3 which were not part of any clonal complex. 
 
As demonstrated in Chapter 3, it is possible to distinguish between PWD and 
commensal E. coli isolates on the basis of their virulence gene profiles.  The difference 
between these two groups of isolates was statistically significant and clustered 
separately using two statistical analysis methods; an agglomerative hierarchical 
algorithm and principle coordinate analysis (PCO).  If this analysis could differentiate 
single isolates, then could this concept be applied to a population of E. coli?  The 
HGMF incubated on MacConkey agar (MacConkey Master Grid) was used as a 
representative E. coli population from the rectal swab samples collected from both 
healthy and scouring weaner pigs.  Could this population be analysed to generate a host 
virulence gene profile, or simply a host profile? 
 
To determine the sensitivity of the population PCR assay the minimum number of 
detectable colonies was determined by plating different ratios of two E. coli isolates 
with distinct virulence gene profiles.  The assay was able to detect a single O157 isolate 
when the DNA concentration was at 100 µg/ml using the multiplex consisting of stx1, 
stx2, eaeA and ehxA.  This level of sensitivity is excellent for O157:H7 which is a 
leading cause of food poisoning in humans, and only requires a low level of 
contamination to cause infection (Koneman et al., 1997; Tortora et al., 1995).  This 
technique can also be used to test cattle faecal samples as they are believed to be the 
main contamination source of O157:H7 (Tortora et al., 1995).  On the other hand the 
multiplex containing F4, F5 and STa was only able to detect 10 colonies of O149:K88 
when the DNA concentration was 100 µg/ml.  However, from the result obtained this 
was sufficient to detect population differences between healthy and scouring weaner 
pigs.   
 
Host profiles were generated for the healthy and scouring weaner pigs, 40 of the 58 
genes analysed were detected, with 13 virulence genes being able to distinguish 
(P<0.05) between the two groups.  Of these 13 genes, 6 (cvaC, bmaE, papC, papG 
allele I’, ehxA and cdt) were not part of the 17 genes that could be used to distinguish 
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between ND, PWD and commensal E. coli isolates in Chapter 3 (Figure 4.33).  The 
papG allele I’, and cdt were present only in scouring weaners while cvaC, bmaE, papG 
and ehxA were only detected in healthy weaners.  These results demonstrate that 
virulence genes can be used as markers for scouring pigs, and also to indicate health 
status.  Interestingly, the cvaC gene is a marker for the colicin V conjugative plasmid 
which is a defense mechanism of E. coli, it is capable of killing other species of bacteria 
including other E. coli isolates.  bmaE and papG are adhesin molecules (Johnson, 1998; 
Johnson & Stell, 2000) and ehxA an enterohaemolysin (Paton & Paton, 1998). 
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Figure 4.33:  Venn diagram showing the virulence genes as defined by Chi-squared 
analysis that can be used to differentiate between the individual E. coli isolates of ND, 
PWD and commensals (Chapter 3) and the host profiles from healthy and scouring 
weaner pigs.  Of the 17 genes defined by Chi-squared analysis in Chapter 3, 7 of these 
genes (LT, aah, AIDA-I, STb, STa, iroNE.coli, & F18) were also defined by Chi-squared 
analysis as significant at P<0.05 to determine if a host profile was from a healthy or 
scouring weaner pig.  
 
 
Cluster analysis using an agglomerative hierarchical algorithm based on the 13 
virulence genes showed segregation between groups of pigs with 4 defined groups.  
There was however, overlapping of groups, which did not allow for the full potential of 
4. 66 
the population PCR assay to be observed until principle coordinate analysis was 
applied.  The PCO analysis was conducted with both the 13 and the full panel of 58 
virulence genes.  Using only the 13 genes produced a tighter clustering effect, and 
allowed for the segregation of the healthy and scouring pigs.  The full panel of genes 
generated different coordinate values which resulted in samples being located in a 
different position, however the same result was achieved.  There was clear segregation 
between the two groups, however the full panel of genes allowed for the variation in the 
healthy pig groups to be observed with two distinct clusters being observed over two 
quadrants. 
 
As the PCO analysis segregated the host profiles of healthy and scouring pigs into 
separate groups, the next step was to determine if this information could be used as a 
surveillance tool for monitoring pig health.  Pig rectal swab samples were taken from 15 
clinically healthy pigs, however the farm on which they were reared is of low health 
status where the pigs suffer a range of illness including colibacillosis.  These pigs are 
denoted as subclinical (low health status), as they may have been exposed to a number 
of diseases.  The virulence gene assay was used to determine the host profiles and these 
were subjected to the full range of statistical analyses.  Chi-squared analysis identified 
18 virulence genes that could be used to differentiate (P<0.05) between the three 
groups.  The original 13 genes remained with 6 additional virulence genes including; 
fyuA, fimH, iha, iss, yjaA, and hlyA.  Of these genes, fyuA, iha, iss and hlyA were not 
detected in the subclinical pigs.  yjaA was found in every subclinical pig, while it was 
only found in 75% of healthy and 58% of scouring pigs and fimH was only found in 
33% of subclinical yet was found in all of the healthy and scouring weaners.   
 
The cluster analysis was based on the 13 virulence genes identified using Chi-squared.  
The subclinical pigs predominantly grouped together in a cluster that contained 5 
scouring and only a single healthy pig.  The PCO method more clearly demonstrated the 
position of the subclinical pigs.  The 13 and 58 virulence gene analyses generated 
different coordinate values for the subclinical pigs, however the overall picture 
presented the same results, the subclinical pigs were located in between both groups, but 
more closely related to the scouring pigs.  The host profiles and PCO analysis shows 
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that the subclinical pigs are carrying the pathogens responsible for disease, but are not 
symptomatic.   
 
From the results obtained it is possible to construct a Venn diagram (Figure 4.34) to 
determine the likely serogroup which the isolates within the diarrhoea sample belong to.  
The Venn diagram indicates the key virulence genes that can be used to distinguish 
between the serogroups; O8G7 – AIDAc, and cdt, O141 – stx2, O149 – F4.  From this 
information Table 4.8 was constructed showing the suspected serogroups.  The 
predominant serogroups are O8G7 and O141, with pig 23 looking like it is affected by 
both serogroups.  The healthy isolates were analysed using the same Venn diagram 
(Figure 4.34) and the host profiles did not contain any of the virulence genes that clearly 
defined a serogroup.  Of the genes that were being carried by the healthy pigs (east1, 
hlyA, iha and one pig carrying STb) these were all common genes shared amongst 
serogroups. 
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Figure 4.34: Venn diagram for the determination of infectious serotype when assessing 
host profiles.  The key virulence genes associated with each of the PWD serotypes; 
O8G7, O141 and O149, allow for the distinction between responsible serotypes. 
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Table 4.8: Based on the virulence gene profiles, the E. coli serogroups involved in 
PWD and being harboured by the subclinical pigs can be determined. 
 
 
Pig Number PWD or LSHP Suspected Serogroup 
13 PWD O45 
14, 17 & 19 PWD O141or O8 not carrying AIDA 
15 & 16 PWD Unknown, not carrying definable genes 
18, 22 & 24 PWD O141 
20 & 21 PWD O8G7 
23 PWD O8 and O141, carrying both Stx2 and CDT
25, 26,28,35,36 & 37 LSHP O141 or O8G7 with no AIDA 
30, 32,,33, 34 LSHP O141 
 
 
The results obtained from analysing the subclinical pig samples from a different farm 
are encouraging, suggesting that this protocol is ideal for monitoring health status in pig 
trials.  PWD models are hard to establish as there are many factors that are part of 
colibacillosis, where the proliferating E. coli is the final stage (Madec et al., 2000).  
Thus a successful colibacillosis model which mimics the farm environment is hard to 
establish.  It would be extremely valuable to develop a tool for assessing vaccine and 
feeding regimes on a farm.  The 58 virulence gene population analysis technique is ideal 
for monitoring changing bacterial populations when a clinical trial is held on a farm; 
rectal swabs are easily collected and animals are not required to be sacrificed.  Figure 
4.35 shows a hypothetical successful outcome from a clinical trial.  Before the trial the 
subclinical pigs would carry virulence genes that would give them a coordinate value 
which would locate them in between the healthy and scouring pigs.  After a successful 
vaccine or feeding regime the pathogenic E. coli would not be present and this would be 
reflected in the coordinate value which would locate the sample in the healthy pig 
region. 
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Figure 4.35:  A hypothetical principle coordinate analysis plot for evaluating the health 
status of a pig herd.  Scouring weaners     are primarily located in Q2, while healthy 
weaners     are located in Q4 and subclinical/low health status weaners    are initially 
located in Q2.  After a successful vaccine or feeding regime the host profile coordinates 
would be altered because the pathogenic E. coli which are carrying the significant 
virulence genes that locate them in Q2 are no longer part of the intestinal flora.  The 
change in host profile would alter the coordinate values and relocate subclinical/low 
health status pigs in Q3 as indicated by the red arrow. 
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Chapter 5 
 
Analysis of Bacterial Populations Isolated from Rectal 
Swabs Collected from Healthy and Scouring Neonatal 
Pigs 
  
5.1 Introduction 
The gut mucosal immune system of a newborn piglet is essentially under-developed.  In 
particular, the various components of the gut associated lymphoid tissue (GALT) that 
make up the mucosal immune system, including: Peyer’s patches, intraepithelial 
lymphocytes and lamina propria, have not had the opportunity to encounter foreign 
antigens.  Development of these components is dependent upon exposure to intestinal 
microorganisms (Moreau & Gaboriau-Routhiau, 2000; Shi & Walker, 2004).  
Therefore, in the first 3-4 days of its life, the piglet is completely dependent upon the 
sow for passive protection conferred by colostral antibodies (Chin & Mullbacher, 2003). 
Thereafter, maternal milk antibodies will continue to provide protection until weaning 
(14-28 days).  With an immature gut and immune system, a neonatal piglet is 
susceptible to infection by opportunistic bacteria. In pigs, E. coli are the primary cause 
of neonatal diarrhoea (Alexander, 1994; DebRoy & Maddox, 2001; Nagy & Fekete, 
1999). 
 
To minimize losses from ND, farmers vaccinate gilts (Section 1.4.1.1) to ensure that 
colostral IgA antibodies against fimbrial and other cell surface antigens are present.  
These antibodies prevent attachment (colonization) of potentially pathogenic strains of 
ETEC (Fairbrother, 1999).  With the exception of fimbrial specific antibodies, the use 
of bacterins also generate antibodies against other bacterial cell surface antigens such as 
porins which are not serogroup-specific.  These antibodies can also prevent colonization 
of non-pathogenic (commensal) strains that would otherwise fulfill an important role in 
developing GALT (Kramer et al., 1995; Van Der Heijden et al., 1989).  
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The bacteria involved in the development of GALT originate from the piglet's 
immediate environment.  Primarily these organisms come from the sow.  The first 
exposure to bacteria occurs in the cervix and vagina (Fahy et al., 1987a).  Subsequent 
exposure occurs as the piglet picks up microorganisms as it suckles on its mother’s teats 
as well as from faecal material in the farrowing crate (Fahy et al., 1987a).   
 
With no immunity in the first moments of life, a piglet is susceptible to infection from 
pathogens carried by the sow.  The sow carries a diversity of organisms, consisting of 
commensal/opportunistic and pathogenic bacteria.  These organisms are harmless to the 
sow because she has either developed immunity to them, or in the case of 
commensals/opportunistic bacteria, they are regulated by the mucosal immune system 
and other gut bacteria.  The newborn piglet does not have the immunity or the gut flora 
to control any of these bacteria.   
 
A piglet is at risk of colonization by harmful bacteria that can result in disease.  The 
exposure of young piglets to pathogenic bacteria has increased with intensive pig 
farming, where a sow is confined to a crate and has no option but to dung where she 
farrows (Fahy et al., 1987a).  As a result, higher rates of morbidity and mortality occur 
due to a number of causative bacteria and viruses (Section 1.4.1), with E. coli being the 
most frequently isolated.  In an Australian study of intensive piggeries, 2426 piglets 
from 283 litters were assessed; 1.7% of neonatal piglet deaths were attributed to 
diarrhoea, with E. coli the most frequent cause (Spicer et al., 1986). 
 
Diarrhoea attributed to E. coli can occur in neonatal piglets as early as a few hours after 
birth, but most commonly occurs within 72 hours of life (Spicer et al., 1986); the 
incidence of mortality decreases in older piglets (Alexander, 1994; Fairbrother, 1999; 
Fahy et al., 1987a).  The initial signs of infection include raised hair and a slight shiver, 
which progresses to watery diarrhoea, varying in colour from brown, to brightly 
coloured creamy-white, grey or fawn.  The onset of diarrhoea causes a piglet to 
deteriorate rapidly and become thin, appear hairy, dehydrated and weak.  As the disease 
progresses, eyes become dull and sunken, emaciation progresses, and ribs, spinal and 
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pelvic bones become increasingly prominent.  If treatment is not administered, piglets 
become recumbent, cold, comatose, and finally die (Alexander, 1994).   
 
While the disease process in neonatal diarrhoea is similar to that of post-weaning 
diarrhoea (PWD), the E. coli implicated are not.  This, however, is only the case in 
Australia.  The majority of the world’s pig producers see the same E. coli in both 
neonatal and weaner pigs with diarrhoea.  In the UK, β-haemolytic E. coli belonging to 
O8, O138, O147, O149 and O157 are the major concern, while Sweden is only affected 
by O149 (Alexander, 1994).  In North America, isolates belonging to the serogroups 
O8, O147, O149 and O157 are implicated (Wilson and Francis, 1986; Alexander, 1994), 
however in recent years O9, O64 and O101 (Fairbrother, 1992) have also been isolated.  
The previously mentioned serogroups are amongst those isolated in Australia; O8, O9, 
O20, O64 and O101.  These E. coli are usually non-haemolytic, and are classified as 
‘class 2’ ETEC, which produce mucoid colonies and usually possess fimbrial adhesins 
belonging to F4, F5, F6 and F41.  These bacteria are generally LT- (negative for heat 
labile enterotoxin) and ST+ (positive for heat stable enterotoxin) (Alexander, 1994; Fahy 
et al., 1987a; Woodward et al., 1993).  In recent years, the ‘class 2’ ETEC isolated from 
piglets with ND in Australia have lacked adhesions.  It was suggested that wide scale 
vaccination programs incorporating pilus antigens may explain why E. coli recently 
isolated from cases of ND lacked fimbrial adhesins (Alexander, 1994). 
 
Vaccination is a routine procedure in Australia and has reduced the incidence of ND 
(Driesen & Sharrock, personal communication).  However, E. coli-associated ND is still 
being detected.  Diarrhoea induces an imbalance in the microbial population of the gut.  
The role of the commensal population in ND has not been studied.  The population 
microbial analysis (PoMA) technique was used to closely examine the bacteria 
associated with healthy and scouring neonatal piglets. 
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5.2 Material and Methods 
 
5.2.1 Sample collection in the form of rectal swab samples from healthy 
and scouring neonatal piglets 
There are two stages before weaning in which diarrhoea can occur; in neonatal piglets 
and young piglets (Fairbrother, 1999).  Diarrhoea in neonatal piglets can occur from 
birth up to the first five days of life, while young piglet (pre-weaning) diarrhoea  occurs 
between 14 days and weaning (Fahy et al., 1987a; Fairbrother, 1999; Liebler-Tenorio, 
1999; Spicer et al., 1986).  There is, however, the stage between 5 to 14 days where 
diarrhoea attributed to E. coli occurs, and for the benefit of this study these piglets are 
treated as neonatal. 
 
Sample collection: Two groups of neonatal piglets were selected for rectal swab 
analysis sampling at QAF Meat Industries, Cowora (Table 5.1).  A male and a female 
piglet between the ages of 0-7 days with no clinical signs of disease were selected from 
6 different litters.  Neonatal piglets with clinical symptoms of E. coli associated 
diarrhoea, as diagnosed by the on farm veterinarian, were also sampled.  Unlike healthy 
neonates, scouring piglets could not be selected to include a male and female from the 
same litter; care was taken to sample from at least 6 different litters.  Once rectums were 
sampled, the swabs were transferred in AMIES transport medium and shipped on ice 
packs directly to EMAI. 
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Table 5.1: Details of rectal swab samples collected from healthy (n=12) and scouring 
(n=12) neonatal piglets. 
 
 
Reference 
Code Piglet Number 
Health 
Status 
Age of Piglet 
(Days) 
Sex 
(M/F) 
Mother’s 
Details 
1 HN1 Healthy 5 F J1475 
2 HN2 Healthy 5 M J1475 
3 HN3 Healthy 4 M F5753 
4 HN4 Healthy 4 F F5753 
5 HN5 Healthy 2 M J5174 
6 HN6 Healthy 2 F J5174 
7 HN7 Healthy 3 M F4872 
8 HN8 Healthy 3 F F4872 
9 HN9 Healthy 6 F H0288 
10 HN10 Healthy 6 M H0288 
11 HN11 Healthy 7 F C7488 
12 HN12 Healthy 7 M C7448 
13 SN1 Scouring 2 M B7054 
14 SN2 Scouring 2 M 15196 
15 SN3 Scouring 6 M 35317 
16 SN4 Scouring 2 F 34749 
17 SN5 Scouring 2 F B7054 
18 SN6 Scouring 3 F H9505 
19 SN7 Scouring 4 F 55452 
20 SN8 Scouring 4 F 55452 
21 SN9 Scouring 4 F 55452 
22 SN10 Scouring 6 F 35317 
23 SN11 Scouring 9 F H0076 
24 SN12 Scouring 9 F H0076 
 
Bacterial isolation: Bacteria were recovered from rectal swabs and stored in 
BHIB/glycerol as previously described in section 2.2.1. 
 
5.2.2 Population based Microbial Analysis (PoMA) of rectal swab 
samples collected from healthy and scouring neonatal pigs 
 
Drop colony counts (DCC) and PoMA enumeration: Bacterial samples were serially 
diluted and enumerated using the DCC technique (Section 2.2.2) on blood, MacConkey, 
KEA and MRS agars.  Bacterial populations were plated using the PoMA methodology 
(Section 4.2.3). 
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PoMA of MacConkey Master Grids: MacConkey Master Grids were replicated onto 
CHROMagar Orientation media (Replica 2, Figure 5.1) to determine the identity of the 
second population on the HGMF.  10 colonies were randomly selected from 5 different 
grids and subjected to a gram stain to phenotype the populations.  Bacterial samples 
were diluted and plated on HGMF (Section 4.2.3) for haemolytic enumeration of the 
enterococci population.   
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Figure 5.1: Schematic drawing showing the replication of HGMF from MacConkey agar onto blood agar (Replica 1) to enumerate and 
determine the percentage of haemolytic colonies present in the population. Replica 2 involved replicating onto CHROMagar for the 
phenotyping of colonies on MacConkey agar. 
5.2.3 Analysis of host virulence gene profiles using the population PCR 
technique 
The HGMF incubated on MacConkey agar (section 5.2.2) were used as the 
representative population for population PCR analysis (described in section 4.2.7). 
 
5.2.4 Identification of gram positive colonies on MacConkey agar 
 
Bacterial strains: Two colonies were selected from each KEA Master grid, a α-
haemolytic and a non-haemolytic isolate (where possible, Table 5.2).  There were no 
colonies present on the KEA Master grid for piglet 22, so this piglet was excluded from 
the analysis.  Each of the colonies was subcultured onto blood agar for confirmation of 
the haemolytic phenotype.  Gram stain analysis (Section 2.2.3) was completed for each 
of the colonies isolated.  The probiotic E. faecium strains were provided by International 
Animal Health and the hospital enterococci were isolated at PaLMs, Royal North Shore 
Hospital, from both clinical and environmental sources.   
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Table 5.2: Details of enterococci strains isolated from healthy (n=24) and scouring 
(n=22) neonatal piglets, including probiotic (n=2) and hospital strains (n=11). 
Abbreviations used are: Vancomycin resistant enterococci (VRE), non-haemolytic 
isolates (nh) and alpha haemolytic isolates (α-h). 
 Type/Origin of Isolate Reference Code 
Haemolytic 
Phenotype 
Source of 
Isolate 
Healthy Neonate 1 nh HN1a
Healthy Neonate 2 α-h HN1a
Healthy Neonate 3 nh HN2a
Healthy Neonate 4 nh HN2a
Healthy Neonate 5 nh HN3a
Healthy Neonate 6 nh HN3a
Healthy Neonate 7 α-h HN4a
Healthy Neonate 8 nh HN4a
Healthy Neonate 9 α-h HN5a
Healthy Neonate 10 nh HN5a
Healthy Neonate 11 nh HN6a
Healthy Neonate 12 nh HN6a
Healthy Neonate 13 α-h HN7a
Healthy Neonate 14 nh HN7a
Healthy Neonate 15 α-h HN8a
Healthy Neonate 16 nh HN8a
Healthy Neonate 17 nh HN9a
Healthy Neonate 18 α-h HN9a
Healthy Neonate 19 nh HN10a
Healthy Neonate 20 α-h HN10a
Healthy Neonate 21 nh HN11a
Healthy Neonate 22 nh HN11a
Healthy Neonate 23 nh HN12a
Healthy Neonate 24 nh HN12a
Scouring Neonate 25 α-h SN13a
Scouring Neonate 26 nh SN13a
Scouring Neonate 27 nh SN14a
Scouring Neonate 28 nh SN14a
Scouring Neonate 29 nh SN15a
Scouring Neonate 30 α-h SN15a
Scouring Neonate 31 α-h SN16a
Scouring Neonate 32 nh SN16a
Scouring Neonate 33 α-h SN17a
Scouring Neonate 34 nh SN17a
Scouring Neonate 35 nh SN18a
Scouring Neonate 36 nh SN18a
Scouring Neonate 37 nh SN19a
Scouring Neonate 38 nh SN19a
Scouring Neonate 39 α-h SN20a
Scouring Neonate 40 α-h SN20a
Scouring Neonate 41 α-h SN21a
Scouring Neonate 42 nh SN21a
Scouring Neonate 43 nh SN23a
Scouring Neonate 44 α-h SN23a
Scouring Neonate 45 α-h SN24a
Scouring Neonate 46 α-h SN24a
Probiotic 47 nh IAHb
Probiotic 48 nh IAHb
Human Clinical (VRE) 49 α-h RNSc
Human Clinical (VRE) 50 nh RNSc
Human Clinical  (Urine) 51 α-h RNSc
Human Clinical  (Blood) 52 α-h RNSc
Human Clinical  (Urine) 53 α-h RNSc
Human Clinical (Urine) 54 nh RNSc
Human Clinical (Urine VRE) 55 nh RNSc
Human Clinical  (Blood) 56 nh RNSc
Human Clinical (Blood) 57 α-h RNSc
Hospital Environmental (Tip) 58 nh RNSc
Hospital Environmental (Drainage) 59 nh RNSc
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a This study, b International Animal Health, c PaLMs Royal North Shore Hospital  
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5.2.5 Virulence gene analysis of enterococci isolates 
 
Virulence genes: Enterococci virulence genes and five antibiotic resistance genes 
(reported in the literature) were selected for analysis.  Three additional primer 
sequences were included for the identification of gram positive cocci (Table 5.3). 
  
Table 5.3: List of virulence genes associated with enterococci, including antibiotic 
resistance genes.  Three primer sequences were included for the species identification of 
isolates. 
 
Gene Name Description/Function 
Virulence Gene 
ace Accessory colonization factor 
efaA E.faecalis endocarditis antigen 
esp Enterococcal surface protein, believed to be involved in adherence 
gelE Gelatinase an extracellular enzyme induced by the fsr quorum sensing gene 
pyrC House keeping gene associated with virulence 
salA Encodes a cell wall associated antigen 
Antibiotic Resistance Genes 
vanA Vancomycin resistance gene 
vanB Vancomycin resistance gene 
vanC1 Vancomycin resistance gene 
Vanc2/3 Vancomycin resistance gene 
emeA Efflux pump associated with antibiotic resistance 
Identification Sequences 
ddlE. faecalis For the identification of E. faecalis 
ddlE. faecium For the identification of E. faecium 
Ent For the identification of Enterococcus isolates 
 
 
 
PCR analysis: Boiled whole cell lysates were used for PCR analysis (Section 2.3.2).  
Bacteria were grown in BHIB overnight with shaking at 37oC; bacterial pellets were 
washed in 1 ml and resuspended in 200 µl of sterile MQH2O.  Solutions were incubated 
at 100oC for 15 minutes, transferred to ice then centrifuged at 10,000 rpm for 5 minutes.  
The boiled lysates were stored at 4oC for no longer than 1 week, 5 µl was used in each 
PCR reaction.  Positive controls used included E. casseliflavus (ATCC 25788, 
vanC2/3), E. gallinarum (NCDO 2313, vanC1), vancomycin resistant enterococci 
(VRE) E. faecium (esp, vanA), and VRE E. faecalis (ace, efaA, esp, gelE, pyrC, salA & 
vanB) which were provided by Clarence Fernandes, PaLMs, Royal North Shore 
Hospital.  
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A series of 3 multiplex (Table 5.4, Sets I-III) and 9 uniplex (Sets IV-XII) primers? were 
adapted from other published protocols and optimised for the amplification of 3 
identification PCRs and 6 virulence genes and 6 antibiotic resistance genes.  PCR 
cocktails for sets I, II and IV were prepared deliver a final volume of 25 µl.  While PCR 
cocktails for sets III and V-XII were prepared to deliver a final volume of 50 µl.  Sets I-
III and X contained 2.5 µl of 10x PCR buffer (Qiagen), 500 µM of each 
deoxynucleoside triphosphate (dNTP-Astral scientific) with 7 mM MgCl2, 50 pmol of 
primers and 2 U of Taq polymerase (Qiagen).   Set IV contained 1 µl of 10x PCR buffer 
(Invitrogen), 200 µl of each dNTP, 2 mM MgCl2, 50 pmol of primers and 0.2 U of Taq 
polymerase (Invitrogen). Set V-VII contained 1 µl of 10x PCR buffer (Invitrogen), 200 
µl of each dNTP, 3 mM MgCl2, 40 pmol of primers and 0.2 U of Taq polymerase 
(Invitrogen). Set VIII and IX contained 1 µl of 10x PCR buffer (Invitrogen) 200 µl of 
dNTP, 2.5 mM MgCl2, 40 pmol of primer and 0.2 U of Taq polymerase (Invitrogen). 
Sets XI and XII consisted of 1 µl of 10x PCR buffer (Invitrogen), 200 µl of each dNTP, 
1.8 mM MgCl2, 50 pmol of primers and 0.2 U of Taq polymerase (Invitrogen).  PCRs 
were conducted using a PC960 Air Cooled Thermal Cycler (Corbett research) with 
program cycles listed in Table 5.5.  Amplicons were visualized by electrophoresis (80 
V, 500 mA for 1 hour) in 2% agarose gels prepared in 0.5X TBE buffer (45 mM 
TrisBase, 45 mM Boric Acid, 10 mM EDTA pH 8) containing 4 µl of 5 µg/ml ethidium 
bromide.  Amplicons were sized with corresponding 100 bp DNA markers (New 
England Biolabs) and processed in a Gel Doc System (BioRad). 
Table 5.4: Summary of 3 multiplex (Set I-III) and 9 uniplex (IV- XII) assays for the amplification of 15 genes. Forward and 
reverse primer sequences for each virulence gene, together with the size of the expected amplicon are also shown. 
  
Primer Set Virulence Gene Primer Name DNA Sequence 5’  3’ Amplified Product (bp) Primer Coordinates 
Ia vanA & vanB 
VanABF 
VanAR 
VanBR 
GTAGGCTGCGATATTCAAAGC 
CGATTCAATTGCGTAGTCCAA 
GCCGACAATCAAATCATCCTC 
VanA 231 
VanB 330 
358-378 
355-375 
568-588 
664-684 
vanC1 VanC1F 
VanC1R 
TGGTATTGGTATCAAGGAAACC 
AGATTGGAGCGCTGTTTTGTC 
447 
139-160 
565-585 
IIa
vanC2  & C3 VanC23F 
VanC23R 
CAGCAGCCATTGGCGTACAA 
CAAGCAGTTTTTGTAGTAGTTC 
597 
431-450 
1006-1027 
ddlE.faecalis
FCLF 
FCLR 
ATCAAGTACAGTTAGTCTT 
ACGATTCAAAGCTAACTG 
941 
98-116 
1038-1021 
IIIa
ddlE.faecium
FCMF 
FCMR 
GCAAGGCTTCTTAGAGA 
CATCGTGTAAGCTAACTTC 
550 
Position in nucleotide 
sequence relative to 
initiation codon 
IVb
Enterococcus Specific 
Ent1 
Ent2 
TACTGACAAACCATTCATGATG 
AACTTCGTCACCAACGCGAAC 
112 
618-639 
708-729 
Vc emeA 455 456 
CCGGAATTCCGTAATCACGATTGCTATTTCACTTG 
GCGCCTAGGTCTATTTTTGCGATTGCCCAAT 
603 744-718 141-162 
VId
ace 
ACE1 
ACE2 
AAAGTAGAATTAGATCCACAC 
TCTATCACATTCGGTTGCG 
320 U 
VIId
efaA 
efaA1 
efaA2 
CGTGAGAAAGAAATGGAGGA 
CTACTAACACGTCACGAATG 
499 U 
VIIIe espA 
esp46 
esp47 
TTACCAAGATGGTTCTGTAGGCAC 
CCAAGTATACTTAGCATCTTTTGG 954 
2256-2279 
3192-3169 
IXe espN 
esp11 
esp12 
TTGCTAATGCTAGTCCACGACC 
GCGTCAACACTTGCATTGCCGAA 
424 
1217-1238 
2171-2149 
Xd
gelE 
gelE1 
gelE2 
AGTTCATGTCTATTTTCTTCAC 
CTTCATTATTTACACGTTTG 
402 U 
XIf
pyrC 
pyrcF 
pyrcR 
CGGGTAGTAAAGCTGCTGC 
CTTCTCCTTCATGCATCACAC 
320 U 
XIIf
salA 
salAF 
salAR 
CATTAACAAGCGTAGCGTTG 
GCCTTTTTCAGGAGTCGTTG 
919 or 922 U 
a Bell et al., 1998, Dutka-Malen 1995, b Ke et al., 1999, c Jonas et al., 2001, d Dupre et al., 2003 e Shankar et al., 1999, f Nallapareddy et al., 2002, U – 
published.
5. 12 
5. 13 
Table 5.5: PCR amplification cycles for multiplex (I-III) and uniplex (IV-XII) PCR assays. 
 
Primer 
Set 
Denaturation 
Temp. (oC) 
Time 
(min) 
Denaturation 
Temp (oC) Time 
Annealing 
Temp. (oC) Time 
Extension 
Temp. (oC) Time 
Number of 
Cycles 
Final Extension 
Temp (oC) 
Time 
(min) 
Quantity of PCR 
product loaded on 
agarose gel 
I 94 3 94 1 min 60 30 s 72 1.5 min 35 72 5 10 μl 
II 94 3 94 1 min 60 30 s 72 1.5 min 35 72 5 10 μl 
III 94 3 94 1 min 50 30 s 72 1 min 35 72 5 10 μl 
IV 95 3 94 30 s 55 30 s 72 1 min 35 72 7 12 μl 
V 94 2 94 1 min 60 1 min 72 1 min 30 72 10 10 μl 
VI 94 2 94 1 min 56 1 min 72 1 min 30 72 10 18 μl 
VII 94 2 94 1 min 56 1 min 72 1 min 30 72 10 10 μl 
VIII 95 2 94 45 s 60 45 s 72 4 min 30 72 7 10 μl 
IX 95 2 94 45 s 63 45 s 72 4 min 30 72 7 10 μl 
X 94 2 94 1 min 56 1 min 72 1 min 30 72 10 10 μl 
XI 94 2 94 1 min 55 1 min 72 45 s 30 72 7 10 μl 
XII 94 2 94 1 min 57 1 min 72 1.5 m 30 72 7 10 μl 
 
Biochemical identification: Isolates 3, 4, 11, 12, 17, 8, 32, 38, 39, 40 and 43 were sent to 
the University of Queensland for biochemical identification to confirm the PCR 
identification.  Briefly, isolates were identified to be gram positive cocci by a gram stain 
and a catalase test (3% hydrogen peroxide) to identify enterococci/streptococci.  A 
Lancefield grouping using an Oxoid streptococci grouping kit identified isolates to be 
group D, now known to be enterococci.  Those isolates that did not group were identified 
using biochemical reactions: carbohydrate fermentation, growth in 6.5% NaCl, growth on 
Bile/Aesculin Agar, and the Oxoid PYR test.  
 
5.2.6 Analysis of the antibiotic susceptibility of enterococci isolates 
Enterococci isolates were sent to Clarence Fernandes at PaLMs, Royal North Shore 
Hospital, for antibiotic sensitivity profiling.  Isolates were subjected to a range of 
antibiotics as listed in Table A5.1 in Appendix 5.  The susceptibility of isolates to 
antibiotics was determined as set out by the NCCLS guidelines. 
 
Population analysis of antibiotic resistance genes: KEA Master Grids were used for 
looking at population antibiotic resistance.  The HGMF was transferred to a 50 ml tube 
containing 5 ml of sterile MQH2O and vortexed until all colonies were removed.  The 
bacteria were pelleted at 10,000 rpm (Eppendorf Centrifuge, 5415C) for 5 minutes, washed 
with MQH2O and resuspended in 200 µl of MQH2O.  Whole cell lysates were prepared as 
previously described (Section 2.3.2), and PCR analysis using assay Sets I-V was 
completed. 
 
5.2.7 Pulsed-Field Gel Electrophoresis (PFGE) of enterococci isolates 
All 59 enterococci isolates were analysed by pulsed-field gel electrophoresis using the 
restriction enzyme SmaI.  This methodology was adapted from published protocols (Murray 
et al., 1990; Osek, 2000a) as described previously in section 2.4.2.  The molecular profiles 
were analysed using an agglomerative hierarchical algorithm, previously described in 
section 3.2.10 and 4.2.6. 
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5.3 Results 
 
5.3.1 Population based Microbial Analysis (PoMA) of rectal swab samples 
collected from healthy and scouring neonatal piglets 
 
DCC and PoMA enumeration: DCC enumeration was used only for MRS bacterial 
enumeration because not all colonies were capable of growth on the HGMF.  Those 
colonies that did grow were impossible to enumerate because the colonies were the same 
colour as the HGMF.  PoMA was used to enumeration colonies capable of growth on 
blood, MacConkey and KEA agars.  
 
Blood agar: Rectal swab samples were collected from healthy and scouring neonatal 
piglets and enumerated using PoMA.  Enumeration of bacteria in healthy pig samples 
revealed similar values (Figure 5.2) with a mean of 2.1x106 ± 4.3 x 105 (SE) CFU/swab. 
This similarity in bacterial number was not observed for bacteria in the samples from 
scouring piglets, a mean of 1.1x107 ± 7.0 x 106 (SE) CFU/swab was calculated.  Even 
though the mean of the scouring piglets was higher than the healthy, this difference was not 
significant using the T-test.  Enumaeration of haemolytic colonies from the blood agar 
replica (Replica 1) showed a higher level of haemolytic bacteria in samples from healthy 
piglets (10.5% ± 3.7 % (SE) /swab) compared to samples from scouring piglets (5.7 ± 1.6% 
(SE) /swab); however, this difference was not statistically significant. 
 
MacConkey agar: PoMA enumeration on MacConkey agar (Figure 5.3) revealed variation  
between individual scouring piglets (1.0 x 107 ± 5.4 x 106 (SE) CFU/swab), while there was 
consistent enumeration values obtained with healthy piglets (8.9 x 105 ± 2.8x105 (SE) 
CFU/swab).  The mean enumeration showed higher levels of bacteria in scouring piglets, 
however this difference was not significant using the T-test.  The level of haemolytic 
bacteria in both healthy and scouring piglets was minimal with the exception of two healthy 
5. 15 
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piglets; 2 and 10, for which 55% and 20% of isolates, respectively, were shown to be 
haemolytic. 
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Figure 5.2: Histogram plots showing single PoMA enumeration of bacteria from (A) healthy (n=12) and (B) scouring (n=12) 
neonatal pig rectal swab samples grown on blood agar.  Enumeration of bacteria from healthy piglets revealed similar quantities 
of bacteria per swab (   ), however there was variation in the number of haemolytic colonies (    ) counted.  There was greater 
variation observed in bacterial numbers recovered from scouring neonatal piglets (C); the calculated mean was greater than the 
corresponding mean for healthy piglets, however this difference was not statistically significant.  
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Figure 5.3: Histogram plots showing single PoMA enumeration of bacteria from (A) healthy (n=12) and (B) scouring (n=12) 
neonatal pig rectal swab samples grown on MacConkey agar.  Enumeration of bacteria from healthy piglets revealed similar 
numbers of bacteria per swab (    ), with only four piglets yielding haemolytic colonies (    ).  There was a larger variation 
observed in bacterial numbers recovered from scouring neonatal piglets (C); the calculated mean was greater than the 
corresponding mean for healthy piglets, however this difference was not statistically significant.  
  
When enumerating the MacConkey master grids there was a second bacterial population 
(Figure 5.4A) present, that was phenotypically different to E. coli.  These were small in size 
and lighter pink than E. coli.  The MacConkey HGMF was replicated onto CHROMagar 
Orientation medium to reveal a blue population (Figure 5.4B).  10 colonies from 5 different 
HGMF were subcultured for gram stain analysis.  All bacteria were identified as gram 
positive cocci, suspected to be enterococci.  Bacterial samples were plated on HGMF and 
incubated on KEA agar.  HGMF incubated on KEA were replicated onto CHROMagar 
Orientation medium, revealing the same blue colonies (Figure 5.5).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
E. coli 
Unidentified 
Colonies 
E. coli 
Unidentified 
Colonies 
 
Figure 5.4: MacConkey HGMF (A) revealed two distinct phenotypes. E. coli are 
characteristically dark pink in colour and occupy the entire square in which they are 
situated in.  The second phenotype was light pink in colour and smaller than the E. coli 
isolates.  MacConkey master grids were replicated onto HGMFs and incubated on 
CHROMagar Orientation media (B), allowing for the identification of the E. coli (mauve) 
and the gram positive cocci (blue). 
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Figure 5.5: (A) HGMF incubated on KEA, the selective medium for enterococci, was 
replicated onto a HGMF and incubated on CHROMagar Orientation media (B), revealing a 
single blue (enterococci) population. 
 
 
All MacConkey Master Grids were replicated onto CHROMagar Orientation medium and 
enumerated (Figure 5.6).  In some of the healthy piglet samples there were negligible E. 
coli and only enterococci were enumerated (piglets 2, 6, 11 and 12), whereas samples from 
other piglets contained minimal enterococci (piglets 9 & 10).  Bacteria in samples from 
piglets; 1, 3, 4, 5, 7 & 8, were enumerated and contained both E. coli and enterococci 
populations in medium to high levels.  When comparing these samples with those from 
scouring piglets, a majority of scouring pigs were dominated by E. coli (13, 14, 15, 17, 19, 
21, 22, & 23) but 4 piglets had high levels of enterococci (16, 18, 20 and 24).  The bacterial 
populations of healthy versus scouring piglets were significantly different (P<0.01, T-test). 
Healthy piglets had 36.8 ± 9.9%/swab E. coli and 62.5 ± 9.8%/swab enterococci, compared 
with scouring piglets which had 82.4 ± 5.1 %/swab E. coli and 17.6 ± 5.0%/swab 
enterococci.   
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Figure 5.6: Histogram plots showing the percentage enumeration of both E. coli (   ) and gram positive cocci (   ) and 
unidentified white colonies (   ) in each pig sample when replicated from the MacConkey master grid onto CHROMagar 
Orientation agar for phenotyping.  The mean percentages of E. coli and gram positive cocci in samples from (A) healthy (n=12) 
and (B) scouring (n=12) pigs were determined with standard errors and plotted in C.  
Pig Number 
0
10
20
30
40
50
60
70
80
90
100
Healthy Scouring
M
ea
n 
%
0
10
20
30
40
50
60
70
80
90
100
Pe
rc
en
ta
ge
 (%
)
   1          2          3          4          5          6          7          8          9         10       11        12    
B 
13        14       15        16        17       18       19        20       21       22        23       24    
Pig Number 
0
10
20
30
40
50
60
70
80
90
100
Pe
rc
en
ta
ge
 (%
)
C 
A 
5. 22 
KEA agar: The MacConkey enumeration revealed a high level of gram positive cocci, so 
the KEA Master grid was used for enumeration of both the total colonies and the total 
number of haemolytic isolates (Figure 5.7).  The mean number of bacteria in samples from 
scouring piglets (6.6 x 106 ± 4.4 x 106 (SE) CFU/swab) was significantly higher than in 
samples from healthy piglets (6.2 x 104 ± 2.6 x 104 (SE) CFU/swab) (P<0.05, T-test).  
When the KEA population was enumerated on the basis of haemolysis, there was an 
elevated haemolytic population in the scouring piglets; 4 scouring piglets yielded over 50% 
haemolytic colonies, while this was the case for only 1 healthy piglet.  However, this 
difference was not statistically significant (T-test). 
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Figure 5.7: Histogram plots showing single PoMA enumeration of bacteria in rectal swab samples taken from (A) healthy 
(n=12) and (B) scouring (n=12) neonatal pigs, grown on KEA agar.  Enumeration of bacteria from both healthy and scouring 
piglets revealed variation in the quantities of bacteria per swab (   ) between individual pigs.  There is no consistency in the 
percentage of haemolytic colonies (    ) between piglets, equating in a large standard error of the mean (C).  There was a higher 
percentage of haemolytic colonies in samples from scouring piglets compared to those from healthy piglets, however this 
difference was not statistically significant.  
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MRS agar: Enumeration using DCC on MRS (Figure 5.8) showed similar bacterial 
enumeration values in healthy piglets with a mean value of 1.1 x 106 ± 2.1 x 104 (SE) 
CFU/swab recovered.  There was greater variation in the numbers of bacteria recovered 
from the scouring piglets with a mean value of 2.9 x 107 ± 9.9 x 106 (SE) CFU/swab.  The 
results were analysed using analysis of variance (ANOVA; drop counts were enumerated in 
triplicate).  The numbers of bacteria in samples from scouring piglets was significantly 
higher than those in samples from healthy piglets (P<0.05, ANOVA). 
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Figure 5.8: Histogram showing enumeration of bacteria from rectal swab samples collected from (A) healthy (n=12,    ) and (B) 
scouring (n=12,    ) neonatal piglets, grown on MRS agar.  Enumeration of bacteria from healthy piglets revealed similar 
numbers of bacteria with a mean of 1.1 x 106 ± 2.1 x 104 (SE) CFU/swab (C).  A larger variation was observed in bacterial 
numbers recovered from scouring neonatal piglets with a mean of 2.9 x 107 ± 9.9 x 106 (SE) CFU/swab (C). The mean number of 
bacteria in samples from scouring piglets was significantly higher than the corresponding mean for healthy piglets (P<0.01, 
ANOVA).     
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5.3.2 PoMA of rectal swab samples from neonatal piglets: Do healthy and 
sick piglets possess different virulence gene profiles?  
The MacConkey Master Grids were used as representative populations for the host 
virulence gene profiling of healthy and scouring neonatal piglets.  The methodologies for 
the PCR analysis of healthy and scouring neonatal rectal swab samples outlined in Chapter 
4 (4.2.7) were followed.  Gene matrices were constructed showing the virulence gene 
profiles (denoted ‘host profile’) of bacteria isolated from healthy and scouring piglet rectal 
swab samples (Appendix 5, Figure A5.1 and A5.2).   
 
There were insufficient piglets sampled from a litter to statistically compare host profiles.  
The siblings from healthy and scouring piglets were analysed to determine the number of 
common genes.  The mean percentage of the common genes carried was 35% ± 10.9% (SE) 
for healthy piglets and 52.6% ± 9.2% (SE) for scouring piglets.   
 
Chi-squared analysis was used to rank the virulence genes in terms of their ability to 
differentiate between healthy and scouring piglets.  In this analysis, only two virulence 
genes (Table 5.6) were able to significantly differentiate between the two groups (P<0.05).  
The two genes were: cdt which was present in 42% of scouring piglets and not present in 
healthy piglets, and iha which was carried by 50% of scouring piglets and only 8% of 
healthy piglets.  The majority of the virulence genes identified were found in a few of the 
piglets.  Most of the genes were present in healthy piglet number 1 (F4, fimH, cvaC, east1, 
STa, kpsMTII, K5, fyuA, iroNE.coli, iutA, iss, ompT and traT) and healthy piglet number 8 
(fimH, iha, papA, papC, papEF, papG allele I, cvaC, east1, kpsMTII, K1, K5, fyuA, 
iroNE.coli, iutA, ibeA, iss, ompT and traT).   
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Table 5.6: Prevalence of the 58 virulence genes was determined as a percentage.  Chi-
squared analysis revealed that only 2 of the 58 virulence genes could be validly used to 
differentiate between groups of healthy and scouring neonatal pigs (P<0.05 in bold). 
 
Virulence Gene Healthy Neonates(% positive) 
Scouring Neonates
(% positive) Chi-squared Value
cdt 0 42 8.26 
iha 8 50 5.45 
yjaA 58 92 3.81 
STa 8 42 3.81 
traT 83 100 2.95 
kpsMTII 0 17 2.95 
rfc 0 17 2.95 
focG 0 17 2.95 
cnf1 0 17 2.95 
STb 0 17 2.95 
iroNE.coli 67 92 2.4 
K1 8 33 2.4 
ibeA 8 0 1.43 
papG allele I 8 0 1.43 
ireA 8 0 1.43 
eaeA 8 0 1.43 
F4 8 0 1.43 
papG allele III 0 8 1.43 
hlyA 0 8 1.43 
sfaS 0 8 1.43 
univcnf 0 8 1.43 
LT 0 8 1.43 
fimH 92 100 1.43 
PAI 8 25 1.25 
papC 8 25 1.25 
kpsMTII 50 67 0.69 
K5 50 33 0.69 
iss 50 67 0.69 
papEF 8 17 0.39 
chuA 25 17 0.25 
fyuA 67 75 0.20 
iutA 67 58 0.18 
east1 33 42 0.18 
cvaC 42 50 0.17 
ompT 75 75 0 
8 8 0 papA 
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Analysis of virulence genes in E. coli populations from scouring piglets identified a lack of 
fimbrial antigens carried by the E. coli, which agrees with current findings described in the 
literature (Alexander, 1994; Fahy et al., 1987a; Woodward, 1993).  Many of these isolates 
were not carrying the toxin genes; only 42% of scouring animals were positive for STa, and 
17% were positive for STb.  This suggests that either or both of the following could be 
occurring: (i) E. coli isolates are carrying previously unrecognised fimbrial and toxin genes, 
and/or (ii) the E. coli in scouring pigs are not a dominant homogenous population, but 
rather are comprised of a mixed population of isolates that together result in diarrhoea.  As 
the neonatal piglet has no immune system, opportunistic bacteria such as E. coli can 
replicate and cause disease in susceptible piglets.  As they are part of the normal flora, these 
bacteria would also be found in healthy piglets, which may explain why Chi-squared 
analysis indicated that only 2 genes could differentiate between the healthy and scouring 
piglets. 
 
As the Chi-squared analysis only identified two genes that could be validly used to 
differentiate between the groups, the full panel of 58 genes were used to generate a cluster 
analysis dendrogram (Figure 5.9) using an agglomerative hierarchical algorithm.  The 
dendrogram was segregated into three divisions; A, B and C, where isolates in A and B 
contained fimH and traT.  Group A was segregated from B based on the possession of 
either fyuA, kpsMTII or ompT.  Group A contained four groups, where A1 and A3 
contained samples from healthy pigs and A2 and A4 were samples from scouring pigs with 
the exception of HN8 in A4.  The segregation of samples was also observed in cluster B, 
where B1 contained samples from healthy pigs and B2, B3, and B4 contained samples from 
scouring pigs.  Group C segregated from both A and B; it contained four samples with all 
but one (SN19) from healthy pigs.  Population profiles of group C revealed the presence of 
only 3 virulence genes. 
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Figure 5.9: A dendrogram showing the similarity relationship between pigs based on the 
virulence genes possessed by E. coli populations from the rectal swab samples.  The 
analysis was based on the full panel of 58 virulence genes. HN denotes healthy neonatal 
piglets and SN denotes scouring neonatal piglets. 
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Groupings of healthy and scouring piglets were observed in the cluster analysis 
dendrogram.  The next step was to subject the same results to principle coordinate analysis 
(PCO) to determine if the healthy and scouring piglet samples grouped on the basis of 
virulence gene profiles.  The full panel of 58 virulence genes was used to generate the PCO 
and examine the relationship between virulence gene combinations (Figure 5.10).  The 
results showed no clear segregation between healthy and scouring piglets; the healthy 
animals were predominantly located in Q2 and Q3, while the scouring animals were 
predominantly located in Q3.  The lack of common virulence genes, and possibly the 
heterogenous nature of the E. coli within each healthy and scouring pig sample, prevented 
samples from being segregated into two separate groups.  These findings correlate with the 
results shown in Chapter 3 where the ND and commensal isolates segregated together on 
the basis of only a few virulence genes.  There were a number of virulence genes carried by 
each pig, however these genes were found in both healthy and scouring pigs (Figure 5.11). 
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Figure 5.10 : Results of Principal coordinate analysis using the full panel of 58 virulence genes to establish a relationship 
between the 12 healthy (A,    ) and 12 scouring (B,    ) neonatal pig samples.  The coordinate value of each host profile is defined 
by 2 dimensions, the X axis is PCO1 (dimension 1), while the Y axis is PCO2 (dimension 2).  The pig number shown identifies 
each individual pig and the composite of the two plots is shown in C. 
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The Venn diagram in Figure 5.11 shows the distribution of virulence genes between the 
healthy and scouring piglet samples.  There are 5 virulence genes that are only found in 
healthy piglets; ibeA, papG allele I, ireA, eaeA and F4, while 10 virulence genes are 
only found in scouring piglets; cdt, cnf1, focG, LT, papG allele III, hlyA, rfc, sfaS, STb 
and unicnf.  Of these genes, only cdt was found in more than 20% of isolates, showing 
that even though there are numerous genes found only in scouring neonates, the Venn 
diagram is deceiving as these isolates are not in sufficient numbers to impact upon the 
cluster analysis dendrogram or PCO analysis.  This is also evident with the 20 genes 
that were common among the healthy and the scouring piglet samples, with 9 of the 
genes found in over 50% of both healthy and scouring piglets; fimH, kpsMTII, fyuA, 
ompT, iroNE.coli, iss, traT, iutA, and yjaA. 
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Figure 5.11: Venn diagram of the distribution of virulence genes identified in E. coli 
populations isolated from healthy and scouring neonatal piglet rectal swab samples.  
The two significant genes determined by Chi-squared analysis are denoted with a 
superscript number.  
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5.3.3 Analysis of enterococci isolates 
Enumeration of the haemolytic colonies replicated from the KEA Master Grid revealed 
higher numbers of isolates recovered from scouring versus healthy piglets.  This finding 
initiated the identification and analysis of these isolates.  Enterococci are important 
agents in nosocomial infections in humans, which raised two questions: (i) are these 
enterococci playing a role in neonatal diarrhoea? and (ii) do they pose a threat by 
transference into the human food chain? 
 
Haemolytic and (where possible) non-haemolytic isolates were selected from each KEA 
Master Grid.  Each isolate was tested using the enterococci specific primer sequence 
(Table 5.4); all 46 isolates were confirmed to be enterococci.  Sequence specific primers 
for E. faecalis and E. faecium were used to identify 3 species within the 46 isolates, 
Enterococcus spp., E. faecalis & E. faecium.   
 
Table 5.7 shows the identity of isolates as determined by PCR analysis, and includes the 
haemolytic phenotype.  Of the isolates from healthy pigs, 9 were Enterococcus spp., 4 
of these were non-haemolytic and 5 were α-haemolytic, while 15 of the isolates were 
identified to be E. faecalis, 13 of which were non-haemolytic and 2 were α-haemolytic.  
Of the isolates from scouring piglets, 11 were identified as Enterococcus spp., 6 as E. 
faecalis and 5 as E. faecium.  Of the Enterococcus spp., 5 were α-haemolytic and 6 were 
non-haemolytic. Four E. faecalis were non-haemolytic and 2 α-haemolytic, while of the 
E. faecium isolates, 2 were non-haemolytic and were 3 α-haemolytic.  The identity of 
these isolates was confirmed by biochemical analyses of 11 of the enterococci carried 
out at the University of Queensland (Table 5.8).  
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Table 5.7: Enterococci isolated from rectal swab samples collected from healthy and 
scouring neonatal piglets were identified using species specific primers for PCR 
analysis. Shown are the species of enterococci, haemolytic phenotype (α-h is alpha 
haemolytic, nh is non-haemolytic) and source of isolate.   
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: IAH; International Animal Health, RNS; Royal North Shore Hospital 
Reference 
Code Type of Isolate Species 
Haemolytic 
Phenotype 
Source of 
Isolate 
1 Healthy Neonate Enterococcus spp. nh HN1 
2 Healthy Neonate Enterococcus spp. α-h HN1 
3 Healthy Neonate E. faecalis nh HN2 
4 Healthy Neonate E. faecalis nh HN2 
5 Healthy Neonate E. faecalis nh HN3 
6 Healthy Neonate E. faecalis nh HN3 
7 Healthy Neonate Enterococcus spp. α-h HN4 
8 Healthy Neonate E. faecalis nh HN4 
9 Healthy Neonate Enterococcus spp. α-h HN5 
10 Healthy Neonate E. faecalis nh HN5 
11 Healthy Neonate E. faecalis nh HN6 
12 Healthy Neonate E. faecalis nh HN6 
13 Healthy Neonate Enterococcus spp. α-h HN7 
14 Healthy Neonate Enterococcus spp. nh HN7 
15 Healthy Neonate Enterococcus spp. α-h HN8 
16 Healthy Neonate Enterococcus spp. nh HN8 
17 Healthy Neonate E. faecalis nh HN9 
18 Healthy Neonate E. faecalis α-h HN9 
19 Healthy Neonate Enterococcus spp. nh HN10 
20 Healthy Neonate E. faecalis α-h HN10 
21 Healthy Neonate E. faecalis nh HN11 
22 Healthy Neonate E. faecalis nh HN11 
23 Healthy Neonate E. faecalis nh HN12 
24 Healthy Neonate E. faecalis nh HN12 
25 Scouring Neonate Enterococcus spp. α-h SN13 
26 Scouring Neonate E. faecalis nh SN13 
27 Scouring Neonate Enterococcus spp. nh SN14 
28 Scouring Neonate Enterococcus spp. nh SN14 
29 Scouring Neonate E. faecalis nh SN15 
30 Scouring Neonate E. faecalis α-h SN15 
31 Scouring Neonate Enterococcus spp. α-h SN16 
32 Scouring Neonate E. faecium nh SN16 
33 Scouring Neonate E. faecium α-h SN17 
34 Scouring Neonate E. faecalis nh SN17 
35 Scouring Neonate Enterococcus spp. nh SN18 
36 Scouring Neonate Enterococcus spp. nh SN18 
37 Scouring Neonate Enterococcus spp. nh SN19 
38 Scouring Neonate E. faecalis nh SN19 
39 Scouring Neonate E. faecium α-h SN20 
40 Scouring Neonate E. faecium α-h SN20 
41 Scouring Neonate E. faecalis α-h SN21 
42 Scouring Neonate Enterococcus spp. nh SN21 
43 Scouring Neonate E. faecium nh SN23 
44 Scouring Neonate Enterococcus spp. α-h SN23 
45 Scouring Neonate Enterococcus spp. α-h SN24 
46 Scouring Neonate Enterococcus spp. α-h SN24 
47 Probiotic E. faecium nh IAH 
48 Probiotic E. faecium nh IAH 
49 Human Clinical (VRE) E. faecium α-h RNS 
50 Human Clinical (VRE) E. faecium nh RNS 
51 Human Clinical  (Urine) E. faecium α-h RNS 
52 Human Clinical  (Blood) E. faecium α-h RNS 
53 Human Clinical  (Urine) E. faecium α-h RNS 
54 Human Clinical (Urine) E. faecium nh RNS 
55 Human Clinical (Urine VRE) E. faecalis nh RNS 
56 Human Clinical  (Blood) E. faecalis nh RNS 
57 Human Clinical (Blood) E. faecalis α-h RNS 
58 Hospital Environmental (Tip) E. faecalis nh RNS 
59 Hospital Environmental (Drainage) E. faecalis nh RNS 
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Table 5.8: Results from the biochemical identification of 11 isolates of enterococci performed at The University of Queensland. 
 
Reference 
Code 
Gram 
Stain Catalase Group LAC ARA Sorbitol Mannitol RAFF 6.5% NaCl Bil/AESC PYR Identification
3 GPC - D + - + + - + - - E. faecalis 
4 GPC - D + - + + - + - - E. faecalis 
11 GPC - D + - + + - + - - E. faecalis 
12 GPC - D + - + + - + - - E. faecalis 
17 GPC - D + - + + - + - - E. faecalis 
18 GPC - D + - + + - + - - E. faecalis 
32 GPC - No Group - + - + - + + + E. faecium 
38 GPC - D + - + + - + - - E. faecalis 
39 GPC - No Group - + - + - + + + E. faecium 
40 GPC - No Group - + - + - + + + E. faecium 
43 GPC - No Group - + - + - + + + E. faecium 
 
5.3.4 Virulence gene analysis of enterococci isolates 
The 59 enterococci isolates were analysed for the presence of 6 virulence genes and 5 
antibiotic resistance genes, one of which included an antibiotic resistance efflux pump 
(emeA).  Figure 5.12 shows the multiplex (I-III) and the uniplex (IV-XII) amplicon 
amplification of the enterococci virulence genes, antibiotic resistance genes and the 
identification sequences.  A few selected PCR results are provided in Appendix 5, Figure 
A5.3 – A5-6. 
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Figure 5.12: Image of an ethidium bromide stained 2% agarose gel with amplified PCR 
products for primer sets I-XII. 
 
 
Gene matrices were assembled showing the virulence gene profiles of the enterococci 
isolates (Appendix 5, Figure A5.7 – A5.10).  The probiotic isolates, along with 4 
Enterococcus spp. from healthy piglets (isolates 1, 2, 14 and 15), 4 Enterococcus spp. from 
scouring piglets (isolates 28, 36, 37 and 44), and 4 E. faecium from scouring piglets 
(isolates 32, 39, 40 & 43) contained none of the virulence genes.  The percentage 
prevalence (Table 5.9) of each gene was identified in healthy and scouring neonates, 
probiotic, human clinical and hospital environmental samples.  The prevalence of virulence 
genes between the groups was analysed using Chi-squared to identify differences between 
the groups.  When comparing the 46 neonatal enterococci with the hospital isolates, the 
difference in abundance of two genes between the groups was statistically significant at 
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P<0.05 (Table 5.10).  vanA was not present in the neonates, but occurred in 18% of hospital 
isolates.  The other significant gene was esp, which was in 39% of neonatal isolates and 
82% of hospital isolates. 
 
 
Table 5.9: Percentage prevalence of the 6 virulence genes and 5 antibiotic resistance genes 
using template DNA extracted from the 59 enterococci isolates from healthy and scouring 
neonatal piglets, probiotic and hospital isolates.  
 
Hospital 
Environmental 
(n=2, % 
positive) 
Scouring 
Neonates 
(n=22, % 
positive) 
Probiotic 
Isolates (n=2, 
% positive) 
Human 
Clinical (n=9, 
% positive) 
Healthy 
Neonates (n=24, 
% positive) 
Virulence 
Gene 
58.3 40.9 0 33.3 0 ace 
66.7 27.3 0 33.3 100 efaA 
58.3 18.2 0 88.9 100 esp 
70.8 27 0 22.2 100 gelE 
66.7 27.3 0 33.3 100 pyrC 
45.8 31.8 0 33.3 100 salA 
0 0 0 22.2 0 vanA 
0 0 0 11.1 0 vanB 
0 0 0 0 0 vanC1 
0 0 0 0 0 vanC2/3 
66.6 0 0 0 50 emeA 
 
 
Table 5.10: Prevalence of virulence and antibiotic resistance genes was determined as a 
percentage.  Two genes (shown in red bold text) can be used to differentiate between 
enterococci of piglet and hospital origin (Chi-squared test, P<0.05). 
 
 
Virulence Gene % Neonatal Isolates % Hospital Isolates Chi-squared Value
0 18 6.90 vanA 
39 82 6.85 esp 
0 9 3.37 vanB 
41 18 2.22 ace 
54 36 1.16 emeA 
39 45 0.15 salA 
50 45 0.07 gelE 
48 45 0.02 efaA 
48 45 0.02 pyrC 
0 0 0 vanC1 
0 0 0 vanC2/3 
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When the enterococci from healthy and scouring piglets and hospital isolates were 
compared in a Chi-squared analysis, 6 of the genes were used to differentiate between the 
groups.  esp could be used with statistical validity to differentiate between healthy and 
hospital isolates and scouring neonatal isolates, while gelE was found in significantly 
higher levels in healthy neonates and hospital isolates compared to scouring neonates.  Ace 
was found in significantly higher levels in healthy neonates than scouring neonates and 
hospital isolates.  EfaA and pyrC were in higher levels in healthy neonatal and hospital 
isolates than in scouring neonates.  vanA was only found in hospital isolates (P<0.05).   
 
 
Table 5.11: Prevalence of virulence and antibiotic resistance genes was determined as a 
percentage. Chi-squared analysis of PCR results for neonatal and hospital isolates revealed 
6 genes that can be used to differentiate between isolates from healthy neonates, scouring 
neonates and hospital samples (P<0.05 in bold).  a and b denote the two groups which a 
particular gene can be used to differentiate between.  
 
Healthy 
Neonates 
Scouring 
Neonates 
Hospital 
Isolates Chi-squared Value Genes (% positive) (% positive) (% positive) 
58a 18b 82a 14.97 esp 
71a 27b 45a 9.09 gelE 
58a 23b 18b 8.41 ace 
67a 27b 45a 7.37 efaA 
67a 27b 45a 7.37 pyrC 
0a 0a 18b 6.9 vanA 
66.7 40.9 36.4 4.26 vanB 
66.6 0 9 3.4 emeA 
45.8 31.8 45.5 1.1 salA 
 
 
 
By analysing the virulence genes from the 3 different enterococci species it is clear to see 
that the virulence genes are associated with certain species (Table 5.12).  The E. faecalis 
were the primary carriers of virulence genes.  Also the virulence genes analysed (ace, efaA, 
esp, gelE, pyrC and salA) were found in at least one E. faecalis isolate.  E. faecium was 
only found to carry the esp gene, while two of the hospital isolates carried the vanA gene 
(49 & 50) and 2 carried the emeA gene (53 & 54).  The majority of Enterococcus spp. only 
carried the esp and emeA genes.  An exception was two isolates (7 & 16) which carried 
efaA, emeA, gelE and pyrC and gelE and pyrC, respectively.  This division of the virulence 
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genes could be clearly seen in the cluster analysis (Figure 5.13); where there are 2 major 
divisions with all E. faecium and Enterococcus in group A and all E. faecalis located in 
group B.  The majority (16) of the scouring neonatal isolates are located in group A, while 
only 6 are located in B.  The hospital isolates are spread evenly among the two groups, 6 in 
A and 5 in B.   
 
 
 
Table 5.12: Percentage prevalence of virulence and antibiotic resistance genes amongst the 
three species of enterococci isolated from healthy and scouring neonatal piglets and 
enterococci of hospital origin. 
 
 
 
 
Enterococcus E. faecalis  E. faecium Virulence Gene  (n=20, % positive)) (n=26, % positive)  (n=13, % positive)
0 80 14.3 ace 
0 100 7.1 efaA 
0 80 42.9 esp 
0 100 14.8 gelE 
10 96 7.1 pyrC 
5 84 0 salA 
0 0 14.3 vanA 
0 3.8 7.1 vanB 
0 0 0 vanC1 
0 0 0 vanC2/3 
50 64 21.4 emeA 
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Figure 5.13: A dendrogram showing the similarity relationship between enterococci 
isolates from healthy and scouring neonatal piglets, probiotic and hospital isolates based on 
the 6 virulence and 5 antibiotic resistance genes.  The cluster analysis relationship was 
established using an agglomerative hierarchical algorithm.  Two distinct groups were seen 
with group A consisting of Enterococcus spp. and E. faecium, while group B consisted only 
of E. faecalis.    
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Principle coordinate analysis (PCO, Figure 5.14) was used to determine the spatial 
relationship between the enterococci based on virulence gene profiles.  The results show 
that virulence gene profiles are specifically associated with species and not the origin of the 
isolate.  Figure 5.14 shows species of E. faecalis and E. faecium are clearly separated with 
Enterococcus in the middle.  Some overlap occurs where common genes or lack of genes 
are found in both species. 
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Figure 5.14: Results of Principal coordinate analysis using the 6 virulence genes and 5 antibiotic resistance genes to establish a 
relationship between the 59 enterococci isolates, on a species basis.  The coordinate value of each host profile is defined by 2 
dimensions, the X axis is PCO1 (dimension 1), while the Y axis is PCO2 (dimension 2).  The reference code (Table 5.2) is used 
to identify isolates, with the values of the isolates identified as Enterococcus spp.     graphed in A.  The values of the E. faecalis      
are graphed in B and the E. faecium     isolates are graphed in C.  The composite of the three plots is represented in C. 
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The Venn diagram in Figure 5.15 shows that vanA and vanB were only found in the 
hospital isolates while the remaining 7 genes were common to all groups analysed.  Figure 
5.16 shows the distribution of virulence genes between the 3 species.  The gene salA was 
found in Enterococcus and E. faecalis only, ace, vanB, gelE, efaA and esp are found in E. 
faecalis & E. faecium, vanA was only found in E. faecium and pyrC and emeA were 
common to all species.  
 
 
 
 Healthy (n=24) Scouring (n=22) 
Hospital Isolates (n=11) 
vanA 
vanB 
ace 
gelE 
efaA 
emeA 
esp 
pyrC 
salA
Healthy Neonates > 50%
Hospital Isolates > 50%
Hospital and Healthy 
neonatal Isolates > 50% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15: Venn diagram of the distribution of virulence genes between enterococci 
isolates from healthy and scouring neonatal piglets and of hospital origin.   
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Figure 5.16: Venn diagram of the distribution of virulence genes between enterococci 
isolates based on species identification.  8 of the 9 identified genes were common to at least 
two of the groups, while vanA was only identified in E. faecium. 
 
 
As the E. faecium and E. faecalis isolated from healthy and scouring neonatal piglets have 
similar virulence genes, but did not carry the vancomycin resistance genes, they should not 
pose a contamination concern when introduced to the human food chain.  Antimicrobial 
resistance of enterococci is of growing concern, even though many of these enterococci are 
part of the normal flora in pigs and humans.  With enterococci being opportunistic 
pathogens, when antibiotics are administered, susceptible pathogens and commensal 
bacteria are destroyed leaving the antibiotic resistant enterococci to flourish and take over.  
While this is of concern, the question remains  whether enterococci are playing a role in the 
infection process in pigs.  It was therefore important to look at the antibiotic susceptibility 
profiling of the 46 isolates from healthy and scouring neonates and compare these to the 
profiles of the probiotic and the hospital both clinical and environmental samples. 
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5.3.5 Analysis of the antibiotic susceptibility of enterococci isolates  
 
Antibiotic profiling of enterococci isolates: The 59 isolates were sent to Clarence 
Fernandes in the Microbiology Department at PaLMs, Royal North Shore Hospital (St 
Leonards, Sydney) for analysis.  The antimicrobial susceptibility testing was completed in 
accordance with the NCCLS testing standards.  All 59 isolates were tested for antibiotic 
susceptibility against penicillin (0.06, 0.25, 2 & 8 mg/L), ampicillin (8 mg/L), 
ticarcillin/clavulanate (12/2 mg/L), piperacillin (16 mg/L), β-Lactamase, erythromycin 
(0.25 & 0.5 mg/L), clindamycin (0.5 mg/L), tetracycline (4 mg/L), gentamicin (4, 512, 
1024 & 2048 mg/L), streptomycin (512 mg/L), cephalotin (8 mg/L), cefepime (8 mg/L), 
meropenem (4 mg/L), trimethoprim (8 mg/L), vancoymcin (4 mg/L).  The antibiotic 
susceptibility profiles of enterococci isolates from healthy neonatal isolates (Table 5.13) 
show very similar profiles.  The majority of isolates were susceptible to 8 mg/L penicillin, 
8 mg/L ampicillin, 16 mg/L piperacillin, 512 mg/L gentamicin, 4 mg/L meropenem, and 4 
mg/L vancomycin. 
 
Table 5.14 shows the antibiotic susceptibility profiles of the scouring neonatal enterococci 
isolates.  These susceptibility profiles are similar to enterococci of the healthy piglet 
isolates, however the majority of these isolates are resistant to 4 mg/L gentamicin and more 
isolates are sensitive to 512 mg/L streptomycin and 8 mg/L trimethoprim.  The antibiotic 
susceptibility profiles of the probiotic, hospital and control bacteria are detailed in Table 
5.15.  Probiotic isolate 47 is sensitive to all but 5 antibiotic concentrations: penicillin (0.06 
and 0.25 mg/L), 4 mg/L tetracyline, 4 mg/L gentamicin and 8 mg/L trimethoprim.  The 
hospital isolates have antibiotic susceptibility similar to isolates from the healthy and 
scouring neonates; they demonstrate resistance in up to 8 mg/L penicillin, 16/2 mg/L 
ticarcillin/clavulanate, eryothromycin (0.25 and 0.5 mg/L), 0.5 mg/L clindamycin, 4 mg/L 
gentamicin, 8 mg/L cephalotin and ceferprime and 4 mg/L meropenem.  Half of the isolates 
are resistant to 8 mg/L ampicillin and piperacillin. 
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Table 5.13: Results from the antibiotic susceptibility testing provided by PaLMs, Royal North Shore Hospital.  Analysis of 
enterococci isolates from healthy neonates revealed both resistance (R) and sensitivity (-) to a range of antibiotics at different 
concentrations (Abbreviations defined in Appendix 5, Table A5.1). 
 
 
 
 
 
 
 
 
 
 
 
Reference 
Code 
Cont PEN 
0.06 
PEN 
0.25 
PEN 
2 
PEN 
8 
AMP 
8 
TIM 
16 
PIP 
16 
Blase ERY 
0.25 
ERY 
0.5 
CLN 
0.5 
TET 
4 
GEN 
4 
GEN 
512 
GEN 
1024 
GEN 
2048 
STM 
512 
CEP 
8 
CFM 
8 
MPM 
4 
TMP 
8 
VAN 
4 
AES 
1 R R R R - - R - - - - R R R - - - - R R R - - R 
2 R R R R R - R R - R R R R R - - - R R R R - - R 
3 R R R R - - R - - R R R R - - - - R R R - - - R 
4 R R R R - - R - - R R R R - - - - R R R - - - R 
5 R R R R - - R - - R R R R - - - - R R R - R - R 
6 R R R R - - R - - R R R R R - - - R R R - R - R 
7 R R R R - - R - - R R R R - - - - R R R - R - R 
8 R R R R - - R - - R R R R - - - - R R R - - - R 
9 R R R - - - - - - - - - R - - - - - - - - R - R 
10 R R R R - - R  - R R R R - - - - R R R - R - R 
11 R R R R R - R R - R R R R R - - - R R R R - - R 
12 R R R R - - R - - R R R R - - - - R R R - R - R 
13 R R R R - - R - - R R R R - - - - R R R R - - R 
14 R R R R - - R - - R R R R - - - - R R R R - - R 
15 R R R R - - R - - R R R R R - - - R R R - R - R 
16 R R R R - - R - - R R R R R - - - - R R - - - R 
17 R R R R - - R - - R R R R R - - - R R R - R - R 
18 R R R R - - R - - R R R R - - - - - R R - - - R 
19 R R R R R R R R - R R R R - - - - R R R R - - R 
20 R R R R - - R - - R R R R R - - - R R R - R - R 
21 R R R R - - R - - R R R R - - - - R R R - R - R 
22 R R R R - - R - - R R R R - - - - R R R - R - R 
23 R R R R - - R - - R R R R - - - - R R R - R - R 
24 R R R R - - R - - R R R R - - - - R R R - R - R 
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Table 5.14: Results from the antibiotic susceptibility testing provided by PaLMs, Royal North Shore Hospital.  Analysis of 
enterococci isolates from scouring neonates revealed both resistance (R) and sensitivity (-) to a range of antibiotics at different 
concentrations. 
 
Reference 
Code 
Cont PEN 
0.06 
PEN 
0.25 
PEN 
2 
PEN 
8 
AMP 
8 
TIM 
16 
PIP 
16 
Blase ERY 
0.25 
ERY 
0.5 
CLN 
0.5 
TET 
4 
GEN 
4 
GEN 
512 
GEN 
1024 
GEN 
2048 
STM 
512 
CEP 
8 
CFM 
8 
MPM 
4 
TMP 
8 
VAN 
4 
AES 
25 R R R R - - R - - R R R R - - - - R R R - R - R 
26 R R R R - - R - - R R R - R - - - - R R R - - R 
27 R R R R - - R - - R R R R R - - - R R R R - - R 
28 R R R R - - R - - R R R R - - - - - R R R - - R 
29 R R R R - - R - - R - R - R - - - - R R - - - R 
30 R R R R - - R - - R R R R R - - - R R R - R - R 
31 R R R - - - - - - R R R R - - - - - - - - R - R 
32 R R R R - - R - - R R R R R - - - R R R - - - R 
33 R R R - - - - - - R R R R - - - - - - - - R - R 
34 R R R R - - R - - R R R R R - - - R R R - - - R 
35 R R R R R - R R - R R R R R - - - R R R R - - R 
36 R R R R - - R - - R R R R R - - - R R R - R - R 
37 R R R R R - R R - - - R R R - - - - R R R - - R 
38 R R R R R - R R - R - R R R - - - - R R R - - R 
39 R R R R - - R - - R R R R R - - - - R R R - - R 
40 R R R R - - R - - R R R R R - - - - R R R - - R 
41 R R R R - - R - - R R R R - - - - R R R R - - R 
42 R R R R R - R - - R R R R R - - - R R R R - - R 
43 R R R R - - R R - R R R R - - - - R R R R - - R 
44 R R R R R - R - - R R R R R - - - R R R R - - R 
45 R R R R - - R R - R R R R R - - - R R R - R - R 
46 R R R R - - R - - - - R R R - - - - R R R - - R 
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Table 5.15: Results from the antibiotic susceptibility testing provided by PaLMs, Royal North Shore Hospital.  Analysis of 
probiotic, and hospital enterococci isolates revealed both resistance (R) and sensitivity (-) to a range of antibiotics at different 
concentrations.  Antibiotic controls included: S. aureus, S. epidermidis, E. coli, E. cloacae & P. vulgaris.  
 
Reference 
Code 
Cont PEN 
0.06 
PEN 
0.25 
PEN 
2 
PEN 
8 
AMP 
8 
TIM 
16 
PIP 
16 
Blase ERY 
0.25 
ERY 
0.5 
CLN 
0.5 
TET 
4 
GEN 
4 
GEN 
512 
GEN 
1024 
GEN 
2048 
STM 
512 
CEP 
8 
CFM 
8 
MPM 
4 
TMP 
8 
VAN 
4 
AES 
47 R R R - - - - - - - - - R R - - - - - - - R - R 
48 R R R R R - R - - R R R - R - - - - R R R - - R 
49 R R R R R - R R - R R R - R - - - - R R R - - R 
50 R R R R R R R R - R R R R R - - - R R R R - R R 
51 R R R R R R R R - R R R - R R R R R R R R - R R 
52 R R R R R R R R - R R - - R - - - - R R R - - R 
53 R R R R R R R R - R R R R R R R R - R R R - - R 
54 R R R R R R R R - R R R - R - - - R R R R R - R 
55 R R R R - - R - - R R R R R R R - - R R R - R R 
56 R R R R - - R - - R R R R R - - - R R R R R - R 
57 R R R R - - R - - - - R - - - - - - R R - - - R 
58 R R R R - - R - - R R R - - - - - - R R - - - R 
59 R R R R - - R - - R - R R - - - - R R R R R - R 
S. aureus R - - - - - - - - - - - - - - - - - - - - - - - 
S. epidermidis R R R - - - - - R - - - - - - - - - - - - - - - 
E. coli R R R R R - - - R R R R - - - - - - R - - - R - 
E. cloacae R R R R R R R - R R R R - - - - - R R - - - R - 
P. vulgaris R R R R R R - - - R R R R - - - - - R - - R R - 
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The antibiotic susceptibility profiles of enterococci from healthy and scouring neonates, 
and probiotic and hospital isolates were statistically analysed using principle coordinate 
analysis (PCO) to identify similarities between the origin the of isolates (Figure 5.17).  The 
results showed similar profiles between isolates from healthy and scouring neonates and 
hospital isolates.  The isolates tested have natural resistance to cephalosporins, linocamides, 
and aminoglycosides.  The resistance to gentamicin (aminoglycoside) is too low to be 
acquired, therefore it is natural resistance.  By examining the antibiotic susceptibility 
profile it appears that enterococci from neonatal piglets have acquired resistance to 
sulfonamides-trimethoprim, penicillins including moderate spectrum penicillins, and 
macrolides. 
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Figure 5.17: Results of Principal coordinate analysis using the antibiotic susceptibility profiles to establish relationships between 
the 59 enterococci isolates.  The coordinate value of each isolate is defined by 2 dimensions, the X axis is PCO1 (dimension 1), 
while the Y axis is PCO2 (dimension 2).  The reference code (Table 5.2) is used to identify isolates.  The values of isolates from 
healthy neonatal isolates (n=24, A     ), scouring neonates (n=22, B    ), probiotic (n=2, C    ) and hospital plus control isolates 
(n=11, C     ) are plotted as a composite represented in C. 
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Population analysis of antibiotic resistance genes: As no antibiotic resistance genes 
were identified in the enterococci isolates, the KEA Master Grid population was 
harvested and the DNA extracted.  The enterococci specific primer was used as a 
positive control, while the E. faecalis and E. faecium identification primers were used to 
detect the presence of these isolates in the samples.  The presence of the antibiotic 
resistance genes vanA, vanB, vanC1 and vanC2/3, and the efflux pump, in enterococci 
isolated from pigs was assessed.  The gene matrix in Figures 5.18 and 5.19 was 
assembled to show the host profile of the antibiotic resistance genes. VanC was 
identified in isolates from both healthy and scouring piglets with isolates from 4 healthy 
and 3 scouring piglets carrying the gene.  E. faecalis was identified in 11 of the 12 
healthy piglets and 10 of the 12 scouring piglets, while E. faecium was only identified in 
isolates from 4 of the healthy piglets and 9 of the scouring piglets.  The gene for the 
emeA efflux pump was present in isolates from 9 of the 12 healthy and all of the 
scouring piglets. 
 
VanA and vanB were not identified in the populations of enterococci from piglets; these 
genes are important in enterococci involved in human infection.  From this result it can 
be concluded that the enterococci recovered in the healthy and scouring neonatal piglets 
are not of human clinical significance.  However, the enterococci isolates have similar 
virulence gene profiles to human clinical isolates and have acquired resistance to a 
number of different antibiotics.  
 
      1         2         3        4         5          6         7        8          9       10          11         12    
Enterococcus   ●      ●       ●      ●       ●       ●       ●      ●       ●       ●         ●         ●     
E. faecalis   ○      ●       ●      ●       ●       ●       ●      ●       ●       ●         ●         ●     
E. faecium   ●      ○       ○      ●       ○       ○       ○      ●       ●       ○         ○         ○     
vanA    ○      ○       ○      ○       ○       ○       ○      ○       ○       ○         ○         ○ 
vanB    ○      ○       ○      ○       ○       ○       ○      ○       ○       ○         ○         ○ 
vanC1      ○      ○       ○      ○       ○       ●       ○      ●       ●       ○         ●         ○     
vanC2/3   ○      ○       ○      ○       ○       ○       ○      ○       ○       ○         ○         ○ 
emeA    ●      ●       ○      ●       ●       ●       ●      ●       ●       ●         ○         ○         
 
 
Figure 5.18: Gene matrix of antibiotic resistance gene profiles of DNA extracted from 
populations of enterococci isolated from rectal swab samples collected from healthy 
neonatal piglets.  The numbers represent piglet numbers and the Enterococcus spp., E. 
faecalis and E. faecium represent the species being identified using the species specific 
primer sequences.  
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                  13      14       15        16       17       18       19        20      21       23       24        
Enterococcus    ●      ●       ●       ●       ●       ●       ●       ●      ●       ●       ●          
E. faecalis          ●      ●       ●       ●       ●       ●       ●       ●      ●       ●       ○              
E. faecium          ●      ●       ●       ●       ●       ●       ●       ●      ●       ○       ●              
vanA                ○      ○       ○       ○       ○       ○       ○       ○      ○       ○       ○              
vanB                ○      ○       ○       ○       ○       ○       ○       ○      ○       ○       ○              
vanC1                  ○      ●       ○       ○       ○       ●       ○       ○      ○       ●       ○ 
vanC2/3               ○      ○       ○       ○       ○       ○       ○       ○      ○       ○       ○ 
emeA                ●      ●       ●       ●       ●       ●       ●       ●      ●       ●       ●              
  
 
Figure 5.19: Gene matrix of antibiotic resistance gene profiles of DNA extracted from 
populations of enterococci isolated from rectal swab samples collected from scouring 
neonatal piglets.  The numbers represent piglet numbers and the Enterococcus spp., E. 
faecalis and E. faecium represents these species being identified using the species 
specific primer sequences.  
 
 
5.3.6 Pulsed-Field Gel Electrophoresis (PFGE) of DNA from 
enterococci isolates 
Both the virulence gene and antibiotic susceptibility profiling showed no differences 
between the enterococci isolated from healthy and scouring piglets and the hospital 
clinical and environmental isolates.  Pulsed-Field Gel Electrophoresis (PFGE) was used 
as an additional technique to identify any similarity or dissimilarity between the 
isolates. 
 
The DNA extracted from enterococci were restricted using the enzyme SmaI which cuts 
at the recognition site: 5’ CCC GGG  3’.  The molecular profiles (Figure A5.11, 
Appendix 5) were analysed using an agglomerative hierarchical algorithm to establish 
relationships between the 59 enterococci isolates and the results depicted as a 
dendrogram in Figure 5.21.  The isolates are identified on the basis of colour with black 
representing those from healthy neonates, red from scouring neonates, green from 
probiotic isolates and the hospital isolates shown in blue.  The dendrogram has four 
separate divisions A, B, C and D.  Group A consists of 17 isolates of which 10 are from 
scouring piglets, with 4 from healthy piglets, 2 from hospital isolates and 1 from 
probiotic isolates.  Group B contains 12 isolates from healthy piglets, 1 from scouring 
neonates and 4 from hospital isolates.  Group C is a mixed group which contains 6 
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isolates from healthy neonates, 8 from scouring neonates, 4 from hospital isolates and 1 
from probiotic isolates.  Section D contains 2 isolates from healthy neonates, 3 from 
scouring neonates and 3 from hospital isolates. 
 
The species of the isolates are shown in Figure 5.20 (Enterococcus spp. in black, E. 
faecium in blue and E. faecalis in red).  It is possible to identify clusters of species 
situated together, however, there is also clustering of isolates from the same pig.  The 
isolates from piglets clustering together correspond to piglets 2, 3, 4, 6, 7, 8, 9, 11, 12, 
14, 18 and 20; and of these piglets, 9 are healthy and 3 are scouring.  When identifying 
the isolates in group A, 13 of 17 are also contained in group A of Figure 5.13 (based on 
virulence genes).  However, looking at the haemolytic profiles, only 5 of the 17 are α-
haemolytic and the remaining are non-haemolytic.  This trend is also apparent in group 
B where there are only 4 α-haemolytic isolates of 17 and these are predominately E. 
faecalis (12).  Group D contains only 1 non-haemolytic isolate of 6 and group C is 
sectioned in 3 parts where C1 are all non-haemolytic, C2 contains 3 α-haemolytic 
isolates and 3 non-haemolytic isolates, while C3 contains 2 non-haemolytic isolates and 
5 α-haemolytic isolates. 
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Figure 5.20: Dendrogram showing the similarity relationships between enterococci 
isolated from healthy and scouring neonatal piglets, probiotic and clinical hospital 
isolates.  PFGE finger prints were analysed using an agglomerative hierarchical 
algorithm to establish similarity relationships in the form of a dendrogram which 
showed clustering of isolates on the basis of species and haemolytic phenotype.  Colour 
indicates species; Enterococcus, E. faecium, and E. faecalis.  Non-haemolytic isolates 
are denoted as nh and α-haemolytic are denoted as α-h. 
 
 
 
C3 
C2 
C1 
A
B
C
D
01 Enterococcus nh
03 E. faecalis nh
02 Enterococcus α-h
59 E. faecalis nh
58 E. faecalis nh
57 E. faecalis α-h
56 E. faecalis nh
55 E. faecalis nh
54 E. faecium nh
53 E. faecium α-h
52 E. faecium α-h
51 E. faecium α-h
50 E. faecium nh
49 E. faecium α-h
48 E. faecium nh
47 E. faecium nh
46 Enterococcus α-h
45 Enterococcus α-h
44 Enterococcus α-h
43 E. faecium nh
42 Enterococcus nh
41 E. faecalis α-h
40 E. faecium α-h
39 E. faecium α-h
38 E. faecalis nh
37 Enterococcus nh
36 Enterococcus nh
35 Enterococcus nh
34 E. faecalis nh
33 E. faecium α-h
32 E. faecium nh
31 Enterococcus α-h
30 E. faecalis α-h
29 E. faecalis nh
28 Enterococcus nh
27 Enterococcus nh
26 E. faecalis nh
25 Enterococcus α-h
24 E. faecalis nh
23 E. faecalis nh
22 E. faecalis nh
21 E. faecalis nh
20 E. faecalis α-h
19 Enterococcus nh
18 E. faecalis α-h
17 E. faecalis nh
16 Enterococcus nh
15 Enterococcus α-h
14 Enterococcus nh
13 Enterococcus α-h
12 E. faecalis nh
11 E. faecalis nh
10 E. faecalis nh
09 Enterococcus α-h
08 E. faecalis nh
07 Enterococcus α-h
06 E. faecalis nh
05 E. faecalis nh
04 E. faecalis nh
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48 E. faecium
47 E. faecium
 
 
 
Figure 5.21: Dendrogram showing the similarity relationships between enterococci 
isolated from healthy and scouring neonatal piglets, and probiotic and clinical hospital 
sources.  PFGE finger prints were analysed using an agglomerative hierarchical 
algorithm to establish similarity relationships in the form of a dendrogram which 
showed clustering of isolates on the basis of origin.  Colour indicates the origin of 
isolates; healthy neonate, scouring neonate, probiotic isolate, hospital clinical and 
environmental sources.   
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Discussion  
In Australia, ND is associated with class 2 ETEC that belong to serogroups O8, O9, 
O20, O64, O101.  These strains are not easily differentiated from PWD strains (O141, 
O148, O149) based on their fimbrial adhesins and heat stable toxins alone. They may be 
distinguished because they are non-haemolytic and by morphology (mucoid 
appearance).  Since only a few selected clones are analysed from clinical submission of 
faecal/rectal swab samples, one cannot preclude the presence of more than one strain or 
serogroup.  To avoid bias, the PoMA approach was taken to examine the presence of 58 
virulence genes in E. coli populations from rectal swab samples collected from healthy 
and scouring neonatal piglets. 
 
In Chapter 3 the analysis of virulence gene profiles using the combination of 58 
identified virulence genes associated with ETEC and ExPEC pathotypes was described.  
Of these isolates, several carried the typical ETEC genes; STa – 35%, STb – 25%, F5 – 
25%, F18 – 10% and F4 – 5%.  The virulence genes of the dominant serogroups, O8, 
O9 and O101 were identified in the Venn diagram (Figure 5.22).  These combinations 
of virulence genes should then have been identifiable in the PCR population analysis of 
healthy and scouring piglets.  Many of the virulence genes that distinguished between 
the serogroups were identified in both healthy and scouring populations of piglets 
(Table 5.16).  The results suggest that a single serogroup is not the dominating 
population in the diarrhoeal samples.  In the healthy samples many of these genes were 
also identified.  If one or two isolates were selected from these samples, then the true 
diversity of the sample could not be identified.  These results highlight the need for the 
population analysis technique. 
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Figure 5.22: Venn diagram of results obtained in Chapter 3 showing the distribution of 
the 31 virulence genes identified from the panel of 58 in the E. coli isolated from 
clinical cases of ND.  The three major serogroups of O8, O9 and O101 were included. 
  
 
Table 5.16: Prevalence of virulence genes in PCR population analysis of healthy and 
scouring rectal swab samples.  The percentage of piglets carrying each virulence gene 
and the associated serogroup(s) were determined. 
 
Healthy  Scouring  Associated Serogroup Virulence Gene (% positive) (% positive) 
iha 8 50 O8 
east1 33 42 O8 
fyuA 67 75 O8 
ompT 75 75 O8 
cvaC 42 50 O101 
KpsmTII 50 67 O101 
iutA 67 58 O101 
iss 50 67 O8 & O9 
STa 8 42 O8 & O101 
iroN 67 92 O8, O9 & O101 E.coli
traT 83 100 O8, O9 & O101 
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When analysing the population PCR results, only two genes were identified which 
could validly be used to differentiate between the two populations; CDT and iha 
(P<0.05, Chi-squared analysis).  There were a number of genes (cdt, cnf1, focG, LT, 
papG allele III, hlyA, rfc, sfaS, STb and unicnf) that were only identified in scouring 
neonates, however each of these genes were only present in one or two piglets.  The 
same was also true for the genes that were only identified in healthy piglets; ibeA, papG 
allele I, ireA, eaeA and F4.  There were no definitive groupings of genes able to 
segregate healthy and scouring piglets, which is why there was no clustering effect 
observed using either the cluster analysis dendrogram or the PCO analysis.  This result 
could be attributed to either or both of the following reasons: 
 
(i) E. coli isolated from ND are harbouring previously unidentified fimbrial and toxin 
genes.  In Chapter 3, it was highlighted that a number of clinical isolates were carrying 
virulence genes commonly associated with ExPEC.  With the vaccination programs 
occurring in Australia, ND E. coli are being isolated without fimbrial antigens.  The E. 
coli cannot inhabit the intestine as the mother is providing maternal IgA which prevents 
these isolates from being a problem.  Before birth, the intestine is bacteria-free, with 
bacteria in the mother’s uterus and cervix having the first opportunity to inhabit the 
intestinal tract.  This may explain the population virulence gene analysis identifying 
ExPEC genes as they have the mechanisms to adhere to the undeveloped intestine, 
whereas ETEC do not.  Also, vaccination against fimbriated E. coli prevents them from 
causing infection.  Even though these E. coli are commensal bacteria in the mother, E. 
coli is an opportunistic organism, especially strains that are equipped with virulence 
genes allowing them to initiate disease.  These commensals can however, only initiate 
disease when there is an opportunity.  What better time than when the immune and 
intestinal system are not fully mature, pathogenic ETEC are kept in check by the 
mother's maternal antibodies, and the gastrointestinal ecosystem has not formed an 
alliance with these bacteria.  There is nothing to oppose them and they are free to 
increase in numbers and initiate disease. 
 
and/or 
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(ii) The E. coli population is a heterogeneous population rather than a homogenous 
population.  Due to the immature immune and intestinal systems, there is no reason why 
a number of bacteria that are opportunistic pathogens cannot initiate disease.  This could 
explain the diversity of virulence genes in each piglet sample, and why there is no 
uniformity between diseased animals.   
 
Enumeration of haemolytic colonies on both blood and MacConkey agars yielded a low 
level of haemolytic colonies, which is consistent with the literature (Alexander, 1994; 
Fahy, 1987a).  Enumeration of E. coli populations on MacConkey agar did not generate 
a significantly higher value in scouring piglets.  This could be attributed to rectal swab 
samples being collected at the onset of diarrhoea when the bacterial shed is not at its 
highest (Tzipori et al., 1980; Svendsen et al., 1971).  Swabs were collected at the first 
sign of infection to avoid antibiotic selection pressure on the bacterial population.  
When analysing the heterogeneity of the E. coli population based on phenotype, a 
second population was observed.  This population was lighter in colour and growth was 
reduced.  Replication onto CHROMagar revealed a blue population which was then 
identified to be enterococci.  This result prompted replication of KEA master grids onto 
blood agar for analysis of haemolytic phenotype.  Enumeration of KEA populations 
generated significantly higher levels of bacteria from scouring piglets compared to 
healthy piglets.  However, due to the variation between animals, this difference was not 
statistically significant.  The prevalence of enterococci in the scouring population adds a 
new dimension to the neonatal diarrhoea puzzle, raising the question: what role do these 
elevated levels of enterococci play in ND?   
 
To establish the role of enterococci in ND, individual clones were selected from both 
healthy and scouring neonatal piglets for further analysis.  Isolates were identified by 
PCR and biochemical analysis revealing the presence of E. faecalis, E. faecium and 
Enterococcus spp.  Of the isolates from healthy piglets, 37.5% were identified as 
Enterococcus spp. and 62.5% were identified as E. faecalis.  The isolates from the 
scouring piglets were considerably different, with 50% of isolates being Enterococcus 
spp., 27.3% being E. faecalis, and 22.7% E. faecium.  During the diarrhoeal disease 
process there is a shift in the population dynamics of the intestinal flora as well as the 
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bacteria excreted in the faeces.  The analysis of the enterococci population has not shed 
any light on the role of the elevated enterococci population in scouring neonatal piglets, 
only that there is a population shift in the bacteria identified. 
 
To better understand the population of enterococci, the virulence genes associated with 
enterococci were researched in the literature.  The virulence gene analysis was 
consistent with the findings in the literature that E. faecalis carries a number of 
virulence genes, while E. faecium is limited to primarily carrying the esp gene (Dupre et 
al., 2003).  An interesting point to note is that the majority of E. faecalis isolates from 
piglets harboured the same virulence genes as the human clinical isolates analysed.  The 
only exception was the vancomycin resistance genes vanA and vanB which were not 
identified in any of the piglet isolates.  The similarity in the virulence gene profiles of 
the clinical human and piglet enterococci isolates was seen in the PFGE analysis.  The 
human isolates were scattered throughout the similarity cluster analysis dendrogram, 
with most exhibiting more similarity to piglet isolates than other human isolates. 
 
As the human and piglet enterococci isolates are so similar, do the latter pose a threat to 
human health?  Of the numerous vancomycin resistance genes that have been identified; 
vanA, vanB, vanC, vanD, vanE, vanG (Depardieu et al., 2004; Linden, 2002), 
enterococci isolates carrying vanA and vanB resistance genes are of primary concern.  
The vanA gene provides resistance to both vancomycin and teicoplanin (Leclercq et al., 
1988; Uttley et al., 1989), while isolates carrying vanB have acquired inducible 
resistance to various levels of vancomycin (Quintiliani et al., 1993).  Currently in 
Australia, only vanC, which endows constitutive low-level resistance to vancomycin, an 
intrinsic property of E. gallinarum (Leclercq et al., 1988; Vincent et al., 1991), E. 
casseliflavus (Navarro & Courvalin, 1994;Vincent et al., 1991) and E. flavescens 
(Navarro & Courvalin, 1994) has been identified in pigs (Hart et al., 2004).  This seems 
to be isolated to specific countries.  A study of E. faecalis and E. faecium isolated from 
pigs in Denmark, Spain and Sweden identified vanA in pigs from all three countries 
(Aarestrup et al., 2002).  VanA has also been identified in enterococci from poultry, 
swine and bovine samples in Costa Rica (Bustamante et al., 2003), and broiler chickens 
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and slaughter pigs in Italy (Del Grosso et al., 2000).  If vanA has been identified in pigs 
in other countries, there is the possibility of this occurring in Australia.   
 
An additional concern relates to the E. faecalis isolates having not only similar 
virulence gene profiles as the human clinical isolates, but also having similar antibiotic 
resistance profiles.  In human nosocomial infections, 90% of infections are attributed to 
E. faecalis because of the repertoire of virulence genes they possess, while only 10% of 
cases are attributed to E. faecium because of its lack of virulence genes (Bertuccini, 
2002; Klare et al., 2001).  E. faecalis and E. faecium are becoming a problem in human 
infections because of their increased resistance to antibiotics in general, not that they are 
specifically resistant to vancomycin.  When antibiotics are used to treat an infection, the 
susceptible bacteria are neutralized, which allows resistant opportunistic bacteria such 
as E. faecalis and E. faecium to build up their numbers and cause secondary infection.  
Nosocomial infections also occur in healthy patients that have suffered an injury and 
that are undergoing antibiotic therapy to prevent an infection (Linden, 2002; Yeh et al., 
2004).  Antibiotic therapy eliminates bacteria that usually control the over population of 
opportunistic enterococci.  However, infections that involve a multidrug resistant strain 
are treated with vancomycin.  If that isolate is carrying vanA or vanB genes, 
antimicrobial therapy is ineffective.  For this reason enterococci carrying vanA or vanB 
resistant genes are seen as a problem. 
 
The results of this study support the findings of the JETACAR report (1999) which 
recommends control of antibiotic usage in animal production.  A concern with the 
antibiotic resistance profiles of these enterococci is transference to humans via the food 
chain.  Neonatal piglets are used in cooking recipes in many cultures.  Cultures 
including Chinese, Italian, Russian and Cuban recipes for suckling piglets:  
 
http://www.italianmade.com/recipes/recipe332.cfm•  
http://www.ruscuisine.com/recipes-by-email/archive/031225.html•  
http://www.epicurious.com/recipes/recipe_views/views/107566•  
http://www.netcooks.com/recipes/Pork/Roast.Suckling.Pig.html• ).   
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This provides a point of direct entry for antibiotic resistant enterococci that are 
harbouring virulence genes into the human food chain.  If population analysis had not 
been used for the enterococci isolates, the presence of vanC would not have been 
detected.  This result demonstrates the need to further investigate populations rather 
than individual isolates.  One such technique used to study the antibiotic resistance of 
populations of bacteria is the HGMF technique (Dunlop et al., 1998a, 1998b, 1998c; 
Jordan, 2003; Jordan et al., 2005).  This technique can be used to determine the 
antibiotic resistance profiles of up to 200 colonies at a time, compared with the 
traditional disk diffusion technique which an only be used for single isolates (Perrin-
Guyomard et al., 2005; Zhuo et al., 2005). 
 
The results from this study are inclusive when defining the role of enterococci in 
scouring neonatal piglets.  There were significant increases in the number of enterococci 
present in scouring piglets and species identification showed a difference in the species 
of enterococci present.  It is unclear whether the enterococci are a consequence of ND 
or if they are playing a more direct role in the disease process.  Enterococci have 
previously been implicated as possible causes of diarrhoea in neonatal piglets (Drolet et 
al., 1990; Cheon & Chae, 1996; Vancanneyt et al., 2001).  Enterococci were suspected 
as the cause of diarrhoea based on histological data revealing extensive colonization of 
the mucosal surface of the small intestine, from the tips to the base of the villi.  The 
pathogenesis of infection was unclear, with no enterotoxin production or substantial 
mucosal injury occuring.  Cheon & Chae (1996) suggested that a decreased activity of 
brush border digestive enzymes interfers with digestion and absorption of the brush 
border.  The diarrhoea occurred in Landrace piglets 2-14 days of age, in which 
approximately 90% of piglets were diarrheic during a 2 week period (Cheon & Chae, 
1996). The enterococci implicated in this outbreak was E. durans, which has also been 
associated with diarrhoea in foals, piglets, calves and puppies (Collins et al., 1988, 
Jergens et al., 1991; Johnson et al., 1985; Rogers et al., 1992).  Biochemical 
identification of the enterococci isolates did not show any E. durans.  This study has 
highlighted the importance of enterococci in neonatal piglets, not only in their health 
status but also as a potential reservoir for antibiotic resistant genes and their 
implications for human health. 
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Chapter 6 
 
General Discussion 
 
Of the species that inhabit the intestinal tract, E. coli is one of the most genetically diverse.  
This conclusion has come from a large number of studies using the technique of MLEE 
(multilocus enzyme electrophoresis) to estimate the genetic diversity in natural populations 
of E. coli (Selander & Levine, 1980).  It is not often appreciated that the soundness of this 
approach is reliant upon the collection of strains used in the analysis (Whittam et al., 1983), 
as well as the number of loci analysed.  To ensure that any inherent diversity was detected, 
Ochman & Selander (1984) obtained strains of E. coli from different animal host species, in 
different geographical localities to form the ECOR collection.  This collection of E. coli is 
frequently used by many researchers to generate diversity estimates ranging from 0.343 to 
0.542 (Selander et al., 1987).  The need to use such a diverse collection to detect diversity 
was recently demonstrated to be unnecessary following MLEE analysis of 151 isolates 
obtained from the duodenum, ileum, colon and faeces of only eight pigs (Dixit et al., 2004). 
These studies showed that different gut regions represented different ecological niches for 
E. coli where the ‘mean amount of among-gut region differentiation was 27%, a value that 
far exceeds the values of 2-5% differentiation observed amongst the ECOR populations 
isolated from different geographical localities (Whittam et al., 1983).  
 
Based on MLEE data, member clones that contributed towards this diverse genomic E. coli 
framework have been subdivided into four major phylogenetic groupings (Herzer et al., 
1990).  Members in groups A and B1 were primarily non-diarrhoea faecal isolates from 
‘non-clinical’ humans and animals.  Therefore, clonotypes that form these two groups are 
considered to be commensals.  On the other hand, members found in group B2 and to a 
lesser extent in group D, were dominated by isolates from diseased individuals and are 
considered to be pathogenic clones (Picard et al., 1999).  It is surprising that phylogenetic 
groupings based on housekeeping enzymes used in MLEE can separate commensal from 
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pathogenic groupings. Clearly, loci variations in housekeeping enzymes have accumulated 
by various genetic mechanisms (Feil & Spratt, 2001) and under selection pressures, evolved 
to endow fitness in both groups.  
 
A key feature associated with the evolution of a pathogen is the acquisition of virulence 
factors that facilitate adherence, colonization, immune evasion and toxin production (Zhang 
et al., 2002).  E. coli isolated from diarrhoea-affected individuals and non-intestinal 
diseased tissues are referred to as intestinal and extraintestinal pathogens, respectively. 
Individual strains linked to each specific clinical condition (eg. travellers & infant 
diarrhoea, urinary tract infections (UTI), meningitis, & osteomyelitis) have been sorted into 
9 pathotypes (Nataro & Kaper, 1998; Section 1.3.1.4), with each pathotype having its own 
set of specific virulence factors (Table 1.3, Chapter 1). For example, enteropathogenic E. 
coli (EPEC) are associated with virulence factors encoded by the LEE (locus of enterocyte 
effacement) locus and include tir, eaeA, bfpA and esp genes, while extraintestinal 
pathogenic E. coli (ExPEC) that cause urinary tract infections carry pap, afa/draBC, 
sfa/focDE, kpsMTI and iutA virulence genes (Johnson et al., 2003).           
      
While diversity studies have utilised E. coli strains from different animal species, the 
majority of the molecular analyses of the pathogenic E. coli subsets have been based on 
isolates of human origin.  The relationship between the distribution of virulence factors and 
their phylogenetic origin or groupings based on MLEE had not been established.  The first 
study to establish such a relationship was conducted by Johnson and colleagues (2001), 
who analysed the ECOR collection for the prevalence of ExPEC virulence genes.  The 
results identified virulence factors exhibiting distinctive patterns of phylogenetic 
distribution.  These findings provided evidence of both vertical and horizontal transmission 
of virulence factors (Johnson et al., 2001).  
   
Prior to this work, the first molecular method that conveyed a positive correlation with 
MLEE phylogenetic groups, is the multiplex PCR developed by Clermont (2000). In that 
study, three genes; chuA (a gene involved in haeme uptake found in EHEC, typically 
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O157); yjaA (a non-virulence factor sequence found in K12) and TSPE4.C2 (an anonymous 
DNA fragment identified from a subtraction library construct), could be used to sort 230 
strains (including members from the ECOR collection) into the four major phylogenetic 
groupings. This was a significant advance because phylogenetic relationships can now be 
determined by an easy to perform PCR assay in lieu of the more laborious method of 
MLEE.  Unfortunately, Clermont’s three non-pathogenic and non-virulent genes cannot be 
used to formally establish a relationship between isolates and pathogenic potential even 
though isolates categorised in B2 and D can be considered as more likely to be pathogenic.  
Our laboratory has recently addressed this deficit by developing and refining a multiplex 
PCR assay for 50 virulence genes assembled from all major human pathotypes (Chin, 2005; 
personal communication). When applied to a range of E. coli isolates, the combination of 
50 virulence genes was successfully used to classify each isolate into groupings that exactly 
corresponded with the Clermont procedure (Wu 2005, personal communication).   
 
If virulence genes can be used to analyse the genetic structure of human and ECOR E. coli 
isolates, then a similar approach should be able to provide information on the genomic 
diversity of porcine E. coli.  As a consequence of Dixit’s (2004) findings, it is of particular 
importance to understand the process of microbial evolution and adaptation employed by 
commensal and pathogenic E. coli in the porcine GIT.  To achieve this, the first step was to 
assemble a collection of commensal E. coli from healthy pigs, and pathogenic E. coli from 
clinical cases of ND and PWD.  These isolates were analysed using the 58 virulence genes.  
An additional 25 virulence genes were identified in these isolates, and 19 of these found to 
be typically associated with ExPEC isolates. 
 
The previous classification (Alexander, 1994; Fahy 1987a, 1987b; Hampson, 1994) of eight 
virulence genes for porcine ETEC (F4, F5, F6, F18, F41, STa, STb & LT) is an over 
simplification of the complexity of virulence genes possessed by porcine ETEC isolates.  
Statistical analysis using an agglomerative hierarchical algorithm to produce a dendrogram 
and PCO analysis demonstrated two distinct groups that could be observed as 
subpathotypes within the porcine ETEC pathotype.  Further analysis of the additional 
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virulence genes identified showed mainly ExPEC genes in ND and commensal isolates, 
while PWD isolates harboured virulence genes associated with a number of pathotypes 
including: ETEC, ExPEC, EHEC/EPEC, EaggEC and DAEC.  Not only were the genes 
associated with ND and PWD isolates from different pathotypes, but these genes were also 
different of the basis of function (e.g. adhesin, toxins). 
 
Amongst the virulence genes, those possessed by the PWD strains included: (i) adhesin 
genes; iha, AIDA and (ii) toxin genes; hlyA, east1 and stx2.  ND isolates possessed: (i) 
adhesin genes; iha and saa, and (ii) fyuA, iroNE.coli, ireA, iutA (Sideophores, responsible for 
iron uptake and regulation) and ompT (an outer membrane protein).  The PWD virulence 
genes encode adhesins and toxins which aid pathogenicity, and which may provide a 
competitive advantage, relative to other pathogens and commensal bacteria, during 
colonization of the intestine. 
 
The virulence genes identified in the ND isolates are commonly associated with ExPEC.  
ExPEC virulence genes have been previously identified in faecal isolates from dogs with 
clinical cases of diarrhoea (Starcic et al., 2002).  When these isolates were identified they 
had the same virulence gene profiles as urinary tract infection (UTI) isolates; the authors 
suggested that perhaps these strains were bifunctional, and capable of causing both 
diarrhoea and UTI (Starcic et al., 2002).  Even though the ND (and PWD) isolates 
possessed ExPEC virulence genes they are not bifunctional as they require at least two of 
the following genes: papAH, afa/draBC, sfa/focDE, kpsMTII or iutA to cause UTI (Johnson 
et al, 2003).  Furthermore, although the ND and PWD isolates contain virulence genes 
identified in E. coli of human origin, they do not have the right combination of virulence 
genes to be of concern to human health, if transferred via the food-chain. 
 
What is the reason for the possession of ExPEC virulence genes by ND and commensal 
isolates?  Even though these genes have been associated with virulence, they have also 
been identified in commensal isolates.  The findings suggest that, rather than virulence 
genes, they may act as self preservation genes or fitness genes (Johnson et al., 2001; Wold 
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et al., 1992).  These genes could be providing ND isolates with a selective advantage when 
compared with other opportunistic E. coli in the intestine, particularly when vaccination 
prevents fimbriated E. coli from colonising.               
 
This is not the first report of ExPEC virulence genes in intestinal E. coli.  A significant 
fraction of strains responsible for UTI (in humans) are thought to originate from intestinal 
E. coli of infected human hosts (Mobley & Warren, 1996).  This data conflicts with current 
beliefs that ExPEC and intestinal pathogens are mutually exclusive based on pathotype and 
phylogenetic criteria (Russo & Johnson, 2000).  Results previously described by Starcic et 
al. (2002) prompted the authors to suggest that the conventional taxonomy in which group 
B2 containing only ExPEC requires reconsideration.  The work presented in this thesis 
supports this proposal - virulence genes known to be associated with ExPEC were found in 
porcine ETEC isolates (some of which were classed in group B2, based on Clermont’s PCR 
methodology).     
 
The question remains how E. coli isolated from porcine ND have acquired ExPEC genes?  
If ExPEC genes have been identified in human commensal isolates as part of the normal 
colonic flora (Wold et al., 1992), then it may also be possible that the normal colonic flora 
of pigs may be carrying a similar repertoire of genes.  E. coli of human origin may have 
been transferred to pigs, and through gene acquisition and selection pressure evolved.  The 
method of MLST (multi locus sequence typing, reviewed in Feil & Sprat, 2001) can be 
used to compare virulence gene sequences.  If there is a high degree of similarity between 
the sequences of virulence genes of human and porcine origin, then it could be deduced that 
the presence of ExPEC virulence genes in porcine isolates is a recent event.  However, if 
there is not a high degree of similarity, then acquisition of these genes is not a recent event, 
but rather they have long been part of the porcine ETEC genetic composition and have 
previously not been identified. 
 
The virulence gene analysis of the PWD isolates demonstrated a statistical difference 
between the commensal and pathogenic E. coli.  With such a distinct difference observed, 
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the aim was to analyse populations of E. coli from healthy and scouring pigs.  The 
hypothesis was that virulence gene analysis of the populations of E. coli would show 
diversity within a population from an individual pig and that the difference in virulence 
genes profiles would allow discrimination between healthy and scouring pig samples.  If 
this was the case, this technique could also be used as a surveillance tool.  Currently there is 
no surveillance technique for the detection of PWD.  Diagnosis is made when the problem 
is occurring, and by the time this happens there could be a large scale problem in an 
intensive piggery. 
 
Development and testing of the population PCR technique revealed that the virulence gene 
combinations in healthy and scouring pigs were significantly different and this difference 
could be statistically differentiated using PCO.  Further confirmation of this assay came 
when pigs sampled from a low health status farm identified the populations of E. coli as 
being subclinical.  These pigs were found to be harbouring potentially pathogenic ETEC 
yet had no signs or clinical symptomology of PWD (denoted as subclincal pigs).  The 
ability of this technique to identify subclincal pigs in a piggery is potentially highly 
valuable.  Currently there is no technique available to assess herd health, only diagnosis 
when a problem occurs.  By this time it is too late with the pigs requiring treatment in the 
form of electrolytes and antibiotics.  Antibiotics are administered not only to pigs that are 
showing clinical symptoms, but also to all suckers 2-3 days prior to weaning (Sharrock, 
personal communication).  In response to these outbreaks, mass vaccination programs are 
initiated in the piggeries.  This is a problem in terms of antibiotic usage, and also raises the 
question of when to cease preventative treatment.  This type of treatment is considerably 
costly to the industry, especially as it may be sustained for a lengthy time frame (up to 1-2 
years) (Sharrock, personal communication). 
 
Vaccination against specific ETEC antigens also applies an additional selection pressure, in 
which E. coli with novel colonization mechanisms or new fimbrial antigens could evolve to 
fill the ecological niche that is now open (Moon & Bunn, 1993).  No scientific evidence has 
been presented to demonstrate that vaccination does indeed apply an additional selection 
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pressure (Moon & Bunn, 1993).  Even with vaccination programs in place for the 
prevention of PWD, it still occurs.  The best way to deal with the problem of PWD is by 
surveillance.  The use of the population PCR virulence gene assay could be used to monitor 
the health status of farms, and identify ‘at risk’ herds.  Preventative treatments could then 
be initiated to prevent animals that are harbouring potentially pathogenic ETEC from 
spreading them to the entire farm. 
 
The population PCR virulence gene assay could be used in clinical trials to assess the 
efficacy of new or current treatment regimes.  Currently there are a number of preventative 
treatments for PWD including: vaccines, antibiotics and in-feed supplements.  However, 
colibacillosis is still problematic, requiring an alternative approach to assess current and 
new preventative measures.  Most of the applications are assessed using experimental 
models for PWD.  Numerous PWD experimental models have been tried (Cox et al., 1991; 
Sarmiento et al., 1988; Wathes et al., 1989), with the general consensus that they are 
difficult to develop, and that reliable, repeatable models, which realistically represent the 
clinical conditions encountered in the field are difficult to achieve (Madec et al., 2000).  
PWD is a multifactorial problem, with the stress encountered at weaning having a negative 
influence on immune functions (Bailey et al., 1992; Hessing et al., 1995; Madec et al., 
2000; Wattrang et al., 1998).  When a host is stress it becomes susceptible to pathogenic 
ETEC, with these bacteria being the final step in the PWD equation (Madec et al., 2000).  
PWD experimental models are unable to mimic real life situations in terms of the stress 
encountered in an intensive piggery (Section 1.4.1.2)(Madec et al., 2000).  The best way to 
test a preventative treatment for PWD is to assess it on the farm.  The population PCR 
virulence gene technique can be used to assess the efficacy of a preventative treatment by 
looking at the presence of potential pathogens in samples collected from control and test 
subject animals.  This concept is about to be put to use in a probiotic trial.  Rectal swab 
samples are to be collected from a number of different farms to identify a suitable farm on 
the basis of health status (i.e. identification of subclincal animals).  The probiotic will be 
assessed for its efficacy in preventing potentially pathogenic E. coli from colonising the 
intestine of weaner pigs.  A successful end result would be a host profile that classifies the 
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animals as healthy.  On-farm testing would assess the ability of this product to work in a 
real life situation.  
 
Another application for this work involves adapting the population PCR analysis for 
surveillance of antibiotic resistance genes.  The HGMF technique can to be used to identify 
resistance against antibiotics on a phenotype basis (Dunlop et al., 1998a, 1998b, 1998c; 
Jordan, 2003; Jordan et al., 2005).   
 
In addition to use in pig farming, the population PCR analysis technique described in this 
thesis may have valuable applications in the area of human health.  Antibiotic resistance in 
E. coli, enterococci (VRE – vancomycin resistant enterococci) and S. aureus (MRSA – 
methicillin resistant S. aureus) are an increasing problem in human health (Collignon, 
2002).  Many bacteria are resistant to ‘last line’ antibiotics including: carbapenems (e.g. 
meropenem), glycopeptides (e.g. vancomycin), fluoroquinolones (e.g. ciprofloxacin), and 
third generation cephalosporins (e.g. cefotaxime). Many of these highly resistant bacteria 
are being identified in Australian hospitals (Bell et al., 1998; Collignon, 2002) and are 
becoming an increasing problem; thus, alternative treatments are required.     
 
The final objective of this project was to identify the diversity of population virulence gene 
profiles in E. coli taken from healthy and scouring neonatal piglets.  The hypothesis was 
that the virulence gene analysis of the populations would show diversity within a sample, 
and that there would be a difference between the E. coli populations isolated from healthy 
and scouring neonatal piglets.  With the results analysed, they showed that the host profiles 
were so diverse that it was not possible to distinguish between healthy and scouring piglets.  
However, during this analysis, the presence of a second population of bacteria was also 
identified.  This population was enterococci, with species differences and higher 
enumeration values of enterococci identified in scouring animals compared to those in 
healthy animals.  The role of this population in scouring piglets remains unclear.  An 
increase in bacterial number, as observed in the scouring piglets, is suggestive of a role in 
diarrhoea.  Previously E. durans has been implicated as a possible cause of diarrhoea in 
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neonatal piglets (Drolet et al., Cheon & Chae, 1996; Vancanneyt et al., 2001), yet E. 
durans was not identified in the isolates sampled.  This may have been because only two 
isolates were selected from each healthy and scouring piglet for analysis.  This result 
highlights the necessity for using the population technique; if this was conducted E. durans 
may have been identified.  The enumeration and species identification results from the 
analysis of the enterococci isolated from healthy and scouring piglets did not provided a 
conclusive answer the determination of the role of enterococci in ND.  The question 
remains: Is enterococci an emerging pathogen in neonatal piglets?   
 
Further analysis of the enterococci selected included antibiotic resistance profiles, virulence 
gene analysis and PFGE profiling.  These results demonstrated a similarity between the 
virulence gene profiles, antibiotic resistance profiles and PFGE obtained from enterococci 
isolates from healthy and scouring piglets when compared to human isolates.  The main 
differential observed, was species based with E. faecalis, E. faecium and Enterococcus spp. 
having difference virulence gene profiles and differences in their PFGE profiles.  With such 
similarity observed between enterococci isolates of piglet and human origin raises the 
concern of transfer of isolates from pigs to humans.  Originally the transfer of antibiotic 
resistant enterococci from animals to humans, especially VRE, was just suspected. 
However, in recent years these suspicions are being confirmed.  In 1997, identical strains of 
VRE were identified in a farmer and his turkeys in Denmark (vanden Bogaard et al., 1997).  
PFGE analysis of a VRE isolate recovered from a hospitalized man in Denmark revealed a 
very similar profile to a VRE clone commonly found in Danish pigs.  The only contact this 
man had with pigs was the consumption of pork (Bojo Jensen et al., 1999).  A report has 
also identified a VRE isolate from urinary tract infections in dogs that has acquired a 
transposon (Tn1546) associated with human isolates (Simjee et al., 2002).   
 
The transfer of enterococci from animals into humans and vice versa in companion animals 
has been established and is presented in the literature.  The similarly identified between 
porcine and human enterococci isolates on the basis of virulence genes and antibiotic 
susceptibility profiles (as presented in Chapter 5) suggests that they could pose a threat if 
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they contaminated the human food-chain.  At this time however, these isolates would not be 
of major concern to human health as the population PCR analysis demonstrated that the 
vancomycin resistance genes vanA and vanB were not present.  There is however a need for 
population PCR surveillance of antibiotic resistance genes in both hospitals and animals to 
identify any potential problems should they transpire.     
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Appendix 1  
 
 
 
Table A1.1 : Key differential media and tests for classifying enteric bacteria 
 
Media and Tests Composition and Procedure 
Triple sugar iron 
(TSI) agar 
Butt reactions:acid (yellow), gas 
Slant reactions: acid (yellow), alkaline (red) 
H2S reaction: blackening of butt (in the absence of acid butt reaction) 
Urea medium Urea agar with phenol red indicator; look for alkaline reaction due to 
urease action of urea, liberating ammonia 
Citrate medium Growth on citrate as sole energy source 
Indole test Peptone broth with high tryptophan content; assay for indole 
Voges-Proskauer 
(VP) test 
Glucose-containing broth; assay for acetoin 
Methyl red (MR) 
test 
Buffered glucose-peptone broth; measure pH drop with methyl red 
indicator 
KCN medium Broth with 75μg/ml potassium cyanide; look for growth 
Phenylalanine 
agar 
Contains 0.1% phenylalanine; after growth, look for phenylpyruvic acid 
production (indicative of phenylalanine deaminase) by adding ferric 
chloride solution and looking for green colour formation 
β-Galactosidase Medium containing the lactose analog, ο-nitrophenylgalactoside (ONPG); 
positive strains cleave this to yield yellow product 
Utilization of 
carbon sources 
Mannitol, tartrate, mucate, acetate, dulcitol, sorbitol, adonitol, inositol 
(Madigan et al., 1997)  
A1.1 
Table A1.2 : Key diagnostic reactions used to separate the various genera of enteric bacteria 
 
Genus H2S (TSI) Urease VP Indole Motility
Gas from 
Glucose β-Galactosidase Lysine Arginine Ornithine ONPG
Escherichia - - - + -/+ + + + -/+ -/+ + 
Enterobacter - - + - - + + -/+ -/+ + + 
Shigella - - - -/+ -/+ - -/+ - - -/+ -/+ 
Edwardsiella + - - + or - + + - + - + - 
Salmonella + - - - - + -/+ + -/+ + - 
Klebsiella - + -/+ - - + + + - - + 
Citrobacter -/+ - - - - + + - -/+ -/+ + 
Proteus -/+ + - -/+ -/+ -/+ - - - -/+ - 
Providencia - - - + + - - - - - - 
Yersinia - + - - - - + - - + + 
Hafnia - - + - - + -/+ + - + + 
 
Genus KCN Citrate Mucate Phenyl-Methyl Red Tartrate Alanine Deaminase DNA (mol % GC)
Escherichia - - + + + - 48-52 
Enterobacter + + + - - - 52-60 
Shigella - - - + - - 50 
Edwardsiella - - - -/+ - - 53-59 
Salmonella - -/+ -/+ + -/+ - 50-53 
Klebsiella + + + - -/+ - 53-58 
Citrobacter -/+ + + + + - 50-52 
Proteus + -/+ - + + + 38-41 
Providencia + + - + + + 39-42 
Yersinia - - - + - - 46-50 
Hafnia + + - + - - 48-49 
    
            (Koneman et al., 1997; Madigan et al., 1997)  
 
 
 
 
A1.2 
 
Table A1.3: Characteristics for preliminary characterization of gram positive bacteria. 
 
Growth at 
Genus Vancomycin Catalase
Gas from 
Glucose 
LAP PYR
Esculin 
Hydrolysis 
Growth 6.5% 
NaCl 
Arginnine 
Dihydrolase 10oC 45oC 
Streptococcus S - - + - v v v - -+ 
Enterococcus S - - + + + + v + + 
Lactococcus S - - + + +- v - + - 
Aerococcus S - - v v - + - v - 
Leuconostoc R - + - - v v - + v 
Pediococcus R - - + - +- v v - v 
Gemella S - - + v - - - - - 
Alloiococcus S + - v + - + - - - 
Vagococcus S - - + +- + +- V + - 
Tetragenacoccus S - - + - NA NA NA - - 
Globicatella S - - - + + + - - - 
Helcococcus S - - - + + v - NA NA 
+ positive reaction, - negative reaction, +- most strains positive, -+ most strains negative, v variable reaction, NA data not available, LAP – 
Leucine aminopeptidase, PYR - pyrrolidonylarylamidase        (Koneman, 1997) 
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Table A1.4: Characteristics for identification of Enterococcus species. 
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E. faecalis γ,β +- + + + + -+ - + + +- +- + - - - - NA NA 
E. faecium Γ,α +- + + + + -+ - + + +- -+ + - + - - NA NA 
E. avium α, γ +- + + NA + - - + + + v - - -+ - + v NA 
E. durans α, β +- + + NA + - - + + + v + - v - - NA NA 
E .gallinarum α, β + + + + + + - + + + +- + + + v - NA NA 
E. malodoratus γ + + + NA -+ - - + + + v - + + NA + - NA 
E. casseliflavus α + + + NA + + + + + + - +- + + - - + NA 
E. mundtii γ +- + + + + - + + + + - + +- + - v + - 
E. hirae γ 
+ positive reaction, - negative reaction, +-+ most strains positive, -+ most strains negative, v variable reaction, +W positive but weak, NA 
+- + + + + - - + + + -+ + NA + - NA + - 
E. raffinosus α, γ +- + + +w + - - + + + -+ - - - - NA + - 
E. pseudoavium α - + - + + - - + + + +- - - + - NA + - 
E. solitarius α + + + + + - - + + + + + + - - NA v - 
E.dispar α, γ NA + + + - - - + + + v + + + - NA NA - 
E. seriolicida α - NA + NA + - - NA + NA - + NA NA NA - + + 
E.sulfureus α - + + + - - + + + + - - + + - NA NA - 
E. flavescens γ + NA NA -+ +- + + + + + - + + + - NA + - 
E. columbae α, γ - + - NA NA - - - + + - - + v - NA + + 
E. cecorum α - NA -+ - + - - - + + - - -+ -+ + NA + + 
E. saccharolyticus α - NA +w + + - - - + + - - + + - NA - - 
data not available, LAP – Leucine aminopeptidase, PYR - pyrrolidonylarylamidase     (Koneman, 1997) 
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 Table A1.5: Characteristics for identification of Enterococcus species with respect to acid production from the below reagents. 
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E. faecalis - -+ + - + +- - - - + - +- + - + +- - +- + + - - 
E. faecium - - + + + v - - - +- +- - + - + - - v -+ + -+ - 
E. avium + - NA + + v - NA - + v +- NA - + +- - +- + + - + 
E. durans - - NA - + - - NA - -+ v - NA - + - - - -+ +- - - 
E. gallinarum - +- + + + +- -+ -+ v + + -+ + + + - - + +- + + - 
E. malodoratus + - NA - + v - NA - + + - NA + NA + + + + + v + 
E. casseliflavus - +w NA + + v - NA +- + + - NA +- + - - + -+ + + - 
E. mundtii - -+ + + + v - - -+ + + - + +- + +- - + - + + - 
E. hirae - NA + - + -+ - - - - +- v + v + - - + -+ -+ - - 
E. raffinosus NA v NA + + + - NA - + + - + + + + + + NA + NA NA 
E. pseudoavium NA - NA - + - - NA - + - - + - + + + - NA + NA NA 
E. solitarius - - + - + + - - - + -+ + - NA - + - + + + - - 
E. dispar NA - NA - + + - NA - - + NA + + + - - + NA + NA NA 
E. seriolicida - NA NA NA + - - - NA + - - - - NA + NA - NA + - NA 
E. sulfureus - NA + - + - - - - - + + + + + + NA + - + - - 
E. flavescens - - + + + - - - + + NA - + + - - - + - + + - 
E. columbae - + v + + - - - + + + v v + + + - + v + + v 
E. cecorum - NA + - + - v - + - + + + + + - - + -+ + - - 
E. saccharolyticus - + + - + - - - + + + + + + + + -+ + - + - - 
+ positive reaction, - negative reaction, +- most strains positive, -+ most strains negative, v variable reaction, +W positive but weak, NA 
data not available, LAP – Leucine aminopeptidase, PYR - pyrrolidonylarylamidase     (Koneman, 1997) 
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Appendix 2 
 
Bacteriological Media 
 
All bacteriological media was prepared according to the manufacturer’s instructions.  Agar 
media were poured into petri dishes; 20 ml for 90 mm round plates and 25 ml for 100 x 100 
mm square plates and stored at 4oC for up to 3 weeks.  Broth cultures were stored up to 2 
months and broth cultures containing glycerol were stored up to 4 months. 
   
A2.1 Blood agar 
Blood Agar Base No. 2 was purchased from Oxoid (Unipath Ltd, Hampshire England, 
Catalogue Code CM271, Lot No: 291 37425, 238746).   
 
Typical Composition in 1 L 
Proteose Peptone  15 g 
Liver Digest   2.5 g 
Yeast Extract   5 g 
Agar    12 g 
Sheep Blood   100 ml 
 
A2.2 CHROMagar Orientation 
CHROMagar Orientation was purchased from Dutec Diagnostics (Croydon, NSW, 
Catalogue Code RT413-24, Lot No. 541-d).  This media is light sensitive and requires 
storage in the dark and avoidance of excessive light. 
 
Typical Composition in 1 L 
Peptone Yeast Extract  16.1 g 
Chromagenic Mix  1.3 g 
Agar    15 g 
 
A1.3 MacConkey agar 
MacConkey agar was purchased from Amyl Media (Dandenong, Vic, Catalogue Code 
AM94, Lot No. 6751). 
 
Typical Composition in 1 L 
Bacteriological Peptone   10 g 
Casein Peptone Pancreatic Digest 10 g  
Lactose    10 g 
Sodium Chloride   5 g 
Bile Salts    5 g 
Neutral Red    0.075 g 
Agar, Bacteriological   13 g 
 
A2.1 
A2.4 Kanamycin Esculin Azide (KEA) agar 
KEA agar was purchased from Amyl Media (Dandenong, Victoria, Cat. AM74, Batch: 
6554).   
 
Typical Composition in 1 L 
Casein Hydrolysate   20 g 
Sodium Chloride   5 g 
Yeast Extract    5 g 
Sodium Citrate   1 g 
Sodium Citrate   1 g 
Esculin    1 g 
Ferric Ammonium Citrate  0.5 g 
Sodium Azide    0.15 g 
Kanamycin Sulphate   0.02 g 
Agar, Bacteriological   13 g 
 
A2.5 MRS agar 
MRS agar was purchased from Amy Media (Dandenong, Victoria), AM104, Batch: 6586. 
 
Typical Composition in 1 L 
Bacteriological Peptone    10 g 
Beef Extract     8 g 
Yeast Extract     4 g 
Dextrose     20 g 
di-Potassum Hydrogen Orthophosphate 2 g 
tri-Ammonium Citrate   2 g 
Agar, Bacteriological    12 g 
Magnesium Sulphate    * 0.2 g 
Manganese Sulphate    * 0.05 g 
Sorbitan Mono-Oleate Complex  1 g 
Sodium Acetate    5 g 
* Reagents in MRS Supplement (SP437, Lot No 7272) 
 
A2.6 Brain Heart Infusion Broth (BHIB)/agar  
BHIB was purchased from Amyl Media (Dandenong, Victoria).   
 
Typical Composition in 1 L 
Blended Peptone No. 1    10 g 
Sodium Chloride      5 g 
Brain Heart Infusion Solid    17.5 g 
Glucose      2 g 
di-Sodium Hydrogen Orthophosphate  2.5 g 
Agar (Agar Only, Amyl, RM250, Batch: 6479) 17 g 
Glycerol  (Freeze down agar/broth only)  200 ml 
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A2.7 Luria-Bertani (LB) broth/agar  
Luria-Bertani broth/agar was prepared from the stock compounds listed below.   
 
Typical Composition in 1 L 
Tryptone (Oxoid, Cat. L42, Batch: 251115)   10 g 
Yeast Extract (Amyl, RM342, Batch: 2761)   5 g 
Sodium Chloride       10 g 
Agar (only for agar plates, not included for broth  
[Amyl, RM250, Batch: 6479]    17 g 
Glycerol (Freeze down broth only)    200 ml 
  
A2.8 Phosphate Buffered Saline 
 
Composition: 
 
Table A2.1: Ingredients required for preparing PBS. 
 
Ingredient Molecular Weight Quantity (g/L) Concentration (mM) 
NaCl 58.44 8 137 
KCl 74.55 0.2 2.68 
NaH2PO4.2H2O 141.96 1.15 8.1 
KH2PO4 136.09 0.2 1.15 
 
Preparation: 
All ingredients listed in Table A1.1 were added to 1L of MQH2O, adjusted pH to 7.2, and 
autoclaved at 121oC for 15 minutes.  The solution was allowed to cool and store at 4oC. 
 
KCl – Potassium Chloride, Ajax Chemicals, analytical univar reagent 500g (1997) Lot No: 
309495 
NaH2PO4.2H2O – Sodium DiHydrogen Orthophosphate Anahydrous, Ajax Chemicals, 
Catalogue Code 471, Lot No: 62940  
KH2PO4 – Potassium dihydrogen Orthophosphate, BDH Chemicals, Kilsyth Victoria, 
Catalogue Code 392, Lot No: 10203 
 
A2.9 Simmons citrate agar 
Simmons citrate agar was purchased from Oxoid (Unipath Ltd, Hampshire England, 
Catalogue Code CM155, Lot No: 219029) 
 
Typical Composition in 1 L 
Magnesium Sulphate   0.2 g 
Ammonium dihydrogen Phosphate 0.8 g 
Sodium Citrate, tribasic  2.0 g 
Sodium Chloride   5.0 g 
Bromothymol Blue   0.08 g 
Agar     15 g 
A2.3 
 
A2.10 Minimal media 
Three separate solutions were prepared: 
 
1. The following reagents were dissolved in 80 ml of MQH2O in a 100 ml bottle: 7 g of 
potassium phosphate, dibasic (K2HPO4, Univar 7282, Lot 10562), 2 g of potassium 
phosphate, monobasic (KH2PO4, Ajax 392, Lot63153), 1 g of ammonium sulfate (NH4SO4, 
Lot 63153 BDH Chemicals 10033) and 0.5 g of sodium citrate (NaC6H5O2..2H2O, BDH 
Chemicals 10242, Lot 30272). 
 
2. 3 g of lactose (Univar 871-500, Batch: 80222310) was dissolved in 80 ml of MQH2O in 
a 100 ml bottle. 
 
3. 16 g of bacteriological agar (Amyl RM250, Lot 6479) was dissolved in 840 ml of 
MQH2O in a 500 ml bottle. 
 
The three solutions were then autoclaved at 121oC for 15 minutes, allowed to cool in a 
50oC water bath for 20-30 minutes and then combined in the 500 ml bottle.  1 ml of 0.2% 
Vitamin B1/10% magnesium sulphate solution (BDH England 44005, Lot 5160720J, and 
Univar Sydney, Lot 10911 respectively) was then added.  Plates were poured as previously 
described. 
 
A2.11 Kovacs reagent 
 
Composition: 
p-dimethylaminobenzaldhyde -  (CH3)2NC6H4CHO   1 g 
(Ehrlich Reagent, APC Finechem 194-100G, Lot 199-04-12)  
iso-amyl alcohol (1-pentanol)      15 ml 
Hydrochloride Acid (HCl)      5 ml 
 
Preparation: 
5 ml of concentrated HCl was slowly added to 15 ml of 1-pentanol, 1 g of Ehrlich reagent 
was added and gently swirled until dissolved.  The reagent was stored in an air tight 
container covered in aluminium foil, at 4oC for up to 2 weeks. 
 
A2.12 MacConkey broth 
MacConkey broth was purchased from Merck (Darmstadt, Germany, Catalogue Code 
1.05396, Lot No. 950) 
 
Typical Composition in 1 L 
Peptone from Casein   20 g 
Lactose    10 g  
Ox bile, dried    5 g    
Bromocresol purple   0.01 g   
A2.4 
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Appendix 3 – Chapter 3 Data 
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Figure A31: Image of an ethidum bromide stained 2% agarose gel showing PCR products 
(multiplex VI) prepared from reference isolates for the detection of the univcnf, iha, 
iroNE.coli, ompT, iss and ireA genes.  Positive and negative controls are denoted as +ve and 
–ve respectively. 
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Figure A3.2: Image of an ethidum bromide stained 2% agarose gel showing PCR products 
(multiplex VIII) prepared from reference isolates for the detection of the LT, F6 and STb 
genes.  Positive controls are denoted as +ve. 
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Figure A3.3: Image of an ethidum bromide stained 2% agarose gel showing PCR products 
(multiplex IX) prepared from reference isolates for the detection of the F4, F5 and STa 
genes.  Positive controls are denoted as +ve. 
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Figure A3.4: Image of an ethidum bromide stained 2% agarose gel showing PCR products 
(umiplex XVI) prepared from reference isolates 3-9 for the detection of the saa gene.  
Positive and negative controls are denoted as +ve and –ve respectively. 
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Figure A3.5: Gene matrix of DNA extracted from E. coli isolated from scouring neonatal piglets determined by PCR, where ○ is 
negative for the gene and ● is positive for the virulence gene. 
 
 1      2       3      4       5      6       7      8       9    10     11    12    13     14     15    16    17     18    19    20      
Adhesins 
afa/draBC    ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
aah (orf A)   ○      ○      ●      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ●            
AIDA-I (orf B) ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○           
AIDAc (orf Bc) ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○            
bfpA   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
bmaE   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○           
eaeA   ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○           
F4   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●           
F5   ○      ○      ●      ○      ○      ○      ●      ○      ○      ○      ○      ●      ●      ●      ○      ○      ○      ○      ○      ○           
F6   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
F18  ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○           
F41  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
fimH  ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●           
focG  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
iha  ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ●      ○           
nfaE  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
paa  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○           
papA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○           
papC  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○             
papEF  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
papG A’  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
papG I        ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●           
papG II       ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○            
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Figure A3.5 continued. 
 1      2       3      4       5      6       7      8       9    10     11    12    13     14     15    16    17     18    19    20      
 
papG III   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
saa  ○      ●      ●      ●      ●      ○      ○      ○      ○      ●      ○      ○      ●      ○      ○      ●      ○      ○      ○      ●           
sfa/focDE  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
sfaS  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
Toxins   
CDT  ○      ○      ○      ○      ○      ●      ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○            
cdtB  ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
cnf1  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
univcnf      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
cvaC  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ●      ○      ○      ○      ○             
EAST1  ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●           
ehxA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○           
hlyA  ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●           
LT  ●      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●           
STa  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
STb  ●      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ●      ○      ●           
Stx1  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
Stx2  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○           
Capsule Synthesis 
kpsMTII  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○           
kpsMTIII  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
kpsMT K1  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○           
kpsMT K5  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
rfc  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
Siderphores 
fyuA  ○      ●      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ●           
ireA  ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○           
iroNE.coli  ○      ●      ○      ●      ●      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ●      ○      ○      ○      ○           
iutA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ●      ○      ○      ○           
A3.5 
Figure A3.5 continued. 
 1      2       3      4       5      6       7      8       9    10     11    12    13     14     15    16    17     18    19    20      
Invasins   
ibeA   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
ipaH  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
Miscellaneous  
chuA  ○      ○      ○      ●      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
iss  ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ○           
ompT  ●      ○      ○      ●      ○      ●      ○      ○      ○      ○      ○      ○      ●      ○      ●      ○      ○      ○      ●      ○           
PAI  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
TSPE4C2  ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ●      ●      ○      ●      ○      ●      ○           
traT  ○      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●           
yjaA  ●      ●      ●      ○      ○      ●      ○      ○      ○      ○      ●      ○      ○      ○      ○      ●      ○      ●      ○      ○          
A3.6 
Figure A3.6: Gene matrix of DNA extracted from E. coli isolated from scouring weaner pigs determined by PCR, where ○ is negative 
for the gene and ● is positive for the virulence gene. 
 
    21  22    23   24  25  26  27  28   29   30    31    32     33   34   35    36    37   38    39   40    41    42   43    44   45   46  47   48  49   50  51  52 
Adhesins 
afa/draBC    ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○          
aah (orf A)   ○   ●   ●   ○   ○   ●   ●   ●   ●    ●    ○    ●    ●    ●    ●    ●    ●    ●    ●    ●    ●    ●    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
AIDA-I (orf B) ○   ●   ●   ○   ○   ●   ●   ●   ●    ●    ○    ●    ●    ●    ●    ●    ●    ●    ●    ●    ●    ●    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○    
AIDAc (orf Bc) ○   ●   ●   ○   ○   ○   ○   ●   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
bfpA   ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
bmaE   ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
eaeA   ○   ○   ○   ○   ●   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
F4   ●   ○   ○   ○   ○   ○   ○   ●   ○    ○    ●    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ●    ●   ●   ●   ●   ●   ●   ●   ●   ●   
F5   ○   ○   ○   ○   ○   ●   ○   ●   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
F6   ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
F18  ○   ●   ●   ○   ○   ●   ○   ●   ○    ●    ○    ●    ●    ●    ●    ●    ●    ●    ●    ○    ●    ●    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
F41  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
FimH  ●   ●   ●   ●   ●   ●   ●   ●   ○    ●    ○    ●    ●    ●    ●    ●    ●    ●    ●    ●    ●    ●    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
focG  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
iha  ●   ○   ○   ○   ●   ○   ●   ●   ●    ●    ○    ●    ●    ●    ●    ●    ●    ●    ●    ●    ○    ●    ●    ●   ●   ●   ●   ●   ●   ●   ●   ●   
nfaE  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
paa  ○   ○   ○   ○   ●   ○   ●   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
papA  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
papC  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○    
papEF  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○    
papG A’  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
papG I        ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○    
papG II       ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
papG III   ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
 
 
A3.7 
Figure A3.6 continued. 
    21  22    23   24  25  26  27  28   29   30    31    32     33   34   35    36    37   38    39   40    41    42   43    44   45   46  47   48  49   50  51  52 
saa  ●   ○   ○   ○   ○   ○   ○   ●   ○    ●    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
sfa/focDE  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
sfaS  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
Toxins  
CDT  ○   ●   ●   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○    
cdtB  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○    
cnf1  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
univcnf      ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
cvaC  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
EAST1  ●   ●   ●   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ●    ○    ●    ●   ●   ●   ●   ●   ●   ●   ○   ●   
ehxA  ○   ○   ○   ●   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
hlyA  ●   ●   ○   ○   ○   ●   ○   ○   ●    ●    ○    ●    ●    ●    ○    ●    ●    ●    ●    ●    ○    ●    ●    ●   ●   ●   ●   ●   ●   ●   ○   ●   
LT  ●   ●   ●   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ●    ●   ●   ●   ●   ●   ●   ●   ●   ○   
STa  ○   ○   ○   ●   ○   ●   ●   ○   ●    ●    ●    ●    ○    ○    ●    ○    ●    ●    ●    ●    ●    ●    ○    ●   ●   ●   ●   ●   ●   ●   ●   ○   
STb  ●   ●   ●   ●   ●   ●   ○   ○   ●    ●    ○    ●    ●    ●    ●    ○    ●    ●    ●    ●    ●    ○    ●    ●   ●   ●   ●   ●   ●   ●   ●   ○   
Stx1  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
Stx2  ○   ○   ○   ○   ○   ○   ○   ○   ○    ●    ○    ●    ●    ●    ●    ●    ●    ●    ●    ●    ●    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
Capsule Synthesis 
kpsMTII  ○   ○   ○   ○   ○   ○   ○   ●   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
kpsMTIII  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
kpsMT K1  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
kpsMT K5  ○   ○   ○   ○   ○   ○   ○   ●   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○           
rfc  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
Siderphores 
fyuA  ●   ○   ○   ●   ●   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ●    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
ireA  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ●    ●    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
iroNE.coli  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
iutA  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
 
A3.8 
Figure A3.6 continued. 
    21  22    23   24  25  26  27  28   29   30    31    32     33   34   35    36    37   38    39   40    41    42   43    44   45   46  47   48  49   50  51  52 
Invasins    
ibeA   ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
ipaH  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
Miscellaneous   
chuA  ○   ●   ●   ○   ○   ●   ●   ●   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ●    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○          
iss  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
ompT  ○   ○   ○   ○   ●   ○   ○   ○   ●    ○    ○    ○    ●    ●    ●    ●    ○    ○    ○    ○    ○    ●    ●    ○   ○   ○   ○   ○   ○   ○   ○   ○   
PAI  ○   ○   ○   ○   ○   ○   ○   ○   ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
TSPE4C2  ○   ○   ○   ○   ●   ○   ○   ○   ○    ○    ○    ○    ○    ○    ●    ●    ○    ○    ○    ○    ○    ○    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○    
traT  ●   ●   ●   ●   ●   ●   ●   ●   ○    ○    ●    ○    ●    ●    ●    ○    ○    ○    ○    ○    ○    ●    ○    ●   ●   ●   ●   ●   ●   ●   ●   ○   
yjaA  ●   ○   ○   ○   ○   ○   ○   ○   ●    ●    ○    ●    ●    ●    ○    ○    ○    ●    ●    ●    ●    ●    ○    ○   ○   ○   ○   ○   ○   ○   ○   ○   
 
A3.9 
Figure A3.7: Gene matrix of DNA extracted from commensal E. coli isolated from healthy pigs determined by PCR, where ○ is 
negative for the gene and ● is positive for the virulence gene. 
 
 
 53   54   55    56   57    58   59   60    61   62   63    64   65    66   67    68   69   70   71     72  73    74   75    
Adhesins 
afa/draBC    ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
aah (orf A)   ●     ○     ○     ●     ○     ○     ○     ○     ○     ○     ○     ○     ○     ●     ○     ○     ○     ○     ○     ○     ○     ○     ○        
AIDA-I (orf B) ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
AIDAc (orfBc) ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
bfpA   ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
bmaE   ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
eaeA   ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
F4   ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ●     ○     ○     ○     ○     ○     ○     ○       
F5   ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
F6   ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
F18   ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
F41   ○     ○     ○     ○     ●     ●     ○     ○     ○     ●     ●     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
fimH  ●     ●     ○     ●     ●     ●     ●     ○     ●     ○     ●     ●     ●     ●     ●     ●     ○     ●     ○     ○     ●     ●     ○       
focG  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○      
iha  ●     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
nfaE  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
paa  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
papA  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
papC  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
papEF  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
papG A’  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
papG I        ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
papG II       ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
papG III   ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
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saa  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ●     ●     ○     ○     ○     ○     ○     ○     ○     ●     ○     ○       
sfa/focDE  ○     ○     ●     ○     ○     ○     ○     ●     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
sfaS  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
Toxins 
CDT  ○     ○     ○     ○     ○     ○     ○     ○     ●     ○     ○     ○     ○     ○     ●     ○     ○     ●     ○     ○     ●     ○     ○       
cdtB  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○      
cnf1  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
univcnf      ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
cvaC  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
EAST1  ○     ○     ○     ○     ○     ○     ○     ○     ●     ○     ○     ○     ○     ○     ●     ○     ○     ●     ○     ○     ●     ○     ○       
ehxA  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○      
hlyA  ●     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
LT  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
STa  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
STb  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○      
Stx1  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
Stx2  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ●     ●     ○     ○     ○     ○     ○     ○     ○     ●     ○     ○       
Capsule Synthesis 
kpsMTII  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
kpsMTIII  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
kpsMT K1  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
kpsMT K5  ○     ○     ○     ○     ●     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
rfc  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○      
Siderphores 
fyuA  ●     ○     ○     ●     ○     ○     ○     ○     ○     ○     ●     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
ire  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
iroNE.coli  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○      
iutA  ●     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
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Invasins  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
ibeA  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
ipaH  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○      
Miscellaneous  
chuA  ○     ○     ○     ●     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
iss  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
ompT  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ●     ○     ○     ○     ●     ○     ○     ●     ○     ○       
PAI  ○     ○     ●     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○       
TSPE4C2  ○     ●     ○     ○     ○     ○     ●     ○     ●     ○     ○     ●     ●     ○     ○     ○     ●     ○     ○     ○     ●     ○     ●       
traT  ○     ●     ○     ○     ●     ○     ○     ●     ○     ○     ●     ●     ●     ●     ○     ●     ●     ●     ○     ●     ●     ●     ○       
yjaA  ○     ○     ○     ○     ●     ●     ○     ●     ○     ●     ●     ○     ○     ●     ○     ●     ○     ●     ○     ●     ○     ○     ○   
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Flooding of a single colony into adjacent squares when 
too much pressure is applied to the replication device, 
releasing excess water across the grid surface, 
allowing bacteria to breach the hydrophobic borders  
A B 
Excessive pressure has been applied to the plate 
when using the replicating device which has released 
water from the agar plate and allowed the bacteria to 
breach the hydrophobic borders 
C 
Incomplete replication usually occurs when agar plates have a 
meniscus and there is a low point in the media, therefore the 
replicating device does not make contact with the HGMF and the 
bacteria are not transferred, leaving a void on the grid, indicated by 
the red circle. 
 
Figure A4.1: Problems associated with HGMF technique A) Partial flooding of the HGMF 
where single colonies are spread to adjacent squares, B) Complete flooding of the HGMF 
C) Incomplete replication of the HGMF due to the agar plate having a meniscus.  
A4.1 
Table A4.1: Raw data generated from analysis of PGFE gel (Figure 4.7), where each band on the gel is given a 1.  Each band on 
the gel is marked with a guide line, numbered 1-32, so corresponding bands across adjacent wells can be identified.  The table of 
results below was then used in an agglomerative hierarchical algorithm to generate a similiarity dendrogram (Figure 4.26).  
E.coli Isolates 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 
 16-1 1 1 0 0 0 0 1 1 1 1 0 0 1 0 0 1 1 1 1 1 0 0 1 1 0 0 0 0 0 0 0 0 
 16-2 0 1 0 0 0 0 1 1 1 1 0 0 1 0 0 1 1 1 1 1 0 0 1 1 0 0 0 0 0 0 0 0 
 16-3 1 1 0 0 0 0 1 1 1 1 0 0 1 0 0 1 1 1 1 1 0 0 1 1 0 0 0 0 0 0 0 0 
 16-4 0 1 0 0 0 0 1 1 1 1 0 0 1 0 0 1 1 1 1 1 0 0 1 1 0  0 1 0 0 0 0 
 16-5 0 1 0 1 0 0 1 1 1 0 1 0 1 0 0 1 0 1 1 1 1 0 1 1 0 1 1 1 0 0 0 0 
 16-6 0 0 0 1 0 0 1 1 1 0 0 0 1 0 0 1 0 1 0 0 0 0 0 1 0 1 1 1 0 0 0 0 
 16-7 1 1 0 1 0 0 1 1 1 0 1 0 1 0 0 1 0 1 1 1 1 0 0 1 0 0 1 1 0 0 0 0 
 16-8 0 1 0 0 0 0 1  1 1 0 0 1 0 1 1 1 1 0 1 0 0 0 1 0 0 0 1 0 0 0 0 
 16-9 0 1 0 0 0 0 1 1 1 1 0 0 1 0 1 1 1 1 1 0 0 0 1 1 0 0 0 1 1 0 0 0 
 16-10 0 1 0 0 0 0 1 1 1 1 0 1 1 0 0 1 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 
 17-1 0 1 1 1 1 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
 17-2 0 1 0 1 1 0 1 0 1 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
 17-3 0 1 0 1 1 0 1 0 1 0 0 0 1 1 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
 17-4 0 1 0 1 1 0 1 0 1 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
 17-5 1 1 0 1 1 0 1 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
 17-6 0 1 0 0 1 0 1 0 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
 17-7 0 1 0 1  0  0 1 0 1 0 1 1 1 0 1 1 1 1 1 1 1 0 0 0 0 0 1 1 0 0 
 17-8 1 1 0 1 1 0 1 0 1 0 1 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 1 1 0 0 
 17-9 0 1 0 1 1 0 1 0 1 0 1 1 0 0 0 1 0 1 1 0 0 0 0 0 0 0 0 0 1 1 0 0 
 17-10 0 1 0 1 1 0 1 0 1 0 0 1 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
 20-1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 0 0 1 0 1 1 0 1 0 0 0 1 1 0 0 1 0 1 
 20-2 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 1 1 1 0 0 0 0 0 0 0 1 1 0 0 1 0 1 
 20-3 1 1 1 0 0 0 0 1 1 1 0 1 1 0 1 0 1 0 1 0 0 0 1 1 0 0 0 0 0 1 1 1 
 20-4 0 1 0 0 0 0 0 0 1 0 0 0 1 1 0 1 1 1 0 1 1 1 0 0 0 1 1 0 0 1 0 1 
 20-5 0 1 0 0 0 0 0 0 1 0 0 0 1 1 0 1 1 1 0 1 1 1 0 0 0 1 1 0 0 1 0 1 
 20-6 1 1 0 0 0 0 0 0 1 0 0 0 1 1 0 1 1 1 0 1 1 1 0 0 0 1 1 0 0 1 0 1 
 20-7 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 1 1 1 0 1 1 1 0 0 0 1 1 0 0 1 0 1 
 20-8 0 1 0 0 0 0 0 0 1 1 1 0 1 1 0 1 1 1 0 1 1 1 1 0 0 1 1 0 0 1 0 1 
 20-9 0 1 0 0 0 0 0 0 1 1 1 0 1 1 0 1 1 1 0 1 1 1 1 0 0 1 1 0 0 1 0 1 
 20-10 0 1 0 1 0 0 0 0 1 1 1 0 1 1 0 1 1 1 0 1 1 1 1 0 0 1 1 0 0 1 0 1 
A4.2 
Figure A4.2: Gene matrix of DNA extracted from E. coli populations isolated from rectal 
swab samples collected from healthy weaner pigs as determined by PCR, where ○ is 
negative for the gene and ● is positive for the virulence gene. 
 
 1      2       3      4       5      6      7       8      9     10     11    12     
Adhesins 
afa/draBC    ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
aah (orf A)   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
AIDA-I (orf B) ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○         
AIDAc (orf Bc) ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○          
bfpA   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
bmaE   ○      ●      ○      ○      ○      ○      ○      ●      ○      ●      ○      ●      
eaeA   ○      ○      ●      ●      ●      ●      ●      ○      ●      ○      ○      ○      
F4   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F5   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F6   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F18   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F41  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
FimH  ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      
focG  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
iha  ○      ●      ●      ●      ●      ●      ●      ○      ●      ●      ○      ○      
nfaE  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
paa  ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      
papA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ●      
papC  ○      ●      ○      ○      ○      ○      ○      ●      ○      ●      ○      ●      
papEF  ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      
papG A’   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
papG I        ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
papG II      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      
papG III   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●           
saa  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
sfa/focDE  ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ●      
sfaS  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      
Toxins 
CDT  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
cdtB  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
cnf1  ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ●      
univcnf      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ●      
cvaC  ○      ●      ○      ○      ○      ○      ○      ●      ●      ●      ●      ●    
EAST1  ○      ○      ●      ●      ○      ○      ○      ●      ●      ●      ●      ●      
ehxA  ○      ○      ○      ●      ●      ○      ○      ●      ○      ○      ○      ○      
hlyA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ●      
LT  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
STa  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
STb  ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○     
A4.3 
 
Figure A4.2 continued. 
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Stx1  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
Stx2  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
Capsule Synthesis 
kpsMTII  ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○    
kpsMTIII  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
kpsMT K1  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○    
kpsMT K5  ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○    
rfc  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○     
Siderphores 
fyuA  ○      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ● 
ireA  ○      ○      ●      ●      ○      ○      ○      ○      ○      ○      ●      ○    
iroNE.coli  ○      ●      ○      ○      ○      ○      ○      ●      ●      ●      ●      ●    
iutA  ○      ●      ○      ○      ○      ○      ○      ●      ●      ●      ●      ●    
Invasins  
ibeA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○   
ipaH  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○     
Miscellaneous  
chuA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
iss  ○      ●      ○      ○      ○      ○      ○      ●      ●      ●      ●      ●    
ompT  ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ●      ●    
PAI  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
TSPE4C2  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○       
traT  ○      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●    
yjaA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
 
 
 
 
A4.4 
Figure A4.3: Gene matrix of DNA extracted from E. coli populations isolated from rectal 
swab samples collected from scouring weaner pigs as determined by PCR, where ○ is 
negative for the gene and ● is positive for the virulence gene. 
 
                            13     14    15     16     17    18    19     20    21    22    23     24     
Adhesins 
afa/draBC    ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○     ○      
aah (orf A)   ○      ○      ○      ○      ○      ●      ○      ●      ●      ●      ●      ●           
AIDA-I (orf B) ○      ○      ○      ○      ○      ●      ○      ●      ●      ●      ●      ●         
AIDAc (orf Bc) ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○          
bfpA   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
bmaE   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○        
eaeA   ●      ●      ●      ○      ●      ○      ○      ○      ○      ○      ●      ○      
F4   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F5   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F6   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F18   ○      ○      ○      ○      ○      ○      ●      ○      ●      ●      ○      ○      
F41  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
FimH  ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      
focG  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
iha  ●      ●      ●      ○      ○      ●      ●      ○      ●      ●      ●      ○      
nfaE  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
paa  ●      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      
papA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
papC  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
papEF  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
papG A’    ○      ○      ○      ●      ●      ○      ○      ●      ○      ○      ○      ○      
papG I        ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
papG II       ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      
papG III   ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      
saa  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
sfa/focDE  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
sfaS  ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      
Toxins 
CDT  ○      ○      ○      ○      ○      ○      ○      ●      ●      ○      ●      ○      
cdtB  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
cnf1  ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      
univcnf      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
cvaC  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○        
EAST1  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
ehxA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
hlyA  ○      ●      ○      ○      ○      ●      ●      ○      ○      ●      ○      ○      
LT  ○      ●      ○      ○      ●      ●      ●      ●      ●      ○      ○      ○      
STa  ○      ●      ○      ○      ○      ●      ●      ○      ●      ●      ○      ○      
STb  ○      ●      ○      ○      ●      ●      ●      ●      ●      ●      ●      ○      
A4.5 
 
Figure A4.3 continued. 
                            13     14    15     16     17    18    19     20    21    22    23     24     
 
Stx1  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
Stx2  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      
Capsule Synthesis 
kpsMTII  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
kpsMTIII  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
kpsMT K1  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○    
kpsMT K5  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
rfc  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○     
Siderphores 
fyuA  ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ○      
ireA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      
iroNE.coli  ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
iutA  ○      ○      ○      ●      ●      ●      ●      ○      ●      ○      ○      ○      
Invasins  
ibeA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○   
ipaH  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○     
Miscellaneous  
chuA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
iss  ○      ○      ○      ●      ●      ○      ●      ○      ●      ○      ○      ○      
ompT  ●      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      
PAI  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
TSPE4C2  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○       
traT  ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      
yjaA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
 
 
A4.6 
Figure A4.4 Gene matrix of DNA extracted from E. coli populations isolated from rectal 
swab samples collected from subclinical/low health status weaner pigs as determined by 
PCR, where ○ is negative for the gene and ● is positive for the virulence gene. 
 
 25   26    27    28   29   30    31   32   33   34    35   36    37   38    39     
Adhesins 
afa/draBC    ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
aah (orf A)   ○     ○     ○     ○     ○     ●     ○     ●     ●     ●     ○     ○     ○     ○     ○ 
AIDA (orf B)  ○     ○     ○     ○     ○     ●     ○     ●     ●     ●     ○     ○     ○     ○     ○ 
AIDA (orf Bc)  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
bfpA   ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
bmaE   ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
eaeA   ○     ○     ○     ○     ●     ○     ○     ●     ○     ○     ○     ○     ○     ○     ○ 
F4   ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
F5   ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
F6   ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
F18   ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
F41  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
FimH  ○     ●     ●     ○     ○     ●     ○     ○     ○     ●     ○     ○     ●     ○     ○ 
focG  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
iha  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
nfaE  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
paa  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
papA  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
papC  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
papEF  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
papG A’  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
papG I        ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
papG II       ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
papG III   ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
saa  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
sfa/focDE  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○    
sfaS  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
Toxins 
CDT  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ●     ●     ○     ○     ○ 
cdtB  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
cnf1  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
univcnf      ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
cvaC  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
EAST1  ●     ○     ○     ○     ○     ●     ●     ●     ●     ●     ○     ○     ●     ○     ○ 
ehxA  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
hlyA  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
LT  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
STa  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ●     ○     ●     ○ 
STb  ●     ●     ○     ●     ○     ●     ○     ●     ●     ●     ●     ●     ●     ○     ● 
A4.7 
 
Figure A4.4 continued. 
 25   26    27    28   29   30    31   32   33   34    35   36    37   38    39     
 
Stx1  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
Stx2  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
Capsule Synthesis 
kpsMTII  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
kpsMTIII  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
kpsMT K1  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
kpsMT K5  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
rfc  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
Siderphores 
fyuA  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
ireA  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
iroNE.coli  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
iutA  ○     ○     ○     ○     ●     ○     ○     ●     ○     ○     ○     ○     ●     ○     ○ 
Invasins  
ibeA  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
ipaH  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
Miscellaneous  
chuA  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
iss  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
ompT  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
PAI  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
TSPE4C2  ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○     ○ 
traT  ●     ○     ●     ●     ●     ●     ●     ●     ●     ●     ●     ○     ●     ●     ● 
yjaA  ●     ●     ●     ●     ●     ●     ●     ●     ●     ●     ●     ●     ●     ●     ● 
 
 
 
 
 
 
 
 
A4.8 
Appendix 5 – Chapter 5 Data 
 
 
Table A5.1: Antibiotic concentrations for testing against Enterococcus isolates. 
 
Code Antibiotic Concentration (mg/L) Antibiotic Type 
CONT Control Plate   
PEN 0.06 Penicillin 0.06 
PEN 0.25 Penicillin 0.25 
PEN 2 Penicillin 2 
PEN 8 Penicillin 8 
Penicillin 
AMP 8 Ampicillin 8 Mosderate-spectrum penicillins 
TIM 16 Ticarcillin/clavulanate 16/2 Broad-spectrum penicillins 
PIP 16 Piperacillin 16 Broad-spectrum penicillin 
Blasé β-Lactamase  Broad-spectrum penicillins 
ERY 0.25 Erythromycin 0.25 
ERY 0.5 Erythromycin 0.5 Macrolides 
CLN 0.5 Clindamycin 0.5 Lincosamides 
TET 4 Tetracycline 4 Tetracyclines 
GEN 4 Gentamicin 4 
GEN 512 Gentamicin 512 
GEN 1024 Gentamicin 1024 
GEN 2048 Gentamicin 2048 
Aminoglycosides/aminocyclitols
STM 512 Streptomycin 512 Antimycobacterials 
CEP 8 Cephalotin 8 1st generation cephalopsporins 
CFM 8 Cefeprime 8 3rd generation cephalosporins 
MPM 4 Meropenem 4 Carbapenems 
TMP 8 Trimethoprim 8 Sulfonomides-trimethoprim 
VAN 4 Vancomycin 4 Glycopeptides 
AES Bile-Aesculin   
 
A5.1 
Figure A5.1: Gene matrix of population DNA extracted from healthy neonatal piglets 
were ○ is negative for the gene and ● is positive for the virulence gene. 
 
 1      2       3      4       5      6      7       8      9     10     11    12     
Adhesins 
afa/draBC    ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
aah (orf A)   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
AIDA-I (orf B)  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○         
AIDAc (orf Bc) ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○          
bfpA   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
bmaE   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
eaeA   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      
F4   ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F5   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F6   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F18   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F41  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
FimH  ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ○      
focG  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
iha  ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      
nfaE  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
paa  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
papA  ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      
papC  ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      
papEF  ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      
papG A’  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
papG I        ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      
papG II       ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
papG III   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
saa  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
sfa/focDE  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
sfaS  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
Toxins 
CDT  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
cdtB  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
cnf1  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
univcnf      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
cvaC  ●      ●      ○      ○      ●      ○      ○      ●      ○      ●      ○      ○      
EAST1  ●      ○      ●      ○      ○      ○      ○      ●      ●      ○      ○      ○      
exhA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
hlyA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
 
A4.2 
Figure A5.1 continued. 
 1      2       3      4       5      6      7       8      9     10     11    12     
LT  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
STa  ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
STb  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○     
Stx1  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
Stx2  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
Capsule Synthesis 
kpsMTII  ●      ○      ●      ●      ●      ○      ●      ●      ○      ○      ○      ○    
kpsMTIII  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
kpsMT K1  ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○    
kpsMT K5  ●      ○      ●      ●      ●      ○      ●      ●      ○      ○      ○      ○    
rfc  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○     
Siderphores 
fyuA  ●      ○      ●      ●      ●      ●      ●      ●      ○      ●      ○      ○    
ireA  ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○    
iroNE.coli  ●      ●      ●      ●      ●      ○      ●      ●      ○      ●      ○      ○    
iutA  ●      ●      ○      ●      ●      ○      ●      ●      ○      ●      ●      ○    
Invasins  
ibeA  ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○   
 ipaH  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○     
Miscellaneous  
chuA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
iss  ●      ●      ○      ●      ●      ○      ○      ●      ○      ●      ○      ○    
ompT  ●      ●      ●      ●      ●      ●      ●      ●      ○      ●      ○      ○    
PAI  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
TSPE4C2  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○       
traT  ●      ●      ●      ●      ●      ●      ●      ●      ○      ●      ●      ○    
yjaA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A4.3 
Figure A5.2: Gene matrix of population DNA extracted from scouring neonatal piglets 
were ○ is negative for the gene and ● is positive for the virulence gene. 
 
 13   14     15     16    17     18    19    20     21    22     23    24     
Adhesins 
afa/draBC    ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
aah (orf A)   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○           
AIDA-I (orf B) ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○         
AIDAc (orf Bc)  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○          
bfpA   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
bmaE   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
eaeA   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F4   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F5   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F6   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F18   ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
F41  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
FimH  ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      
focG  ○      ○      ○      ○      ●      ●      ○      ○      ○      ○      ○      ○      
iha  ○      ○      ●      ○      ●      ●      ○      ○      ○      ●      ●      ●      
nfaE  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
paa  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
papA  ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      
papC  ○      ●      ○      ●      ○      ●      ○      ○      ○      ○      ○      ○      
papEF  ○      ○      ○      ●      ○      ●      ○      ○      ○      ○      ○      ○      
papG A’  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
papG I        ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
papG II       ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
papG III   ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○           
saa  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
sfa/focDE  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
sfaS  ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      
Toxins 
CDT  ○      ●      ●      ○      ○      ○      ○      ●      ●      ●      ○      ○      
cdtB  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
cnf1  ○      ○      ○      ●      ○      ●      ○      ○      ○      ○      ○      ○      
univcnf      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      
cvaC  ●      ●      ○      ●      ●      ●      ○      ○      ○      ○      ○      ●      
EAST1  ●      ●      ○      ○      ○      ○      ○      ●      ●      ●      ○      ○      
exhA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
hlyA  ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      
LT  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ○      
STa  ○      ○      ○      ○      ○      ○      ○      ●      ●      ●      ●      ●          
STb  ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ●     
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Figure A5.2 continued. 
 13   14     15     16    17     18    19    20     21    22     23    24     
Stx1  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
Stx2  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
Capsule Synthesis 
kpsMTII  ●      ●      ○      ●      ●      ●      ○      ○      ●      ○      ●      ●      
kpsMTIII  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
kpsMT K1  ○      ○      ○      ●      ●      ○      ○      ○      ○      ○      ●      ●      
kpsMT K5  ●      ●      ○      ○      ●      ●      ○      ○      ○      ○      ○      ○      
rfc  ○      ●      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○     
Siderphores 
fyuA  ●      ●      ○      ●      ●      ●      ○      ●      ●      ●      ●      ○      
ireA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
iroNE.coli  ○      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●        
iutA  ●      ●      ○      ●      ●      ●      ○      ●      ●      ○      ○      ○      
Invasins  
ibeA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
ipaH  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○     
Miscellaneous  
chuA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
iss  ●      ●      ○      ●      ●      ●      ○      ●      ○      ○      ●      ●      
ompT  ●      ●      ●      ●      ●      ●      ○      ●      ○      ●      ○      ●      
PAI  ●      ●      ○      ○      ○      ○      ○      ○      ○      ●      ○      ○      
TSPE4C2  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○       
traT  ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      ●      
yjaA  ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
 
A4.5 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10
0b
p 
D
N
A
 L
ad
de
r 
26     27     28      29      30     34   +ve -ve
pyrC 320bp
 
 
1517bp 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
500bp 
 
400bp 
 
300bp 
 
200bp 
 
 
100bp 
 
Figure A5.3: Image of an ethidum bromide stained 2% agarose gel showing PCR 
products (uniplex XI) prepared from enterococci isolates for the detection of the pyrC 
gene.  Positive and negative controls are denoted as +ve and –ve respectively. 
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Figure A5.4: Image of an ethidum bromide stained 2% agarose gel showing PCR 
products (uniplex VI) prepared from enterococci isolates for the detection of the ace 
gene.  Positive and negative controls are denoted as +ve and –ve respectively. 
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Figure A5.5: Image of an ethidum bromide stained 2% agarose gel showing PCR 
products (uniplex IV) prepared from enterococci isolates for the detection of the 
Enterococcus specific region .  Positive and negative controls are denoted as +ve and –
ve respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A5.6: Image of an ethidum bromide stained 2% agarose gel showing PCR 
products (uniplex V) prepared from enterococci isolates for the detection of the emeA 
gene.  Positive and negative controls are denoted as +ve and –ve respectively. 
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Figure A5.7: Virulence gene matrix of enterococci DNA extracted from healthy neonatal piglets. 
  
      1        2        3        4        5        6        7         8        9      10      11      12      13       14      15      16       17     18      19      20      21      22      23       24  
ace     ○      ○      ●      ●      ●      ●      ○      ●      ○      ●      ●      ○      ○      ○      ○      ○      ●      ●      ○      ●      ●      ●      ●      ●      
efaA     ○      ○      ●      ●      ●      ●      ●      ●      ○      ●      ●      ●      ○      ○      ○      ○      ●      ●      ○      ●      ●      ●      ●      ●      
emeA     ○      ○      ●      ●      ●      ●      ●      ○      ●      ○      ●      ●      ●      ○      ○      ○      ●      ●      ●      ○      ●      ●      ●      ●      
esp     ○      ○      ●      ●      ●      ●      ○      ●      ○      ●      ●      ○      ○      ○      ○      ○      ●      ●      ○      ●      ●      ●      ●      ●      
gelE     ○      ○      ●      ●      ●      ●      ●      ●      ○      ●      ●      ●      ○      ○      ○      ●      ●      ●      ○      ●      ●      ●      ●      ●      
pyrC     ○      ○      ●      ●      ●      ●      ●      ●      ○      ●      ○      ●      ○      ○      ○      ●      ●      ●      ○      ●      ●      ●      ●      ●      
salA     ○      ○      ●      ●      ○      ○      ○      ○      ○      ●      ●      ○      ○      ○      ○      ○      ●      ●      ○      ●      ●      ●      ●      ●      
Van A     ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
Van B     ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
Van C     ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
 
 
  
Figure A5.8: Virulence gene matrix of enterococci DNA extracted from scouring neonatal piglets. 
 
      25      26      27      28      29      30      31      32      33      34      35       36      37      38       39      40      41      42      43      44      45      46  
ace      ○      ●      ○      ○      ●      ●      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      
efaA      ○      ●      ○      ○      ●      ●      ○      ○      ○      ●      ○      ○      ○      ●      ○      ○      ●      ○      ○      ○      ○      ○      
emeA      ●      ○      ●      ○      ○      ●      ●      ○      ●      ○      ●      ○      ○      ●      ○      ○      ○      ●      ○      ○      ●      ○      
esp      ○      ○      ○      ○      ●      ●      ○      ○      ○      ●      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○      ○      ○      
gelE      ○      ●      ○      ○      ●      ●      ○      ○      ○      ●      ○      ○      ○      ●      ○      ○      ●      ○      ○      ○      ○      ○      
pyrC      ○      ●      ○      ○      ●      ●      ○      ○      ○      ●      ○      ○      ○      ●      ○      ○      ●      ○      ○      ○      ○      ○      
salA      ○      ●      ●      ○      ●      ●      ○      ○      ○      ●      ○      ○      ○      ●      ○      ○      ●      ○      ○      ○      ○      ○      
Van A      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
Van B      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○       
Van C      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      
Figure A5.9: Virulence gene matrix of enterococci DNA extracted from probiotic E. 
faecium isolates. 
 
              47       48 
ace  ○ ○  
efaA  ○ ○ 
emeA  ○ ○ 
esp  ○ ○ 
gelE  ○ ○ 
pyrC  ○ ○ 
salA  ○ ○ 
VanA  ○ ○ 
VanB  ○ ○ 
VanC  ○ ○ 
 
 
 
Figure A5.10: Virulence gene matrix of enterococci DNA extracted from hospital 
isolates.  
 
 
              49       50       51       52       53        54       55       56       57       58       59 
ace  ○        ○        ○        ○        ○        ○        ●        ○        ○        ●        ○ 
efaA  ○        ○        ○        ○        ○        ○        ●        ●        ●        ●        ● 
emeA  ○        ○        ○        ○        ●        ●        ○        ●        ○        ●        ○ 
esp  ○        ●        ●        ●        ●        ●        ●        ●        ○        ●        ● 
gelE  ○        ○        ○        ○        ○        ○        ●        ●        ●        ●        ● 
pyrC  ○        ○        ○        ○        ○        ○        ●        ●        ●        ●        ● 
salA  ○        ○        ○        ○        ○        ○        ●        ●        ●        ●        ● 
 
 
 
                49    50     51     52     53      54     55     56     57     58     59     60     61 
Van A       ●      ●      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○ 
Van B    ○      ○      ○      ○      ○      ○      ●      ○      ○      ○      ○      ○      ○ 
Van C    ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ○      ●      ● 
 
 
 
Note: isolates 60 and 61 were positive controls for VanC only 
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Figure A5.11: Visualisation under UV light of an ethidium bromide stained pulsed-
field gel electrophoresis gel showing the molecular finger prints of enterococci isolates 
from neonatal piglets. 
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